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Te beginnen met de mensen met wie ik het geluk heb gehad intensief te mogen 
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Ook van harte bedankt aan mijn promotor, professor Chris Stevens. We hebben 
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van de chemie en het onderzoeksproject is uiteindelijk helemaal anders uitgedraaid 
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Bart, Inge, Tina, Guido, Nicola, An, Sven M., Matthias, Bert, Nicolai, Davy, Griet, 
Dominick, Sven C., Berten, Yves, Jan, Eva, Kurt, Diederica, Mirjana, Laurent, 
Viviane, Sandra en Pieter. Ook meer in het bijzonder aan mijn bureaugenoten: 
Ellen, David, Willem en Bram! Mijn appreciatie gaat ook uit naar de 
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thesisstudenten die mij als hun begeleider moeten verdragen hebben: Wouter, 
Vicky, Annelies, Bart, Miet en Steve. We komen elkaar vast nog wel eens tegen. 
 
Ook bedankt aan Prof. Waroquier, Veronique en Karen van het “Center for Molecular 
Modeling”. Samenwerken tussen sterk gespecialiseerde mensen is niet gemakkelijk. 
Het heeft een tijd geduurd, maar in the end kunnen we fier zijn op het resultaat! 
Also many thanks to prof. Zhdankin and his colleagues for their kind help with the x-
ray analyses. 
 
Tenslotte kom ik bij de mensen die alles van op de eerste rij hebben meegemaakt, 
misschien soms zonder te begrijpen waarrond het eigenlijk altijd draaide. Het was 
niet gemakkelijk om al die verhalen te volgen, maar ik hoop dat vandaag alles 
misschien iets duidelijker of concreter wordt. Als jullie de draad toch verliezen, 
onthou dan maar dat het au fond gewoon gaat om spelen met molecuultjes. Veel 
belangrijker was jullie rol buiten de chemie, bij die dingen die zorgen voor een 
stabiel evenwicht in leven en werk, zoals vriendschap, een goede babbel, een gezellig 
thuiskomen, hulp in noodgevallen en de ongelofelijke steun bij alles wat we 
ondernemen! Daarom, aan mijn ondertussen sterk uitgebreide en nog steeds 
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ondertussen uit elkaar gegaan en dat geeft misschien aanleiding tot meer 
gevarieerde gesprekken, ‘s avonds aan tafel: we hebben nu elk ons verhaal van de 
dag te vertellen. Ik sta hier nu met en dankzij jouw steun. Ik ben er zeker van dat 
we binnen een paar jaar hier weer staan, maar dan met de rollen omgekeerd!  
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1 Biological importance of amino phosphonates 
Nature has chosen phosphates as essential chemicals in many critically 
important biological processes and materials. They are so versatile and 
fundamentally important in the chemistry of living systems, in so many ways, 
that it would be difficult to imagine any other chemical types that would be 
able to meet the manifold demands of living systems as we know.1 The 
phophate group is present in (i) structural elements of the cell (e.g. DNA, 
phospholipids and protein phosphates), in (ii) intermediates of important 
biochemical pathways (e.g. sugar phosphates, isopentenyl pyrophosphate), in 
(iii) the energy management of the cell (e.g. ATP, phosphoenol pyruvate (PEP)) 
and in (iv) messenger molecules (e.g. myoinositol triphosphate, cAMP). 
 
Their phosphonate counterparts are found far less widespread in living 
organisms.2 Ciliatine or 2-aminoethane phosphonic acid 1 was the first one to 
be discovered.3 Even more exciting was the discovery of naturally occurring 
phosphonates possessing remarkable biological activity despite their relatively 
simple structural features, as for instance the antibacterial fosfomycin4 2 and 
the antimalarial fosmidomycin5-8 3, isolated from fermentation broths of 
Streptomyces species. These and other examples caused organophosphorus 
chemistry to achieve an important and well-recognized place in the search for 
new drugs.9,10 The biological potential of phosphonic acid derivatives may arise 
from several rationales. Firstly, the methylene group attached to phosphorus 
is isosteric with an oxygen of a phosphate. However, the high stability of the 
C-P bond would block any natural process involving hydrolysis of a phosphate 
group. This can be applied in the development of antiviral agents based on 
naturally occurring nucleotides.11-14  
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Application of the same principle resulted in a major breakthrough in the 
treatment of bone diseases such as osteoporosis and Paget’s disease. 
Bisphosphonic acids (e.g. 4-6) are isosteric with pyrophosphoric acid but are 
hydrolytically stable, in this way blocking bone resorption.15,16 Their activity 
additionally results from the second interesting property of the phosphonate 
group, namely its ability to complex divalent cations such as Ca2+. Current 
clinical research in the field of bisphosphonates is focussing on derivatives 
containing nitrogen atoms in their side chains (e.g. Zoledronate 6) which are 
showing enhanced activities and pharmacological properties.17-20 
 
Finally, phosphonic acids are considered to resemble their naturally occurring 
carboxylic acid counterparts, notwithstanding substantial differences with 
respect to size, shape and acidity.21,22 This is of particular importance in the 
field of amino acids (amino phosphonates). More generally, the tetrahedral 
structure of the phosphonate group resembles that of the transition state of a 
nucleophilic attack on an acyl group (e.g. a peptide). Since enzymes act as 
catalysts because they are more closely complementary to the transition states 
than to the substrates or products of a reaction, phosphono peptides emerge 
as inhibitors of a wide range of enzymes,23 such as elastase (e.g. 7),24-26 
dipeptidyl dipeptidase IV (e.g. 8),27-30 thrombin (e.g. 9),31-33 HIV-protease (e.g. 
10),34,35 etc… Good results are also obtained with metalloproteases (such as 
carboxypeptidase A (e.g. 13)36) because of the good recognition of the 
tetrahedral transition state analogue together with the Zn2+ complexing 
properties of the phosphonic acid.37  
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Phosphonic acid containing enzyme inhibitors have already found practical 
use in the past. The first is alafosfalin 11 which is readily transported into the 
bacterial cell and is subsequently hydrolysed. The resulting phosphono 
alanine is a good inhibitor of the alanine racemase, which is essential to the 
bacterial cell wall synthesis.38 Phosphonomethyl glycine (glyphosate) 12 on the 
other hand was developed by Monsanto as an environmentally friendly total 
herbicide with very low mammalian toxicity. Glyphosate selectively inhibits 5-
enolpyruvoylshikimate 3-phosphate synthase (EPSPS), blocking the 
biosynthesis of aromatic plant metabolites, including the aromatic amino 
acids.39  
 
Apart from their enzyme inhibitory activity, also neuroactive amino 
phosphonic acid derivatives have been found.40 Phosphonylated analogues of 
glutamate, the most important excitatory neurotransmitter in the mammalian 
CNS, act as specific agonists or antagonists of certain glutamate receptor 
subtypes. Furthermore, a considerable enhancement of antagonist potency 
was achieved by synthesizing conformationally restricted analogues of AP5 14. 
This can be performed by incorporating the amino group into a heterocyclic 
ring system (e.g. CPP 15, CGS19755 16).41,42 This illustrates the potential of 
azaheterocyclic phosphonates. Because of the success of constrained amino 
acids in drug design and biomechanistic investigation of receptor-bound 
ligand conformations,43 also the corresponding amino phosphonates deserve 
appropriate attention. 
 
N
(HO)2P
O
NH
COOHCOOH
H2N
(HO)2P
O
(R)-CPP (15)(S)-AP5 (14)
NH
COOH
(HO)2P
O
CGS19755 (16)  
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More recently phosphonates have also found application as antigens for the 
preparation of catalytic antibodies, because of their excellent transition state 
analogy with the hydrolysis of amino acids. The mammalian immune system 
is capable of synthesizing large folded polypeptides (immunoglobulins or 
antibodies) that bind virtually any natural or synthetic molecule with high 
affinity and exquisite selectivity. Being carboxylate hydrolysis transition state 
analogues, phosphonates (e.g. 17) can be used as antigens to generate specific 
antibodies that catalyze the hydrolysis of the parent carboxylate (e.g. 18).44 
 
P
O
OH
O
N
H
O COOH
HN
O
CF3
O
O
H
N
HN
O
R
O
COOH
17
18 (R = CH3 or CF3)
 
 
 
2 Goal of the current research 
Despite the interesting potential of the azaheterocyclic phosphonates, this 
class of compounds is less well studied. Therefore, additional synthetic 
methods are required to obtain a wider variety of compounds belonging to this 
class. Mainly two strategies can be applied covering this challenge: (i) 
phosphonylation of a preformed azaheterocyclic ring, or (ii) cyclization of a 
phosphonylated precursor. The latter can be considered to be the most 
versatile pathway (see chapter 2 for an overview). Furthermore, it offers the 
opportunity to use an eminent property of the phosphonate group, namely its 
ability to stabilize carbanions in the α-position. 
 
The β-lactam heterocycle is the active part of an important class of antibiotics, 
including penicillin.45 In this regard, preliminary investigation at the 
department of organic chemistry, faculty of bioscience engineering, Ghent 
University has revealed an interesting pathway for the synthesis of 4-
phosphono β-lactams.46,47 Although the use of anionic organophosphorus 
reagents for carbon-carbon single bond formation pales in comparison to their 
applications in olefinations,48 intramolecular alkylation of the phosphorus 
stabilized anion was selected to construct the four-membered ring in 23. The 
starting N-chloroacetyl aminoalkyl phosphonates 21 were synthesized via one-
pot acylation – phosphonylation of suitable imines 19. However, the obtained 
reaction mixtures were generally impure, hence leading to low yields of the 
desired products 23 after laborious chromatographic separations. Further 
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investigation will be performed in order to study the different conversions 
happening in the one-pot reaction. Aliphatic and α,β-unsaturated imines merit 
special attention. An optimization of the reaction and broadening of the scope 
should allow for the synthesis of more diverse phosphono β-lactams. Also 
further modification including nitrogen deprotection and phosphonate 
dealkylation will be evaluated in the light of potential biological activity. 
 
N
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R2 P(OR3)2
N
R1
O
Cl
O
R2 H
N
R1
O
Cl
Cl-
R2 P(OR3)2
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O
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R1
R2 H
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yla
tio
n
Phosphonylation
1.1 eq. 
toluene, -40°C
10 min.
Cl
Cl
O
19
20
22
21
23
1.2 eq. NaH, 
ether, ∆, 3 h
1.1 eq. P(OMe)3
toluene, ∆, 2 h
 
 
Next to the one-pot acylation – phosphonylation protocol, also a reversed, 2-
step pathway towards the N-chloroacetyl aminoalkyl phosphonates 21 will be 
evaluated. Several methods are known for the phosphonylation of imines 19. 
The most promising results were reported by Afarinkia and coworkers49 when 
using highly nucleophilic silylated phosphite reagents: high yields and short 
reaction times. Furthermore, only 1,2-adducts are formed under these 
conditions when using α,β-unsaturated imines. Subsequent acylation should 
then proceed smoothly using acid chlorides and a base. Using chlorobutyryl 
chloride, six-membered rings can be formed via intramolecular alkylation. 
 
N
P(OMe)2R1
R2
O
Cl
O
N
O
R2
P(OMe)2
O
R1
Base
25
24  
 
Special attention should be given to N-chloroacetyl aminoalkenyl 
phosphonates 21a-f. Upon deprotonation with a strong base, an ambident 
anion is formed which can lead to a six-membered or a four-membered 
lactam. In initial experiments, only the four-membered rings have been 
formed, which was quite surprising given the high ring strain compared to the 
  6 
six-membered lactams. Further research is necessary to determine the scope 
and to discover the underlying reasons of this unexpected selectivity.  
 
N
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N
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R
O
Cl
N
P(OMe)2
O
R
O
Cl
N
RO
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26 27
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N
O
R
P(OMe)2
O
29  
 
For this reason, the stabilizing effect of the phenyl group will be evaluated by 
substituting it with an alkyl group. An electron withdrawing nitro substituent 
can be introduced on the aromatic ring to favour six membered ring formation. 
Also the ambident nature of the anion will be investigated using protonation 
and intermolecular acylation experiments. Finally, ab initio calculations in 
collaboration with the Center for Molecular Modelling (under the guidance of 
Prof. Waroquier, Faculty of Sciences, Ghent University) will be performed to 
find an explanation for the unexpected regioselectivity in agreement with the 
experimental results. 
 
Development of a satisfactory method for the preparation of α-aminoalkyl 
phosphonates should allow these as starting materials for the synthesis of 
more diverse azaheterocyclic phosphonates. Ring-closing metathesis (RCM) 
has been generally recognized as a valuable approach for the formation of 
medium-sized rings. Therefore, phosphonylated diallylamines 32 will be 
evaluated as substrates of an RCM reaction for the synthesis of phosphono 
pyrrolines 31 and the corresponding phosphono pyrroles 30 via oxidation. 
 
R1 P(OMe)2
R2
N
O
R3
R4
N P(OMe)2
R2
R4
R3
O
N P(OMe)2
R2
R4
R3
O
3130 32  
 
RCM would also offer an approach to phosphonylated bicyclic carbapenem-
type lactams 33. The four-membered ring 23c can be formed first as described 
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before, followed by five-membered ring formation via RCM. Also the reverse 
pathway is possible, starting with the formation of the five-membered ring 34. 
 
N
O
Ph
(MeO)2P
O
N
O
(MeO)2P
O
N
Cl
O
(MeO)2P Ph
O
N
(MeO)2P
O
23c
33
21e34
O
Cl
 
 
Although the Diels-Alder reaction is a much older reaction than RCM, it is still 
of current interest for the synthesis of cyclic compounds. Furans have been 
widely used as dienes in this type of reactions. N-acyl aminoalkyl 
phosphonates 36 derived from furfuraldehyde should be perfectly suitable as 
substrates for an intramolecular Diels-Alder reaction yielding tricyclic 
phosphono pyrrolidines. Furthermore, this type of reactions is known to show 
excellent stereoselectivity. 
 
N
P(OMe)2
O
O
N
O
R
O
P(OMe)2
O
35
36
heat
R
O
 
 
In summary, three types of C-C bond formation will be evaluated for the 
synthesis of azaheterocyclic phosphonates: (i) intramolecular alkylation of a 
phosphonate stabilized carbanion, (ii) ring closing metathesis (RCM) and (iii) 
[2+4] cycloaddition. Although all three are valuable methods for the 
construction of heterocycles, only the first one has been modestly explored for 
the synthesis of azaheterocylic phosphonates (see the overview in chapter 2). 
Furthermore, a satisfactory method for the phosphonylation of imines should 
be acquired, in order to obtain suitable α-aminoalkyl phosphonates as starting 
materials 
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  CHAPTER 2   
 
Literature Overview on 
Azaheterocyclic Phosphonates 
 
 
 
 
 
 
 
Since the first synthesis of aminoalkyl phosphonates,50,51 their isolation from 
natural sources2,3 and the discovery of their biological activity, many 
researchers have also focussed their attention to azaheterocyclic 
phosphonates.52 Numerous synthetic pathways have been developed towards 
these interesting compounds that can mainly be subdivided into two classes: 
the phosphonylation of a preformed azaheterocycle or the cyclization of a 
suitable phophonylated substrate. From this perspective, the synthesis of non-
aromatic three-, four-, five-, six- and larger membered rings has been fully 
reviewed.53 Within the scope of this research, an overview will be presented 
dealing with the most interesting synthetic routes towards four- and five-
membered phosphonylated azaheterocycles and demonstrating their biological 
potential. For a comprehensive overview, the reader is kindly invited to look up 
our review article.53 
 
1 Four membered rings: azetidines and azetidinones 
1.1 Ring closure by nucleophilic substitution 
Although L-azetidin-2-carboxylic acid is a potent proline mimetic,54 very little 
is still known about the biological activity of its phosphonate analogue. 
Racemic azetidinyl-2-phosphonic acid 42 can be prepared from 3-
(benzyloxy)propanal 37 which is converted to the corresponding 
hydroxyphosphonate by a Pudovik reaction with diisopropyl phosphite. 
Selective substitution of the primary mesylate with an amine followed by 
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intramolecular substitution of the secondary mesylate in the presence of 
K2CO3 finally yields azetidinyl phosphonate 41.55 
 
BnO O HO P(OiPr)2
OH
O2 steps, 58%
MsO P(OiPr)2
OMs
O
(83%)
RHN P(OiPr)2
OMs
O
RNH2 N
R
P(OiPr)2
O
N
R
P(OH)2
O
TMSBr
CH3CN
K2CO3
toluene
water
DME
MsCl
pyridine
CH2Cl2
H
37 38 39
40a (88%)
40b (83%) 41a (62%)
41b (58%)
41c (66%)
41d (48%)
42b (70%)
42c (63%)
40c (80%)
40d (82%)
a R = allyl
b R = Bn
c R = 2-hydroxyethyl
d R = nPr
 
 
More recently, the first asymmetric synthesis of azetidinyl-2-phosphonic 
acids was published.56 Starting from readily available β–amino alcohols, the 
required aminomethyl phosphonates 45a-c are prepared via a two-step 
sequence involving: (i) oxazolidine-formation in the presence of formaldehyde, 
and (ii) acid-catalyzed ring opening of the oxazolidine followed by nucleophilic 
addition of diethyl phosphite to the iminium intermediate. Intramolecular 
alkylation of the phosphonate stabilized carbanion generated in chloroamine 
46 using LiHMDS, then yields the azetidin-2-yl phosphonates 47. During 
these transformations total retention of configuration at the stereogenic 
centers is observed. Only with compound 45a, a rearrangement occurs 
leading to 46a in good yield. 
 
R3 OH
R2 NH
R1
OHR3
R2 N
R1
P(OEt)2
O
SOCl2
Cl
R2 N
R1
P(OEt)2
O
LiHMDS
-78°C, THFCH2Cl2 N
R1R2
R3 P(OEt)2
O
R4R4
O
N
R1
R2
R3
R4
CH2O HP(O)(OEt)2
43 44 45 (68-78%)
citric acid
46b,c 47a-c
a R1 = Bn, R2 = Ph, R3 = R4 = H
b R1 = Me, R2 = Me, R3 = H, R4 = Ph
c R1 = Me, R2 = Me, R3 = Ph, R4 = H
(30 - 75%)(70 %)#
R3
R4
 
#Compound 45a having a benzylic amine gives rearranged chloride 46 in good yield: 
SOCl2
CH2Cl2Ph N
Bn
OH
N
Bn
ClPh
P(OEt)2 P(OEt)2
OO (92%)
45a 46a  
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During ring closure, exclusively 2,3-trans azetidines 47 are formed, due to 
the bulkiness of the lithiated phosphoenolate. Similar experiments with an 
ester group instead of a phosphonate group yield a mixture of 2,3-cis and 
2,3-trans azetidines 49. Clearly, the steric interaction between the sp2 ester 
enolate and the α-phenyl substituent is less severe in this case. 
 
N
Bn
Ph P(OEt)2
O
N
Me
Ph P(OEt)2
O
N
Me
Ph P(OEt)2
O
N
Bn
ClPh
COOEt
LiHMDS
-78°C, THF
N
Bn
Ph COOEt
N
Bn
Ph COOEt
+
36% de
(2S,3R)-47a (2S,3R,4S)-47b (2R,3S,4S)-47c
48 (2S,3S)-49 (2R,3S)-49
 
 
Ring closure through intramolecular alkylation of a phosphonate stabilized 
carbanion has also been applied in the synthesis of phosphono β-lactams. 
The epoxide 51 is formed in situ by addition of one equivalent of LiHMDS to 
amide 50. A second equivalent was used to form the lactam 52 in a 
stereospecific manner: only the trans-β-lactams are formed. Nitrogen 
deprotection can then be performed using cerium ammonium nitrite (CAN) 
and the obtained 4-phosphono β-lactams 53 are potential precursors for the 
synthesis of carbapenems.57-59  
 
N
OH
Br
O
P(OEt)2
OR
LiHMDS
N
O
P(OEt)2
OR
O
LiHMDS, rt.
N
RO
H H
P(OEt)2
OHO
(37 - 61%)
(2S,3R)-50 51
(3S,4R,1'R)-52
R = p-MeOPh, p-MeOBn
THF, 0°C
CAN
N
HO
H H
P(OEt)2
OHO
(3S,4R,1'R)-53  
 
 
1.2 Nucleophilic phosphorylation 
The apparently most obvious method to synthesize phosphonylated 
azaheterocycles is starting from the desired cyclic compound bearing a 
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suitable leaving group which is then substituted by a phosphorus reagent. 
However, examples of this method are rather scarce in literature. 
 
4-Acetoxy-azetidin-2-ones are excellent substrates in substitution reactions. 
The C4 carbon atom, which is connected to a nitrogen and an oxygen atom is 
very reactive towards nucleophilic agents due to the neighbouring group 
effect. The substitution by trialkyl phosphite was first explored by Clauβ and 
co-workers60 and further developed by Campbell & Carruthers.61,62 When 4-
acetoxy-azetidin-2-one 54 is heated in trialkyl phosphite, phosphonylated 
azetidinones 55 are formed via an atypical Michaelis-Arbuzov reaction, 
together with the corresponding alkyl acetate. No reaction occurred with tris-
(2,2,2-trichloroethyl) phosphite because of its reduced nucleophilicity. 
However, using methyl phosphonites instead of the corresponding trialkyl 
phosphites, the reaction proceeds faster and yields the 4-phosphino 
azetidinones in 42 to 93% yield.  Performing the reaction with dialkyl 
phosphite anions fails due to β-lactam cleavage because of the strongly basic 
nature of the reagents. Later on, this methodology was also applied with 
toluene as a solvent,63 with 3-substituted 4-acetoxy azetidinones64 and with 
4-acetoxy azetidines.65  
 
NH
O
OAc
P(OR)3
NH
O
P(OR)2
O
54
55a R = Me (82%)
55b R = Et (90%)
55c R = Bn (46%)
55d R = CH2CCl3 (0%) 
 
4-Sulfinyl azetidin-2-one 56 is another substrate with an appropriate leaving 
group for a substitution reaction with a phosphorus reagent. Treatment of 56 
with diethyl trimethylsilyl phosphite (DEPTMS) in the presence of ZnI2 at 
room temperature for 6 h gives the 4-phosphono azetidin-2-one 58 in 77% 
yield.66 Also this reaction is not a real substitution reaction, which is 
indicated by the stereochemistry of the reaction. Due to the action of the 
Lewis acid, a reactive iminium salt 57 is formed that reacts in situ with the 
phosphorus nucleophile. 
 
NH
O
S
TBDMSO O
Ph
(EtO)2P-O-SiMe3
cat. ZnI2
dry CH3CN; rt.; 6 h
(77%)
NH
O
TBDMSO
NH
O
TBDMSO
P(OEt)2
O
P(OEt)2
O
(3S,4R)-56 57
(3S,4R)-58
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More harsh conditions are necessary for the direct substitution of the mesyl 
group in azetidine 59. Only the diethyl phosphite anion is capable of 
performing the substitution reaction leading to 3-phosphono azetidine 60. 
However, the yield is very low.67 
 
N
OMs
Ph
Ph NaH/HP(O)(OEt)2
DMF; 26 h; 90°C
(32%)
N
P(OEt)2
Ph
Ph
O59 60  
 
 
1.3 Cycloaddition 
Cycloaddition is a convenient way to construct four-membered ring systems. 
Azetidinones are often synthesized from ketenes and imines. Ketenes bearing 
heteroatom substituents have been developed and successfully applied to 
synthesize functionalized β-lactams.68 However, reactions with phosphono 
ketenes were mostly limited to some electrophilic reactions in order to prove 
their generation.69,70 
 
Cycloaddition has been used only once for the construction of a monocyclic 
phosphono-β-lactam.71 In the presence of excess benzylideneaniline 63, 
ketenes 62 lead to cycloadducts 64 in 7 to 65% yield. Methyl- and 
chloro(diethylphosphono)ketenes 62 are generated in situ from the 
corresponding acid chlorides and triethylamine. The stereochemistry of β-
lactams 64 could not be determined. However, after the reductive removal of 
the chlorine atom, it could be proven that the resulting azetidinones 65 are 
trans isomers. 
(EtO)2P
R1 O
Cl
Et3N C O
R1
(EtO)2P
N
CHCl3
N
O
Ph P(OEt)2
R1
O
O
Zn
∆, MeOH
R2
R2
N
O
Ph P(OEt)2
R2
O
O
61 62
64
65
63
R1 = H, Me, Cl
R2 = H, OMe
(7 - 65%)
R1 = Cl
 
 
In conclusion, it is clear that cycloaddition can be a promising synthetic 
route to phosphono β-lactams since the reaction is stereoselective. However, 
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the reaction is not well explored, probably due to the instability of the 
phosphono ketenes leading to reaction conditions that are difficult to control. 
 
2 Five membered rings – pyrrolidines, pyrrolines and 
pyrrolidinones 
Five membered azaheterocycles are more widespread in organic and medicinal 
chemistry than the corresponding three and four membered rings. Much 
research has been done on the synthesis of phosphonic acid analogues of both 
natural and unnatural amino acids. In this chapter several methods will be 
discussed for the synthesis of the phosphonic acid analogue of proline 
(sometimes called phosphono proline). Different types of activities are 
associated with peptides containing phosphono proline. They are used for 
instance as antiviral agents because of their HIV protease inhibiting 
activity72-74 or as inhibitors of dipeptidyl peptidase IV (see chapter 2, section 
2.4). 
 
Furthermore phosphono proline derivatives can be active as such. Compound 
66 has bactericidal, fungicidal and herbicidal activity.75 Recently, 3-
phosphonylated pyrrolidines were found to be Edg receptor agonists, useful for 
treating immune mediated diseases.76,77  
 
N
O
OH
OH
(HO)2P
O
N
H
P(OH)2HOHN
O
N
P
O
OR
O
Cl
Cl
BrBr
N
P
O
OR
O
Cl
Cl
N
P
O
OR
O
H
SEt
N
P
O O
O O
N
N
N
N
NH2
OH
O
OH
N
N
N NH
NH2
O
66
67 68 69
71
70
 
 
 
Other active 1-phosphono pyrrolidines are obtained by choosing particular 
alkyl side chains for the phosphoramidate. With 1,2-dibromo-2,2-
dichloroethyl, vinylthio or 2,2-dichlorovinyl groups, 1-phosphono pyrrolidines 
67-69 show acaricidal and insecticidal activity.78-81 Nucleoside containing 1-
phosphono pyrrolidines 71 are capable of treating hepatitis infections, 
particularly, hepatitis B viral infections.82,83 Also, 3-phosphono pyrrolidinones 
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are of interest as lactam antibiotics. The phosphorus containing antibiotic SF-
2312 70, produced by Micromonospora sp., is active against Pseudomonas 
aeruginosa and Proteus vulgaris.84 
 
2.1 Ring closure by nucleophilic substitution 
δ-Chloro-α-aminobutane phosphonic acid 74 was formed by condensation of 
γ-chlorobutyraldehyde 72 with benzylcarbamate 73 and PCl3, and 
subsequent acidic hydrolysis. The water soluble aminoalkyl phosphonic acid 
was then easily ring-closed to the racemic proline mimetic 75a under basic 
conditions.85 The nucleophilic amino group can also be generated by 
reduction of oxime 77. The corresponding racemic diethyl phosphono proline 
75b is then obtained in slightly higher yield.86 In both cases, an amino group 
was used as an internal nucleophile. However, no examples could be found 
in which a phosphonate stabilized carbanion was used to form the 5-
membered ring. 
 
H
O
Cl
H2N O Ph
O
P(OR)2
NH2
Cl
O
N
H
P(OR)2
O
P(OEt)2
O
Cl
O
P(OEt)2
NOH
Cl
O
+ + PCl3
1) HOAc
2) H2O/HCl
base
72
73
7475a (R = H; 34%)
75b (R = Et; 50%)
(38%)
NH2OH
EtOH
(90%)
Zn/HCOOH
76 77
R = H
R = Et
 
 
 
2.2 Nucleophilic phosphorylation 
The benzotriazole (Bt) moiety serves as a good leaving group in α-position of a 
nitrogen atom and is easily eliminated in the presence of a Lewis acid to 
generate an iminium cation, which is subsequently attacked by a 
nucleophile.87,88 Pyrrolidinone 79 can be prepared by reacting 2,5-dimethoxy-
2,5-dihydrofuran (78) with benzotriazole and a primary amine.  During this 
synthesis benzotriazol-1-yl (Bt1) as well as benzotriazol-2-yl (Bt2) 
pyrrolidinone is formed. However, both Bt1 and Bt2 are good leaving groups 
and give rise to the same iminium cation. Treatment of 79 in dry THF with 
triethyl phosphite in the presence of 1 equivalent of ZnBr2 produced 
phosphono pyrrolidinones 80 in moderate to good yields.89 Stereogenic 
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centers at the N(1)-position displayed poor control of the facial selectivity for 
phosphite addition onto the iminium ion, resulting in little or no 
diastereoselectivity at C(5). 
 
P(OEt)3, ZnBr2
dry THF N
O P(OEt)2
OR(49 - 85%)
R = HOCH2CH2-, p-MeOC6H4CH2-, m,p-(MeO)2C6H3CH2-,
      p-MeOC6H4CH2CH2-, (HOCH2)PhCH-, (COOMe)(PhCH2)CH-
80
OMeO OMe AcOH
reflux
24h
NO Bt
1 or 2
R
79
BtH
RNH2
78
 
 
A diastereoselective version of the reaction is achieved when using the cyclic 
hemi-aminal 81 as substrate. Treatment of 81 with triethyl phosphite in the 
presence of the mild Lewis acid ZnBr2 yields one single diastereomer in 77%. 
Subsequent hydrogenation gives the deprotected pyrrolidine (-)-75b in 63% 
overall yield as a single enantiomer.90 The same method is also applicable for 
the synthesis of phosphono piperidines.91 Also the other enantiomer (+)-75b 
can be prepared in the same way. After deprotonation with LDA or BuLi, this 
enantiomer was alkylated in the 2-position with retention of the configuration 
by applying the Self-Regeneration of Stereocenters (SRS) principle.92 In this 
specific case, the SRS was believed to be caused by the special properties of 
the phosphorus stabilized anion (see chapter 3, section 2.4).93  
 
P(OEt)3, ZnBr2NO
Ph
Bt
CH2Cl2
NO
Ph
P(OEt)2
O N
H
P(OEt)2
O
Pd/C, H2
(77%)
(89%)
(3S,5R,7aR)-(+)-81 (3S,5R,7aR)-(+)-82 (2R)-(-)-75b  
 
An asymmetric synthesis of 5-phosphono pyrrolidinone is based on a similar 
principle. Here, the hemiaminal like C-O bond is cleaved by the action of 
TiCl4. The iminium ion is then trapped by trimethyl phosphite with the 
formation of 84 in 62% diastereomeric excess. As compared to the formation 
of pyrrolidine 75b, less stereocontrol is observed during the addition 
reaction.94 
 
N O
Ph
O
P(OMe)3
NO
HO
Ph
P(OMe)2
O
1 equiv. TiCl4
84 (62% de)(3R,7aS)-(-)-83
(86%)
 
 
Despite the simplicity of the experiments and their often very satisfying 
results, electrochemistry is not a standard reaction in a synthetic lab. 
However, the methodology is also useful for the synthesis of functionalized 
azaheterocyclic compounds. The anodic oxidation of cyclic amides and 
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carbamates in methanol has been shown to give α-methoxylated 
products.95,96 The initiation step of the oxidation involves electron transfer 
from the lone pair electrons of the nitrogen atom to the anode. Next an 
iminium salt is formed that can be trapped by the solvent (e.g. methanol). 
The reaction is also applicable to N-sulfonamides and phosphonamidates.97 
The methoxy group can be easily substituted with a phosphonate as 
presented before using a Lewis acid such as TiCl4 or BF3.OEt2.96,97 
 
N
X
()n
N
X
()n
-2e
CH3OH
OMe
85 86
LA
P(OR)3
N
X
()n
P(OR)2
87
R = Me, Et
(56 - 100%)
O
X = COOMe, Ts, P(O)(OEt)2
n = 1, 2  
 
With N-protected 4-hydroxyproline derivatives, oxidative decarboxylation 
occurs during anodic oxidation. Subsequent substitution in the presence of 
TiCl4 affords the phosphonylated pyrrolidine 90 in 96% de.98 
 
NHOOC
OSiMe2tBu
COOMe
-2e
CH3OH
NMeO
OSiMe2tBu
COOMe
TiCl4, P(OMe)3
(90%)
(80%)
N
OSiMe2tBu
COOMe
(MeO)2P
O
(2S,4R)-(-)-88 89 90 (96% de)  
 
A similar oxidative decarboxylation of proline derivatives can be performed 
using Pb(OAc)4. The obtained 2-hydroxypyrrolidines 92 are then converted to 
the corresponding phosphonates 93 by a reaction with trialkyl phosphite in 
the presence of trimethylsilyl triflate. As mentioned before, an intermediate 
iminium ion is formed, to which the phosphite adds.99 
 
N
()n
N
()n
Pb(OAc)4
P(OR2)3
R1 R1
N
()n
R1
HOOC HO
HCl(aq)
TMSOTf
(80-97%)
(R2O)2P
O
91
92 93
(87 - 100%)
(46-87%)n = 1,2
R1 = Z, PNZ
R2 = Me, Et, iPr 94 (R1 = H)  
 
2.3 Electrophilic phosphorylation 
When lactone enolates are trapped with a dialkyl chlorophosphate reagent, a 
vinyl phosphate is obtained that can rearrange to the α-phosphono lactone 
upon further treatment with base.100 An N-alkyl lactam undergoes a similar 
rearrangement to afford an α-phosphono lactam. The enolate is made in THF 
by adding LDA (1.1 equivalent) followed by the chlorophosphate, together 
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with 1 equivalent of HMPA to facilitate the vinyl phosphate anion formation. 
After adding a second equivalent of LDA to initiate the rearrangement, the 
reaction is quenched with acetic acid in ether.101 Similar results can be 
obtained when 2 equivalents of LDA are added at once in the first step (R = 
Me, 65%).102 
 
NO
R
1) 1,1 equiv. LDA
2) 1,2 equiv.
ClP(O)(OEt)2,
N
R
+
NO
R
(EtO)2P
1) 1,1 equiv. LDA
2) AcOH/Et2O
NO
R
(EtO)2P
OO
(EtO)2PO
a R = n-C8H17
b R = farnesyl
96a,b 97a,b
98a (68%)
98b (10%)
Farnesyl =
95a,b
HMPA
O
2
 
However, some side reactions occur under the strong basic conditions with 
the farnesyl side chain, resulting in lower yields. Using dialkyl 
chlorophosphite instead prevents this side reaction. The desired α-
phosphono lactams 100 are then obtained by oxidation of the phosphonite 
using air103,104 or hydrogen peroxide.101 The main advantage of this P(III) 
method is the use of only one equivalent of base, to form the enolate anion. 
No further treatment with base is necessary for the rearrangement and the 
amount of side products is significantly reduced.101 
 
N
O
R
(CH2)n
1) 1,1 equiv. LDA
2) 1,2 equiv. ClP(OEt)2
    THF - HMPA
3) 10 equiv. H2O2
N
O
R
(CH2)n
P(OEt)2
O
99 100 (24 - 75%)
R= farnesyl
n = 1, 2, 3  
 
Furthermore, α-substituted α-phosphono lactams are also accessible via the 
P(III) reagent. The P(V) reagent fails to react, because vinyl phosphate anion 
formation is required for the rearrangement, which is obviously not possible 
in the case of pyrrolidinone 101. 
 
NO
R
P(III) method
P(V) method
NO
R
(EtO)2P
O
101
102
 
 
The major drawback of the P(III) method is the formation of small amounts of 
bisphosphonates. However, this can be used for the synthesis of 
bisphosphonates when the conditions are slightly modified. When 2 
equivalents of base and chlorophosphite are used, the bisphosphonates 103 
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are the main products next to small amounts of monophosphorylated 
compounds.105 
 
NO
R
()n 1) 2,2 equiv. LDA
2) 2,3 equiv. ClP(OEt)2
    THF - HMPA
3) H2O2
NO
R
(EtO)2P
P(OEt)2
()n
O
O
95a n = 1; R = n-C8H17
95b n = 1; R = farnesyl
95c n = 2; R = farnesyl
103a (94%)
103b (77%)
103c (50%)  
 
 
2.4 Ring closure by nucleophilic addition 
Ring closure with the formation of azaheterocycles can be invoked by the 
attack of a nucleophilic nitrogen atom onto an electrophilic center in the 
same molecule. Since both functional groups have to be present in the 
precursor, one of them needs to be temporarily deactivated. Most of the time, 
non nucleophilic nitrogen groups are used which are then converted to a 
nucleophilic species to invoke the ring closure. 
 
Debenzylation of an amine106 or reduction of a cyanide107 or nitro108-110 
functionality has been used to generate a nucleophilic amine group prior to 
ring closure towards phosphono pyrrolidinones. The temporarily deactivation 
of the amino nucleophile can also be performed by the synthesis of the 
corresponding imine,111 which allows the incorporation of a chiral auxiliary.  
 
The stereoselectivity of the Michael addition of phosphonate stabilized anions 
to acrylates can be mediated by camphor-like protecting groups.112,113 Imino 
phosphonate 105 is formed in 66% yield with 71% de. The minor 
diastereomer was easily removed by flash chromatography on silica gel. After 
hydrolysis, the enantiomerically pure (5S)-pyroglutamic acid mimetic 106 
could be isolated (ee ≥ 95%), while the chiral auxiliary was recovered in 60% 
yield. Reduction with LiBH4/BF3.OEt2 proceeded without isomerization and 
resulted in the phosphonylated analogue 75b of proline which can not be 
obtained by alkylation of 104 with diiodopropane and subsequent hydrolysis. 
When substituted acrylic esters are used, the diastereoselectivity is highly 
dependent on the substitution pattern.114 
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P(OEt)2
ZnCl2
MeOOC P(OEt)2
N
OCOOMe
HOAc/H2O
(64%)
N
H
O(EtO)2P
O
(66%)
LiBH4
BH3.Et2O
N
H
(EtO)2P
O
(61%)
R = or
OH
104 105
(5S)-106 (ee > 95%)
(2S)-75b
N
R
O
R
 
 
Also the electrophilic center in the precursor molecule can be masked to 
allow chemical transformations prior to ring closure. The carbonyl 
functionality in 112 for instance is protected as an acetal. Addition of 
lithium, sodium or potassium diethyl phosphite to the chiral sulfinimine 
moiety results in the corresponding aminoalkyl phosphonates 108 in high 
yield and high diastereomeric excess. Treatment with acid to remove the 
sulfinyl auxiliary and hydrolyse the acetal, results in the corresponding 
amino carbonyl intermediate, which immediately cyclizes to give phosphono 
pyrrolines 109 and tetrahydropyridine 110.115 NMR data suggest that 
azepine 111 occurs in an equilibrating mixture with its open form. 
Hydrogenation of the mixture gave the corresponding seven membered cyclic 
amino phosphonate 114 in 49% yield. 
  
R1
N
H
R2O OR
2
()n S
p-Tolyl
O
R1
H
N
R2O OR
2
()n S
p-Tolyl
O
M+-PO(OEt)2
(EtO)2P
O
N P(OEt)2
O
R
NR P(OEt)2
O
N P(OEt)2Me
O
N
H
P(OEt)2
O
R
N
H
R P(OEt)2
O
N
H
P(OEt)2Me
O
H+/H2O
R1 = H, Me, Ph
R2 = Me, -CH2CH2
-
n = 1, 2, 3
107 108
(R)-(+)-109a: R = H (72%)
(R)-(+)-109b: R = Me (69%)
PtO2, H2
EtOH
(R)-(-)-110a: R = Me (82%)
(R)-(-)-110b: R = Ph (80%)
(R)-111
(R)-(-)-75b: R = H (72%)
(2R,5S)-(-)-112: R = Me (69%)
(2R,6S)-(-)-113a: R = Me (87%)
(2R,6R)-(-)-113b: R = Ph (87%)
(2R,7S)-(-)-114 (49%)
87-95%
72-98% de
 
 
In a second example, an N-protected amino acid is then coupled to the free 
amino group of 115. The acetal moiety is then hydrolyzed in acidic medium 
and the resulting mixture can be treated with several triphenyl phosphite 
reagents in acetic acid to give diastereomeric mixtures of the protected 
diphenyl phosphonates 117. After deprotection, the free diastereomers can 
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be separated by column chromatography (with exception of the L-Pro, L-Ala, 
L-Ile and L-Arg derivatives). The real intermediate reacting with triphenyl 
phosphite actually remains unknown. Hydrolysis of acetal 116 followed by 
heating in CCl4 under reflux leads to the formation of the cyclic hemiaminal 
120.116,117 
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The obtained peptides, consisting of the phosphonylated analogue of proline 
coupled with a regular amino acid, are inhibitors of dipeptidyl peptidase IV 
(DPP IV). DPP IV is a post proline cleaving enzyme that has been found in a 
variety of mammalian cells and tissues.  An extensive review about the 
structural properties and clinical aspects of DPP IV has been published very 
recently.118 It plays a role in glucose homeostasis, through proteolytic 
inactivation of the incretins, and in the imune system, by influencing T-cell 
activity. DPP IV is also implicated in HIV-1 entry, malignant transformation 
and tumor invasion. Therefore, inhibitors of DPP IV may have therapeutic 
utility in the modulation of the rejection of transplanted tissue by the host 
organism and in treatment of type 2 diabetes.119 Several other inhibitors of 
DPP IV are known, but unfortunately most of these are unstable in aqueous 
solution at neutral pH. For the diphenyl phosphonates, no cytotoxicity was 
observed in human peripheral blood mononuclear cells and also no acute 
systemic or local toxicity was seen upon single intravenous injection in 
rabbits. The best results are obtained with proline as amino acid and with R1 
an electron withdrawing group (e.g. AA = Proline, R1 = 4-COOMe: IC50 = 20 
nM). However, the most potent inhibitors are also the most unstable 
compounds.117 Furthermore, this class of pyrrolidine phosphonates is 
claimed to have inhibitory effects to a wider group of serine peptidases and 
proteases, e.g. prolyl oligopeptidase, dipeptidyl peptidase II, fibroblast 
activation protein a (FAPa) and elastase and are therefore useful as anti-
inflammatory agents, anticoagulants, anti-tumor and anti-AIDS agents, and 
for treating vascular and autoimmune diseases.120-122 Using the same 
methodology omitting the amino acid coupling reaction in step one, 
unprotected diphenyl pyrrolidine-2-phosphonate can be obtained, which has 
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been succesfully applied as a ligand in the copper-catalyzed arylation of 
amines.123 
 
The internal nucleophile can also be generated by deprotonation. A 
carbanion is formed by α-deprotonation of the phosphonate 121 that attacks 
the carbonyl group by which it is coupled to Wang resin. Pyrrolinone 122 is 
then released through Dieckmann condensation leading to cleavage from the 
resin (81% overall yield). Tetrabutylammonium hydroxide is preferred as a 
base because of the more convenient work-up.124 This method also has the 
advantages utilizing solid phase chemistry. 
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Similar to this methodology is the ring expansion of aziridines 123 that 
starts with an intramolecular addition reaction to generate the nitrogen 
nucleophile which is the active nucleophile in the ring closure. This 
cyclization was reported to be strongly influenced by steric hindrance and by 
the actual lifetime of the anion.125 
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The intramolecular aminomercuration of alkenylamines is a useful approach 
to substituted heterocyclic amines in which the electrophilic center is 
generated to invoke ring closure. The starting α-amino-δ-alkenyl 
phosphonates 128 are synthesized by bubbling ammonia through a solution 
of γ-alkenylaldehydes or ketones in dialkyl phosphite. Ketones are 
transformed in reasonable yields (50 – 70%), however aldehydes give rather 
poor yields (15 – 30%). Cyclization of the α-amino-δ-alkenylphosphonates 
128 is initiated by addition of Hg(OAc)2 to the double bond followed by 
cyclization through intramolecular nucleophilic attack of the free amine. 
Using α-amino-ε-alkenylphosphonates it is possible to obtain the six-
membered analogues in similar yields (55%). The reaction is regiospecific in 
most cases,126-128 although in one case (R1 = H; R2 = R3 = R4 = Me; R5 = Et) the 
formation of 3 – 7% of the six membered ring 133 is observed. 
Demercurization is finally achieved by a reduction with NaBH4. Formation of 
free radicals during the reduction accounts for the formation of side products 
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such as dialkylmercury compounds or ring opening to the starting material 
128. The stereoselectivity of the aminomercuration depends to a large extent 
on the reaction conditions. When the cyclization of 128 is performed in 
THF/H2O, the stereoselectivity is different compared to the reaction 
performed in acetone for the cyclization and in dichloromethane for the 
reduction. 
 
R2 R4
R3
R1
O
HP(O)(OR5)2
NH3
(70%)
R2 R4
R3
R1
P(OR5)2H2N
O
Method A/B
N
H
P(OR5)2
H
HgOAc
N
H
P(OR5)2
AcOHg
+
N
H
P(OR5)2iPr
H N
H
P(OR5)2H
iPr
OO
+
N
H
P(OR5)2+
127 128
129 130
133131 132
Method A: 1) Hg(OAc)2; acetone - 2) NaBH4; CH2Cl2
Method B: 1) Hg(OAc)2; THF/water - 2) NaBH4; THF/water
R1 = H
R2 = R3 = R4 = Me
R5 = Me or Et
O
O
O
NaBH4
 
 
 
2.5 Cycloaddition 
The 1,3-dipolar cycloaddition reaction is one of the most useful methods for 
the construction of five membered rings in a convergent and stereocontrolled 
manner.129 To obtain phosphonylated azaheterocycles, a phosphonate group 
can be comprised in the 1,3-dipole (e.g. phosphonylated nitrile ylids and 
phosphonoazomethine ylids) or in the 1,3-dipolarophile (e.g. vinyl 
phosphonates). 
 
The use of nitrile ylids as 1,3-dipoles in cycloadditions has received a lot of 
attention as a route to a variety of five-membered nitrogen containing rings. 
Due to the electron withdrawing effect of the phosphonate moiety, N-
phosphonomethyl imidoyl chlorides 136 are potential precursors of 
phosphorylated nitrile ylids 137 via a 1,3-dehydrohalogenation process in 
basic medium. These imidoyl chlorides can be synthesized by a reaction of 
isocyanomethyl phosphonate 134 with an acid chloride. Upon treatment with 
triethylamine, a 1,3-dipolar species 137 is formed, which is trapped in situ 
with methyl acrylates giving a mixture of cycloadducts 138a-c and 139a-c. 
These regioisomers are difficult to separate by chromatography. When 
nitroalkanes are used as dipolarophiles however, 2-phosphonopyrroles 
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141a-d are obtained in moderate yield after elimination of nitrous acid and 
aromatization.130 
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Another example of the formation of an imidoyl chloride concerns the 
reaction of isocyanomethyl phosphonate 134 with sulfenyl chlorides. The 
cycloaddition is then performed in a solid-liquid medium using a KOH/Al2O3 
mixture in THF. With dimethyl fumarate, pyrrolines 143 are formed in 61% 
yield. With acetylene dicarboxylate however, aromatization occurs and 2-
phosphono pyrroles 144 are isolated in moderate yields.131 1-Isocyanomethyl 
phosphonates can also be used immediately in a cycloaddition reaction 
under basic catalysis to yield 5-phosphono pyrrolines.132,133 
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Reaction of carbanions of N-(phosphonomethyl) imines 145 with α,β-
unsaturated esters can lead to three different products: an acyclic adduct 
150 through a Michael addition, pyrroline 148 through a cycloaddition and 
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subsequent elimination of the diethyl phosphite anion, or pyrrolidine 149. 
When sodium hydride is used as a base at room temperature, pyrrolidines 
149 are formed exclusively in good yields (77–90%) due to the 
stereospecificity of the reaction related to the concerted mechanism. However 
when a lithium base is used such as butyllithium or LDA, pyrroline 148 is 
formed as a side product depending on the temperature profile of the 
reaction. In case of the lithium bases, an acyclic derivative is formed first 
that is then cyclized to a mixture of isomers. However, the yield is low 
because of the disfavoured 5-endo-trig mechanism.134-136 
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The same methods with more common 1,3-dipoles are applicable towards 
azaheterocyclic phosphonates when vinyl phosphonates are used as 
dipolarophiles. When phenylazirines 152 are irradiated with UV-light, again, 
nitrile ylids 153 are formed which can react in situ with activated C=C or C=X 
(X = N, O, S) bonds. The P=O bond of phosphonates, however, is not active in 
this kind of reaction, although the phosphonate group is able to activate a 
C=C bond. Irradiation of azirines 152 in the presence of vinyl phosphonate 
yields two regioisomers 153 and 154 which can be separated by preparative 
GC. Both regioisomers are isolated as a mixture of the cis and trans 
isomers.137 
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Cycloaddition of vinyl phosphonate with azomethine ylids instead of nitrile 
ylids has also been evaluated. Treatment of phenylthioglycinate 155 with 
NaH yields an intermediate azomethine ylid that can react with vinyl 
phosphonate with the formation of ethyl 4-phosphono prolinate 158. 
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However, the major drawback of this approach is the formation of large 
amounts of 1,4-adduct 157 that causes the yield to drop to 26%.138 
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Cycloaddition of N-benzylidene glycinate anions appeared to be impossible 
under thermal conditions. However, in the presence of a catalytic amount of 
AgOAc as a Lewis acid, the reactions proceed in good yields. 
Tetrabutylammonium chloride (TBAC) has to be added as a phase transfer 
catalyst in the solid-liquid system, resulting in long reaction times. However 
in this case, the cycloaddition reaction is regioselective with the trans 
pyrrolidine 161 predominating.139  
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2.6 Addition to cyclic imines 
Nucleophilic addition of a dialkyl phosphite to an 1,2-unsaturated 
azaheterocycle is one of the most direct ways to synthesize cyclic α-
aminoalkyl phosphonates. For the synthesis of the phosphonate analogue of 
proline, pyrroline would be an interesting starting product. However, 
pyrroline is unstable and trimers 163a are rapidly formed upon standing. 
Nevertheless, when dialkyl phosphite is added to these trimers, the desired 
phosphonylated pyrrolidines 75a and 164b are obtained in good yields by 
thermal depolymerization of the trimer.140-143 The obtained pyrrolidine 75a 
was then easily converted to amide 165, which has angiotensin enzyme 
inhibitory activity.144 
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To avoid problems concerning the inherent instability of the pyrroline, it can 
also be generated in situ by oxidation of pyrrolidine,145,146 decarboxylation of 
N-benzyl proline,145 intramolecular hydroamination of a suitable 
aminoalkyne147 or intramolecular condensation of a suitable γ-amino 
ketone.148 One-pot reaction with a dialkyl phosphite then yields the 
corresponding phosphono proline derivatives. In contrast with unsubstituted 
pyrrolines, the commercially available 2-methyl-1-pyrroline is a stable 
compound and has been succesfully used in an addition reaction with dialkyl 
phosphites at room temperature.149,150 
 
Compared to pyrrolines, the addition of phosphites to nitrones generally 
proceeds more readily. Many examples have been reported in the 
literature151-157 because of the usefulness of 1-phosphoryl-pyrroline-N-oxides 
as alternatives for 5,5-dimethyl-1-pyrroline N-oxide (DMPO 166) which is one 
of the most widely used spin traps.† DMPO rapidly scavenges free radicals 
generating secondary radicals, so called spin adducts. The non-zero nuclear 
spin of the β-H on the aminoxyl spin adduct provides remarkably suitable 
EPR information useful for the diagnosis of the structure of the free radical 
addend. However, the same hydrogen atom is also responsible for the 
instability of the spin adducts. The stability of the adducts is greatly 
enhanced when a phosphonate group is incorporated. Furthermore, 
additional structural information can be obtained due to the non-zero 
nuclear spin of the phosphorus atom. The commercial diethoxyphosphoryl 5-
methyl-1-pyrroline-N-oxide (DEPMPO 167) exhibits unique specificity in the 
spin trap adduct EPR spectra with substantial improvement in stability.159 
The instability of DMPO spin adducts can also be overcome by substituting 
the β-H itself by a phosphorus atom, resulting in the spin trap 2-
diethoxyphosphoryl 5,5-dimethyl-1-pyrroline-N-oxide (DEP-DMPO 168).152 
Some nitroxides were also shown to exert a cardioprotective action that was 
attributed to their antioxidant action, through reduction of the hydroxyl 
radical formation and the tissue lipid peroxidation.160 
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† Spin traps were developed in order to accumulate (“trap”) highly reactive, primary radicals 
which cannot otherwise be observed directly. The ultimate goal in biomedical research is to 
detect critical bioradicals in vivo.158 
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2.7 Miscellaneous 
The halogen atom transfer radical cyclization (HATRC) of N-allyl α-
perchloroamides is a valuable technique for the preparation of 
pyrrolidinones. One of the main advantages of this rearrangement is the 
preservation of all carbon-halogen functions on the final skeleton which 
remain available for further functionalization. The reaction has also been 
exploited for 2-phosphono allyl derivatives 169, yielding 4-phosphono 
pyrrolidinones 172 in quite reasonable yields (44 – 71%).161 The cyclization 
reaction is initiated by halogen abstraction by the Cu(I)Cl catalyst. The 
resulting radical invokes ring closure via a 5-exo-trig mechanism. The 
reaction is terminated by recombination of a chlorine atom of the catalyst 
with the radical 171. The phosphonolactams could then be rearranged to the 
unsaturated lactams 173 upon treatment with alkoxides.  
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Also carbene mediated cyclizations are compatible with the phosphonate 
group of the substrates. The [Rh2(OAc)4]-catalyzed intramolecular CH-
insertion of α-diazo-α-diethoxyphosphono acetamides 174 affords α-
phosphono lactams 175 and 176 in high yield. The regioselectivity of the 
reaction is strongly determined by electronic effects and in several cases, 
mixtures are obtained. The phosphonate moiety not only has a stabilizing 
effect on the carbenoid carbon atom, it also has a profound influence on the 
stereoselectivity. The bulky phosphonate group appears to induce a 
remarkable preference for the formation of the five membered ring with 
stereocontrol in favour of the trans diastereomer.162,163 Furthermore, the 
reaction can be performed in water when hydrofobic substrates are used.164 
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Table 1:  Regioselectivity in the intramolecular C-H insertion reaction 
 R1 R2 R1’ R2’ Yield 175 Yield 176 
a nBu nBu Pr Et 0% 87% 
b tBu CH2CH2Ph - Ph 0% 81% 
c CH2CH2OMe CH2CH2OMe - OMe 0% 89% 
d CHMePh nBu Me, Ph Et 18% 76% 
e Et Et Me H 18% 50% 
 
 
Also asymmetric carbenoid insertions have been evaluated. Using chiral 
dirhodium(II) catalysts and substrates 174, the corresponding 
phosphonylated lactams could only be obtained in moderate ee.165 However, 
when chiral δ-amino α-diazo β-ketophosphonates 178 were used, 3-
oxopyrrolidine phosphonates 179 were formed with high stereoselectivity 
through intramolecular metal carbenoid NH-insertion. The corresponding 
phosphono proline derivatives 180 can be obtained after enolization and 
reduction of the keto moiety.166 
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Phosphonylation of amides using Vilsmeier-type conditions has been used for 
the synthesis of bisphosphonates containing an amino group. When two 
equivalents of POCl3 are added to a mixture of pyrrolidinone 181 and two 
equivalents of trialkyl phosphite, the carbonyl group is transformed into a 
diphosphonate moiety by consecutive addition and elimination of the 
phosphorus oxychloride reagents. Recently the reaction has been optimized 
and the bisphosphonate 182 can be obtained in 59% yield. It can be further 
oxidized to nitrone 183 which can be used in spin trap experiments.167-170 
Furthermore, bisphosphonate 182 is used to monitor the intracellular pH in 
vivo via non-invasive 31P-NMR spectroscopy and displays a 4-fold higher 
sensitivity than inorganic phosphate or other commonly used 
phosphonates.171-173 The preparation method has also been extended to four 
and six membered rings, however resulting in lower yields (resp. 28% and 
19%).170 
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When pyrrolidinone 181 is treated with a mixture of H3PO3 and PCl3, the free 
phosphonic acid analogue of pyrrolidine 182 is obtained together with small 
amounts of side products.174 This bisphosphonic acid is useful for treating or 
preventing disorders of calcium and phosphate metabolism.175 Furthermore, 
it is claimed to have a synergistic effect on certain neoplasm inhibitors and is 
therefore useful for the treatment of bone-metastasizing tumors.176 Due to its 
Ca2+ complexing abilities it is also used as hardening retardant for gypsum177 
and as a component in anticalculus or antiplaque compositions in oral care 
products.178 Finally it has proven to reduce the calcification of the rat 
aorta.177 
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1 Synthesis of α-aminoalkyl phosphonates 
1.1 Introduction 
A classical method for the synthesis of α-aminoalkyl phosphonate 
compounds is the Kabachnik – Fields reaction, which was discovered in 1952 
independently by Kabachnik and Medved179 and Fields.180 The reaction 
comprises a three-component condensation of a hydrophosphoryl compound, 
a carbonyl compound (aldehyde or ketone) and an amine. After the discovery 
in the late 1960’s that α-aminoalkyl phosphonates possess practically useful 
properties, an increasing number of researchers in organic chemistry, biology 
and medicine have focussed their attention to their synthesis and properties. 
However, all this research resulted only recently in a generally accepted 
viewpoint on the mechanism of the Kabachnik – Fields reaction.181   
 
Two pathways to the α-aminoalkyl phosphonates are applicable, since two 
nucleophiles are present in the reaction mixture. Condensation of the 
carbonyl compound and the amine involves imine formation first, followed by 
addition of the phosphite, which in fact is a Pudovik‡ reaction. This reaction 
pathway occurs when an amine of low basicity is used, which manifests 
proton donor properties and forms a pre-reaction complex of the type 186 
with the phosphite. 
 
                                           
‡ The Pudovik reaction is known as the catalysed or non-catalysed addition of 
hydrophosphoryl compounds to imines and was described in 1952182 almost simultaneously 
with the pioneering research by Kabachnik and Medved. 
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Condensation of the carbonyl compound and the phosphite gives rise to a α-
hydroxyphosphonate (Abramov reaction) and is then followed by the 
replacement of the hydroxyl group by the amine to yield the corresponding α-
aminoalkyl phosphonate. The ‘hydroxyphosphonate’ mechanism generally 
operates when more basic amines are used, e.g. cyclohexylamine 189, that 
show a higher tendency towards hydrogen bond formation with the phosphite 
hydrogen atom (pre-reaction complex 190). 
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Often it is not clear which mechanism occurs under the conditions 
applied.183 Furthermore, it can not be excluded that both mechanisms 
operate together. Therefore, the fame of the Kabachnik-Fields reaction often 
suffers from low yields, long reaction times and disappointing final product 
selectivity. In this regard, our attention should be focussed on the 
phosphorus nucleophile used in the reaction, to be precise, a dialkyl 
phosphite.  
 
Several excellent phosphorus containing nucleophiles are known, for 
instance phosphines. Being a third period element, phosphorus is a large 
and highly polarizable atom with low electronegativity (i.e. 2.1, which is the 
same as for the hydrogen atom, and only modestly lower than that of carbon 
(2.5)). Therefore, phosphorus has enhanced nucleophilic properties compared 
to nitrogen, which is in the same group in the periodic table. However, in 
case of dialkyl phosphites, the nucleophilicty is significantly reduced due to 
the electron withdrawing oxygen atoms and due to the lack of a free electron 
  33 
pair. Indeed, the structure of dialkyl phosphite is best represented by the 
tetrahedral structure 184 and therefore it is named sometimes dialkyl H-
phosphonate. Dialkyl phosphites occur in equilibrium with their 
corresponding σ3λ3 form 193. However, this equilibrium is shifted very much 
to the σ4λ5 H-phosphonate form 184 (log K = -7.2),184 which is the only one 
that can be detected by 1H or 31P NMR. The existence of trialkyl phosphites 
and the unexpectedly high acidity of dialkyl phosphites however, reveal the 
reality of the σ3λ3 isomer 193. 
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The reduced nucleophilicity of dialkyl phosphites can be conveniently 
overcome in principally three ways. The use of bases has been applied 
frequently in the synthesis of α-aminoalkyl phosphonates. With strong bases 
the corresponding sodium,185 lithium186,187 or potassium188 salts 194 are 
obtained quantitatively, and are then used in a separate reaction step as the 
nucleophile. Weaker bases like triethylamine, tetramethylguanidine,189 or 
sodium alkoxides190 help to shift the equilibrium to the σ3λ3 phosphite form 
during the addition reaction, resulting in a considerable rate enhancement.  
 
In contrast to the use of base to enhance nucleophilicity of the dialkyl 
phosphite, also acid catalysis has proven useful in the synthesis of α-
aminoalkyl phosphonates. Addition of dialkyl phosphites to imines has been 
facilitated by the use of for instance Me2AlCl,191 BF3,192 SnCl4193 and ZrCl4.194 
Also three component Kabachnik-Fields type reactions, involving a carbonyl 
compound, an amine and a dialkyl phosphite, have been reported to proceed 
smoothly using a variety of catalysts, such as LiClO4,195 InCl3,196 TaCl5197 or 
lanthanide-triflates.198,199 Also Brønsted acids have been applied with the 
same purpose.200 
 
A very elegant method to circumvent the drawbacks of dialkyl phosphites as 
nucleophiles is to convert them into the corresponding dialkyl trimethylsilyl 
phosphites (DAPTMS). This is easily done by adding TMSCl together with 
triethylamine to trap the liberated HCl. DAPTMS exists as a σ3λ3 phosphite 
which is confirmed by its 31P chemical shift being clearly in the region of 
tricoordinated phosphites. Therefore, nucleophilicity is significantly 
increased. Furthermore, the presence of a silyl group is known to enhance 
nucleophilicity of the phosphorus atom, while the phosphorus increases the 
electrophilicity of the silicon centre.201 The use of DAPTMS reagents in 
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reaction with aldimines in order to obtain α-aminoalkyl phosphonates will be 
evaluated and discussed in this chapter (sections 1.2 and 1.3). 
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δ(31P) = 128.0 ppm 
 
Finally, trialkyl phosphites are typical σ3λ3 phosphites and hence are 
expected to have good nucleophilic properties. However, upon addition of 
trialkyl phosphites, phosphonium salts are obtained initially, which need to 
be dealkylated in order to obtain the corresponding phosphonates. Therefore, 
additives are often used to perform or facilitate this dealkylation, e.g. AlCl3,202 
Sc(O3SOC12H25)3,203 TMSBr,204,205 LiClO4,206,207 lanthanide triflates198 and 
Me2S·Br2.209 
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1.2 Phosphonylation using dialkyl trimethylsilyl phosphite 
To evaluate the addition reaction of DAPTMS to aldimines, the silylated 
reagent was freshly prepared for each batch by adding a slight excess (1,1 
equivalent) of TMSCl to a cooled mixture of DAP and triethylamine in 
dichloromethane.49 The formation of the σ3λ3 DAPTMS (δ(31P) = 126-128 ppm) 
from σ4λ5 DAP (δ(31P) = 7-11 ppm) was monitored easily via 31P NMR. During 
this reaction, hydrochloric acid is deliberated which precipitates as 
triethylammonium chloride from the reaction mixture. After complete 
conversion of the DAP (usually within 30 minutes), the imine of choice was 
added to the reaction mixture. 
 
Several imines were tested (Table 2), however, all giving only slow conversion 
at room temperature. In most cases, the reaction was stopped when side 
products started to build up after extended reaction periods. When the 
reaction was refluxed instead, faster conversion to the desired aminoalkyl 
phosphonate was observed. However, at these higher temperatures, also 
increased side product formation was found. Due to incomplete conversion 
and side product formation, a time consuming purification using acid/base 
extraction or column chromatography was required, giving rise to 
considerable product losses. In conclusion, the results obtained using 
DEPTMS as a highly nucleophilic phosphite form are not in agreement with 
the excellent yields reported using similar substrates.49 Due to very long 
reaction times and product losses during obligatory purification, this method 
is less useful from a preparative point of view. 
 
Table 2: Phosphonylation of imines with DEPTMS 
Imine Conditions Conversion# Yield 
1 eq. DEPTMS; CH2Cl2, 2 weeks, rt. 67% 52% crude 
N
N
H
 1 eq. DEPTMS; CH2Cl2, 48 h, ∆ 85% 72% crude 
H
N
 
1 eq. DEPTMS; CH2Cl2, 14 h, ∆ 98% 63%
§ 
O
H
N
 
1.1 eq. DEPTMS; CH2Cl2, 48 h, rt. 78% 52%
§ 
H
N
 
1.2 eq. DEPTMS; CH2Cl2, 24 h, ∆ 86% 40%
§ 
N
H
 
1 eq. DEPTMS; CH2Cl2, 72 h, rt. 85% 32%
§ 
# Measured using 1H NMR 
§ Purification by column chromatography 
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1.3 Regioselectivity of dialkyl trimethylsilyl phosphite addition 
In theory, a nucleophile can interact with two electrophilic centers when a 
carbon, carbon double bond is conjugated with an electron deficient sp2 or sp 
carbon atom (as for instance in aldehydes, ketones, esters, imines and 
nitriles): reaction at the electrophilic carbon atom of the functional group 
itself (1,2-addition) or reaction via its mesomeric form with the double bond 
(1,4-addition). Recently, the phospha-Michael addition has been reviewed in 
full.210 The regioselectivity is strongly dependent on the type of phosphorus 
nucleophile used, on the substrate and on the reaction conditions used 
(thermodynamic control vs. kinetic control). 
 
1.3.1 Addition of DAPTMS to α,β-unsaturated imines 
DEPTMS is reported to add to α,β-unsaturated imines containing one or 
more phenyl groups with complete 1,2-regioselectivity. The corresponding α-
aminoalkenyl phosphonates can be obtained in high yield and purity after 
column chromatography.49,211 Therefore, the tryptamine derived imine 19f 
was reacted with 1 equivalent of DEPTMS using the reported conditions. An 
incomplete reaction was observed even after extended reaction times and at 
reflux temperatures. Furthermore, increasing amounts of side products were 
formed during the course of the reaction (31P NMR). Nevertheless, the α-
aminoalkenyl phosphonate 22g could be obtained in pure form using column 
chromatography (EtOAc/PE: 80/20). TLC analysis of the crude reaction 
mixture also revealed a second spot with a very high retention (Rf = <0.05). 
The corresponding products could be obtained in very small quantity from 
the column chromatographic purification using a more polar 
CH3CN/EtOAc/MeOH mixture (50/47/3). The 31P NMR spectrum showed 6 
peaks and the 1H NMR spectrum lacked alkenyl signals.  MS data suggested 
the presence of two phosphonate groups and therefore, the reaction was 
repeated using 2 equivalents of DEPTMS. After three days of reflux in 
dichloromethane, the 31P NMR spectrum consisted exclusively of the 
aforementioned six peaks. Similar results were obtained with other nitrogen 
substituents (iPr and Bn). The products were finally identified as 3-
phosphonyl 1-aminoalkyl phosphonates (PAP) 196g using 1D and 2D NMR 
techniques.  
 
H
N
NH
1 eq. DEPTMS
HNEt3Cl, CH2Cl2
P(OEt)2
HN
NH
O
+ ?
19f 22g  
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In order to evaluate this surprising reaction on other α,β-usaturated imines, 
DEPTMS was prepared on a large scale and subsequently purified by 
filtration of the triethylammonium chloride salts. The solvent was then 
carefully evaporated under reduced pressure (bp. DEPTMS 66°C at 15 
mmHg). The residue, still containing visible amounts of ammonium salt, was 
then dissolved in diethyl ether and filtrated again.† DEPTMS was then 
obtained as a colourless, clear liquid with a strong smell and can be dosed 
more easily. Care has to be taken to avoid contact with moisture (e.g. from 
the air) during all handlings. DEPTMS and DMPTMS can be stored in pure 
form for at least two months at -32°C.   
 
Table 3: Synthesis of PAP's 196 with DAPTMS 
Imine 19 Product Yield# Diast. ratio 
196c (R = Me) 70% 19/81 
19b H
N Ph
 
P(OR)2
HN Ph
O
(RO)2P
O
 
196d (R = Et) 80% 29/71 
196e (R = Me) 36% 71/29 
19d H
N
 
P(OR)2
HN
O
(RO)2P
O
 
196f (R = Et) 40% 67/33 
19f 
H
N
NH
 
P(OR)2
HN
O
(RO)2P
O
NH
 
196g (R = Et) 82% 29/71 
196h (R = Me) 77% 32/68 
19g 
H
N
 
P(OR)2
HN
O
(RO)2P
O
 
196i (R = Et) 78% 33/67 
196j (R = Me) 82% 49/51 
19h 
H
N
 
P(OR)2
HN
O
(RO)2P
O
 
196k (R = Et) 85% 36/64 
19q 
H
N
 P(OR)2
HN(RO)2P
O
O  
196l (R = Me) 74% 36/64 
19r 
H
N
 P(OR)2
HN(RO)2P
O
O  
196m (R = Me) 60% - 
19w 
H
N
 
P(OR)2
HN
P(OR)2
O
O  
196n (R = Me) 46% 22/78 
19x 
H
N
 
P(OR)2
HN
P(OR)2
O
O  
196o (R = Me) 20% 12/88 
# Complete conversion was observed in all cases. Yields reported are after 
column chromatography or acid base extraction. 
 
                                           
† Preparation of DEPTMS in diethyl ether was unsuccesful 
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Surprisingly, the pure DEPTMS did not react with imines at all. Several α,β-
unsaturated and aromatic imines were tested without any success. Afarinkia 
and coworkers49 mentioned that the excess of TMSCl used in their procedure 
catalyzed the reaction. However, still no reaction occurred when TMSCl was 
added, even when equivalent amounts were used. Then it was reasoned that 
chloride could be necessary to desilylate the intermediate phosphonium salt 
197. However, addition of LiCl also did not get the reaction to work (Table 4). 
 
N
HR1
R2
P
OEt
OEt
OSiMe3
HN
PR1
R2
OEt
OEt
O
Si
Cl-
HN
PR1
R2
OEt
OEt
O
19 195b
197
22
 
 
Finally, ammonium chloride was added as a readily available substitute for 
the in situ formed triethylammonium chloride in the Afarinkia procedure.49 
The same results were obtained for both salts when N-benzyl imine 19b was 
reacted with two equivalents of DEPTMS in dichloromethane at reflux 
temperature. The corresponding PAP 196d was the only reaction product 
after 72 hours of reflux and aqueous work-up. The reaction was easily 
monitored using 31P NMR.# The imine 19b very quickly vanished, however 
mostly in favour of the 1,2-addition product (α-aminoalkyl phosphonate 22c 
or “AP”). The PAP 196d was formed more slowly, while the AP disappeared 
again upon prolonged heating (Figure 1).§ 
 
Table 4: Effect of additives on the addition of DEPTMS to imine 19b 
 Additive Temperature Reaction time¤ 
1 None Reflux ∞ 
2 TMSCl Reflux ∞ 
3 LiCl Reflux ∞ 
4 HNEt3Cl Reflux 72 h 
5 NH4Cl Reflux 72 h 
6 (NH4)2SO4 Reflux 3 h 
7 H2SO4 RT 30 min 
¤ Reaction time required for complete conversion at the specified 
temperature in dichloromethane. 
 
 
                                           
# A small sample was taken out of the reaction mixture and centrifuged to obtain a clear 
NMR sample. The NMR measurement was performed without locking the signal (as no 
deuterated solvent was present which posed no problem given the short time scale of a 31P 
experiment. This technique has also been used for 1H NMR measurements.212 
§ PAP 196d was easily recognized in the 31P spectrum (see chapter 3, section 1.3.2 for 
spectroscopic characteristics). No reference data about AP 22c were available in the 
literature. However, a 1,2-selective protocol was developed (chapter 3, section 1.4) which 
allowed to obtain AP 22c in pure form. 
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N
Bn
H
2 equiv. DEPTMS
HNEt3Cl, CH2Cl2, ∆
HN
Bn
P(OEt)2
(EtO)2P
O
O
19b 196d
+ P(OEt)2
HN
Bn
O
22c
 
Figure 1: Composition of the reaction mixture during the reaction of 19b with 
DEPTMS in the presence of HNEt3Cl, measured by NMR. Imine 19b (); AP 22c (); 
PAP 196d (∆). 
 
 
Furthermore, an acidification of the reaction mixture was observed. This was 
probably due to the formation of ammonia or triethyl amine and hydrochloric 
acid from the corresponding salts under thermal conditions. This was 
observed visually by salt formation in the cooling system due to 
recombination of the base and acid vapours in the head space. Protons can 
play a crucial role in the addition reaction, in the first place to activate the 
imine by protonation. Secondly, as can be seen from the atom balance, a 
proton should be assimilated during the addition reaction. Therefore, 
ammonium sulphate was selected as an additive instead of the chloride salts. 
The sulphate is sligthly more acidic and furthermore, sulphuric acid can be 
formed which is far less volatile than hydrochloric acid. Indeed, a remarkable 
rate enhancement was observed: complete conversion to PAP 196d took 
place in three hours at reflux temperature. Even more, when concentrated 
sulphuric acid (1 equivalent H+) was added at room temperature to a mixture 
of N-benzyl imine 19b and DEPTMS in dichloromethane, the reaction 
mixture started to boil almost instantaneously and the PAP 196d was formed 
in 30 minutes at room temperature.  
 
 
 
 
0%
20%
40%
60%
80%
100%
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No one so far has reported correctly on the regioselectivity of the DEPTMS 
addition to imines or on the exciting effects of acid addition to the reaction 
mixture. Several related substrates were evaluated in the double addition 
reaction (Table 3). Similar results were obtained with dimethyl trimethylsilyl 
phosphite (DMPTMS).213 For all imines, a faster reaction was observed with 
more bulky nitrogen substituents. For imines derived from aniline, only 1,2-
addition was observed. 
 
1.3.2 Spectroscopic characteristics of PAP’s 196 
Spectroscopic analysis of the newly formed products was complicated by two 
factors. Firstly, products 196c-l,n,o were obtained as a mixture of two 
diastereomer pairs. This caused most peaks to double. Secondly, the 
complexicity of the NMR spectra was increased due to the presence of 
multiple phosphorus couplings. As an example, the 31P spectrum (with 
broadband 1H-decoupling) of PAP 196j is depicted in figure 2. The major 
isomer can be recognized by 2 doublets. Each doublet represents 1 
phosphorus atom, with a scalar coupling over 4 bonds (4JPP = 5.9 Hz). The 
minor isomer does not show a similar P,P coupling and appears as two 
singlets. The lack of a P,P coupling should be contributed to the specific 
conformation of this minor isomer. In some cases, little broadening of the two 
singlets indicated the presence of a very small coupling.# Only in the case of 
PAP 196l, both couplings were resolved (Major: 4JPP = 5.2 Hz, minor: 
4JPP = 2.2 Hz). The occurrence of two diastereomeric pairs of PAP 196k was 
confirmed by their separation in low yield using column chromatography. 
Furthermore, only two doublets (4JPP = 3.0 Hz) were observed for PAP 196m 
with only one chiral centre. 
 
                                           
# The resolution of the applied 31P experiments was 0.74 Hz at 121.66 MHz (65536 
datapoints with 48.78 kHz sweep) 
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Figure 2: 31P NMR spectrum of PAP 196j 
 
 
Also the 13C NMR spectrum (with broadband 1H-decoupling) was affected by 
the inherent complexicity of the PAP diastereomeric pairs. The nitrogen 
attached CHP was represented by 8 peaks (figure 3). Each isomer showed a 
large 1JCP coupling (151 and 160 Hz) and a smaller 3JCP coupling (14 and 
17 Hz). Additional NMR data of PAP’s 196 are collected in chapter 4, section 
3.2 and appendix B. 
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Figure 3: 13C NMR spectrum of PAP 196j 
 
  43 
1.3.3 Mechanistic investigation of the double DAPTMS addition to imines 
Mainly three parameters influencing the reaction arise from the observations 
described in chapter 3, section 1.3.1. The rate of the reaction is strongly 
affected by the availability of protons in the reaction mixture. Even more, in 
the absence of protons, no reaction occurs at all. Secondly, bulky nitrogen 
groups greatly enhance the formation of PAP. With a sterically less 
demanding phenyl group, only 1,2-addition of the phosphite is observed, 
even after prolonged heating of the reaction mixture. Finally, monitoring the 
PAP formation using NMR (Figure 1) shows that the 1,2-addition product 22c 
is formed during the reaction.  
 
No observations have been made concerning the role of the nucleophile. 
Therefore, PCl3 was selected as another σ3λ3 phosphorus nucleophile, 
however lacking the TMS group. TMSCN on the other hand, still contained 
the TMS group, but consisted of another nucleophilic species. However, in 
both cases no double addition products were obtained. TMSCN was only 
capable of performing a regular Strecker type 1,2-addition in high yield. This 
illustrates again the unique properties of silyl esters of phosphorus.201  
 
N
H
2 equiv. TMSCN, H2SO4
CH2Cl2, 24 h, rt. (81%)
HN
CN
19g 198  
 
To establish the role of the acid, an experiment was set up adding different 
amounts of sulphuric acid to a mixture of imine 19g and DMPTMS in 
dichloromethane (Table 5). Even though only partial conversion was observed 
after 24 h with 0.1 equivalent of sulphuric acid H+ (entry 3), the reaction 
seemed to be only slowed down using subequivalent amounts of H+.  
 
Table 5: Role of sulphuric acid 
 H2SO4 Reaction time Result
# 
1 1 eq. H+ 1 h 100% PAP 
2 0.5 eq. H+ 24 h 100% PAP 
3 0.1 eq. H+ 24 h 32% PAP, 24% AP, 44% imine 
# Determined with 1H NMR after alkaline aqueous work-up. 
 
 
From monitoring the reaction with 0.5 equivalent of sulphuric acid, it was 
again shown that the 1,2-adduct prevails in an early reaction stage. 
Therefore, it is reasonable to suggest it as an intermediate that is converted 
later on to enamine 202 via an SN’ type substitution (Figure 4, pathway B). 
However, the 1,2-addition pathway can also be considered as a dead-end 
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side pathway. The PAP 205 is then formed via a parallel 1,4-addition to the 
activated imine 199 (pathway A). However, complete conversion to the PAP 
via the latter pathway is only possible when the 1,2-addition is reversible. 
 
R1 H
N
R2
R1 H
N
R2H
H+
R1 P
N
R2H
OR3
OR3
OTMS
R1 P(OR3)2
N
R2H
O
TMS
R1 H
HN
R2
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3O
R3O OTMS
R1 H
N
R2
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3O
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R1 H
N
R2
(R3O)2P
OTMS
R1
N
R2
(R3O)2P
OTMS
P
OR3
OR3TMSO
Aqueous work-up
R1
HN
R2
(R3O)2P
O
P(OR3)2
O
POTMS(OR3)2
1,2-addition
Pathway A
1,4-addition
-POTMS(OR3)2
19a-x 199 200 201
202 203 204
205
196
Pathway B
SN'-like substitution
 
Figure 4: Proposed reaction mechanisms of the double phosphite addition 
 
 
The initial equilibrium (199  200  201) was studied in a separate 
experiment. When dimethyl 1-amino-1-phenylmethyl phosphonate 22ad was 
N-silylated using TMSCl and subsequently treated with a large excess of 
DEPTMS, mainly the diethyl phosphonate 22ae was recovered next to small 
amounts of 22ad. When the same experiment was repeated without silylation 
and using simply diethyl phosphite, no exchange occurred at all. This clearly 
demonstrated the reversibility (200  201) of the reaction and the leaving 
group capacity of the intermediate positively charged phosphonium group. 
Also a tris(trimethylsilyl)phosphonium group has been reported as a leaving 
group before.214 
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Ph P(OMe)2
HN
O
1) TMSCl, Et3N
2) DEPTMS
Ph P(OEt)2
HN
O
HP(OEt)2
O
Ph P(OMe)2
HN
O
22ad22ad 22ae  
 
When α-aminoalkyl phosphonate 22i was submitted to N-silylation and an 
excess of DMPTMS, a mixture of four compounds was found after aqueous 
work-up. 
 
HN
P(OEt)2
O
1) TMSCl, NEt3
2) DMPTMS
HN
P(OEt)2
O
(MeO)2P
O
HN
P(OMe)2
O
(MeO)2P
O
HN
P(OMe)2
O
(EtO)2P
O
HN
P(OEt)2
O
(EtO)2P
O
22i
206
196i 207
196h
 
 
The same experiment was then repeated with PAP 196h. However, only 
exchange of the phosphonate group in the neighbourhood of the nitrogen 
atom was observed. This indicates that phosphonate group exchange is 
probably nitrogen assisted. The nitrogen atom first hands over the obligate 
TMS group to yield a phosphonium group and then helps to kick it out by 
delocalisation of its lone pair. 
 
NH
R2
TMS
R1 P
O
MeO OMe
NH
R2
R1 P
OTMS
MeO OMe
N
HR1
H R2
NH
R2
TMS
R1 P
O
EtO OEt
208
199
206
+ DMPTMS
- DMPTMS + DEPTMS
- DEPTMS
196h  
 
Also in the case of alkenyl phosphonate 210, which was formed using an 
Arbuzov reaction with trimethyl phosphite and cinnamyl bromide, no 
substitution of the dimethyl phosphonate groep was observed.  
 
Br
1.1 equiv. P(OMe)3
neat, 80°C, 6h
P(OMe)2
O
P(OEt)2
O
DEPTMS
209 210 211  
 
While the equilibrium (199  200  201) was now well established, the 
further course of the reaction however remained unclear. Both pathways A 
and B in Figure 4 yield the same intermediate enamine 202 which again is 
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expected to participate in an equilibrium with imine 203 and iminium ion 
204. However, none of these intermediates could be detected so far using 
NMR spectroscopy. This would require that the second phosphite addition to 
iminium ion 204 proceeds much faster than the NMR timescale. 
Furthermore, the proposed reaction mechanisms require an external proton 
source as one equivalent of protons is incorporated in the final product 196. 
Therefore, the experiment using only 0.1 equivalent of sulphuric acid 
together with 2.0 equivalents of DEPTMS was repeated and monitored using 
NMR. Under these conditions, the reaction proceeded very sluggishly and the 
formation of PAP 196 was stopped completely after 3 to 4 hours. From that 
point on, the intermediate enamine 202 started to build up, while the rest of 
the imine is slowly consumed (Figure 5). After 72 hours at room temperature, 
water was added for work-up. However, during the work-up procedure, the 
composition of the mixture completely changed. The enamine 202 was 
completely converted to PAP 196 and part of the imine to aminoalkenyl 
phosphonate 22.  
Figure 5: Composition of the reaction mixture during the reaction of 19g with 
DEPTMS in the presence of 0.1 equivalent H2SO4 (0.2 equivalent H+), measured by 
NMR. PAP 196i (); Enamine 202 (); AP 22i (∆); Imine 19g ().  
 
 
This observation displays a remarkable proton hunger of the reaction. All 
protons present in the reaction medium, even in bounded form (e.g. 
ammonium salts), are consumed very rapidly. However, when a depletion of 
protons occurs in the reaction mixture, it blocks. It might be reasoned that 
imine 19a-x can still be activated by intermolecular silyl transfer of one of 
the adducts (indicated as “TMS+” in Figure 6). However, Michael addition or 
SN’ substitution then would yield N-silyl enamine 215 which can not 
participate in the equilibrium as shown in Figure 4. Therefore, the reaction 
blocks at the enamine stage in the absence of protons. When protons are 
0
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Work-up 
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added (in any form, e.g. slightly basic water during work-up), the enamine-
imine tautomerization is again allowed to proceed and the remaining 
DAPTMS can add to the imine to form the final product (PAP). 
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Figure 6: Possible reaction mechanism in the absence of protons 
 
 
The enamine formation is clearly much slower in absence of protons. This 
probably demonstrates the kinetic difference between activation of the imine 
19 by a proton and transfer of a large TMS group. Also 1,2-addition seems to 
be blocked under proton depleted conditions. Formation of adduct 214 is 
probably disfavoured because of sterical hindrance of the bulky TMS groups. 
 
The occurrence of enamine 202 in the proton depletion experiment is derived 
from the 31P and 1H NMR spectra. A new peak in the 31P spectrum (δ(31P) = 
±27 ppm in the reaction medium) is attributed to enamine 202. This is 
supported by the characteristic signals in the vinylic region of the 1H 
spectrum. To be entirely sure about the identity of the newly detected 
intermediate, some further experiments were performed. 
 
Imine 19g was reacted with 1 equivalent of AlCl3 and 0.9 equivalent of 
DEPTMS in dry dichloromethane under a nitrogen atmosphere (experiment 
A). The AlCl3 was supposed to act as an activator of the reaction 
(complexation with the imine nitrogen atom, compared to protonation of the 
imine by sulphuric acid), leaving no protons in the reaction medium. Only 
0.9 equivalents of DEPTMS was used in order to avoid the presence of an 
excess of DEPTMS during the work-up. After 2 h at room temperature, the 
DEPTMS is completely consumed and a fast extraction using 1 M NaOH(aq) 
resulted in a large amount of 1,4-adduct next to PAP 196i. The resulting 31P-
spectrum is depicted at the top in Figure 7. The PAP 196i is recognized as 
two doublets and two singlets, while the large singlet at ± 28 ppm is from the 
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1,4-adduct in its imine form 216a (a clear aldimine proton resonance is 
observed at 9,6 ppm in the 1H-NMR spectrum, no vinylic protons were 
visible). 
 
N
R
H
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    0.9 eq. P(OEt)2OTMS
2) H2O
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19g,h
217
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216a R = iPr
216b R = tBu
 
 
Imine 19g was also reacted with 0.9 equivalents of DEPTMS and 0.1 
equivalent of H2SO4 in dry dichloromethane under a nitrogen atmosphere 
(experiment B). As can be derived from Figure 5, a small amount of PAP 
would be formed very fast initially, but then the reaction would block, 
building up slowly the same 1,4-adduct, which could again be isolated after 
basic extraction (since no DEPTMS was left during extraction), giving a 
similar 31P-spectrum (second plot in Figure 7). When neutral water was 
added for work-up of the reaction, also aldehyde 217 was detected at 27.6 
ppm, resulting from hydrolysis of 216a during work-up  (3rd plot in Figure 7). 
 
In order to prove the structure of the 1,4-adduct, imine 216b was 
synthesized using a literature procedure.  Exclusive 1,4-addition to tBu 
imine 19h was reported using triethyl phosphite and formic acid in 
ethanol.215 Imine 216b was suggested as the intermediate and was treated 
with oxalic acid in water to yield the corresponding aldehyde 217. The 
intermediate imines were never isolated in the reported article and spectral 
data are only available for the aldehyde 217. Therefore, imine 19g was 
reacted with 0.96 eq. of triethyl phosphite and 1.04 equivalents of formic acid 
in ethanol (experiment C). Complete conversion took place in 1 h at room 
temperature. The 31P-spectrum after evaporation of the ethanol is shown as 
the fourth plot in Figure 7 (no aqueous work-up was performed, causing a 
little broadening of the peaks of the ‘crude’ reaction mixture. Mind that 
traces of PAP 196i are also formed under these conditions).  This clearly 
shows that the intermediate is the same product in all three experiments. 
Upon hydrolysis using 1 M oxalic acid in water, the same aldehyde is 
obtained in all three experiments (δ(31P) = 27.6 ppm, plot five in Figure 7).  
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Figure 7: a) Results of experiment A after basic work-up. PAP 196i can be clearly 
distinguished (28.4 – 29.8 ppm) next to imine 216a (28 ppm). b,c) Results of 
experiments B after basic (b) or neutral (c) work-up. The same peaks are visible. The 
hydrolysis product of imine 216a is observed at 27.6 ppm. (d) This spectrum of the 
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crude reaction mixture of experiment C after evaporation of the solvent shows that 
imine 216a is formed almost exclusively under these conditions, next to very small 
amounts of PAP. (e) Spectrum of the pure aldehyde 221. 
 
 
However, the reported value for aldehyde 217 is 24.4 ppm. Also a very low 
chemical shift (9.0 ppm) was reported for the aldehyde proton, causing a 
little bit suspicion. Therefore, the experiment was repeated exactly as 
reported using imine 19e. Aldehyde 217 was obtained in pure form using 
column chromatography. Spectral data were now in agreement with our 
previous results: δ(31P) = 27.6 ppm and the aldimine proton appears as a 
multiplet at 9.67 ppm in 1H NMR. The structure was confirmed using 2D 
COSY and HSQC experiments. 
 
In this way, all intermediates in the proposed reaction mechanisms (Figure 4) 
have been detected and identified. From the evolution of the reaction 
intermediates in function of the reaction time (Figure 5), it is clear that the 
1,2-adduct (AP) 22 is not a real intermediate of the PAP formation. After the 
initial AP formation (which can also be noticed in Figure 1), also the 1,2-
addition is blocked by the absence of protons, while the enamine is still 
formed very slowly. Furthermore, the observation of a considerable higher 
reaction rate for imines bearing more sterically demanding N-substituents, 
(tBu>iPr>Bn>>Ph) is in favour of the tandem 1,4-1,2-addition, since the 1,2-
addition should be slowed down by the steric bulk. Therefore, pathway A is 
presented as the principal reaction mechanism of the double DAPTMS 
addition. In literature, one case of a double addition of ketene silyl acetals 
218 to α,β-unsaturated imines can be found, also proceeding in a 1,4-1,2-
tandem fashion and also requiring a proton source.216  
 
R1
N
H
R2
0.5 eq. TiX4
OEt
OTMS
R1
HN
R2
COOEt
EtOOC
CH2Cl2, -78°C
+
19 218 219  
 
In case of the DAPTMS addition however, the mechanism is more 
complicated due to the parallel and reversible 1,2-addition. It can be 
concluded that the fast development of 1,2-adduct 22 in the reaction mixture 
should be a result of kinetic control, while the PAP 196 is the 
thermodynamic more stable final product.  
 
In summary, the aforementioned observations lead to a new insight 
regarding the use of dialkyl trimethylsilyl phosphite which contradicts earlier 
research:211 while it is present in its apparently most nucleophilic form, 
dialkyl trimethylsilyl phosphite fails to react either in a 1,2- or a 1,4-addition 
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in the absence of a protic acid. However, in a sufficiently acidic medium, 
dialkyl trimethylsilyl phosphite is able to convert α,β-unsaturated imines 19 
very fast to the diphosphonates 196 in one single step via a sequential 
tandem 1,4-1,2-addition. A number of other synthetic pathways towards 
diphosphono glutamic acid analogues can be found in literature that can be 
subdivided in two groups. The first group uses β-phosphono aldehydes that 
are converted to the corresponding imines and subsequently 
phosphonylated.217-219 The second group uses a Michael type addition of N-
protected aminomethyl phosphonate anions to a vinyl phosphonate.113,220 
However these methods are far less versatile and are all comprising multiple 
steps. 
 
1.3.4 What about trialkyl phosphites? 
The newly discovered221 unusual behaviour of dialkyl trimethylsilyl 
phosphites towards α,β-unsaturated imines prompted us to evaluate other 
methods presented in literature to exclusively yield 1,2- or 1,4-adducts. In 
particular, the resemblance of trialkyl phosphites to dialkyl trimethylsilyl 
phosphites, put forward these nucleophiles as potential tandem addition 
candidates. Nevertheless, the use of trialkyl phosphites may require special 
conditions in order to obtain similar results.  
 
The addition of triethyl phosphite to α,β-unsaturated imines has been 
reported to proceed with complete 1,4-regioselectivity when tBu groups were 
used on nitrogen.215 A slight excess of formic acid was added to dealkylate 
the intermediate phosphonium salt 220.  
 
R H
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H
N
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H+/H2O
R
(EtO)2P
O
H
O
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This method was used earlier in this research (chapter 3, section 1.3.3) to 
reveal the identity of the 1,4-adducts as intermediates in the tandem 
DAPTMS addition to α,β-unsaturated imines. However, the corresponding iPr 
imine 19g was used and small amounts of double addition products could be 
detected using 31P NMR (see Figure 7d). Therefore, the reaction was repeated 
using less steric nitrogen substituents. The ratios of both products were 
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measured using 31P NMR from the crude reaction mixtures after standard 
aqueous work-up.  
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R = tBu; 216b:196k = 99 : 1
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Less steric nitrogen substituents gave rise to higher conversion to the PAP’s 
196. In case of imine 19a, the PAP 196b was the major reaction product next 
to residual starting material 19a, since only 1 equivalent of the nucleophile 
was used. This reactivity order is opposite to the results with DAPTMS as a 
nucleophile; highly steric tBu groups gave the best results with DAPTMS, 
while with imine 19a only the 1,2-adducts could be obtained. 
 
When two equivalents of phosphite were used together with two equivalents 
of formic acid, the PAP’s were obtained in short times and high yields (Table 
6). With tBu imine 19h, only the 1,4-adduct could be obtained. Comparable 
to the DAPTMS additions, the role of the acid was also essential to this 
reaction. The reaction proceeded violently upon addition of formic acid to a 
solution of the imine and TAP in ethanol (or methanol). Next to imine 
activation and enamine tautomerization, the acid (or its conjugated base) is 
also required for dealkylation of the phosphonium intermediates. 
 
Table 6: Addition of TAP to α,β-unsaturated imines 19 
Diast. Ratio 
Imine R TAP Product Time Yield 
TAP DAPTMS# 
19h tBu TEP  Exclusive 1,4-addition 
19g iPr TEP 196i 24 h 90% 38/62 33/67 
19b Bn TEP 196d 30 min 78% 33/67 29/71 
19d Allyl TEP 196f 30 min 70% 72/28 67/33 
19a Ph TMP 196a 30 min 86% 34/66 - 
19a Ph TEP 196b 30 min 86% 21/79 - 
# From Table 3 
 
 
From these experimental results it is clear that both addition reactions of 
TAP and DAPTMS to α,β-unsaturated imines 19 proceed very fast in acidic 
media, yielding the corresponding diphosphonates 196 in high yield and 
purity. Both reactions proceed via the tandem 1,4-1,2-addition mechanism, 
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which is also indicated by the similar diastereomeric ratios (Table 6). In case 
of TAP, the 1,4-addition is clearly favoured, causing the 1,4-adduct to be the 
sole reaction intermediate, or final product in case the subsequent 1,2-
addition is blocked (e.g. due to steric hindrance). From the discussion in 
chapter 3, section 1.3.3, it became clear that the mechanism is more 
complicated for the DAPTMS addition. In that case, the 1,2-addition is 
favoured kinetically over the 1,4-addition, causing the 1,2-adducts to appear 
very fast in the reaction mixture. Therefore, it should be concluded that TAP 
is more sterically demanding in this type of reactions than DAPTMS, which is 
quite surprising at first sight comparing the OEt with the OTMS group. 
 
A possible explanation for this unexpected behaviour of DAPTMS can be 
found in the reaction mechanism of DAPTMS additions often presented in 
literature.222 In this mechanism, coordination of the imine nitrogen atom with 
the silicon atom is suggested, which would bring the (bulky) nucleophile in 
the close neighbourhood of the electrophilic center. Because of the presence 
of both a nucleophilic and an electrophilic center in the silylated phosphite, 
the subsequent transformation then occurs via a classic ‘push-pull’ 
mechanism.201 
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The 1,4-addition with DAPTMS on the other hand, probably proceeds similar 
to that with TAP, i. e. without prior coordination with nitrogen. Furthermore, 
the fast 1,2-addition of DAPTMS has proven to be a reversible reaction, which 
makes the 1,2-adduct only a transient intermediate. Therefore, only limited 
amounts of substrate (imine) are available for the 1,4-addition, causing it to 
be the rate determining step. The final 1,2-addition proceeds smoothly 
through nitrogen, silicon coordination. The number of reactive imine 
molecules is increased when the 1,2-addition is slowed down by sterically 
demanding nitrogen substituents, resulting in a faster 1,4-addition and 
subsequent PAP formation. When TAP is used, no 1,2-adduct formation is 
observed because of the lack of coordination. 1,4-Addition proceeds through 
a classical nucleophilic attack. The final 1,2-addition then is the rate 
determining step, which, for clear reasons, is disfavoured by the same 
sterically demanding nitrogen substituents. These exceptional reaction 
kinetics, rather than simply steric differences, may explain the opposite 
reactivity order for both reagents. 
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1.3.5 Diphosphonic acids 
Since the α-amino phosphonates mostly exert their activity as amino acid 
analogues, most examples of active compounds comprise the free phosphonic 
acids rather then the corresponding esters. In contrast to carboxylic acids, 
the phosphonic acids are dibasic and are significantly more acidic (pKa1 = 
2.2-3.0, pKa2 = 7.7-9.0).223 A general method for dealkylation of phosphonates 
is the use of TMSBr.224  
 
When PAP 196h is treated with 5 equivalents of TMSBr and stirred for 1 h at 
room temperature in dichloromethane, the corresponding silylester 225 is 
obtained.§ Then water is added to hydrolyse the silylesters and the 
corresponding phosphonic acids are obtained as a viscous oil after 
evaporation of the volatiles. 
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When the same conditions were used with N-tBu PAP 196j and N-Bn PAP 
196c, the corresponding diphosphonic acids 226b,c were obtained as a solid 
in quantitative yields. While the oily iPr-derivative 226a was slightly soluble 
in water (and D2O), the solids were insoluble in water, methanol, DMSO, 
acetone, chloroform, dichloromethane and benzene. Therefore, their 
structure could only be confirmed by mass spectroscopy with electron spray 
ionization and 31P NMR in D2O. No satisfying 1H and 13C NMR data could be 
recorded because of the too low solubility.  
 
The corresponding sodium salts were expected to be more soluble. Therefore, 
NaOD was added to a suspension of diphosphonic acid 226b in D2O. This 
resulted in a clear solution, however with structural alterations to the 
product according to 31P NMR. When solid NaHCO3 was used as a milder 
base, solubility remained too low. Finally a suspension of 226b in D2O 
turned into a clear solution upon addition of an excess of triethylamine. In 
order to avoid the presence of free triethyl amine during product 
characterization, a suspension was made of the phosphonic acids in 
methanol. Then a large excess of triethyl amine was added and a white solid 
was obtained after evaporation of the volatiles. The triethylammonium salts 
were very soluble in D2O and spectral data were easily collected confirming 
the structure of the parent diphosphonic acids.   
                                           
§ This can be easily observed by a 5 and 15 ppm drop of the 31P chemical shifts.  
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From an atom efficiency point of view, the two step preparation of the free 
phosphonic acids via the corresponding ester is not favourable. Therefore, a 
straightforward one-pot synthesis was evaluated using tris(trimethylsilyl) 
phosphite as a nucleophile (P(OTMS)3), which is known to show even slightly 
improved nucleophilicity compared to the corresponding dialkyl esters 
(DAPTMS).201 The tandem 1,4-1,2-addition then should yield the 
corresponding bis(trimethylsilyl) phosphonates 230 which can then be 
hydrolyzed to the corresponding diphosphonic acids. 
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P(OTMS)3 can be prepared starting from phosphoric acid 184a. Addition of 
two equivalents of TMSCl smoothly results in the disilyl ester 227 and 
hydrochloric acid at room temperature in dichloromethane. In order to 
achieve complete conversion to the σ3λ3 phosphite 228, the presence of a 
base is required to shift the tautomeric equilibrium. At least three 
equivalents of base have to be added together with the final equivalent of 
TMSCl in order to neutralize the liberated hydrochloric acid. The course of 
the reaction can be easily monitored using 31P NMR. Removal of the 
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triethylammonium chloride salts by filtration resulted in too high degrees of 
hydrolysis. Therefore, the P(OTMS)3 reagent was used in situ as a mixture 
with the ammonium salts. 
 
The reaction of P(OTMS)3 with imine 19h in refluxing dichloromethane was 
monitored using 31P NMR (Figure 8). A similar reaction course was found as 
can be seen in Figure 1 for the DEPTMS addition in the presence of Et3NHCl. 
The 1,2-addition proceeds relatively fast, while the PAP is formed more slowly 
as the final product of the reaction. After 40 h, 1 equivalent of sulphuric acid 
was added which caused the reaction to speed up as could be expected. 
Finally, the salts were filtered of and the reaction solvent was replaced with 
methanol. Stirring was continued at room temperature and the free 
phosphonic acids precipitated during an overnight period. The use of 
methanol instead of water to perform the trimethylsilyl deprotection was 
justified because of the formation of silyl ethers that are more volatile and 
more easy to remove from the final reaction mixture than the corresponding 
silanols. 
 
 
Figure 8: Course of the diphosphonylation reaction of imine 19h (R = tBu) with 2 
equivalents of P(OTMS)3 in the presence of HNEt3Cl at 40°C. One equivalent of 
sulphuric acid H+ was added after 40 h. PAP 230b (); AP 229b (); 
P(OTMS)3 228 (∆). 
 
 
Then imines carrying other nitrogen substituents were evaluated. The same 
tendency in reactivity was found as with DAPTMS: more steric substituents 
speed up the PAP formation. Addition of sulphuric acid did result in an 
acceleration of the reaction, although not as enormous as was the case with 
DAPTMS. This may be due to the buffering capacities of the ammonium salts 
still present in the reaction mixture.  
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When sulphuric acid was added as a proton source, no precipitation 
occurred during the methanolysis of the silyl esters in several cases (or only 
in low yield). This might be contributed to the sulphate ions present in the 
reaction mixture, which may tend to form complexes with the PAP’s 
preventing them to precipitate. Highly viscous, yellow oils were obtained after 
evaporation of the volatiles, which showed better solubility than the 
precipitated diphosphonic acids. Spectral data (including MS) indicated that 
both forms originate from the same product. Further research may be 
required to determine the exact properties of this kind of diphosphonic acids. 
 
 
Figure 9: Course of the diphosphonylation reaction for different PAP’s 226b (R = tBu 
(■)); 226a (R = iPr (∆)); 226c (R = Bn ()) with 2 equivalents of P(OTMS)3 in the 
presence of HNEt3Cl and one equivalent of sulphuric acid at 40°C. The course of PAP 
226b (R = tBu) without addition of sulphuric acid is added for reference purposes 
(). 
 
 
1.3.6 Biological perspectives 
The obtained diphosphonates can be of major importance because of their 
high similarity to glutamic acid. (S)-Glutamic acid (Glu) is the main excitatory 
neurotransmitter in the central nervous system (CNS) and operates through 
two main heterogeneous classes of receptors: ionotropic225-227 (iGluR’s) and 
metabotropic228-231 (mGluR’s) receptors. Both classes are further subdivided 
into several subclasses, but the number of functional receptors in the CNS is 
not known. Selective Glu agonists and antagonists are not only important for 
the characterization of different Glu receptor subtypes, but also for the 
treatment of CNS diseases232 such as epilepsy, Huntington’s disease, 
Parkinson’s disease, dementia, chronic pain,…233 Therefore, the Glu receptor 
field has been, and continues to be, in a state of almost explosive 
development.234-236 A number of phosphonic acid Glu analogues is known as 
t/h 
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potent selective Glu antagonists or agonists.237 Substitution of the 
carboxylate group by a bioisosteric phosphonic acid group is known to 
increase the receptor selectivity.233 For instance (S)-AP4 231 is shown as a 
group III mGluR agonist, some 10-fold more potent than Glu.238 (S)-AP5 14 
activates the same group III receptors, but with markedly lower potency and 
selectivity. (R)-AP5 232 on the other hand does not interact detectively with 
mGluR’s, but is a potent and selective competitive NMDA (iGluR) antagonist. 
Conformational restriction, such as in CPP 15, is known to enhance 
selectivity. 
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The diphosphonic acid analogue 233 (“PAP4”) has been tested several times 
as a Glu-analogue without any activity so far.239-243 However, further research 
into new bioisosteres has been indicated as a fruitful path to new subtype-
selective mGluR ligands. 
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1.4 Direct phosphonylation of aldimines with dialkyl phosphites 
The addition of dialkyl phosphites to imines, as presented by Fields180 and 
Pudovik,182 to give the corresponding α-aminoalkyl phosphonates, is an 
interesting reaction regarding straightforward methodology and the 100% 
atom efficiency. Furthermore, all expensive or toxic additives that are 
presented to improve the reaction yield (see chapter 3, section 1.1) are 
redundant. However, without additives, very high temperatures are necessary 
and the reaction is performed without solvent (or with a large excess of 
dialkyl phosphite as reagent and solvent) giving rise to highly viscous 
reaction mixtures and uncontrolled crystallization.244-247 Furthermore, the 
reaction suffers from thermal breakdown of labile compounds.  
 
However, while the reaction is very sluggish or non-specific in most solvents, 
good results were obtained when lower alcohols were used.248 Even then, two 
equivalents of phosphite are necessary to get complete conversion in 
reasonable reaction times. Using these conditions, complete conversion is 
usually obtained after 2 to 3 hours of reflux. The resulting reaction mixture 
then consists of the desired α-aminoalkyl phosphonate and 1 equivalent of 
phosphite, which can be removed using a simple acid base extraction. HCl 
salts of some α-aminoalkyl phosphonates containing 2 phenyl rings are quite 
soluble in dichloromethane. Therefore, diethyl ether should be the solvent of 
choice for the acidic extraction step. The alcoholic solvent should be chosen 
in function of the phosphite ester, since some transesterification was 
observed at higher temperatures. 
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The methodology is applicable for a wide range of aldimines: aromatic and 
aliphatic, sterically hindered, electron poor and electron rich imines all react 
with the phosphite with comparable ease and yield (Table 7). Ketimines, 
neither hydrazones nor aldehydes showed any reaction under the same 
conditions. α,β-Unsaturated imines are an interesting special case in the 
light of the results presented in chapter 3, section 1.3. In all cases, exclusive 
1,2-addition of dialkyl phosphites is observed. Several reaction mechanisms 
have already been presented for the formation of α-aminoalkyl 
phosphonates.249 From our experiences, the reaction mechanism proposed by 
Sobanov and coworkers250 is most likely. This mechanism involves H-bridge 
type interaction between the nitrogen atom and the phosphite proton. The 
transition state is presented as a four membered ring complex which finally 
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yields the α-aminoalkyl phosphonate through reorganisation of bonds. This 
kind of interactions should be more favoured in protic solvents. 
 
Table 7: Synthesis of α-aminoalkyl phosphonates 22 
Nr R1 R2 R3 Yield(%)# 
22b CH=CHPh Bn Me 96 
22c CH=CHPh Bn Et 95 
22d CH=CHPh PMB Me 86 
22e CH=CHPh Allyl Me 95 
22f CH=CHPh CH2C(CH3)=CH2 Me 74 
22h CH=CHPh iPr Me 94 
22i CH=CHPh iPr Et 95 
22j CH=CHPh tBu Me 97 
22k CH=CHPh tBu Et 93 
22l CMe=CHPh Allyl Me 90 
22m C(isoamyl)=CHPh Allyl Me 88 
22n CCl=CHPh Allyl Me 54 
22o CHPh=CHMe Allyl Me 86 
22p CHBn=CHMe Allyl Me 29§ 
22q CH[(CH2)2Ph]=CHMe Allyl Me 44
§ 
22r CH=CH(o-NO2Ph) Bn Me 77
¤ 
22s CH=CH(o-NO2Ph) CH2C≡CH Me 58 
22u 
 
Bn Et 88 
22v 
 
Allyl Me 85 
22w 
 
iPr Me 39 
22x 
 
tBu Me 60 
22y Furyl Bn Me 89 
22z Furyl Allyl Me 89 
22ab Furyl tBu Me 63 
22ac Ph Bn Me 89 
22ad Ph iPr Me 94 
22ae Ph iPr Et 84 
22af cHex iPr Me 93 
22ag iPr Bn Me 84 
22ah iPr iPr  Me 86 
# Yield determined after acid/base extraction. 
§ Yield starting from the aldehyde 
¤ Isolated as the hydrochloride salt 
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It should be noted that no explicit nucleophilic attack of the phosphite 
occurs to the imine. This may explain the excellent results using a “poor” 
nucleophile. The absence of 1,4-adducts in the case of α,β-unsaturated 
imines indeed supports the four membered ring complex. In the case of a 
“real” nucleophilic attack of the dialkyl phosphite through its σ3λ3 tautomer, 
1,4-addition should be at least a competing reaction as it is the case with 
similar trialkyl and dialkyl trimethylsilyl phosphites. 
 
In conclusion an excellent high yielding, straigthforward, very mild and 
economic reaction pathway is presented here towards α-aminoalkyl 
phosphonates starting from aldimines. The exclusive 1,2-addition of dialkyl 
phosphites to α,β-unsaturated imines supports the mechanism involving a 
four-membered ring complex as a transition state. Furthermore, performing 
the reaction in a non-corrosive solvent makes it very well suitable for medium 
scale continuous production using a microreactor system.248 
 
The obtained dialkyl α-aminoalkyl phosphonates 22 can be converted to the 
corresponding monoalkyl phosphonates 237, which might be of interest in 
view of their bioavailability to living cells. Monodealkylation can be obtained 
using base mediated hydrolysis from the corresponding dialkyl phosphonates 
only under drastic experimental conditions. Potassium trimethylsilanolate 
(KOTMS), however, has been recently presented to afford the desired 
monoalkyl phosphonates with high purity and yield in anhydrous THF, 
diethyl ether or dichloromethane.251 KOTMS is a common equivalent of 
hydroxide anion.252 However, it has two unique advantages over hydroxide 
anion: (i) it has appreciable solubility in organic solvents and (ii) the oxygen 
silicon bond can be very often easily cleaved under mild reaction conditions. 
 
When aminoalkyl phosphonate 22ad was treated with 1.5 equivalent of 
KOTMS in anhydrous ether, the corresponding mono potassium salts 237a 
precipitated after 1 h at room temperature and were easily isolated by 
filtration. Phosphonates 22af,z required two days at room temperature before 
precipitation occurred. The selective monodealkylation can be explained by a 
nucleophilic attack of the silanolate anion onto the phosphonate group. A 
pentacoordinated intermediate 235 is formed, which returns to the more 
stabile σ4λ5 phosphonate 236 form by elimination of methoxide. Methoxide 
subsequently attacks the silicon atom and the resulting methoxysilane is 
removed during filtration and evaporation. A second nucleophilic attack is 
disfavoured because of the presence of a net negative charge on the 
phosphonate group. It should be noted that the central, tetrahedral 
phosphorus atom in 237 is surrounded by four different substituents, 
causing it to be chiral. However, no diastereomers were observed using NMR 
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which can probably be explained by the existence of a mesomeric equilibrium 
distributing the negative charge equally over both oxygen atoms. 
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1.5 Conclusion 
Because of the biological potential of α-aminoalkyl phosphonates and 
phosphonic acids, numerous preparation methods have been presented in 
literature during the last six decades involving additions of phosphorus 
nucleophiles to imines or three component reactions of an aldehyde or 
ketone, an amine and a phosphorus nucleophile. Nevertheless, not a single 
research group has properly addressed the regioselectivity related to the use 
of α,β-unsaturated imines.  
 
Tricoordinated phosphites, such as dialkyl trimethylsilyl phosphites or 
trialkyl phosphites, initially react with α,β-unsaturated imines in a 1,4-
fashion. However, the resulting enamine easily undergoes tautomerization 
yielding a β-phosphono imine, which is again susceptible to 1,2-addition by 
the phosphite. The results from this research reveal that the phosphite 
nucleophiles do not show an absolute preference to 1,4-addition. Therefore, 
the β-phosphono imine is further processed to the double addition product. 
The complex spectra of the obtained PAP’s combined with the distinct 
properties of both phosphite reagents have caused researchers to fail to 
observe this particular reactivity. These special properties of DAPTMS and 
TAP have been discussed in chapter 3, section 1.3.3 and 1.3.4.  
 
DAPTMS has a high tendency towards 1,2-addition to imines because of 
coordination between the nitrogen and the silicon atom. This caused the 1,4-
addition to proceed much slower than the 1,2-addition and explains why 
DAPTMS was reported earlier to perform the addition with complete 1,2-
regioselectivity. However, although kinetically favoured, 1,2-addition of 
DAPTMS is reversible causing the 1,2-adduct to disappear again from the 
reaction mixture in favour of the 1,4-adduct, even when only one equivalent 
is used. This was expressed in the initially reported results by the decreasing 
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yields when the bulk of the nitrogen substituents was increased. 
Furthermore, neither 1,2-adition, nor 1,4-addition occurs at all in the 
absence of protons. 
 
TAP on the other hand shows a high tendency towards 1,4-addition to 
imines, probably because of the softness and steric bulk of the nucleophile. 
The enamine and β-phosphono imine are easily formed but the 1,2-addition 
is slowed down. This caused Teulade and Savignac215 to report exclusive 1,4-
addition of TAP to tBu-imines, while imines with less sterically demanding 
nitrogen substituents probably gave mixtures of “unidentifiable” products.  
 
Dialkyl phosphite, finally, has been reported as a poor nucleophile, requiring 
some type of activation in order to perform nucleophilic additions. DAP was 
reported to add to imines only under harsh conditions using no solvent and 
high temperatures. This may not be suitable for labile products and may 
cause difficulties regarding mixing of the reaction and isolation of the end 
products. This was easily overcome in this research by performing the 
reaction in a protic solvent (alcohols) with 2 equivalents of DAP. Imines 
smoothly react with DAP under these conditions at moderate temperatures. 
The products are conveniently isolated by acid/base extraction, which allows 
large scale preparations. Furthermore, complete 1,2-regioselectivity can be 
observed in case of α,β-unsaturated imines, indicating that a third 
mechanism is operating during the reaction: a four membered transition 
state complex is formed through H-bridge type interactions yielding 
exclusively the 1,2-addition products through reorganization of bounds. 
 
In conclusion, a new light has been thrown on the phosphite additions to 
imines. Large differences have been established between three types of 
phosphorus nucleophiles. Furthermore, also the reaction conditions are 
critical for the final result of the reaction. Nevertheless, 1,2-, 1,4- and 
1,2/1,4-adducts are accessible using the methods developed in this section. 
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2 Synthesis of 4-phosphono β-lactams 
2.1 Introduction 
Since the advent of the antibiotic era with sulfonamides in the 1930’s, 
medical science has witnessed the successful therapeutic application of 
numerous classes of antibiotics, targeting different units of the bacterial cell 
(Figure 10). From these classes, compounds targeting the bacterial cell wall 
are of special interest. The bacterial cell wall is a macromolecular structure 
consisting of peptidoglycan that is essential to all bacteria and has general 
functional and structural features that are highly conserved across multiple 
pathogens. Most importantly, it is not present in mammalian cells and 
therefore, antibiotics targeting the bacterial cell wall have a low incidence of 
mechanism-based toxicity.253 
 
Figure 10: Sites of action of various antimicrobial agents (adaptation from ref. 254). 
PABA, p-aminobenzoic acid; DHFA, dihydrofolic acid; THFA, tetrahydrofolic acid. 
 
 
Peptidoglycan consists of linear glycan chains of alternating N-
acetylglucosamine and N-acetylmuramic acid units connected by β(14) 
linkages. These chains are interlinked by short peptides (transpeptidation) to 
form a rigid, polymeric material, which main functions are to preserve cell 
integrity by withstanding the internal osmotic pressure, to maintain a well 
defined cell shape and to participate in the cell division process.255 A group of 
enzymes that belong to a protein family collectively known as “penicillin 
binding proteins (PBP)” are responsible for the transpeptidation reaction. PBP 
transpeptidases bind to the D-Ala-D-Ala residues of a ‘donor’ peptidoglycan 
strand and the terminal D-Ala residue is cut off. An acyl-enzyme 
intermediate is formed between the carbonyl of the penultimate D-Ala and an 
active site serine of the PBP, which reacts with the amine of an ‘acceptor’ 
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peptidoglycan strand to form a cross-link between the strands. PBP 
carboxypeptidases on the other hand moderate the degree of cross-linking by 
removing the terminal D-Ala of the peptidoglycan, hence preempting the 
possibility of cross-linking.256 
 
The activity of β-lactams drugs such as penicillin and cephalosporin, comes 
from their ability to mimic the D-Ala-D-Ala moiety of peptidoglycan. When 
the PBP-enzymes are submitted to these substrate mimetics, the initial 
acylation reaction remains enabled (with opening of the β-lactam), but the 
capacity for deacylation is abolished causing the enzyme to fail to complete 
its catalytic cycle.257 The loss of these enzymatic activities yields a cell wall 
unable to withstand osmotic forces. Bacteriolysis is accelerated by the action 
of autolysins destroying the existing cell wall.258 
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The introduction of antibiotics helped drop the death rates from infectuous 
diseases from 797 per hundred thousand in 1900 to 36 per hundred 
thousand in 1980, a 20-fold improvement.259 However, antibiotics select for 
those very rare bacteria in a population that are less susceptible and allow 
them to become dominant in the population as susceptible bacteria die off. 
This process has already resulted in some fully resistant pathogens.254,260 β-
Lactams in particular have been exposed to serious resistance problems. For 
example, clinically significant antibiotic resistance to penicillin V has ensued 
from introduction into human therapeutic use after only one year.259 The 
underlying mechanisms of this resistance are (i) alterations (mutations) in 
the PBP transpeptidases, (ii) the occurrence of β-lactam hydrolytic 
deactivating enzymes (β-lactamases), (iii) reduced permeability of the 
antibiotics (because of porin deficiency in the outer membrane of Gram 
negative organisms or modification of the cell wall) and (iv) acquisition and 
activation of efflux exporter proteins.257,261 
 
Of these resistance mechanisms, the occurrence of β-lactamases is clinically 
the most important. These enzymes have in common with the PBP’s to 
undergo acylation at an active site serine by β-lactam antibiotics. However, in 
β-lactamases the acyl-enzyme complex is easily hydrolysed, regenerating the 
active enzyme together with the ring-opened inactive antibiotic. The number 
of known β-lactamase enzymes is currently approaching 500.262 They are 
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subdivided into 4 classes: class A, C and D are constituted active site serine 
enzymes and class B consists of Zn2+ requiring enzymes.257,261,263 Intriguingly, 
class A and C β-lactamases are believed to have evolved from the  PBP’s by 
acquiring a catalytic hydrolytic step and reduced peptidoglycan 
recognition.264-266 
 
Two main therapeutic strategies have been adopted to counteract bacterial 
resistance to β-lactam antibiotics. One involves the design of new antibiotics 
which are not susceptible to β-lactamase catalysed hydrolysis. The other is to 
use an inhibitor of the β-lactamase together with a normal β-lactam 
antibiotic. 
 
An historic overview of the development of new β-lactam antibiotics can be 
found in many review articles.258,267 Initially, new antibiotic derivaties were 
obtained by altering the side chains present on the bicyclic β-lactam core in 
penicillin or cephalosporin. This resulted in enhanced or broadend activity 
and improved pharmakinetic properties. However, it was only with the 
introduction of the methoxy group directly on the four membered azetidinone 
ring in Temocillin 240 that an important break-through was achieved in 
terms of β-lactamase stability. 
 
Next to side chain and substitution pattern alteration, also structural 
modifications to the bicyclic cephem and penam unit have been made. The 
oxacephem Latamoxef 241 is very active against Gram-negative aerobes and 
anaerobes. Carbapenems (e.g. imipenem 242) on the other hand have the 
broadest spectrum of activity of all β-lactam antibiotics and great β-
lactamase stability (resulting from the trans-configured 6-hydroxyethyl 
group).268-270  
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Also certain monocyclic β-lactams have been found to possess excellent 
antibiotic activities. The first members of this class were nocardicins, which 
however do not have any clinical importance.271,272 The only clinical used 
monocyclic β-lactam is Azthreonam, which is a semisynthetic member of the 
monobactam family. Monobactams (or Sulfazecines as they were called in 
early publications) were isolated in 1981 by two research groups 
independently from bacterial media and are characterized by a sulfonic acid 
substituent on nitrogen.273,274  
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However, isolation from fermentation broths was not a valuable technique, 
since mixtures of monobactams were obtained. In order to improve the 
activity against Gram-negative bacteria, (semi)synthetic pathways to the 3-
monobactam building block 244a were developed from natural penam275 and 
cephem276,277 nuclei. The total synthesis starting from threonin presented by 
the Squibb group278 led to the 3-amino 4-methyl sulfonylated azetidinone 
building block 244b, which was the basis for further functionalization to 
Azthreonam 246. Because of the 4-methyl substituent, it is highly resistent 
to β-lactamases.279 Furthermore, it shows low toxicity and excellent 
pharmacologic properties.  
 
Further structural modification of the monobactam core as a lead structure 
resulted in other classes of antibacterial monocyclic β-lactams such as N-
sulphato lactams, N-phosphato lactams, phosphams and oxamazins.267,280,281  
Phosphams, carrying a monoalkyl phosphonate group on the nitrogen atom, 
offer increased β-lactamase stability at the expense of lower antibacterial 
activity.279,282 Recent research has shown that monocyclic β-lactams, which 
do not show the typical anionic center, can possess potent antibacterial 
activity, indicating that the mechanism of action for these lactams is totally 
different from all previous classes. Examples are N-thiolated 2-
azetidinones,283,284 N-aryl 3,3-dichloro-4-aryl-2-azetidinones,285 N-aryl 3,3-
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diphenyl-4-aryl-2-azetidinones286 and N-thiazolyl 3-chloro-4-aryl-2-
azetidinones.287 Although the perceived failure of new technologies to create 
another golden era of new antibacterial classes has led many large 
pharmaceutical companies to prioritise other areas of research,288,289 
continuing efforts towards old and new targets290-292 have resulted in several 
antibacterial agents currently at or beyond phase 1 clinical trials (e.g. 2 
carbapenems and 3 cephalosporins).280,293,294 
 
As already mentioned, a second strategy to counteract bacterial resistance to 
β-lactam antibiotics through the action of β-lactamases, is the development 
of β-lactamase inhibitors.295 These compounds may not show antibacterial 
activity on themselves, but are used in preparates with (older) β-lactam 
antibiotics to ensure their proper functioning. Two clinical important groups 
are clavulanic acid 247 and the penicillanic acid sulphones (sulbactam 248 
and tazobactam 249).258,296 Also monocyclic β-lactams have been found with 
good inhibitory activity towards β-lactamases.297  
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Phosphonates have been studied as potential transition state analog 
inhibitors of β-lactamases. Acyclic phosphonate monoesters 250 are 
inhibitors of class C and A β-lactamases with increasing activity correlated to 
the leaving group capacity of the phenol group. The mechanism is based on 
phosphorylation of the active site serine residue.298-301 Also 
phosphonamidates 251 which bear a simple resemblance to penicillin type 
structures have been found active as active site phosphorylation agents in 
class C β-lactamases.302 Their activity is pH dependent as the nitrogen atom 
has to be protonated in order to become a good leaving group. Their 
mechanism for phosphyl group transfer involves a pentacoordinate 
intermediate with trigonal bipyramidal geometry. The difference between 
class A and C can be found in the amino acids that are participating in the 
proton transfer steps. As a consequence of this difference, the deacylation of 
the enzyme is the rate determining step in class C β-lactamases.  
 
The mechanism based inactivators which have been used against the serine 
enzymes are generally ineffective against this class of enzymes. Class B 
lactamases are inhibited by several thiol derivatives because of their ability to 
coordinate at the zinc active site.262,303  
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In recent years, β-lactam compounds have also found utility as inhibitors of 
other ‘serine’ enzymes and, in particular the family of serine proteases. These 
enzymes are involved in numerous important physiological processes 
including protein tunrover, digestion, blood coagulation, wound healing,… 
Therefore, protease inhibitors have considerable potential utitlity for 
therapeutic intervention in a variety of disease states such as cancer, viral 
infections, inflammation, Alzheimer’s disease, etc…304 Inhibition of these 
enzymes by β-lactams is also believed to originate from the inability of the 
acyl-enzyme complexes, formed by nucleophilic attack of the active site 
serine residue on the β-lactam ring, to undergo efficient deacylation. For this 
reason, several compounds that were known as β-lactamase inhibitors, were 
also found to inhibit certain serine proteases.305,306 
 
Also monocyclic azetidinones are suitbale serine protease inhibitors, provided 
that they are adequately functionalized with substituents raising specific 
enzyme recognition and chemical activation towards nucleophilic attack. 
Monocyclic azetidinones have been found that inhibit elastase (HLE and 
PPE),307-309 HCMV protease,310-312 thrombin313 and human chymase.314 
Irreversible acylation of the enzyme is often obtained by having leaving 
groups in the 3-, 4- or 1-position of the 4-membered ring or by activating a 
second functional group through ring-opening of the β-lactam that can react 
with another amino acid residue in the active center of the enzyme (the so-
called double hit or suicide mechanism).307,315 
 
The widespread biological potential of the azetidinone ring has stimulated a 
tremendous amount of investigations, including the development of synthetic 
pathways to basic azetidinone skeletons.45 However, only a limited number of 
synthetic patways towards phosphono β-lactams have been presented in 
literature so far (see chapter 2, section 1). [2+2] Cycloadition between a 
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ketene and an imine, which is probably the most exploited reaction in the 
stereospecific synthesis of β-lactams, has not proven useful yet in the 
synthesis of phosphonylated lactams. While the formation of the β-lactam 
ring via C3-C4 ring closure is less well known, it represents however a 
valuable alternative for the synthesis of 4-phosphono lactams 23. N-
chloroacetyl 1-aminoalkyl phosphonates 21 would be appropriate substrates 
for ring closure via an intramolecular alkylation reaction of a phosphorus 
stabilized anion. These N-chloroacetyl 1-aminoalkyl phosphonates 21 can be 
prepared via two related pathways: (i) acylation of a suitable 1-aminoalkyl 
phosphonate 22, or (ii) one-pot phosphonylation of an in situ generated N-
acyliminium ion 20. 
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2.2 Preparation of N-chloroacetyl 1-aminoalkyl phosphonates 
2.2.1 Acylation of 1-aminoalkyl phosphonates 
Acylation of the 1-aminoalkyl phosphonates obtained in chapter 3, section 
1.4 can be performed using acid chlorides. THF was selected as the best 
solvent after some initial experiments. The reactivity of the 1-aminoalkyl 
phosphonates was strongly dependent on the substrate properties. 1-Furyl 
methyl phosphonates reacted violently with the acid chloride simply using 
triethyl amine to scavenge the liberated hydrochloric acid (Table 8, entry 1-2). 
Complete conversion took place in typically 30 minutes at room temperature. 
When 1-(2-phenylethenyl) phosphonates were used as substrates, an excess 
of pyridine relative to the acid chloride (entry 9 vs. 11) was required as a 
nucleophilic catalyst in order to obtain a clean and complete conversion to 
the acylated products after stirring the reaction mixture for 2 h at room 
temperature (entry 9-16). The excess of acid chloride is easily removed by 
washing the reaction mixture with a saturated NaHCO3(aq) solution, while 
pyridine and any residual starting material were removed by subsequent 
washing with 0.5 M HCl(aq).  
 
R1 P(OR3)2
HN
R2
O
Cl R4
O
+
R1 P(OR3)2
N
R2
O
R4
O
22
135
21
1.5 eq.
Table 8
 
 
With 1-phenyl or 1-alkyl methylphosphonates, acylation proceeded sluggishly 
producing many side products (entry 20-27). The strongest acylation 
conditions proved to be refluxing in THF using pyridine as a base and 0.2 
equivalent of DMAP as a nucleophilic catalyst. Nevertheless, in many cases, 
the desired products could not even be obtained in satisfying purity after 
column chromatography. Furthermore, substrates with bulky nitrogen 
substituents (tBu) or sterically hindered acid chlorides (e.g. pivaloyl chloride) 
failed to react in all cases. Also PAP’s 196 have been used as a substrate in 
the acylation reaction, although without any success. Regardless of their use 
as a precursor of 4-phosphono β-lactams, related N-chloroacetyl 1-
aminoalkyl phosphonates may also have some biological significance. N-
acylated 1-aminoalkyl phosphonates are known to be well transported 
through biological membranes.316 
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2.2.2 One-pot phosphonylation of N-acyliminium ions 
N-acyliminium ions 20 are well known to have highly versatile reaction 
characteristics, which is reflected in an impressive number of synthetic 
applications.317,318 Being related to the Mannich reagents 259, their imino 
carbon atom is even more electron-poor because of the presence of an 
electron withdrawing carbonyl group. Due to this strongly electrophilic 
nature, they are readily attacked by nucleophiles, e.g. phosphorus 
nucleophiles, which has been extensively exemplified for the synthesis of 
azaheterocyclic phosphonates in chapter 2. Because of their limited stability 
and high reactivity, acyliminium ions are almost always generated in situ. N-
acyliminium ions can be generated for instance by heterolysis of amides 
bearing a leaving group on the α-carbon (see chapter 2, sections 1.2 and 2.2 
for relevant examples), by oxidation of amides or by N-acylation of imines. 
 
N
R3 R4
R2R1
N
R3 R4
R1
O
R2
256 20
Cl-
N
R3 R4
R1
O
R2
Cl
257  
 
When an aromatic imine 19 was treated with 1.1 equivalent of chloroacetyl 
chloride in toluene at –40°C, acyliminium salt 20 was formed.46,47 The 
structure of this species is often presented as 257 in which a covalent bond 
exists between the chlorine and the imine carbon atom. Due to their 
hydroscopic nature, the acyliminium intermediates 20 could not be isolated 
from the reaction mixture for structural characterization. Nevertheless, the 
reaction can be followed visually by the precipitation of the salts in toluene, 
which clearly points to the ionic nature of these species. It should be noted 
that from both proposed structures 20 and 257 the same reactivity can be 
expected and therefore, the acyliminium adducts will be presented in their 
ionic form in the rest of this manuscript.  
 
Reaction of the acyliminium intermediates 20 with 1.1 equivalent of trialkyl 
phosphite was then evaluated. Trialkyl phosphites were selected in this case 
because of their enhanced nucleophilic properties compared to dialkyl 
phosphites and because of the possibility of dealkylation of the intermediate 
phosphonium adducts 258 by chloride ions present in the reaction medium. 
High temperatures are normally required for this Arbuzov type dealkylation 
reaction and alkyl halides are deliberated from the reaction mixture. The N-
chloroacetyl aminoalkyl phosphonates 21 should then be obtained after 
simply evaporating the solvent (Table 9). 
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Table 9: Initial results for the one-pot synthesis of N-chloroacetyl aminoalkyl 
phosphonates 21. 
N
R1 H
R2
N
R1 H
R2Cl
O Cl
P(OR3)3
N
R1 P
R2Cl
O
OR3
OR3
O
Cl
R3
N
R1 P(OR3)2
R2Cl
O
ClCOCH2Cl
- R3Cltoluene, -40°C
O
∆
3 h
10 min19
20 258
21
 
SM R1 R2 R3 Product Yield 21 (%)§ 
19b Phenylethenyl Bn Et 21c 26 
19b Phenylethenyl Bn Me 21b 35 
19z Furyl Bn Me 21h 32 
19y Furyl Ph Me 21g 24 
§ Yield determined after column chromatography 
 
However, using these very convenient reaction conditions, the N-chloroacetyl 
aminoalkyl phosphonates 21 could be only obtained in satisfying purity after 
column chromatography. The best results were obtained with trimethyl and 
triethyl phosphite, while triisopropyl phosphite is probably to steric for the 
addition reaction. Yields were generally low due to the formation of a major 
side product which was easily observed in 31P NMR spectra as two doublets 
(dimethyl ester: δ = 10.1 and –3.9 ppm, JPP = 25.5 Hz; diethyl ester: δ = 7.3 
and -6.3 ppm, JPP = 26.7 Hz). However, this side product was never recovered 
during column chromatographic purifications. The occurrence of two 
doublets in 31P NMR implicated the presence of two phosphorus atoms in one 
molecule, which was finally identified as 1-phosphono vinyl phosphate 259. 
To confirm the proposed structure 259, it was synthesized according to a 
literature procedure from chloroacetyl chloride and trialkyl phosphite.319 The 
mechanism of this reaction involves a Perkow and an Arbuzov type reaction.  
 
Cl
Cl
O 1 eq. P(OR)3
∆, 3 h
OP(OR)2
P(OR)2
O
O
135a
259a (R = Me; 63%)
259b (R = Et; 55%)  
 
The side product can thus be generated from unreacted chloroacetyl chloride 
present in the reaction medium and trialkyl phosphite. However, the same 
side product 259 was found when only 1.0 equivalent of chloroacetyl chloride 
was used or when a small amount of iminium salt 20 is separated from the 
reaction medium through filtration under an inert atmosphere and treated 
with the trialkyl phosphite. Therefore, vinyl phosphate 259 is probably 
formed via two concurrent pathways to give the same intermediate 260: non-
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regiospecific attack of the phosphite on the carbonyl group of the 
acyliminium ion (pathway B) or reaction with unreacted chloroacetyl chloride 
(pathway C). 
 
R1 H
N
R2
N
R2Cl
O
R1 H
O
Cl
Cl
R1 P
N
R2Cl
O
O
OR3
OR3
R3
Cl-
Cl-
R1 P(OR3)2
N
R2Cl
O
O
O
P(OR3)3
P(OR3)3Cl
O
P(OR3)2
P(OR3)2
O
O
Cl
OP(OR3)2
P(OR3)2
O
R3
O
R3 Cl
Cl
P(OR3)3
O
Cl
Cl
19
20
P(OR3)3
Pathway B
Pathway A
Pathway A
21
261
262
259a R = Me
259b R = Et
Pathway B
260
P(OR3)3
258
P(OR3)3
Cl
Cl
O
P(OR3)3
Pathway C
135a
 
 
These results clearly indicate that the reaction conditions applied so far were 
not optimal. In order to influence the regioselectivity of the phosphite 
addition, DEPTMS was evaluated as phosphonylation agent.  However, 
incomplete conversion and side product formation were observed. When 
bromoacetyl chloride was used to acylate the imine, even more vinyl 
phosphate 259 was formed during the phosphonylation step, as could be 
expected from the known increasing reactivity of Cl>Br>I in the Perkow 
reaction.320 With trichloroacetyl chloride, complex mixtures were obtained. 
 
Using the initial reaction conditions (1.1 equivalent of chloroacetyl chloride 
was added to a solution of imine 19b in dry toluene under a nitrogen 
atmosphere), precipitation of the iminium salts 20 occurred within 10 
minutes at -40°C. Triethyl phosphite was then added and the mixture was 
refluxed for 2 hours. After evaporation of the solvent under reduced pressure, 
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the ratio of pathway A versus pathway B/C ratio was determined to be 1.6 
using 31P NMR (Table 10, entry 1) and also the 1H NMR spectrum showed a 
lot of impurities. From this mixture, the desired N-chloroacetyl 1-aminoalkyl 
phosphonate 21c could be obtained in pure form by column chromatography 
in 26% yield. 
 
Table 10: Effect of different reaction parameters to the formation of N-chloroacetyl 
aminoalkyl phosphonate 21c 
H
N Ph Cl
Cl
O
P(OEt)3
P(OEt)2
N Ph
O
Cl
O
-40°C, 10 min 2 h
19b 21c  
 
Entry ClCH2COCl P(OEt)3 
Ratio 
21c/259b# 
1 1.1 eq., toluene 1.1 eq., 2h, ∆ 1.6 
2 1.0 eq., toluene 1.1 eq., 2h, ∆ 2.8 
3 1.0 eq., acetonitrile 1.1 eq., 2h, ∆ - 
4 1.0 eq., THF 1.1 eq., 2h, ∆ 6.1 
5 1.0 eq., toluene 1.1 eq., 2h, 66°C 2.1 
6 1.0 eq, THF 1.1 eq., 2h, ∆, passive air cooling 8.3 
7 1.0 eq., THF 1.0 eq., 2h, ∆, passive air cooling 13.7 
 
# Ratio 21c:259b (pathway A to pathway B/C) determined by 31P NMR. Vinyl phosphate 259b 
is the major side product and can be recognized by two doublets around 10.1 and -3.9 ppm for 
the methyl esters 259a and 7.3 and -6.3 ppm for the ethyl esters 259b with a coupling 
constant of 25.5 Hz and 26.7 Hz, respectively. 
 
 
To minimize the effect of pathway C, a limiting amount of chloroacetyl 
chloride was used in a second experiment for comparison, giving a higher, 
more favourable ratio (entry 2). The precipitation of the intermediate 
acyliminium salt 20 from the reaction mixture will affect the addition step. 
Therefore, more polar solvents compared to toluene were selected. The 
reaction failed using the very polar acetonitrile (entry 3) but when THF was 
used, a strong beneficial effect could be observed (entry 4). This could be 
explained by the lack of precipitation of the intermediate salts, together with 
an enhanced stabilization of the positively charged transition state of the 
phosphite addition. This positive effect was not due to a temperature effect 
(bp. THF = 66°C; bp. toluene = 110°C), since the results of entry 5 are similar 
to those of entry 2. The conditions of entry 4 were then repeated using 
passive air cooling instead of intensive cooling with a double jacket water 
cooler (entry 6). Again, the result of the reaction was improved, probably 
because of the enhanced removal of ethyl chloride (bp. 12°C) from the 
reaction atmosphere. 
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Since we showed before that phosphite is able to attack at the carbonyl 
group of the acyliminium salts, the excess of phosphite was also omitted, 
causing the A/B ratio to rise up to a level where side product determination 
via NMR-measurements became almost impossible. Using these optimal 
conditions, the desired N-chloroacetyl 1-aminoalkyl phosphonate 21c was 
obtained in quite pure form (purity >90% from the 1H NMR spectrum) after 
evaporation of the solvent. Even though subsequent column chromatography 
resulted in great losses, the yield almost doubled (46%) compared to the 
initial procedure. Furthermore, the obtained reaction mixture had a much 
higher purity and therefore could be used immediately in the next step, as 
will be discussed below (chapter 3, section 2.3). 
 
Using the obtained optimal conditions, the method was extended to other 
imines.321 The yields mentioned in Table 11 are isolated yields after column 
chromatography. This purification step always caused great losses, probably 
due to the high affinity of the products towards silicagel. However, for imines 
19a,b,d,z and 19aa, the products can be obtained from the reaction mixture 
in high yields and in quite pure form (purity > 90%) after evaporation of the 
solvent. Surprisingly, the reaction did not work well for imines derived from 
benzaldehyde. Several reaction conditions were tested, but in all cases, 
incomplete conversion of the imines was observed with 1H NMR.  
 
Table 11: Yields of N-chloroacetyl 1-aminoalkyl phosphonates 21 
SM R1 R2 R3 Product Yield 21 (%)§ 
19b Phenylethenyl Bn Et 21c 46 
19b Phenylethenyl Bn Me 21b 55 
19d Phenylethenyl Allyl Me 21e 41 
19g Phenylethenyl iPr Me 21f 27# 
19h Phenylethenyl tBu Me  Complex 
19a Phenylethenyl Ph Me 21a 43 
19s o-Nitro-phenylethenyl Bn Me  Complex 
19ad Ph Bn Et 21k (39)¤ 
19ac Ph Ph Et  0 
19aa Furyl Allyl Me 21i 43 
19z Furyl Bn Me 21h 57 
19y Furyl Ph Me 21g 35 
19ah iPr Bn Me  0 
19u 
 
Bn Me  0 
 
§ Yield determined after column chromatography 
# 27% of the 1,2-adduct was isolated next to 7% of the 1,4-adduct 
¤ Yield estimated by 1H NMR without isolation of the product 
 
 
An important requirement for the reaction to minimize side product 
formation is to work under strictly dry conditions. Chlorinated amides 263 
are found in the final reaction mixture due to hydrolysis of the iminium 
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cation when traces of water were present. Furthermore, the reaction is not 
suitable for alifatic imines, since an α-proton in the iminium salt is easily 
eliminated with the formation of the corresponding enamides upon heating, 
even in the presence of the nucleophilic phosphite. Therefore, elimination 
should occur much faster than nucleophilic attack. Imine 19u derived from 
(-)-myrtenal was selected as a non-aromatic aldehyde without α-proton to 
study the stereochemistry of the reaction. Several reaction conditions were 
evaluated, but the desired product could never be isolated. The resulting 
mixture consisted mainly of vinyl phosphate 259a, diene 266, formed by 
elimination of the γ-proton, and a small amount of 1-aminoalkyl phosphonate 
22t, probably formed by phosphite addition after deacylation of the iminium 
salt.  
 
H
N
Bn
O
Cl
Cl
H
N
BnCl
O
OP(OMe)2
P(OMe)2
O
O
P(OMe)2
HN
Bn
O
H
N Ph O
Cl
Cl
P(OR)3, heat
H
N Ph
Cl
O Cl
H
N Ph
Cl
O
1)
2) P(OMe)3
+
19u
266 259a
+
22t
heat
19ah 20ah 265
N
HR1
R2 O
Cl
Cl
N
HR1
R2
O
Cl
Cl
H2O, trace
N
H
R2
O
Cl +
O
R1 H
19
20
263 264
 
 
When α,β-unsaturated acyliminium salts 20 were treated with trialkyl 
phosphite, 1,4-regioselectivity could be expected similar to previous research 
of Savignac and Teulade.215 A side product could be observed in the crude 1H 
NMR spectrum of 1-aminoalkenyl phosphonates 21b,c,e,f. However, only 
with a bulky iso-propyl group on nitrogen, the product could be isolated in 
7% yield.  Complete 2D spectral analysis of the products obtained from the 
reaction with iso-propyl imine 19g, revealed their identities: the 1,2-addition 
product 21f was formed next to the corresponding 1,4-product (ratio 3:1). 
When the more steric demanding triethyl phosphite was used, this ratio is 
slightly higher in favour of the 1,4-product. However, 1H NMR chemical shifts 
and multiplicities substantially differed from those seen for similar products 
derived from imines 19b,d (1,4-adducts were only present in minor 
quantities in the crude reaction mixture and could not be isolated). In order 
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to confirm the structure of the 1,4-adducts derived from imines 19b,d,g, 
another pathway towards these enamides was evaluated.** 
 
β-Phosphono aldehyde 217 was synthesized according to a literature 
procedure.215 Using the specified conditions, a very fast and regioselective 
addition of triethyl phosphite occurred to imine 19h and the corresponding 
aldehyde could be obtained after acid hydrolysis. Subsequent careful 
distillation resulted in considerable product losses due to break down. The β-
phosphono aldehyde 217 was then easily converted to the corresponding 
imines, which were then treated with chloroacetyl chloride in the next step. 
Because of the presence of α-protons in the resulting acyliminium salt, HCl is 
easily eliminated upon refluxing for 2 h (vide supra). However, when 
triethylamine was added as a proton acceptor, the desired enamides 267b-d 
were obtained smoothly in higher purity after 1 h at room temperature. 
Finally, the enamides 267b-d were obtained in pure form using column 
chromatography. Only the (E)-isomers were observed. 
 
H
N
tBu
1 eq. P(OEt)3
HCOOH, EtOH
10 min. rt
19h
H
N
tBu
(EtO)2P
O
HOAc/NaOAc/H2O
30 min., rt.
H
O(EtO)2P
O
1 eq. RNH2
MgSO4, CH2Cl2
rt., o.n.
H
N
R
(EtO)2P
O
2) Et3N, THF, rt., 1 h
O
Cl
Cl1) 1 eq.
(EtO)2P
N
R
O
Cl
O
216b
R = iPr; 216a (87%)
R = Allyl; 216c (92%)
R = Bn; 216d (96%)
217
two steps: 39%
R = iPr; 267b (45%)
R = Allyl; 267c (31%)
R = Bn; 267d (30%)
10 min. rt.
 
 
Comparison of the spectral data unambiguously revealed the identity of the 
1,4-addition side products in the acyliminium/phosphite reaction. In all 
cases, 1,4-adducts were present in the reaction mixture (Table 12) when α,β-
unsaturated imines were used. This incomplete regioselectivity significantly 
                                           
** The structure of the 1,2-adducts was comfirmed by comparison with the results obtained 
in chapter 3, section 2.2.1. 
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lowered the yield of the desired N-chloroacetyl 1-aminoalkenyl phosphonates 
21, especially when bulky nitrogen substituents are used. However, when 
tBu-imine 19h was selected in order to facilitate the 1,4-addition, it failed to 
react with the chloroacetyl chloride, probably due to sterical hindrance, 
leading to complex reaction mixtures after the phosphite addition. Also, when 
an electron withdrawing nitro group was introduced on the phenyl ring, the 
reaction failed (imine 19s).  
 
Table 12: Ratio of 1,4- vs. 1,2-addition of TAP to α,β-unsaturated acyliminium salts 
Imine R Phosphite 1,4:1,2# 
19a Ph TMP 0:100 
19b Bn TEP 24:76 
19b Bn TMP 22:78 
19d Allyl TMP 18:82 
19g iPr TEP 33:67 
19g iPr TMP 29:71 
# Determined by 1H NMR integration measurements 
 
 
Finally, the reaction was evaluated with various related acid chlorides (Table 
13). This resulted mostly in complex reaction mixtures. Only with 
chlorobutyryl chloride, the corresponding N-acyl aminoalkyl phosphonates 
could be obtained in moderate yields. 
 
Table 13: Evaluation of different acid chlorides 
N
R1 H
R2
R3
O
Cl
THF
P(OMe)3
THF
N
R1 P(OMe)2
R2
O
R3
19
O  
Imine R1 R2 R3 Product Result 
19b CH=CHPh Bn CCl3  Complex mixture 
19b CH=CHPh Bn CH2CH2CH2Cl 25a 38% (31:69)
# 
19d CH=CHPh Allyl CH2CH2CH2Cl 25b 45% (11:89)
# 
19b CH=CHPh Bn C(CH3)=CH2  Complex mixture 
19aa Furyl Allyl C(CH3)3  Complex mixture 
# Yield of the 1,2-adduct after column chromatography. Ratio 1,4:1,2 
phosphite addition given in parentheses (from 1H NMR integration 
measurements). 
 
2.2.3 Conclusion 
The best results for the synthesis of the N-chloroacetyl aminoalkyl 
phosphonates 21 were obtained using the two step phosphonylation-
acylation sequence with overall yields from 88 to 92% for furyl or 
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phenylethenyl derivatives (Table 14). Mixtures of low purity and difficult 
purification, were obtained from phenyl and alkyl derivatives, because of the 
difficulties encountered during the acylation step. 
 
The one-pot acylation/phosphonylation could be advantageous when 
comparing the ease and time consumption of the reaction. However, the 
methodology was not useful at all for alkyl imines. Furthermore, competitive 
1,4-addition was observed in the case of α,β-unsaturated imines, causing the 
yields to drop. Finally, the obtained reaction mixtures were less pure, 
requiring an additional chromatographic purification step in order to obtain 
the N-chloroacetyl aminoalkyl phosphonates 21 in pure form. 
 
Table 14: Comparison of the synthesis of N-chloroacetyl aminoalkyl phosphonates 
21 via the two step phosphonylation/acylation (see chapter 3, sections 2.2.1 and 1.4) 
and via the one step acylation/phosphonylation (see chapter 3, section 2.2.2) 
Product 2 steps 1 step 
R = Me 21b 92% 55% 
P(OR)2
N
BnCl
O
O  
R = Et 21c 90% 46% 
P(OR)2
N
Cl
O
O  
R = Me 21e 91% 41% 
P(OR)2
N
Cl
O
O  
R = Me 21f 91% 27% 
O
P(OR)2
N
Cl
O
O  
R = Me 21i 88% 43% 
O
P(OR)2
N
BnCl
O
O  
R = Me 21k 88% 57% 
P(OR)2
N
BnCl
O
O  
R = Et 21p 76% 0% 
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2.3 Ring closure towards 4-phosphono β-lactams 
The classical methods for the formation of the β-lactam ring can be classified 
as (i) Staudinger’s ketene-imine reaction, an overall [2+2] cycloaddition, (ii) 
cyclization reactions of β-amino acids and esters and (iii) carbene insertion. 
However, the obtained N-chloroacetyl 1-aminoalkyl phosphonates 21 
appeared to be excellent substrates for ring closure to 4-phosphono-β-
lactams 23, through an unusual C3-C4 bound formation. When treated with 
sodium hydride, a phosphorus stabilized carbanion was formed, which led to 
the four membered heterocycle upon refluxing for two or three hours in THF. 
No side products were formed during this procedure and the 4-phosphono β-
lactams 23 were obtained in excellent yields. When ether was used as a 
solvent, longer reaction times were required, indicating the need for some 
heating to form the highly strained 4-membered heterocycle. When LiHMDS 
was used as a base instead of NaH, the reaction proceeded smoothly at room 
temperature yielding the products in the same purity and yield after typically 
1 h. Only when the p-methoxy benzyl derivative 21d was used, extended 
reaction times were required to obtain complete conversion (up to 6 h of 
reflux in THF using NaH as a base). In case of N-chloroacetyl aminoalkenyl 
phosphonates 21a-f (R1 = phenylethenyl) an ambident allyl anion is formed 
upon deprotonation. However, ring closure proceeds with exclusive 4-
membered ring formation. The origin of this particular selectivity will be 
investigated in chapter 3, section 2.4. 
 
Table 15: Synthesis of 4-phosphono β-lactams 23 
 
N
R1 P(OR3)2
O
R2
O
Cl NaH, THF, ∆, 2-3 h
or
LiHMDS, THF, rt, 1h
N
O R2
P(OR3)2
R1 O
21 23  
 
SM R1 R2 R3 Product Yield (%)# 
21a 2-Phenylethenyl Ph Me 23a 90 
21b 2-Phenylethenyl Bn Me 23b 75 
21c 2-Phenylethenyl Bn Et 23c 92 
21d 2-Phenylethenyl PMB Me 23d 39 
21e 2-Phenylethenyl Allyl Me 23e 62 
21f 2-Phenylethenyl iPr Me 23f 85 
21g Furyl Ph Me 23g 89 
21h Furyl Bn Me 23h 99 
21i Furyl Allyl Me 23i 55 
21k Phenyl Bn Me 23j 92 
# The 4-phosphono β-lactams 23 are obtained in high purity (>98%) after 
simple aqueous work-up on condition that purified N-chloroacetyl 
aminoalkyl phosphonates 21 are used as starting material. 
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The C3-C4 ring closure has already been evaluated for similar carboxylates.322 
However, for the carboxylates, longer reaction times are necessary (one to 
several days at room temperature) and the yields are lower, indicating a 
difference between the stabilizing effect of the carboxylate and phosphonate 
group towards the anion. This can also be illustrated by the use of LiHMDS 
as a base; 4-phosphono β-lactams 23 are formed in typically 1 h at room 
temperature while the 4-alkoxycarbonyl β-lactams are not formed at all 
under these conditions: in this case an amide enolate is formed more readily 
yielding pyrrolinones via a Dieckmann type condensation.323 
 
N
PMBCl
O
Ph
COOtBu
LiHMDS
ref. 322
N
PMBCl
O
Ph
COOtBu
N PMB
O
Cl
HO
Ph
N PMB
O
Cl
O
Ph
268 269
270 271  
 
Given the good yields of the final ring closure step, we were now able to 
synthesize 4-phosphono β-lactams 23 in a three or four step sequence. 
However, the intermediate purification of the N-chloroacetyl 1-aminoalkyl 
phosphonates 21 constituted a major drawback for the synthesis pathway, 
seriously lowering the overall yield. Therefore, we succesfully attempted to 
use the N-chloroacetyl 1-aminoalkyl phosphonates 21, obtained via the 
acyliminium addition method, directly in the ring closing reaction without 
prior chromatographic purification. The desired β-lactams 23 were obtained 
in reasonable purity (>90%) and with good overall yields after a simple 
aqueous work-up of the final reaction mixture. Furthermore, they could be 
obtained in pure form by a final chromatographic step with much smaller 
losses than the N-chloroacetyl 1-aminoalkyl phosphonates 21 because of 
their lower affinity for silicagel. Both yields are mentioned in parentheses in 
the scheme below. 
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N
HR1
R2
1) 1 eq.
2) 1 eq. P(OR3)3
    ∆, 2 h
Cl
Cl
O
THF, -40°C, 10' N
O R2
R1
P(OR3)2
O
1.2 eq. NaH
THF, ∆, 3 h
19
23
R1 = PhCH=CH; R2 = Bn; R3 = Et (92%, 60%)
R1 = PhCH=CH; R2 = Allyl; R3 = Me (85%, 40%)
R1 = PhCH=CH; R2 = iPr; R3 = Me (81%, 51%)
R1 = Furyl; R2 = Allyl; R3 = Me (62%, 25%)  
 
 
In an attempt to introduce more diverse substituents on the lactam nitrogen 
atom, N-deprotection was evaluated first. Treatment of N-benzyl lactam 23c 
with Pd/C under 4 bar H2-atmosphere only resulted in hydrogenation of the 
double bond. Treatment with HCl in ether or p-toluene sulphonic acid in 
toluene at reflux temperatures did not offer the desired deprotection either. 
Oxidative removal of the p-methoxybenzyl group of lactam 23d using CAN 
resulted in a complex mixture. When N-allyl lactam 23e was refluxed in 
EtOH in the presence of Pd/C for 4 days, no reaction occurred. 
 
NH
O
P(OR3)2
R O
N
O
P(OEt)2
R1 O
N
O
P(OEt)2
R1 O
N
O
P(OMe)2
R1 O
N
O
P(OMe)2
R1 O
PMB
Bn Bn
N
O
P(OEt)2
O
Bn
Ph
H2, 4 bar
Pd/C
EtOH, rt.
14 h
H2, 4 bar, Pd/C
EtOH, rt., 14 h
Pd/C, EtOH, 
∆, 4 days
27223c
273
23d
23c
23e
1) 3 eq. CAN, CH3CN:H2O = 9:1
    0°C -> rt, 12 h
2) NaHSO3(aq)
H+
R1 = CH=CHPh
R = R1 or CH2CH2Ph
 
 
Also the deprotection of the phosphonate ester groups was problematic. 
Refluxing in 6 M aqueous HCl resulted only in starting material. Conversion 
of the alkyl esters to silyl esters followed by methanolysis resulted in complex 
mixtures. Also partial deprotection using KOTMS (see chapter 3, section 1.4) 
resulted in complex mixtures. 
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N
O R1
P
Ph
O
N
O Bn
P(OEt)2
Ph
O
6 M HCl(aq)
acetone, ∆
12 h
N
O R1
P(OR2)2
Ph
O
OR3
OR2
R2, R3 = H
1.5 eq KOTMS
ether, rt, 4 days
R1 = Bn, allyl
R2 = Me, Et; R3 = H
N
O
P(OMe)2
Ph
O
23c
23c,e
274 23e
1) 5 eq. TMSBr, 
    CH2Cl2, rt, 45 min
    
2) MeOH, 3 h, rt.
N
O Bn
P(OEt)2
Ph
O
1) 5 eq. TMSI, CH2Cl2, rt, 1 h
2) propylene oxide, MeOH
23c
R2, R3 = H
R2, R3 = H
 
 
Finally, the ring closure was also evaluated for N-chlorobutyryl aminoalkyl 
phosphonates 25 in order to obtain six-membered lactams 24. Sodium 
hydride and LiHMDS were used as a base under the same conditions used 
for the preparation of the β-lactams. However, complex mixtures were 
obtained in all cases (Table 16). Then the temperature was lowered to -78°C 
during base addition to avoid lithium-halogen exchange and afterwards 
stirring was continued for 2 h at room temperature. From this reaction, 
lactam 24 could be obtained in 15% yield using column chromatography. 
Using the same conditions, the furyl derivative 25f resulted again in a 
complex mixture. Therefore, no further research has been performed. The 
difficulties encountered during the formation of these six-membered rings are 
somewhat surprising, since the four-membered rings are formed so easily.  
 
Table 16: Preparation of 6-phosphono δ-lactams 24. 
N
P(OMe)2R1
R2
O
Cl
O
Base, THF N
O
R2
P(OMe)2
O
R1
25 24  
SM R1 R2 Base Temp. Result 
25a CH=CHPh Bn NaH Reflux Complex mixture 
25b CH=CHPh Allyl NaH Reflux Complex mixture 
25a CH=CHPh Bn LiHMDS rt Complex mixture 
25b CH=CHPh Allyl LiHMDS rt Complex mixture 
25b CH=CHPh Allyl LiHMDS -78  0°C 15% 
25c Furyl Bn LiHMDS -78  0°C Complex mixture 
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2.4 Origin of regioselectivity towards four-membered phosphono 
lactams 
 
Allyl anions are stabilized by resonance and are considerably more stable 
than the corresponding alkane anions. Allyllithium, for instance, has a 
stabilization energy of -65.8 kJ/mol, wheras that of n-propyllithium has been 
calculated to be +16.7 kJ/mol.324 Considerable further stabilization can arise 
when an allylic anion contains one or two heterosubstituents, as is the case 
in N-chloroacetyl aminoalkenyl phosphonates 21a-f. Furthermore, the 
unsymmetrically substituted allyl anion is an ambident anion, which can 
react with electrophiles at two sites, conveniently visualized below by the two 
mesomeric resonance contributors 26 and 27. 
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O
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With N-chloroacetyl aminoalkenyl phosphonates 21a-f, only cyclization to the 
highly strained four-membered ring is observed, while formation of a six-
membered ring is generally accepted to proceed more smoothly. A similar 
result with an amide stabilizing group instead of a phosphonate has been 
presented in literature without any further comments on the nature of this 
unexpected selectivity.325,326 The proposed 4-phosphono β-lactam structure 
was confirmed upon further spectroscopic investigation. The very high 
infrared absorption of the carbonyl (> 1750 cm−1) is typical for highly strained 
rings. Furthermore, the ring CH2(3) appears as a second order spin system at 
3.2 ppm in the 1H NMR spectrum (Figure 11), involving a geminal coupling 
constant of 14.6 - 15.3 Hz and also quite large 31P couplings (5.5 - 5.8 Hz), 
indicating the near presence of the phosphorus atom. According to the 
integrals of the signals in the region of 6 - 7 ppm in the proton spectrum, two 
alkenyl protons are present in the molecule. An (E)-coupling of 16.2 Hz was 
found for all five products, next to smaller 31P couplings. All aforementioned 
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phosphorus couplings disappeared when the proton spectrum was run with 
selective 31P decoupling. All 13C peaks could be attributed to the appropriate 
carbon in the azetidinones using 2D techniques (HSQC and HMBC) together 
with DEPT spectra. The quaternary carbon atom bearing the phosphonate 
group is expressed as a doublet (J = 166.7 - 168.5 Hz) in the 13C spectrum, 
with a chemical shift clearly within the aliphatic region (58.06 - 59.82 ppm). 
From this carbon, a clear HMBC coupling was observed with the CH2(3) of 
the four-membered ring. 
 
Figure 11: 1H NMR spectrum of lactam 23e (R = allyl). HMBC couplings that are 
common for all 4-alkenyl 4-phosphono β-lactams 23a-f are indicated in the 
diagramma. 
 
 
An overview of the regioselectivity of intermolecular reactions between 
heteroatom-stabilized allyl anions and electrophiles has been presented by 
Katritzky and coworkers.324 However, no general conclusion could be drawn 
from this extensive work. Nevertheless, some important directing factors 
could be identified such as the nature of the electrophile, steric 
characteristics of the anion and the electrophile, coordination between the 
electrophile and the substrate prior to bond formation, nature of the 
counterion, reaction conditions, etc… An influence of the reaction conditions 
or the counterion can be excluded on the basis of the results reported in 
chapter 3, section 2.3. The same four-membered ring preference was 
observed in diethyl ether or in THF, at 20°C or at 66°C, with sodium as a 
counterion or with lithium.  
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O R
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O
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The phosphonate group itself is found to behave mainly like a huge 
hydrogen-like atom, having a low electronegativity, being highly ionic inside, 
and therefore polarising the adjacent carbon frame.327 Its influence is 
relatively poor on neutral organic groups, but is impressive through 
electrostatic interactions on a negative charge in α-position, especially when 
anion delocalisation is possible into the carbon skeleton.328 Because of their 
importance in olefination reactions, some experimental and theoretical 
research has already been devoted to these phosphonate stabilized 
carbanions.329,330 The main conclusions for allyl phosphonic diamides 275 
can be summarized as follows:331 
 
P
O
NH2
NH2
1
2
3
275  
 
 The carbanion is planar (sp2). However, according to the bond lengths, 
the structure appears to be midway between a vinyl substituted planar 
carbanion and a typical allyl anion. 
 Charge stabilization is primarily coulombic. No valence type bonding 
to phosphorus d orbitals is observed. The P-C1 bond is considerably 
shortened, becoming almost ylidic in character. 
 The localization of electronic charge remains heavily in the region of 
the allyl unit and is equally distributed over C1 and C3. 
 
However, the high number of functionalities in substrate 21a-f compared to 
the simple allyl phosphonic diamide model, calls for an in depth investigation 
of this reaction. Furthermore, the intramolecular reaction under investigation 
involves complications compared to the intermolecular reactions, such as 
anion geometry and substrate conformation. 
 
The following aspects have been taken into consideration and will be 
discussed below: (i) structural properties of the substrate, (ii) Hard-Soft, 
Acid-Base (HSAB) considerations, (iii) geometry of the allyl anion, (iv) 
transition state conformation. 
 
2.4.1 Structural properties of the substrate 
In order to investigate the role of the phenyl group in substrates 21a-f, the 
preparation of analogous N-chloroacetyl aminoalkenyl phosphonate 21q was 
evaluated. Starting from crotonaldehyde 276, the corresponding benzylimine 
could not be obtained via condensation in the presence of MgSO4 or TiCl4, 
probably because of its thermal instability. With solid potassium hydroxide 
as a dehydrating agent, the reaction proceeded fast at 0°C to yield imine 19o 
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together with degradation products. Kugelrohr distillation yielded the 
unstable imine 19o in maximum 30% yield. It could be stored several days at 
-32°C, but was better used immediately in the next reaction. Reaction with 
DEPTMS resulted in PAP formation. No efforts were made however to isolate 
the product 196p from the unpure reaction mixture. A fast reaction of imine 
19o with chloroacetyl chloride and triethyl phosphite yielded the 
corresponding N-chloroacetyl aminoalkenyl phosphonate 21q in only 9% 
yield after column chromatography, next to 5% of the 1,4-adduct 277 
(mixture of E and Z isomers). Treatment of 21q with sodium hydride in THF 
resulted in complex mixtures. 
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Then (-)-myrtenal 279 was selected from the chiral pool as a stable α,β-
unsaturated aldehyde and to evaluate the stereochemistry of the final ring 
closure. Condensation with benzylamine quantitatively yielded the stable 
imine 19u. One-pot phosphonylation of the acyliminium salt with triethyl 
phosphite had already proven not to be suitable for imine 19u (see chatper 3, 
section 2.2.2). α-Aminoalkyl phosphonate 22u could be obtained using 
DEPTMS or DEP. Almost no chiral induction coming from the chiral auxiliary 
was observed since both diastereomers were present in almost equal 
amounts. Acylation proceeded smoothly with triethyl amine as a base in THF. 
In this case, both diastereomers could be separated using column 
chromatography. No absolute attribution of the stereochemistry was 
performed, since treatment of a pure isomer of 21p with sodium hydride 
resulted in a racemic β-lactam 23l: no memory of chirality332 was observed as 
was the case for similar carboxylates.323  
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The ring closure reaction was hampered due to the more steric substitution 
pattern of the allyl anion, resulting in longer reaction times and lower purity 
of the final reaction mixture. After three hours of reflux in THF, no starting 
material was present anymore (31P NMR). Using column chromatography, the 
racemic β-lactam 23l could be separated from the reaction mixture together 
with another product in low purity. A phosphonate substituted quaternairy 
carbon (JCP = 216 Hz) was clearly visible in the alkene region of the 13C 
spectrum. According to the DEPT spectrum, one CH is missing to be in 
accordance with the structure of the six-membered ring 280. All 
spectroscopic observations pointed to 281, which was formed by protonation 
of the unreacted anion during work-up (see chapter 3, section 2.4.2). 
Furthermore, the mass spectrum was clearly indicating the presence of a 
chlorine atom. In conclusion, this result clearly showed that substituents on 
the double bond have no impact on the regioselectivity of the ring closure 
reaction. 
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Finally, an electron withdrawing substituent was introduced on the aromatic 
ring in order to investigate the electronic effects of the reaction. The nitro 
substituent in 283 was believed to stabilize the anion to a greater extent in 
the γ-position, possibly leading to six-membered ring formation. The electron 
withdrawing effect was illustrated by the downfield shift of the =CHPh in the 
13C spectrum of 22r. However, the desired N-chloroacetyl aminoalkyl 
phosphonate 283 could not be obtained either through the one-pot acylation-
phosphonylation, neither through the two step phosphonylation-acylation. 
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2.4.2 HSAB considerations 
In the past, the regioselectivity of intermolecular reactions of allyl anions 
have sometimes been explained using the HSAB theory.324 In the present 
intramolecular case, a soft electrophile is used (an alkyl chloride) in the 
alkylation reaction. However, it is not straightforward to predict the softest 
center of the allyl anion 284. Even more, it may be reasonable to suggest 
that the hard/soft properties of both nucleophilic centers in allyl anion 284 
are very similar. 
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O
Cl
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? ?
284  
 
In order to investigate these properties experimentally, the synthesis of N-
acetyl aminoalkenyl phosphonate 255b was started. This substrate has 
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similar steric and electronic properties as the corresponding N-chloroacetyl 
derivatives, but is not prone to intramolecular reactions because of the lack 
of a leaving group. Therefore, it would be a suitable model for the ring closure 
substrates. The synthesis is very similar to the corresponding chloroacetyl 
derivatives. However, some problems were encountered in the acetylation of 
aminoalkenyl phosphonate 22h. Using the strongest acylation conditions 
obtained before (see chapter 3, section 2.2.1), only 20% conversion was 
obtained. Altering these conditions finally led to 100% conversion and 66% 
yield of the crystalline N-acetyl aminoalkenyl phosphonate 255b after a final 
washing step with 0.5 M HCl(aq) to remove any residual pyridine. 
 
O
H
N
H
iPrNH2
CH2Cl2
MgSO4
(98%)
285 19h
DMP, MeOH
(94%)
HN
P(OMe)2
A/B-extract.
O
22h
Table 17
N
P(OMe)2
O
O
255b
 
Table 17: Acetylation conditions  
 Conditions Conversion# Yield (255b) 
1 1) 1,1 eq. AcCl; 2 eq. Pyridine; 0,2 eq. 
DMAP; THF;rt., 1 h 
2) 1 N HCl(aq) 
20% - 
2 1) 1,5 eq. AcCl; 2 eq. Pyridine; 0,2 eq. 
DMAP; THF;rt., 2 h 
2) NaHCO3(aq) 
30% - 
3 1) 1,5 eq. AcCl; 2 eq. Et3N; 0,2 eq. 
DMAP; THF;rt., 19 h 
2) NaHCO3(aq) 
10% - 
4 1) 1,5 eq. AcCl; 2 eq. Pyridine; 0,2 eq. 
DMAP; THF;rt., 1 h; ∆, 1 h  
2) NaHCO3(aq) 
100% 66% 
# Measured using 1H NMR after washing the reaction mixture with an 
aqueous, saturated NaHCO3 solution. 
 
 
The obtained substrate analogue 255b was then submitted to deprotonation 
with LiHMDS at -78°C. An intense red-brown color indicated the formation of 
the anion. An excess of MeI was then added and the reaction mixture was 
allowed to warm up to room temperature. However, this procedure resulted 
in a complex mixture of reaction products. MeI was selected as a soft 
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electrophile, mimicking the ring closure. A second attempt was then made, 
adding deuterium oxide after initial anion formation, providing hard 
deuterons to the anion. This procedure resulted in the recovery of 12% of 
deuterated starting material next to two novel compounds, which appeared 
in a 1:1 ratio. However, structure characterization using NMR was not 
possible at this stage. Therefore, water was added in a third experiment 
instead of deuterium oxide. The same products were obtained in similar 
proportions. However, no successful structure elucidation was performed due 
to great product losses during aqueous work-up and failure to separate both 
products using column chromatography. 
 
1) 1,5 eq. LiHMDS, 
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255b
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2) 3 eq. MeI,
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3) H2O
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SM 255b + 2 unknown compounds
12%, 44%, 44%
 
 
In order to avoid unwanted deprotonation of the acetyl group by the bulky 
LiHMDS base, sodium hydride was then evaluated to generate anion 286. No 
colour change occurred at -78°C and therefore, the reaction mixture was 
allowed to warm up to room temperature over a one hour period prior to 
addition of the electrophile. In this way, complete deprotonation occurred 
which was again indicated by the red-brown colour. Addition of water or 
deuterium oxide now resulted in the original yellow colour. Two products 
were obtained after further aqueous work-up (with 90% of total mass 
recovered), which could now be separated using column chromatography. 
Next to the starting allyl phosphonate 255b (δ(31P) = 26.6), also the vinyl 
phosphonate 287 (δ(31P) = 15.7) was found (ratio 13:87), which is formed 
through γ-protonation of the ambident anion 286. The structure was 
confirmed using 2D NMR techniques (especially HMBC, Figure 12). Only the 
(E)-isomer of 287 is formed, which was concluded after comparing C-P and 
H-P coupling constants with literature data.333 
 
In a second experiment, MeI was used as the electrophile. According to the 
31P NMR spectrum, two vinyl phosphonates were formed (δ(31P) = 16.2 and 
16.3). From the carbon spectrum of the crude reaction mixture, it was 
concluded that only the (E/Z)-isomers of 288 were formed. The introduction 
of a methyl group was confirmed via a LC/MS analysis. Purification via 
column chromatography, however, failed.  
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Figure 12: 1H NMR spectrum of vinyl phosphonate 287 (R1 = iPr, R2 = CH3CO). 
Selected HMBC couplings are indicated. 
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In conclusion, these experiments confirm the ambident nature of the allyl 
anion, as already calculated by Denmark and coworkers for less complex 
compounds.331 The complete γ-alkylation with methyl iodide is remarkable, 
however, and has also been reported for similar allyl phosphonates carrying 
a trimethylsilyloxy instead of an amide group in α-position.334 On the 
contrary, complete α-alkylation is observed α-aminoalkenyl phosphonates 
having the amine incorporated in a morpholine ring.335 Therefore, it must be 
concluded that HSAB principles do not play an important role in the 
regioselectivity in this specific case. 
 
2.4.3 Geometry of the allyl anion 
So far, the allyl anion was always presented as a single isomer. However, 
given the complex substitution pattern of allyl phosphonates 21a-f, the 
actual geometry of the anion should be investigated. This geometry can have 
a profound influence on the ring closure to the six membered ring. No ring 
closure is possible starting from the (Z)-allyl anion 284, since a six-
membered ring containing a double bond with “trans” geometry would be 
obtained. Both isomeric anions (E)-284 and (Z)-284 can, however, ring close 
to the four-membered ring without any complication of this kind. 
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To investigate this issue, the energetically most favoured structure of the free 
carbanion is calculated with the GAUSSIAN 03 software package336 in 
cooperation with the Center for Molecular Modelling of Ghent University 
(Head: Prof. Waroquier). This structure was found by applying various 
internal rotations around single bonds and selecting stepwise the most stable 
conformation along the rotational potential (B3LYP/6-31+g(d) level). Since 
THF was used as a solvent, solvation may be expected to be important. The 
solvation originates from two contributions: coordination of ether oxygens to 
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the sodium cation (coordination solvation) and the electrostatic effect of the 
solvent dielectric (dielectric solvation). The latter effect is the simplest to treat 
from computational point of view, as it is usually approximated by enclosing 
the molecule in a cavity within a continuous dielectric. The coordination 
solvation energy (CSE) is estimated by coordinating the sodium ion to one or 
more ether oxygens. Dimethyl ether (DMEt) was chosen as the coordinating 
solvent instead of THF. DMEt has about the same basicity and steric effect, 
but is significantly smaller for computations. An important question then 
concerns the degree of coordination. For solvent separated ion pairs, four-
coordinated lithium cations have been recognized in NMR studies.337,338 But 
for contact ion pairs as encountered here, the coordination may be expected 
to be less due to the electrostatic effect of the counterion. The degree of 
coordination for our system is estimated by coordinating the sodium cation 
with one or two DMEt molecules and calculating the CSE energies. 
Coordination of the first two ethers is highly exothermic as the CSE amounts 
to -53.8 kJ/mol and -88.7 kJ/mol. These results indicate that coordination 
with two ether molecules will be preferred. 
 
The optimized structures for anion 284b (R = Bn) are represented in Figure 
13. It can be concluded from these structures, that these anions adopt a 
conformation which allows six-membered ring formation. However, according 
to the indicated distances, the geometry seems to be better suitable for four-
membered ring formation at first sight. Of course, these structures do not 
reveal the actual transition state of the ring closure reaction, which will be 
discussed in chapter 3, section 2.4.4. 
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Figure 13: Optimized conformation of the anion 284b (R = Bn) in the gas phase, 
including a Na+ counterion, or including the counterion together with one or two 
DME molecules. 
 
 
From these optimized structures, the atomic charges could be calculated 
according to the CHELPG scheme at the B3LYP/6-31+g(d) level of theory 
(Table 18). It is clear from these results that the major part of the negative 
charge is almost equally divided over both the α- and the γ-carbon. The 
remaining negative charge can be found mainly at the phosphoryl oxygen 
atom. The phosphorus atom remains highly positively charged, which 
illustrates the conclusion of Denmark & Dorow329 that the stabilizing effect of 
the anion by the phosphonate group is primarily coulombic. 
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Table 18: Atomic charges 
 284b + Na 284b + Li 284b + Na + 1DMEt 284b + Na + 2DMEt 
C1 -0.34 -0.42 -0.34 -0.30 
C2 0.04 0.01 0.09 0.10 
C3 -0.51 -0.40 -0.47 -0.49 
N -0.04 0.02 -0.01 -0.02 
P 0.81 0.96 0.80 0.83 
O1 -0.64 -0.69 -0.70 -0.61 
 
 
2.4.4 Transition state conformation 
To unravel the experimentally determined reaction preference towards the 
four-membered lactams, calculations were required to determine the reaction 
barriers. The transition states towards four- and six-membered ring 
formation are visualized in Figure 14. Both transition states resemble an 
intramolecular SN2-like reaction characterized by an umbrella-like inversion. 
In the reacting anion, the C5 carbon atom is oriented towards the α-carbon 
atom, which is the reactive center for four-membered ring formation.  
 
In case of six-memberd ring formation, large distortions are needed from the 
original geometry of the anion in order to adapt the SN2-like transition state 
(the C2C1NC4 dihedral angle has to evolve from -82.2° to -36.0°). In order to 
get an idea about the energetic variations in terms of the C2C1NC4 dihedral 
angle, the rotational potential was calculated in relation to of this geometrical 
variable. This was done by stepwise varying the C2C1NC4 torsional angle and 
optimizing all other degrees of freedom. The results are shown in Figure 15. 
In the transition state for four- and six-membered ring formation, this tortion 
angle reaches a value of -116° and -36° respectively. Due to the strongly 
asymmetric shape of the rotational potential around the minimum, the 
associated energy to induce this distortion amounts to approximately 10 and 
38 kJ/mol. 
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Figure 14: Conformers of the transition state 
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Figure 15: Part of the rotational potential in terms of the C2C1NC4 dihedral angle. 
The required transition states for four- and six-membered ring formation are 
indicated by a grey circle. 
 
 
When focussing on reaction barriers instead of rotational potentials, the 
energy difference ∆(∆E‡) between the transition state and the reactant can be 
calculated. For the current application we are interested in the difference 
between the reaction barrier for four- and six-memberd ring formation (∆(∆E‡) 
= ∆E‡(6) - ∆E‡(4)). Calculations for the gas phase predict a preference for the 
four-membered ring (∆(∆E‡) = 16 to 22 kJ/mol depending on the level of 
theory used). Inclusion of the sodium cation increases the reaction barriers 
with approximately 60-80 kJ/mol at all levels of theory. Similar findings were 
found by Ando.339 Moreover, there is no clear preference anymore between 
four- and six-membered ring formation. ((∆(∆E‡) = 3.4 kJ/mol).  However, 
since all reactions were performed in THF, solvation of the counterion is 
expected to be important. Including bulk solvent effects lowers the barriers to 
about 95 and 121 kJ/mol (at the B3LYP/6-31+g(d) level) for four- and six-
membered ring formation and the preference for cyclization at the α-position 
is correctly predicted (∆(∆E‡) = 26 kJ/mol). Finally, also two explicit solvent 
molecules were taken into account as explained previously. Also in this case, 
a clear preference for four-membered ring formation is found (∆(∆E‡) = 
26.8 kJ/mol).  
 
In conclusion, the experimental four-membered ring preference is in 
accordance with theoretical predictions, provided solvent effects are taken 
into account properly. The underlying reason for this preference must be 
tracked back to the high amount of energy needed to reach a conformation 
suitable for six-membered ring formation in the transition state. Anchoration 
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of the phosphoryl group with a carbonyl group has already been suggested as 
the basis for stereoselectivity in certain intermolecular reactions.340-342 The 
same type of coordination may cause the hindered rotation around the C-N 
bond in this case (Figure 16). The results of the theoretical calculations have 
shown that the lithium or sodium counterion is coordinated to a large extent 
with the phosphoryl oxygen atom. However, nor in the optimised anion 
structures, nor in the transition state structure, the amide carbonyl group 
was found in close vicinity to the phosphoryl group and the counterion. 
Therefore, the observed hindered rotation should be attributed to the steric 
bulk of the substrates, rather than to anchoration by the lithium cation after 
deprotonation. 
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Figure 16: Intramolecular anchoration 
 
 
The effect of the steric bulk is expected to be similar in the anion and in the 
parent protonated form 21a-f (compared to anchoration which would only be 
possible in the anion state). Therefore, an important feature of the optimized 
anion structure (Figure 13) is also applicable to its parent N-chloroacetyl 
aminoalkenyl phosphonate: namely, the amide part of the molecule is 
directed towards the phosphonate side, or is more easily rotated in that 
direction, while the nitrogen alkyl substituent points towards the alkenyl 
system. These specific conformational properties can be demonstrated and 
exploited in more complex intramolecular reactions using this type of 
substrates (see chapter 3, section 3 and 4). 
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2.5 Biological evaluation of 4-phosphono β-lactam dialkyl esters 
The influence of several 4-phosphono β-lactams 23 on the growth of fungi 
(Table 19) and bacteria (Table 20) was tested in cooperation with Kemin 
Pharma Europe. However, no promising activity could be observed.  The 
growth of microorganisms was measured in the presence of the test 
compound at a concentration of 100 ppm. For comparison, the used control 
substances (antibiotics) result in 0% growth at a concentration of 1 ppm and 
lower. The test organisms were carefully chosen to represent each a specific 
class of microorganisms: yeasts (Candida albicans, Cryptococcus 
neoformans), moulds (Aspergillus fumigatus, Trichophyton mentagrophytes), 
Gram negative bacteria (Escherichia coli, Pseudomonas aeruginosa) and Gram 
positive bacteria (Staphylococcus aureus, Enterococcus faecalis, Chlostridium 
perfringens). 
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Table 19: Percentage growth of fungi in the presence of 100 ppm 4-phosphono β-
lactams 23 
 C. albicans C. neoformans A. fumigatus T. mentagrophytes 
23b 93.7 56.2 94.7 54.6 
23f 89.8 43.0 83.5 58.3 
273 96.8 53.2 79.3 40.3 
23e 89.8 49.2 88.9 51.0 
23i 91.6 52.2 84.8 58.6 
 
 
Table 20: Percentage growth of bacteria in the presence of 100 ppm 4-phosphono β-
lactams 23 
 E. Coli P. Aeruginosa S. Aureus E. faecalis C. perfringens 
23b 95.6 95.3 89.0 93.8 99.3 
23f 95.4 95.7 94.0 94.7 98.7 
273 97.3 95.0 89.7 89.4 96.6 
23e 95.2 94.7 91.8 94.7 98.5 
23i 97.0 92.5 94.4 94.7 99.3 
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2.6 Conclusion 
In conclusion, preparation of 4-phosphono β-lactams starting from N-
chloroacetyl aminoalkyl phosphonates can be conveniently performed 
through the formation of a phosphorus stabilized anion and subsequent 
intramolecular alkylation. The required N-chloroacetyl aminoalkyl 
phosphonates can be prepared in two ways. The first one involves a two-step 
sequence starting with the phosphonylation of a suitable imine followed by N-
acylation of the resulting aminoalkyl phosphonates. This method proved to 
be the most versatile in regard to substrate variability and product yields. 
The second method involves a one-pot acylation – phosphonylation of an 
aromatic imine through an intermediate acyliminium ion. More side reactions 
are observed using this pathway. However, within a narrow spectrum of 
imines, it can be a valuable, fast alternative to the two step method. 
 
The ring closure of N-chloroacetyl aminoalkenyl phosphonates was studied in 
more details. When these substrates are deprotonated, an allyl anion is 
formed which can be alkylated at two positions. Even though γ-alkylation 
would provide a six-membered ring, only α-alkylation is observed yielding a 
more strained four-membered ring. The main reason four this unexpected 
behaviour was found in the specific conformation of the N-chloroacetyl 
aminoalkenyl phosphonates and the corresponding anions. Due to a 
restricted rotation about the N-C(P) σ-bound, the transition state required for 
six-membered ring formation is considerably higher in energy than that for 
four-membered ring formation. From these results it is clear that the N-alkyl 
and P-alkenyl group are rotated easily towards each other. This property will 
be exploited in the next chapters to perform other intramolecular conversions 
of this type of substrates. 
 
Finally, transformations of the obtained 4-phosphono β-lactams appeared to 
be very difficult. The corresponding free phosphonic acids could not be 
obtained in pure form. Nevertheless, the parent esters were tested for their 
activity against bacteria and fungi, however without any success. 
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3 Synthesis of 2-phosphono pyrroles 
3.1 Introduction 
Pyrroles represent an important class of heterocycles that display remarkable 
physiological (antibacterial, antiviral, anti-inflammatory, antitumor, 
antioxidant, hypocholesterolemic and immunosuppressant) activities.343-348 
Furthermore, they are useful intermediates in the synthesis of natural 
products as well as in heterocyclic chemistry349 and they are widely used in 
material science.350 As a consequence, many synthetic methods are known 
for the construction of the pyrrole nucleus. The most frequently used 
methods include the classical Hantzsch procedure, the cyclocondensation of 
primary amines with 1,4-dicarbonyl compounds (Paal-Knorr synthesis), and 
various cycloaddition strategies.351,352 Nevertheless, only very little is known 
about the properties of phosphonylated pyrroles. This might be caused by the 
limited number of synthetically useful pathways towards these class of 
compounds.  
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2-Phosphono pyrroles can be obtained through direct phosphorylation of a 
pyrrole nucleus, however only in low to moderate yields (23-54%).353-355 
Nitrile ylids containing an electron withdrawing phosphonate group have 
been reacted with alkynes131,356,357 or alkenes containing a suitable leaving 
group130,133,358 to yield 2-phosphono pyrroles via a 1,3-dipolar cycloaddition 
(for an example, see chapter 2, section 2.5). Addition of enolates and 
enamines to phosphono azoalkenes 296 or addition of cyano methyl 
  105 
phosphonate anion to azoalkenes was shown to lead to 1-amino 3-
phosphono pyrroles.359-361 One example was presented in which a Boc 
protected 3-oxo 2-phosphono pyrrolidine was converted to the corresponding 
3-hydroxy 2-phosphono pyrrole by treatment with trifluoroacetic acid.166 
Finally, only one example of a metal mediated ring closure between an alkyne 
and a C-N double bond using Pd has been reported.362  
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For the synthesis of 2-phosphono pyrroles, we focussed our attention to 
another organometallic reaction which found its great breakthrough in the 
late 1990’s: ring-closing metathesis. Retrosynthetically, ring closure of a 
suitable functionalized diallylamine 32 would lead to the 2-phosphono 3-
pyrroline 31 which would be converted to the corresponding pyrrole 30 by 
oxidation. Diallylamine 32 would be obtained for instance from a suitable 
aldehyde 299 and an allylamine through phosphonylation (see chapter 3, 
section 1.4) and benzylation.363 
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Olefin metathesis was discovered in the 1960’s and was observed as a 
rearrangement around the double bounds in a mixture of olefins.364 Various 
(mixtures of) metals could be used for these reactions and a generally 
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accepted mechanism for this metal mediated rearrangement was proposed by 
Chauvin.365 When two alkenes are present in the same molecule, 
intramolecular rearrangement may result in a cyclic structure. This type of 
metathesis is known as Ring-Closing Metathesis (RCM). Since the discovery 
and development of practical useful, well-defined ruthenium based 
metathesis catalysts (e.g. 300 – 301) in the past decennium,364,366-368 ring-
closing metathesis has found wide application in the synthesis of complex 
(hetero)cyclic compounds.369-373  The use of RCM to form heteroaromatic 
compounds, however, has only recently appeared in the literature.374-376  
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3.2 Benzylation of α-aminoalkenyl phosphonates 
Cinnamaldehyde could be easily condensed with allylamine and 
phosphonylated using dimethyl phosphite in high yield and purity (see 
chapter 3, section 1.4). The resulting α-aminoalkenyl phosphonate 22e was 
then treated with 1 equivalent of benzyl bromide in the presence of a large 
excess (7 equivalents) of K2CO3 in acetone (dilution: 0.35 M). Complete 
conversion was only obtained after more than 22 h of reflux. When repeating 
the experiment for preparative reasons, a rate enhancement could be 
observed when the reaction medium was more concentrated. Therefore, a 
solid state experiment was evaluated in wich the starting material 22e was 
coated onto solid K2CO3 together with 1 equivalent of benzyl bromide by 
evaporating the solvent from the previously made dispersion. To obtain an 
optimal result, very fine K2CO3 should be used, for instance by grinding it in 
a mortar. The reaction medium obtained by this procedure was very much 
suited for microwave (MW) heating377 in an open vessel. 
 
The results of microwave irradiation are compared to those of conventional 
heating in Table 21. An enormous rate enhancement can be observed using 
MW conditions and solid state reaction media: up to 93% conversion to 32a 
as a single reaction product in 5.5 minutes (entry 4). However, one should 
not neglect the effect of the higher concentration in the solid state medium: 
1.5 minutes of MW heating followed by storage for 14 h at room temperature 
(entry 5) nearly gives the same result as 2.5 minutes of MW heating (entry 3). 
Also a sample left at room temperature for 12 minutes without any 
irradiation, already showed 22% conversion. Furthermore, the results 
obtained using this MW protocol are poorly reproducible, probably because of 
the problematical diffusion in the solid state reaction medium. 
 
Table 21: Evaluation of different heating conditions for the synthesis of N-benzyl 
aminoalkenyl phosphonates 32a 
H
O
285
P(OMe)2
HN
O
1.0 eq. BnBr
K2CO3
P(OMe)2
N
O
22e 32a
Bn
 
 Dilution Heating Reaction time Conversion 
1 0.35 M Conventional heating (∆) 22 h 99% 
2 - MW, open vessel, 450 W 30” 16% 
3 - MW, open vessel, 850 W 2’30” 63% 
4 - MW, open vessel, 850 W 5’30” 93% 
5 - MW, open vessel, 850 W 1’30” + 14 h rt 66% 
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Several other substrate/reagent combinations were tested under 
conventional and MW heating conditions. In all cases, either no reaction or 
complex mixtures were observed. Changing to KOH as a stronger base 
instead of K2CO3 also resulted in complex mixtures. In conclusion, no good 
general alkylation method for α-aminoalkenyl phosphonates using MW 
heating could be developed.  
 
P(OMe)2
HN
R
O
R = iPr
0.35 M in acetone
reflux
Br1 eq.
P(OMe)2
N
O
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P(OMe)2
N
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N Bn
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Benzylation of N-allyl α-aminoalkenyl phosphonates is possible in reasonable 
reaction times (16 to 20 h) using a slight excess (1.5 equivalents) of benzyl 
bromide and high substrate concentrations (e.g. 1 to 1.5 M). Even shorter 
reaction times are possible by adding 0.5 equivalent of NaI to the reaction 
mixture (5-10 h). The reaction can be conveniently monitored using 31P NMR. 
After complete conversion of the starting material, the obtained reaction 
mixture mainly consists of the end product and the excess of benzyl bromide. 
Acid base extraction was not useful to isolate the benzylated aminoalkenyl 
phosphonates. Pure samples were obtained using column chromatography, 
however, resulting in considerable product losses. The results of the 
benzylation, phosphonylation and condensation reaction are presented in 
Table 22. Commercial aldehydes 299d and 299e were purchased as E/Z-
mixtures. Although both isomers displayed different reaction rates, they were 
equally converted to the corresponding end products.  
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Table 22: Synthesis of N-benzyl aminoalkenyl phosphonates 32 
R1 H
R2
O
R1 P(OMe)2
R2
HN
O
R3
R1 P(OMe)2
R2
N
O
R3Ph(i)
299
(iii)
22
32
(ii)
 
(i) 1.1 eq. of amine, 2 eq. MgSO4, CH2Cl2, rt., 12 h; 
(ii) 2 eq. DMP, MeOH, ∆, 2-3 h; 
(iii) 1.5 eq. BnBr, acetone (1.0 M solution), K2CO3, 0.5 eq. NaI, ∆, 5 - 10 h.  
 
SM R1 R2 R3 22
¤ 32# 
299a Ph H H 22e 95% 32a 61% 
299b Ph Me H 22l 90% 32b 50% 
299c Me Bn H 22p 27% 32c 50% 
299d Ph isoamyl H 22m 88%* 32d 54%* 
299e Me Ph H 22o 80%* 32e 35%* 
299f Me CH2CH2Ph H 22q 44% 32f 92% 
299a Ph H Me 22f 74% 32g 86% 
299g 
 
H 22v 80% 32h 66% 
299h Ph Cl H 22n 63%  - 
¤ Yield from 299 after acid/base extraction (see chapter 3, section 1.4) 
# Yield after column chromatography 
* Mixture of E and Z isomers 
 
 
Next to the commercial aldehydes, a literature procedure378 was evaluated in 
order to prepare more diverse substrates 299c,f. For this reason, cyclohexyl 
imine 19p was prepared using 10 g of crotonaldehyde 276, 30 g of 
cyclohexylamine (2.2 eq.), 14 ml of benzene and 5.9 g of K2CO3. The imine 
can only be obtained in pure form as a colourless oil (40% yield) after two 
consecutive vacuum distillations (at 10 and 42 mbar respectively) and should 
be stored at –20°C, shielded from sunlight.  
  
H
O 2.2 eq. c-hexNH2
0.5 eq. K2CO3
benzene
(40%)
H
N
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19p
1 eq. LDA
(1 eq. HMPA)
THF, 0°C, 10' H
N
1.07 eq. RBr
-78°C, 4 h
H
N
R
NaOAc/HOAc
H2O, 1h, rt.
H
O
R
H
O
R +
308
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Treatment of imine 19p with LDA at 0°C yields an ambident anion 306 which 
is subsequently trapped with an alkyl bromide at –78°C.379,380 The 
intermediate imine 307 is then treated with an aqueous acetate buffer 
mixture to perform the hydrolysis and the double bond isomerization# 
yielding the desired 2-butenal derivatives 299. Complete regioselectivity was 
claimed in the original paper for the chex-imine.378 Although the 
corresponding tBu imine is far more easy to prepare and to isolate, it is not 
selected for this alkylation reaction since regioselectivity is known to be 
rather poor.381  
 
Table 23: Preparation of α-substituted crotonaldehydes 299c,f 
 R HMPA Yield 299:308§ 
1 Allyl + 77% 86:14 
2 Bn + 95% 93:7 
3 Bn - 82% 97:3 
4 CH2COOMe + To low conversion 
5 CH2COOMe - To low conversion 
6 CH2CH2Ph + 80% 92:8 
   § Determined from the crude reaction mixture using GC-MS 
 
 
Unfortunately, the yields as well as the regioselectivity were less 
advantageous in our hands (Table 23). HMPA382 seemed to have a beneficial 
influence on the reaction yield, but lowered the regioselectivity somewhat. No 
separation of the isomeric products was possible using column 
chromatography and therefore, only the benzyl and phenylethyl derivatives 
were useful in the following reaction steps. In both cases, the crude reaction 
mixture was used to form the imines and α-aminoalkenyl phosphonates. 
Phosphonate 22p could be obtained in pure form by crystallization. 
 
 
 
 
 
 
 
 
 
                                           
# In one case (R = CH2COOMe) spontaneous isomerization of the double bond in imine 307 
occurs from the 3-position to the 2-position. 
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3.3 Ring closure to 2-phosphono 3-pyrrolines 
Grubbs’ 2nd generation catalyst 302 was selected to perform the ring closure 
of substrates 32, because of its stability to ambient conditions, its high 
activity and its excellent thermal stability.367,383 The catalyst 302 was added 
to a 0.1 M solution of substrates 32 in dry dichloromethane and the reaction 
was conveniently monitored using 31P NMR. Notwithstanding the presence of 
a nucleophilic nitrogen atom, pyrrolines 31 were formed very smoothly in 3 
to 5 h at room temperature as a single reaction product (δ(31P) = 24.58-
24.91 ppm).¤ Most examples of azaheterocyclic ring formation presented in 
literature are dealing with non-nucleophilic nitrogen groups (e.g. amides, 
carbamates, sulfonamides,…).371-373 Failure of RCM reactions with substrates 
containing a nucleophilic nitrogen atom adjacent to the metathesized alkene 
is often attributed to poisoning of the catalyst or disfavoured conformation of 
the substrate.384-390 After complete conversion of the starting aminoalkyl 
phosphonates 32 (3-5 h at room temperature), the phosphono pyrrolines 31 
could be obtained in pure form as a colourless oil via an acid base extraction 
of the reaction mixture, which illustrated the basic properties of the pyrroline 
(Table 24). Pyrroline 31f could not be isolated. Instead, 1-benzyl-3-(2-
phenylethyl)-1H-pyrrole was formed, probably due to aromatization through 
elimination of the phosphonate group during work-up. This reaction was not 
observed in any of the other cases. 
 
Table 24: Synthesis of 2-phosphono 3-pyrrolines 31 via RCM 
 
R1 P(OMe)2
R2
N
O
R3Ph
N P(OMe)2
R2
Ph
R3
O
32
31
5 mol% 302
CH2Cl2, 3-5h
 
 
SM R1 R2 R3 Product* 
32a Ph H H 31a 44% 
32b Ph Me H 31b 58% 
32c Me Bn H 31c 62% 
32d Ph isoamyl H 31d 70% 
32e Me Ph H 31e 54%§ 
32f Me CH2CH2Ph H - - 
32g Ph H Me - - 
* Yield after acid/base extraction 
§ Spontaneous oxidation to pyrrole 30e using air 
was observed during work-up. 
 
In the case R1 is phenyl, styrene is formed during the ring-closing reaction, 
which unlike ethene does not boil off from the reaction mixture. Liberation of 
                                           
¤ In case of phosphonate 32e, complete conversion to pyrroline 31e needed 3 h at reflux 
temperature. The E/Z isomers of phosphonates 32d and 32e were converted at different 
eaction rates to the same product. 
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ethene from the reaction mixture is often indicated as the driving force in 
RCM reactions. A closer look to the crude 1H NMR spectrum revealed the 
presence of stilbene, which could also be obtained as colourless crystals from 
the reaction mixture. Stilbene is probably formed together with ethene via 
cross metathesis of styrene in a second catalytic cycle. It should be noticed 
that two active species of the catalyst are present in the reaction mixture: 
carbene 310, which is presented as the propagating species in the general 
Chauvin mechanism,365 and Grubbs’ carbene 302, which is regenerated 
during the catalytic cycle in this case.  
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While substituted double bounds are often not well tolerated by ruthenium 
based catalysts,391 R1 (Ph or Me) and R2 groups very much are in this case, 
even under very mild conditions. However, when phosphonate 32g (R3 = Me) 
was selected as a substrate in the RCM reaction, no reaction occurred at all 
and the starting material was recovered, even under reflux conditions in 
CH2Cl2 or benzene. When switching to refluxing chlorobenzene as a solvent, 
31P NMR showed the disappearance of the starting material and the 
simultaneous appearance of a signal at 10.4 ppm. Upon work-up, this signal 
proved to be the corresponding enaminophosphonate resulting from the 
migration of the double bound towards the phosphonate. These observations 
indicated that the RCM reaction is most likely initiated via the least hindered 
double bond and that the following intramolecular conversions are less 
dependent on the steric bulk of the olefin. When two substituted double 
bonds are present in the molecule, the initiation seems to be delayed to such 
a large extent that no reaction is possible anymore.391 
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3.4 Ring closure – oxidation to 2-phosphono pyrroles 
In order to obtain phosphono pyrroles 30, the use of tetrachloroquinone 
(TCQ) has already proven effective in combination with catalyst 302.392 An 
increasing interest exists in combining ring-closing metathesis with a second 
reaction step (such as RCM and a Pd mediated coupling reaction,393,394 a 
double bond isomerisation,395-397 a Diels-Alder,398 an oxidation399 or a 
dihydroxylation reaction400) in order to obtain complex, highly functionalized 
molecules in a one-pot reaction. When phosphonates 32 are treated with 
catalyst 302 and 1 equivalent of TCQ, the expected pyrroles 30 are formed as 
a single reaction product (δ31P = 13-15 ppm) after stirring for up to 16 h at 
room temperature. Monitoring the reaction using 31P NMR, a minor decrease 
of the RCM reaction rate was observed by the action of TCQ. When catalyst 
302 was allowed to react for 2 h with the substrate (giving approximately 
60% conversion to the pyrroline) before the addition of TCQ, the pyrroles 
were obtained after 5-7 h at room temperature.#  
 
Table 25: Synthesis of 2-phosphono pyrroles 30 via RCM 
 
R1 P(OMe)2
R2
N
O
Ph N P(OMe)2
R2
Ph
O
32
30
5 mol% 302
1 eq. TCQ
CH2Cl2, 5-7h
 
 
SM R1 R2 30
* 
32a Ph H 30a 75% 
32b Ph Me 30b 84% 
32c Me Bn 30c 72% 
32d Ph isoamyl 30d 70% 
32e Me Ph 30e 75%# 
32f Me CH2CH2Ph 30f 71% 
* Yield after column chromatography 
 
 
A mechanism for this ring-closing metathesis with in situ oxidative 
aromatization has already been proposed before, in which TCQ is considered 
as a hydrogen acceptor.392 No ruthenium is really required for the 
oxidation,401,402 as pure 31b and 31d are also converted to the corresponding 
pyrroles 30b,d by stirring with TCQ at room temperature for 22 h. However, 
this is considerably slower than in the presence of catalyst 302. Two reaction 
pathways may be considered to explain these results: (a) hydrogen atoms are 
transferred in the process of oxidative addition and reductive elimination 
which involves hydride complexes with the metal or (b) hydrogen donor and 
                                           
# Complete conversion to pyrrole 30e was achieved after 5 h at reflux followed by 12 h at 
room temperature. 
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acceptor are brought together by simultaneous coordination to the central 
metal of the catalyst, followed by direct transfer of the hydrogen atoms from 
the pyrroline to the TCQ.403 In light of the mild reaction conditions in 
combination with the fact that no pyrrole formation is observed in the 
absence of TCQ, the assumption that hydrogens are transferred via pathway 
(b) seems to be reasonable. 
 
With these excellent RCM results in hand, we tried to ring close 
phosphonates 22e and 22m possessing a free NH group. When the reaction 
was monitored using 31P NMR, decreasing reaction rates were observed, and 
a maximum conversion of only 30% was reached (Figure 17). This kind of 
behaviour suggests catalyst inhibition by the pyrroline 311a,b rather than by 
the starting material 22e,m.  
 
Figure 17: Conversion of 22e to 311a at room temperature in the presence of 5 
mol% of catalyst 302, measured by 31P NMR. (%311a in the reaction mixture versus 
time in hours). 
 
 
When TCQ was added together with catalyst 302, the formed pyrroline 311 
was oxidized immediately in the reaction mixture and 100% conversion to the 
pyrrole 312a,b was observed at room temperature in dichloromethane in 
75 h. However, during the course of the reaction, side products started to 
appear. Therefore, the reaction was repeated at higher temperatures in order 
to decrease the reaction time and the concomitant side product formation. 
Cleaner reaction mixtures were obtained at reflux temperatures in 23 h in 
dichloromethane or in 7 h in benzene. Even though the reaction mixture was 
much less clean than in the case of the N-benzyl substrates 32, and pyrroles 
312 could only be obtained in low yields after a laborious chromatographic 
purification, the reaction sequence clearly illustrates the synergism between 
ruthenium mediated ring-closing metathesis and oxidation by TCQ: 
inhibition of the catalyst is avoided by instantaneous conversion of the 
0%
20%
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60%
80%
100%
0 10 20 30 40 50 60 70 80 t/h 
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nucleophilic nitrogen atom to a non-nucleophilic form and aromatization is 
probably the major driving force of the reaction sequence. To the best of our 
knowledge, this is the first example of RCM using the 2nd generation Grubbs’ 
catalyst 302 on secondary free amines without the need to convert them to a 
hydrochloric salt. Furthermore, the failure of RCM reactions with substrates 
containing a NH functionality should be attributed to its nucleophilic 
properties rather than to the need of a proper conformation for ring closure. 
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We tried then to exploit the observed synergism between RCM catalyst 302 
and TCQ to perform a ring-rearrangement metathesis (RRM)404 using 
substrate 32h derived from myrtenal. RRM is a combination of ring opening 
metathesis (ROM) and RCM. ROM has been used already to polymerize 
highly strained cycloalkenes like cyclobutenes405 and norbornenes.406 The 
high strain in these rings constitutes the driving force for the ROM reaction. 
However, with the development of highly active metathesis catalysts in the 
last decade, a wide area of substrates has been used in RRM reactions.407-409 
Nevertheless, even with the powerful new catalysts, an equilibrium is always 
established which can be shifted to one side by means of a sufficient change 
in free energy. This can be achieved by means of the properties of the 
substrate (e.g. release of ring strain, decrease of steric bulk,…) or by 
presenting a “sink” to one of the products of the equilibrium (e.g. an 
additional RCM with release of ethene).410 The sink would be provided in this 
case by the aromatization of pyrroline 31h to the corresponding pyrrole 30h. 
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Several reaction conditions were evaluated with 5 mol% of catalyst 302 in 
0.1 M solutions of the amine 32h (Table 26). However, when no TCQ was 
added, the reaction mixture mainly consisted of starting material next to five 
or six unidentified side products (entry 1, 3). No reaction occurred at all in 
the presence of TCQ at room temperature or when refluxing in 
dichloromethane or benzene (entry 2, 4, 5). Finally, the hydrochloride salt of 
32h was formed prior to the metathesis reaction. However, regardless of the 
temperature profile of the reaction, only starting material was recovered after 
aqueous work-up (entry 6, 7). 
 
Table 26: Evaluation of the RRM reaction of 32h with 5 mol% of Ru catalyst 302 
 SM Solvent TCQ Conditions Result 
1 32h CH2Cl2 - rt., 23 h SM + unidentified side products 
2 32h CH2Cl2 1 eq. rt., 24 h SM 
3 32h CH2Cl2 - ∆, 2.5 h SM + unidentified side products 
4 32h CH2Cl2 1 eq. ∆, 3.5 h SM 
5 32h Benzene 1 eq. ∆, 2 h SM 
6 32h.HCl CH2Cl2 - rt., 3.5 h SM 
7 32h.HCl CH2Cl2 - ∆, 1 h SM 
 
 
The failure of the reaction may be explained in terms of steric bulk, which 
inhibits the catalyst initiation. Substituent effects have been shown to have a 
large effect on the course of an RRM reaction.410 Furthermore, the release of 
ring strain from 32h is only minor, since the most strained four-membered 
ring continues to exist in the pyrroline 31h.  
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3.5 Spectral characteristics of 2-phosphono pyrroles 
When looking at the 13C chemical shifts in the 2-phosphono pyrrole nucleus, 
a surprising influence of the phosphonate group can be noted. Due to the 
inductive effect of the nitrogen atom, C4 is clearly shifted downfield, while C3 
is more shielded because of the mesomeric effect of the nitrogen atom. The 
electron withdrawing phosphonate group is able to invert the nitrogen 
mesomeric effect at C2 causing it to appear at lower field. Notwithstanding 
the electron withdrawing capacities of the nitrogen atom, C1 is very much 
shielded. This illustrates the electron donating capacities of the phosphonate 
group.225 Phosphorus, carbon couplings are present throughout the pyrrole 
nucleus and are fairly constant in all derivatives. More detailed spectral data 
can be found in the experimental section (chapter 4, section 5.4) and in 
appendix E. 
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3.6 Evaluation of the preparation of bicyclic phosphono β-lactams via 
RCM 
Although most antibiotics possess a bicyclic β-lactam core (see chapter 3, 
section 2.1), phosphonylated bicyclic β-lactam compounds have only been 
studied very scarcely, without any promising antibacterial activity so 
far.64,411-416  From the results in the previous section, it was clear that the 
Grubbs’ 2nd generation catalyst 302 is able to convert phenyl or methyl 
substituted double bonds and furthermore well tolerates the phosphonate 
and amino groups in the substrate. Furthermore, β-lactams are well 
tolerated under metathesis conditions.417 Therefore, RCM constitutes a 
valuable technique for the preparation of bicyclic phosphono β-lactams 
starting from the already obtained monocyclic derivatives. 
 
Phosphono β-lactam 23e was selected as the substrate for the RCM reaction, 
which should lead to a carbapenem-like skeleton 33. A 0.3 M solution of the 
β-lactam 23e in dichloromethane was refluxed in the presence of 5 mol% of 
catalyst 302. Complete conversion was obtained in only 1h. However, only 
the dimer 314 was formed as a mixture of (E)- and (Z)-isomers. A more dilute 
reaction medium (up to 0.03 M) and prolonged reaction times were believed 
  118 
to lower the degree of dimerization in the final reaction mixture. Nevertheless, 
the desired bicylic lactam was never formed, which may that the rigid β-
lactam has lost the favourable conformation of its precursor 21.  
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1.1 eq. LiHMDS
2 h, rtX = Cl, H
312a (19%)
O
NaH
X = Cl
X = 
Cl
34 (X = Cl, 63%)
315 (X = H, 68%)
100% conversion
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To avoid these conformation problems, the five-membered ring was formed 
first via RCM with N-chloroacetyl aminoalkenyl phosphonate 21e. It was 
shown in chapter 3, section 2.4.4 that both alkenyl ends are directed towards 
each other. The reaction proceeded very smoothly indeed, affording pyrroline 
34 in 63% yield after column chromatography. The pyrroline 34 was then 
treated with LiHMDS in order to invoke ring closure. However, no ring-closed 
product could be detected in the final reaction mixture. Aqueous work-up 
resulted in considerable losses and only pyrrole 312a could be isolated in low 
yield using column chromatography. With NaH, a more complex reaction 
mixture was obtained, however also containing pyrrole 312a. Chlorine was 
expected to play an essential role in the mechanism of this transformation. 
However, when N-acetyl pyrroline 315 was submitted to treatment with 
LiHMDS, the same pyrrole 312a was obtained in low yield. No further 
investigations were performed to reveal the reaction mechanism. 
 
 
3.7 Conclusion 
From the results in chapter 3, section 2.4 it was clear that N-allyl 
aminoalkenyl phosphonates should be excellent substrates for a RCM 
reaction. This was confirmed by their conversion to 2-phosphono 3-
pyrrolines and 2-phosphono pyrroles. Notwithstanding the presence of a 
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basic nitrogen atom in the substrates, the RCM reaction was performed 
smoothly by Grubbs’ 2nd generation ruthenium catalyst. The resulting 
pyrrolines were smoothly oxidezed to the corresponding pyrroles in one-pot 
or in a second step using TCQ. 
 
Inhibition of the RCM catalyst by the pyrrolines was observed, however, when 
secondary amines were used in the reaction. Nevertheless, the corresponding 
1H-pyrroles could be obtained when the oxidation of the intermediate 
pyrrolines was performed in situ. This behaviour indicates the great 
synergism between TCQ and the Grubbs’ 2nd generation catalyst. 
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4 Synthesis of tricyclic phosphono pyrrolidines 
4.1 Introduction 
Few reactions can compete with the Diels-Alder cycloaddition with respect to 
the degree of structural complexicity that can be achieved in a single 
synthetic step. It is well-known that aromatic heterocycles, such as furans 
and thiophenes, can undergo Diels-Alder reactions as the 4pi diene 
components despite their aromaticity and hence expected decreased 
reactivity.418-421 Also the intramolecular Diels-Alder reaction (IMDA) is 
amenable to the use of furans as dienes and is frequently designated as the 
IMDAF reaction. The scope of the reaction is quite broad with respect to the 
diene (furan), the dienophile, and the tether linking the two.422 Furthermore, 
the IMDAF reaction is particularly attractive as two or more rings can be 
constructed in a single step with high regio- and stereocontrol, providing a 
convenient entry into polycyclic targets including natural products.423-430 
 
4.2 Synthesis and structural characterization 
The allylaminofuran-2-ylmethyl phosphonate 22z is a suitable substrate for 
the IMDAF reaction. Furthermore, it was clear from the results in chapter 3, 
section 2.4 that when aminoalkyl phosphonate 22z was acylated at nitrogen,  
the N-alkyl substituent should be directed towards the furane heterocycle, or 
should be easily rotated in that direction. This predicted conformation would 
greatly enhance the IMDAF reaction. To investigate this hypothesis, 
aminoalkyl phosphonate 22z (see chapter 3, section 1.4) was treated with 
various acid chlorides. As reported in chapter 3, section 2.2.1 these reactions 
proceeded smoothly at room temperature, yielding the corresponding amides 
36 in high purity. With pyvaloyl chloride, however, complex mixtures were 
obtained under different reaction conditions. When allylaminofuran-2-
ylmethyl phosphonate 22z was refluxed in toluene, only break down of the 
starting material was observed upon prolonged heating times. However, when 
the corresponding amides 36 were refluxed in toluene, complete conversion 
to the ring closed products 35 was observed in all cases. The results in Table 
27 indicate that the reaction time was strongly dependent on the steric bulk 
of the amide chain. With a chloroacetyl group, 24 h of reflux was required, 
while the ring-closed product 35e (R = CCl3) was already formed during the 
acylation reaction at room temperature and subsequent aqueous work-up. 
This reactivity order was in accordance with the results reported for similar 
substrates 317 only missing the phosphonate group and can be explained by 
a combined steric and electronic effect in the amide side chain.431 
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However, a remarkable influence of the phosphonate group was observed. 
While amides 318a and 318c could only be obtained in low yield because of 
the poor conversion, the corresponding phosphono amides 36a,c gave 
complete conversion and could be obtained in reasonable yields after column 
chromatography. The positive influence of high tether substitution on IMDAF 
reactions is often attributed to the Thorpe-Ingold effect (gem-dialkyl effect) or 
to the active rotamer effect.422,431,432 The latter is in complete accordance with 
the results discussed in chapter 3, section 2.4. 
 
Table 27: IMDAF reaction of (acylallylamino)furan-2-ylmethyl phosphonates 36 
 R 
Yield 
36 
Yield 
35§ 
Isomer 
ratio 35 
Time 
35 
Conversion 
317318# 
a CH2Cl 98% 75% 27/73 20 h 43% 
b (CH2)2CH2Cl 88% 47% 20/80 4.5 h - 
c iPr 88% 53% 17/83 7 h 62% 
d CHCl2 96% 94% 35/65 3 h 100% 
e CCl3 99%
¤ 99% 21/79 1 h¤ 100% 
§ All adducts 35 are formed with 100% conversion. Yields reported are 
isolated yields, after column chromatography or crystallization 
# 30-40 h reflux in acetonitrile (results from ref. 431) 
¤ The cycloadduct 35e was already formed at room temperature during the 
acylation reaction and subsequent work-up. The obtained mixture of 36e 
and 35e is refluxed for 1 h in order to obtain complete conversion to 35e. 
 
 
The structure of the tricyclic pyrrolidines was confirmed by its 2D DQFCOSY, 
HSQC (Figure 18) and HMBC spectra and on comparison with data from 
compounds 318.  The 1H NMR spectrum is characterized by a large difference 
  122 
in chemical shift of both NCH2 protons, clearly indicating that they are on 
opposite sides of a rigid ring system. Similar to pyrrolidines 318, the 
phosphono pyrrolidines 35 were isolated as a mixture of two isomers. Ghelfi 
and coworkers showed, based on a NOESY experiment, that the configuration 
of the tricyclic skeleton in 318 was exo and that the two isomers were amide 
rotamers.431 However, in case of phosphono pyrrolidines 35, the isomers might 
originate from three diverse structural properties: (i) amide rotamers, (ii) endo- 
or exo-annulation, or (iii) configuration of the C(2) centre. 
 
Figure 18: HSQC spectrum of the major isomer of 35e (R = CCl3). 
 
 
The exclusive formation of exo-fused adducts in the research of Ghelfi and 
coworkers is by no means an exception. Most studies using similar substrates 
show exclusive exo-adduct formation when the reaction is performed under 
thermodynamic control.422-438 Endo-fused (kinetic) products are normally 
formed under high-pressure-mediated conditions.434 Nevertheless, it is 
reasonable to suggest the appearance of an endo-fused isomer next to the exo-
fused isomer based on the results of Tromp and coworkers.439 They found that 
more steric substituents on the tether can favour the formation of endo-fused 
adducts. Therefore, the bulky phosphonate group may be able to alter the 
N CCl3
O
P(OMe)2
O
O
1
2
34
56
7
8 9
6a 6b 5 
4a 4b 2 7 
8/9 
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reaction selectivity, yielding a mixture of both adducts. However, having a 
close look to the 1H NMR and DQFCOSY data of both isomers of 35e, the 
differences in the multiplicities and coupling constants are too little to explain 
a complete transformation of the tricyclic skeleton. Comparison with typical 
coupling constants from similar compounds revealed the presence of an exo-
fused skeleton in both isomers (Figure 19).  
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Figure 19: Comparison of typical coupling constants from literature sources439-441 
with those measured in both isomers of pyrrolidine 35e.§ 
 
 
Both isomers were also submitted to a catalytic amount of CuCl in 
dichloromethane with TMEDA as a ligand under an argon atmosphere. Under 
these conditions a radical is typically generated at the CCl3 moiety, causing 
ring closure to the double bond. However, both isomers were recovered 
unchanged after the reaction. This result might - suggest that both isomers 
have indeed an exo-configuration, since only in the endo-fused product, the 
CCl3 moiety would be able to come in the close neighbourhood of the double 
bond, giving rise to the formation of an additional six-membered ring.  
 
N
P(OMe)2
H
O
CCl3
O
O
0.3 eq.CuCl
0.6 eq. TMEDA
14 h, rt., [Ar]
no reaction
35e  
                                           
§ Similar coupling constants were measured for pyrrolidines 35a-d (see chapter 4, section 
6.3 or appendix F 
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In a further attempt to reveal their identity, we tried to separate both isomers 
of pyrrolidine 35e. This was conveniently achieved by washing the crystals 
three times with acetone. The remaining solid was the pure major isomer 
35e’, while the acetone contained a mixture of both isomers. From this 
mixture, the minor isomer 35e” could then be recovered in pure form using 
column chromatography. Both isomers were stable at room temperature for 
at least 1 month. Amide rotamers generally show rotational barriers between 
63 and 96 kJ/mol442 and are thus in thermal equilibrium at room 
temperature. Furthermore, no rotamers were observed in NMR for the open 
precursors 36. Therefore it was concluded that the observed isomers were 
not rotamers, but originated from an incomplete stereocontrol of the IMDAF 
reaction at C(2).  
 
In order to reveal the three-dimensional positioning of the phosphonate 
group, DIFNOE experiments were performed on both isomers. Optimal 
results in terms of minimal signal overlap, substraction artefacts and signal 
to noise ratio were obtained when using highly dilute samples in benzene-d6 
instead of in deuterated chloroform. Oxygen was removed from the solutions 
by flushing with nitrogen gas. Considerable nuclear Overhauser effects were 
observed between CH(5) and CHα(6) and CHα(4), confirming the exo-fused 
skeleton of both isomers (Figure 20). A clear difference between both isomers 
was observed, however, when the nuclear Overhauser effect at CH(2) was 
studied: the bulky phosphonate is β-oriented in the major isomer 35e’.  
 
While absolute stereocontrol of substituents on the diene or dienophile is 
often observed, this is not always the case for tether substituents, regularly 
giving mixtures of both isomers.434-436 Furthermore, the observed 
stereoisomer ratio may be the result of thermodynamic control and may not 
be the isomer ratio formed in the initial reaction mixture. Equilibration can 
occur under thermal conditions via a consecutive retro-Diels-Alder, Diels-
Alder reaction.422,443,444 To investigate this kind of behaviour, pure samples of 
the major 35e’ and minor isomer 35e” were heated in toluene (110°C). No 
change at all occurred to the minor isomer 35e” over a 20 h period. The 
major isomer 35e’ on the other hand, was slowly converted to the minor 
isomer 35e”. After 1 h at 110°C, only 2% conversion was observed. This did 
not reflect at all the 25/75 ratio observed after 1 h at 110°C starting from the 
open precursor 36e (Table 27) and again contested the presence of rotamers. 
When heating was continued for 20 h, 95% conversion to 35e” was observed. 
The slow conversion of the major to the minor isomer suggests 
retrocycloaddition of the less stable cycloadduct. This is in agreement with 
the stereochemistry generally observed during IMDAF reactions: when a 
single bulky substituent is present on the tether, the most stable cycloadduct 
will be formed in such a way as to minimize non-bonded interactions.  
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Figure 20: Stereochemical analysis of isomers 35e’ and 35e”. Percent nuclear 
Overhauser effect (NOE) is indicated (measured via a DIFNOE experiment with 
irradiation of CH(5)). Energy optimized 3D structures (MM2) of both isomers are 
depicted for reference purpose. 
 
 
An additional experiment was performed using a substrate without an amide 
substituent. In order to circumvent the need for an amide substituent to 
increase the amount of active rotamer (vide supra), N-allyl aminoalkyl 
phosphonate 22z was allylated using an excess of allyl bromide in the 
presence of NaI. After refluxing for 4 h in acetone, complete conversion of the 
starting material 22z was obtained, yielding a mixture of diallylamine 319 
and the ring closed product 320. This mixture was then refluxed in toluene 
during 4 h, yielding the ring-closed product 320. Notwithstanding the 
presence of the chiral CHP centre, only one isomer could be detected by 
NMR. Therefore, the relative stereochemistry at the CHP centre apparently 
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was fixed during the ring closure reaction or equilibration via 
retrocycloaddition was fast in this case.  
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This was also observed when the amide group was included in the tricyclic 
skeleton. For this reason, aminoalkyl phosphonates 22y,ab were treated with 
acryloyl and cinnamoyl chloride respectively. The corresponding 
pyrrolidinones 323 were obtained as single isomers upon refluxing the 
amides 321 and 322 in toluene or THF. However, the stereochemistry of the 
two stereocentres could not be determined via DIFNOE experiments. 
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4.3 Conclusion 
In conclusion, the excellent results of the IMDAF reaction with (acyl-
allylamino)furan-2-ylmethyl phosphonates 36 additionally reflect the 
particular conformational properties of N-acyl aminoalkyl phosphonates as 
described in chapter 3, section 2.4. Using this cycloaddition methodology, 
complex azaheterocyclic phosphonates can be obtained in a small number of 
synthetic steps that might be used as novel conformationally-constrained 
amino acid analogues.445 Furthermore, a high degree of stereocontrol is 
observed during the cycloaddition reaction. Only the exo-fused products were 
obtained. Two isomers can be formed originating form incomplete 
stereocontrol at the C2 stereocentre. However, the most stable stereoisomers, 
having an α-oriented phosphonated group, are formed under thermodynamic 
control. 
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  CHAPTER 4   
 
Experimental Procedures 
 
 
 
 
 
 
 
1 Instrumental Material 
1.1 Column Chromatography 
The purification of the reaction mixtures was performed by column 
chromatography with silica gel (Acros, particle size 0.035-0.070 mm, pore 
diameter ca. 6 nm). Solvent systems were determined via initial TLC analysis 
(Merck Kieselgel 60F254, precoated 0.25 mm). As detection methods UV light, 
adsorption with iodine vapours or colouring with KMnO4 was used. 
1.2 NMR Spectroscopy 
High resolution 1H NMR (270 MHz), 13C NMR (68 MHz) and 31P NMR (109 
MHz) spectra were recorded on a Jeol JNM-EX 270 NMR spectrometer. 1H 
NMR, 13C NMR and 31P NMR spectra were acquired at 300 MHz, 75 MHz and 
121 MHz, respectively, with a Jeol JNM-EX 300 NMR spectrometer. Peak 
assignments were obtained using DEPT, HSQC, HMBC, COSY and DQFCOSY 
spectra. The compounds were diluted in deuterated solvents, with 
tetramethylsilane (TMS) as internal standard. 
1.3 Mass Spectrometry 
Low resolution mass spectra were recorded on a Varian MAT 112 
spectrometer (EI, 70 eV) by using GC-MS coupling or via a direct inlet system 
on an Agilent 1100 Series VS (ESI, 4000V) mass spectrometer. Some volatile 
samples were recorded on a HP 6890 GC coupled with a HP 5973 MSD (Mass 
Selective Detector, quadrupole). 
1.4 Infrared Spectrometry 
IR spectra were obtained using a Perkin Elmer Spectrum One infrared 
spectrometer. For liquid samples, the spectra were collected by preparing a 
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thin film of compound between two sodium chloride plates. Crystalline 
compounds were mixed with potassium bromide and pressed until a 
transparent potassium bromide plate was obtained. 
1.5 Gas Chromatography 
Gas chromatography was performed using an Agilent 6890 Series gas 
chromatograph. A fused silica capillary column was used (type AT-1, film 
thickness 0.25 µm, length 30 m, i.d. 0.25 mm) with He as carrier gas. The 
GC was coupled with a FID detector (H2 gas).  
1.6 Dry Solvents 
Diethyl ether, tetrahydrofuran and toluene were distilled from sodium 
benzophenone ketyl prior to use, whereas dichloromethane was distilled from 
calcium hydride. Methanol was heated in the presence of magnesium metal, 
distilled and kept over molecular sieves. Acetonitrile was distilled from 
calcium hydride and kept over molecular sieves. 
1.7 Melting Point 
Melting points of crystalline compounds were determined with a Büchi 540 
apparatus. 
 
 
2 Synthesis of aldimines 
Unless otherwise stated, aldimines have been prepared by mixing the aldehyde 
with 1 equivalent of amine (1.1 equivalent in case of volatile amines) and 2 
equivalents of MgSO4 in dry dichloromethane. The mixture was then stirred 
overnight and shielded from moisture using a CaCl2 tube. The imines were 
obtained in high purity and yield after filtration of the solids and evaporation 
of the solvent under reduced pressure. 
 
Phenyl-(3-phenylpropenylidene)amine (19a) 
1H NMR δ (300 MHz, ppm): 7.12-7.55 (12H, multiplet, =CH, 
CHarom); 8.27 (1H, dd, J = 6.1 Hz, J = 2.2 Hz, N=CH). Yield: 96%. 
Orange solid. 
 
 
 
Benzyl-(3-phenylpropenylidene)amine (19b) 
1H NMR δ (300 MHz, ppm): 4.69 (2H, s (br.), NCH2); 6.95-6.97 
(2H, multiplet, HC=CH); 7.20-7.37 (8H, multiplet, CHarom); 7.43-
7.48 (2H, multiplet, CHarom); 8.09-8.13 (1H, multiplet, N=CH). 
Yield: 96%. Orange oil. 
N
H
N
H
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(4-Methoxybenzyl)(3-phenylpropenylidene)amine (19c) 
1H NMR δ (300 MHz, ppm): 3.77 (3H, s, OCH3); 4.64 (2H, 
s, NCH2); 6.85-6.90 (2H, multiplet, HC=CH); 6.95 (2H, d, 
J = 4.1 Hz, CHarom); 7.19-7.38 (5H, multiplet, CHarom); 
7.44-7.48 (2H, multiplet, CHarom); 8.08-8.12 (1H, multiplet, 
N=CH). 13C NMR δ (75 MHz, ppm): 55.39 (OCH3); 64.79 
(NCH2); 114.12 (CHPMB); 127.36 (CHarom); 128.38 (=CH); 128.95, 129.28, 129.42 
(CHarom); 131.42 (Cq,arom); 135.86 (Cq,arom); 141.99 (=CHPh); 158.84 (OCq,arom); 163.15 
(N=CH). Yield: 94%. Orange oil. 
 
Allyl-(3-phenylpropenylidene)amine (19d) 
1H NMR δ (300 MHz, ppm): 4.15 (2H, ~dq, J = 5.8 Hz, J = 1.4 Hz, 
NCH2); 5.12-5.25 (2H, multiplet, =CH2); 6.03 (1H, ddt, J = 17.3 Hz, 
J = 10.2 Hz, J = 5.8 Hz, HC=CH2); 6.88-6.99 (2H, multiplet, 
HC=CH); 7.27-7.48 (5H, multiplet, CHarom); 8.03-8.06 (1H, 
multiplet, N=CH). Yield: 97%. Yellow oil. 
 
Isopropyl-(3-phenylpropenylidene)amine (19g) 
1H NMR δ (300 MHz, ppm): 1.22 (6H, d, J = 6.3 Hz, CH3); 3.41 (1H, 
septet, J = 6.3 Hz, CH); 6.90 (1H, d, J = 3.0 Hz, =CH); 6.92 (1H, s, 
=CH); 7.26-7.38 (3H, multiplet, CHarom); 7.44-7.48 (2H, multiplet, 
CHarom); 8.04 (1H, dd, J1 = 5.5 Hz, J2 = 3.0 Hz, N=CH). Yield: 98%. 
Yellow oil. 
 
t-Butyl-(3-phenylpropenylidene)amine (19h) 
1H NMR δ (300 MHz, ppm): 1,27 (9H, s, CH3); 6.89-7.00 (2H, 
multiplet, HC=CH); 7.26-7.59 (5H, multiplet, CHarom); 8.03-8.07 (1H, 
multiplet, N=CH). Yield: 98%. Yellow crystals. 
 
 
 
Allyl-(2-methyl-3-phenylpropenylidene)amine (19i) 
1H NMR δ (300 MHz, ppm): 2.17 (3H, d, J = 1.4 Hz, CH3); 4.20 
(2H, ~dq, J = 5.0 Hz, J = 1.4 Hz, NCH2); 5.14 (1H, dq, J = 10.3 Hz, 
J = 1.7 Hz, =CHAHB); 5.20 (1H, dq, J = 17.2 Hz, J= 1.7 Hz, 
=CHAHB); 6.03 (1H, ddt, J = 17.2 Hz, J = 10.3 Hz, J = 5.5 Hz, 
HC=CH2); 6.80 (1H, s (br.), =CHPh); 7.25-7.43 (5H, multiplet, CHarom); 8.00 (1H, s (br.), 
N=CH). Yield: 96%. Yellow oil. 
 
Allyl-(2-benzylidene-5-methylhexylidene)amine (19j) 
Predominantly E. 
1H NMR δ (300 MHz, ppm): 0.88 (3H, ~t, J = 6.3 Hz, CH=); 1.26-
1.43 (4H, multiplet, CH, CH3); 1.50-1.63 (2H, multiplet, CH2); 
2.59-2.65 (2H, multiplet, CH2Cq=); 4.15-4.19 (2H, multiplet, 
NCH2); 5.09-5.22 (2H, multiplet, =CH=); 5.95-6.10 (1H, multiplet, 
N
H OMe
N
H
N
H
N
H
N
H
N
H
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=CH); 6.72 (1H, s, =CHPh); 7.18-7.42 (5H, multiplet, CHarom); 7.89 (1H, s, N=CH). 
Yield: 94%. Yellow oil. 
 
But-2-enylidene-t-butylamine (19q) 
1H NMR δ (270 MHz, ppm): 1.20 (9H, s, CH3); 1.86 (3H, d, J = 7.6 Hz, 
CH3CH=); 6.20 (2H, multiplet, HC=CH); 7.85 (1H, d, J = 8.4 Hz, N=CH).  
Yield: 94%.  
 
Benzyl-[3-(2-nitro-phenyl)propenylidene]amine (19s) 
1H NMR δ (300 MHz, ppm): 4.74 (2H, s, CH2Ph); 6.92 (1H, dd, 
J = 8.8 Hz, J = 16.0 Hz, =CHNCH); 7.21-7.38 (5H, multiplet, 
CHBn); 7.41-7.48 (1H, multiplet, CH(4)); 7.49 (1H, d, 
J = 16.0 Hz, =CHPh); 7.57-7.63 (1H, multiplet, CH(3)); 7.66-
7.69 (1H, multiplet, CH(2)); 7.98 (1H, d, J = 8.3 Hz, CH(5)); 
8.20 (1H, d, J = 8.8 Hz, N=CH). Yield: 95%.  
 
[3-(2-Nitro-phenyl)propenylidene]prop-2-ynylamine (19t) 
1H NMR δ (300 MHz, ppm): 2.54 (1H, t, J = 2.2 Hz, ≡CH);  4.48 
(2H, t, J = 2.2 Hz, NCH2); 6.91 (1H, dd, J = 15.7 Hz, J = 8.8 Hz, 
=CH); 7.41-7.72 (CHarom, =CHPh); 8.01 (1H, dd, J = 8.1 Hz, 
J = 1.2 Hz, CH(5)); 8.40 (1H, dt, J = 8.8 Hz, J = 2.0 Hz, N=CH). 
Mp.: 105-106°C. Yield: 91%. Orange Crystals. 
 
 
Benzyl-(6,6-dimethyl-bicyclo[3.1.1]hept-2-en-2-ylmethylidene)amine (19u) 
1H NMR δ (300 MHz, ppm): 0.81 (3H, s, CH3); 1.13 (1H, d, J = 9.1 Hz, CHAHB); 1.33 
(3H, s, CH3); 2.10-2.21 (1H, multiplet, CH); 2.35-2.55 (3H, 
multiplet, CH2CH= & CHAHB); 3.05 (1H, ~t, J = 5.6 Hz, CHCq=); 
4.61 (1H, d, JAB = 14.0 Hz, NCHAHB); 4.70 (1H, d, JAB = 14.0 Hz, 
NCHAHB); 6.03 (1H, s br., =CH); 7.19-7.33 (5H, multiplet, CHarom); 
7.91 (1H, s, NCH). 13C NMR δ (75 MHz, ppm): 21.06 (CH3); 26.04 (CH3); 31.46 (CH2); 
32.53 (CH2CH=); 37.74 (Cq); 40.26 (CHCq=); 41.10 (CH); 64.76 (NCH2); 126.87 (CHarom); 
127.96 (2 x CHarom); 128.46 (2 x CHarom); 134.78 (=CH); 139.90 (Cq,arom); 148.51 (=Cq); 
163.09 (N=CH). IR ν (cm-1): 1634 (C=N). MS m/z (%): 240 (100, [M+H]+). Yield: 99%. 
Yellow oil. 
 
Allyl-(6,6-dimethyl-bicyclo[3.1.1]hept-2-en-2-ylmethylidene)amine (19v) 
1H NMR δ (300 MHz, ppm): 0.79 (3H, s, CH3); 1.12 (1H, d, 
J = 9.1 Hz, CHAHB); 1.33 (3H, s, CH3); 2.11-2.19 (1H, multiplet, 
CH); 2.35-2.58 (3H, multiplet, CH2CH= & CHAHB); 3.05 (1H, td, 
J = 5.6 Hz, J = 1.4 Hz, CHCq=); 4.06 (1H, dd, JAB = 15.0 Hz, 
J = 6.0 Hz, NCHAHB); 4.13 (1H, dd, JAB = 15.0 Hz, J = 6.0 Hz, NCHAHB); 5.07-5.17 (2H, 
multiplet, =CH2); 5.93-6.06 (2H, multiplet, 2x =CH); 7.82 (1H, s (br.), N=CH). Yield: 
97%. Yellow oil. 
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Isopropyl-(6,6-dimethyl-bicyclo[3.1.1]hept-2-en-2-ylmethylidene)amine 
(19w) 
1H NMR δ (270 MHz, ppm): 0.79 (3H, s, CH3); 1.12 (1H, d, J = 9.1 Hz, 
CHAHB); 1.15 (3H, d, J = 6.3 Hz, CH(CH3)2); 1.17 (3H, d, J = 6.3 Hz, 
CH(CH3)2); 1.33 (3H, s, CH3); 2.11-2.17 (1H, multiplet, CH); 2.34-2.52 
(3H, multiplet, CHAHB, CH2CH=); 2.97 (1H, td, J = 5.8 Hz, J = 1.4 Hz, 
CHCq=); 3.34 (1H, septet, J = 6.3 Hz, CH(CH3)2); 5.94 (1H, multiplet, 
=CH); 7.82 (1H, s, N=CH). 13C NMR δ (75 MHz, ppm): 20.85 (CH3); 24.19 (CH(CH3)2); 
24.27 (CH(CH3)2); 25.91 (CH3); 31.36 (CH2); 32.27 (CH2CH=); 37.59 (Cq); 40.03 
(CHCq=); 40.94 (CH); 61.28 (CH(CH3)2); 133.29 (CH=); 148.39 (=Cq); 159.32 (N=CH). IR 
ν (cm-1):  1634 (C=N). MS m/z (%): 192 (100, [M+H]+). Yield: 99%. Yellow oil. 
 
t-Butyl-(6,6-dimethyl-bicyclo[3.1.1]hept-2-en-2-ylmethylidene)amine (19x) 
1H NMR δ (300 MHz, ppm): 0.78 (3H, s, CH3); 1.11 (1H, d, J = 8.8 Hz, 
CHAHB); 1.18 (9H, 3x CH3); 1.33 (3H, s, CH3); 2.10-2.16 (1H, multiplet, 
CH); 2.34-2.52 (3H, multiplet, CHAHB, CH2CH=); 3.01 (1H, td, J = 
5.8 Hz, J = 1.4 Hz, CHCq=); 5.93 (1H, multiplet, =CH); 7.81 (1H, s, 
N=CH). 13C NMR δ (75 MHz, ppm): 20.86 (CH3); 25.99 (CH3); 29.90 
(3x CH3); 31.42 (CH2); 32.28 (CH2CH=); 37.56 (Cq); 39.68 (CHCq=); 40.99 (CH); 56.37 
(Cq(CH3)3); 132.60 (CH=); 148.98 (=Cq); 156.06 (N=CH). IR ν (cm-1): 1633, 1616, (C=N, 
C=C). MS m/z (%):  206 (100, [M+H]+). Yield: 95%. Yellow oil. 
 
Phenyl-(furan-2-ylmethylidene)amine (19y) 
1H NMR δ (270 MHz, ppm): 6.55 (1H, multiplet, =CH); 6.95 (1H, 
multiplet, =CH); 7.20-7.26 (3H, multiplet, CHarom); 7.36-7.41 (2H, 
multiplet, CHarom); 7.61 (1H, multiplet, =CHO); 8.28 (1H, s, N=CH).  
Yield: 95%. 
 
 
Benzyl-(furan-2-ylmethylidene)amine (19z) 
1H NMR δ (270 MHz, ppm): 4.77 (2H, s, NCH2); 6.45-6.48 (1H, 
multiplet, =CH); 6.75-6.77 (1H, multiplet, =CH); 7.30-7.33 (5H, 
multiplet, CHarom); 7.49-7.51 (1H, multiplet, =CHO); 8.15 (1H, s, 
N=CH).  Yield: 91%. Brown oil. 
 
Allyl-(furan-2-ylmethylidene)amine (19aa) 
1H NMR δ (300 MHz, ppm): 4.23 (2H, ~dq, J = 6.0 Hz, J = 1.4 Hz, 
NCH2); 5.13-5.30 (2H, multiplet, =CH2); 5.99-6.13 (1H, multiplet, 
HC=CH2); 6.46-6.49 (1H, multiplet, =CH); 6.75-6.77 (1H, multiplet, 
=CH); 7.51 (1H, s (br.), =CHO); 8.10 (1H, d, J = 0.8 Hz, N=CH).   Yield: 
92%. Brown oil. 
 
t-Butyl-(furan-2-ylmethylidene)amine (19ab) 
1H NMR δ (300 MHz, ppm): 1.30 (9H, s, 3x CH3); 6.47 (1H, dd,  
J = 3.3 Hz, J = 1.1 Hz, CH=Cq); 6.69-6.71 (1H, multiplet, CH=CHO); 7.51 
(1H, s (br.), =CHO); 8.08 (1H, d, J = 1,4 Hz, CH=N);  
Yield: 93%. Brown oil. 
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Benzylidene-benzylamine (19ad) 
1H NMR δ (270 MHz, ppm): 4.75 (2H, s, NCH2); 7.19-7.36 (8H, 
multiplet, CHarom); 7.74-7.76 (2H, multiplet, CHarom); 8.29 (N=CH). 
Yield: 97%. Yellow oil.  
 
 
Benzylidene-isopropylamine (19af) 
1H NMR δ (300 MHz, ppm): 1,26 (6H, d, J = 6,3 Hz, CH3); 3,52 (1H, 
septet, J = 6,3 Hz, CH); 7,38 (3H, multiplet, CHarom); 7,72 (2H, multiplet, 
CHarom); 8,29 (1H, s, N=CH). Yield: 98%. Yellow oil. 
 
 
 
(Cyclohexylmethylidene)isopropylamine (19ag) 
1H NMR δ (300 MHz, ppm): 1.14 (6H, d, J = 6.3 Hz, CH3); 1.08-1.37 
(5H, multiplet, CH2); 1.61-1.83 (5H, multiplet, CH2); 2.05-2.19 (1H, 
multiplet, CH); 3,21 (1H, septet, J = 6,3 Hz, CH); 7.47 (1H, dd, J = 5.8 
Hz, N=CH). Yield: 95%.  
 
 
Benzyl-isobutylidene-amine (19ah) 
1H NMR δ (300 MHz, ppm): 1.11 (6H, d, J = 6.9 Hz, CH3); 2.42-2.58 
(1H, multiplet, CH); 4.55 (2H, s, NCH2); 7.20-7.35 (5H, multiplet, 
CHarom); 7.65 (1H, ~d, J = 5.0 Hz, N=CH). Yield: 91%. Colourless oil. 
 
 
Benzyl-(pyridin-3-ylmethylidene)amine (19aj) 
1H NMR δ (270 MHz, ppm): 4.82 (2H, multiplet, NCH2); 7.26-7.31 
(5H, multiplet, CHarom); 7.33-7.35 (1H, multiplet, CHarom); 8.11-8.12 
(1H, multiplet, CHarom); 8.37 (1H, s, N=CH); 8.62-8.63 (1H, multiplet, 
CHarom); 8.87-8.89 (1H, multiplet, CHarom).  Yield: 99%. Yellow oil. 
 
 
 
3 Synthesis of α-aminoalkyl phosphonates 
3.1 Phosphonylation using dialkyl trimethylsilyl phosphite 
A solution of 5 mmol of DEP and 5.5 mmol of triethyl amine in 8 ml of dry 
dichloromethane was stirred at 0°C under a nitrogen atmosphere. Then 
5.5 mmol of TMSCl in 2 ml of dry dichloromethane was added using a 
syringe. Precipitation of ammonium salts occurred immediately and stirring 
was continued for 30 minutes at 0°C. The reaction was monitored using 31P 
NMR. When the conversion was not complete, TMSCl was added in portions 
of 0.5 mmol until a complete conversion was obtained. The mixture was then 
H
N
H
N
H
N
H
N
N
H
N
  133 
allowed to warm to room temperature before 5 mmol of the selected imine, 
dissolved in 2 ml of dry dichloromethane, was added using a syringe. Further 
reaction proceeded under the conditions mentioned in Table 2. Then the 
mixture was poured into 20 ml of a saturated NaHCO3(aq) solution. The 
organic phase was collected and the aqueous phase was extracted two more 
times with 5 ml of dichloromethane. The crude products were obtained after 
drying using MgSO4 and evaporation of the solvent under reduced pressure. 
Further purification was performed using column chromatography. 
 
Diethyl (2E)-1-anilino-3-phenylprop-2-enyl phosphonate (22a)  
1H NMR δ (300 MHz, ppm): 1.31 (3H, t, J = 7.2 Hz, CH3); 1.36 
(3H, t, J = 7.2 Hz, CH3); 4.03-4.25 (4H, multiplet, CH2O); 4.48 
(1H, ddd, JHP = 25.9 Hz, J = 6.1 Hz, J = 1.4 Hz, CHP); 6.27 (1H, 
ddd, J = 15.8 Hz, J = 6.1 Hz, JHP = 5.1 Hz, =CH); 6.66-6.77 
(4H, multiplet, =CHPh, 3 x CHarom); 7.13-7.36 (7H, multiplet, 
CHarom). 13C NMR δ (75 MHz, ppm):  16.40 (d, JCP = 5.8 Hz, 
CH3); 16.58 (d, JCP = 5.8 Hz, CH3); 54.06 (d, JCP = 154.6 Hz, CHP); 63.11 (d, JCP = 6.9 
Hz, CH2O); 63.59 (d, JCP = 6.9 Hz, CH2O); 113.86, 118.60 (CHarom); 123.57 (d, JCP = 
4.6 Hz, =CH); 126.67, 127.93, 128.63, 129.35 (CHarom); 133.05 (d, JCP = 12.7 Hz, 
=CHPh); 136.36 (d, JCP = Cq,arom, Cq,arom); 146.62 (NCq,arom). 31P NMR δ (121 MHz, 
ppm): 22.95. IR ν (cm-1): 3293 (NH); 1224 (P=O); 1043, 1017 (P-O). MS m/z (%): 
208 (100, [M+H-PO(OEt)2]+); 346 (74, [M+H]+). Mp.: 84.5°C.  Yield: 63%. Yellow 
crystals. 
 
Diethyl {(2E)-1-[2-(1H-indol-3-yl)ethylamino]-3-phenylprop-2-enyl} 
phosphonate (22g)  
1H NMR δ (300 MHz, ppm): 1.22 (3H, t, J = 7.2 Hz, 
CH3); 1.24 (3H, t, J = 7.2 Hz, CH3); 1.32 (1H, s (br.), 
NH); 2.86-3.00 (3H, multiplet, NCHAHBCH2); 3.02-3.12 
(1H, multiplet, NCHAHB); 3.70 (1H, ddd, JHP = 19.1 Hz, 
J = 8.3 Hz, J = 0.7 Hz, CHP); 4.01-4.15 (4H, multiplet, 
OCH2); 6.08 (1H, ddd, J = 15.9 Hz, J = 8.3 Hz, J = 
5.8 Hz, =CHCHP); 6.49 (1H, dd, J = 15.9 Hz, J = 4.8 Hz, =CHPh); 6.92 (1H, d, 
J = 2.2 Hz, =CHN); 7.03 (1H, ~dt, J = 7.4 Hz, J = 1.1 Hz, CHCHCqNH); 7.13 (1H, J = 
7.7 Hz, J = 1.1 Hz, CHCHCqCq ); 7.17-7.33 (6H, multiplet, 5 x CHarom, CHCqNH); 7.56 
(1H, d, J = 7.7 Hz, CHCqCq); 8.91 (1H, s, NHindole). 13C NMR δ (75 MHz, ppm): 16.41 
(CH3); 16.44 (CH3); 25.57 (CH2CH2N); 48.15 (d, JCP = 16.2 Hz, CH2N); 59.11 (d, 
JCP = 155.8 Hz, CHP); 62.72, 52.81, 62.84, 62.95 (OCH2); 111.38 (CHCqNH); 112.92 
(=Cq); 118.65 (CHCqCq); 118.94 (CHCHCqN); 121.64 (CHCHCqCq); 122.42 (=CHN); 
124.23 (d, JCP = 6.9 HZ, =CHCHP); 126.49 (2 x CHarom); 127.29 (CqCqCH2); 127.79 
(CHarom); 128.52 (2 x CHarom); 133.96 (d, JCP = 13.9 Hz, =CHPh); 136.30 (d, 
JCP = 2.3 Hz, Cq,arom); 136.52 (CqN).  31P NMR δ (121 MHz, ppm): 24.44. IR ν (cm-1): 
3257 (NH); 1231 (P=O); 1052, 1026 (P-O). MS m/z (%): 275 (100, [M+H-PO(OEt)2]+); 
413 (30, [M+H]+).  Yield: 44%. Yellow oil. 
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Diethyl (2E)-1-(isopropylamino)-3-phenylprop-2-enyl phosphonate (22i)  
1H NMR δ (300 MHz, ppm): 1.02 (3H, d, J = 6.1 Hz, CHCH3); 
1.09 (3H, d, J = 6.3 Hz, CHCH3); 1.31 (3H, t, J = 7.3 Hz, CH3); 
1.33 (3H, t, J = 7.3 Hz, CH3); 1.60 (1H, s (br.), NH); 2.95 (1H, 
septet, J = 6.2 Hz, NCH); 3.77 (1H, dd, JHP = 21.2 Hz, J = 8.5 
Hz, CHP); 4.09-4.26 (4H, multiplet, CH2O); 6.12 (1H, ddd, J = 
16.0 Hz, J = 8.5 Hz, JHP = 5.6 Hz, =CH); 6.60 (1H, dd, J = 16.0 
Hz, JHP = 4.7 Hz, =CHPh); 7.23-7.41 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, 
ppm):  16.58 (CH3); 16.62 (CH3); 21.72 (CHCH3); 24.01 (CHCH3); 46.23 (d, JCP = 16.2 
Hz, NCH); 56.71 (d, JCP = 155.8 Hz, CHP); 62.76 (d, JCP = 6.9 Hz, CH2O); 63.14 (d, JCP 
= 6.9 Hz, CH2O); 125.27 (d, JCP = 6.9 Hz, =CH); 126.57; 127.86; 128.67 (CHarom); 
133.62 (d, JCP = 13.9 Hz, =CHPh); 136.60 (Cq,arom). 31P NMR δ (121 MHz, ppm): 
24.85. IR ν (cm-1): 3307 (NH); 1239 (P=O); 1056, 1028 (P-O). MS m/z (%): 174 (100, 
[M+H-P(O)(OEt)2]+); 312 (17, [M+H]+). Chromatography: Rf = 0.20 (EtOAc).  Yield: 
40%. Yellow oil. 
 
Diethyl (benzylamino)[(1R,5S)-6,6-dimethylbicyclo-[3.1.1]hept-2-en-2-
yl]methyl phosphonate (22u) 
The product was obtained as a mixture of two diasteromers (ratio 
45:55), indicated as m (minor) and M (Major) whenever possible. 
1H NMR δ (300 MHz, ppm): 0.91 (3H, s, CH3, M); 0.94 (3H, s, 
CH3, m); 1.20-1.32 (10H, multiplet, CH3, CH2CH3, CHAHB); 2.08-
2.20 (2H, multiplet, NH, CH); 2.31-2.50 (4H, multiplet, CHAHB, 
CH2CH=, CHCq=); 3.43 (1H, d, JHP = 21.2 Hz, CHP, m); 3.45 (1H, d, JHP = 20.9 Hz, 
CHP, M); 3.60 (1H, d, JAB = 13.2 Hz, NCHAHB, m); 3.63 (1H, d, JAB = 13.2 Hz, 
NCHAHB, M); 3.87 (1H, d, JAB = 13.2 Hz, NCHAHB, m+, M); 4.01-4.18 (2 x 4H, 
multiplet, CH2O); 5.58-5.52 (2 x 1H, multiplet, =CH); 7.23-7.31 (2 x 5H, multiplet, 
CHarom). 13C NMR δ (75 MHz, ppm): 16.34; 16.44; 16.52 (CH3CH2); 21.18 (CH3, M); 
21.56 (CH3, m); 26.28 (CH3, m); 26.37 (CH3, M); 31.64 (CH2CH=, m); 31.67 (CH2CH=, 
M); 32.11 (CH2); 37.76 (Cq, m); 38.28 (Cq, M); 40.67 (CH, m); 40.87 (CH, M); 43.03 
(CHCq=, M); 43.25 (CHCq=, m); 51.26; 51.44; 51.48; 51.67 (CH2N); 59.90 (d, 
JCP = 156.9 Hz, CHP, m); 60.29 (d, JCP = 156.9 Hz, CHP, M); 61.94; 62.03; 62.40; 
62.48; 62.57 (CH2O); 122.82 (d, JCP = 13.8 Hz, =CH, m); 123.20 (d, 
JCP = 13.8 Hz=CH, M); 127.00 (CHarom); 128.30 (3 x CHarom); 128.36 (CHarom); 139.73 
(Cq,arom); 142.41 (d, JCP = 5.8 Hz, =Cq); 142.51 (d, JCP = 5.8 Hz, =Cq). 31P NMR δ (121 
MHz, ppm): 24.37 (M); 24.57 (m). IR ν (cm-1): 3320 (NH); 1681 (C=C); 1237 (P=O); 
1036 (P-O). MS m/z (%): 240 (100, [M+H-PO(OEt)2]+); 378 (22, [M+H]+). 
Chromatography: Rf = 0.43 (EtOAc/PE 60/40). Yield: 32%. Yellow oil. 
 
Diethyl (allylaminofuran-2-yl)methyl phosphonate (22aa)  
1H NMR δ (300 MHz, ppm): 1.14 (3H, t, J = 7.0 Hz, CH3); 1.24 (3H, 
t, J = 7.0 Hz, CH3); 1.90 (1H, s (br.), NH); 2.99 (1H, dd, 
JAB = 13.9 Hz, J = 6.6 Hz, NCHAHB); 3.18-3.26 (1H, multiplet, 
NCHAHB); 3.79-4.16 (5H, multiplet, CH2O, CHP); 5.01-5.10 (2H, 
multiplet, =CH2); 5.66-5.80 (1H, multiplet, HC=CH2); 6.25-6.30 (2H, 
multiplet, 2 x =CH); 7.32-7.34 (1H, multiplet, =CHO). 13C NMR δ (75 MHz, ppm): 
16.35 (d, JCP = 5.8 Hz, CH3); 16.48 (d, JCP = 5.8 Hz, CH3); 50.18 (d, JCP = 16.2 Hz, 
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NCH2); 53.29 (d, JCP = 161.5 Hz, CHP); 62.87 (d, JCP = 6.9 Hz, OCH2); 63.13 (d, 
JCP = 6.9 Hz, OCH2); 109.22 (d, JCP = 6.9 Hz, =CHCq); 110.60 (=CH); 117.02 (=CH2); 
135.74 (HC=CH2); 142.52 (=CHO); 149.84 (=CqO).  31P NMR δ (121 MHz, ppm): 
21.82. IR ν (cm-1): 3471 (NH); 1248 (P=O); 1053, 1031 (P-O). MS m/z (%):136 (100, 
[M+H-PO(OEt)2]+) ; 274 (11, [M+H]+). Chromatorgraphy: Rf = 0.25 (EtOAC/Et3N : 
99/1). Yield: 52%. Brownish oil. 
 
 
3.2 Preparation of 3-phosphonyl-1-aminoalkyl phosphonates 
3.2.1 General procedure for the preparation of DAPTMS 
Dialkyl phosphite (30 mmol) was mixed with 33 mmol of triethylamine (1.1 
eq.) in 40 mL of dry dichloromethane in an oven dry flask under a nitrogen 
atmosphere. The mixture was then cooled to 0°C and 33 mmol of TMSCl (1.1 
eq.) was added using a syringe. After 1 h at 0°C, the DAP was completely 
converted to the DAPTMS (this could easily be monitored using 31P NMR 
(DAP: δ = 5-15 ppm; DAPTMS: δ = 120-130 ppm). The triethylammonium 
chloride salts were removed by filtration (care had to be taken to avoid 
contact with moisture) and the dichloromethane was evaporated under 
reduced pressure. Then, 20 mL of dry diethyl ether was added to the residue 
in order to precipitate the remaining triethylammonium chloride from the 
mixture. After filtration and evaporation of the solvent, the DAPTMS was 
obtained as a clear, colourless liquid and could be stored for several weeks at 
-20°C when kept away from moisture. 
 
3.2.2 Preparation of 3-phosphonyl aminoalkyl phosphonates (PAP’s) 
5 Mmol of a suitable α,β-unsaturated imine dissolved in 15 mL of dry 
dichloromethane was allowed to stirr at room temperature under a nitrogen 
atmosphere. Then, 10 mmol of DAPTMS and 2.5 mmol of sulfuric acid (1 eq. 
of H+) were added consecutively. CAUTION: the reaction may proceed very 
vigorously upon addition of sulfuric acid and the solvent may start to boil. 
The mixture was allowed to react for 1 h at room temperature and was then 
poured into 20 mL of a saturated NaHCO3(aq) solution. The organic phase is 
recovered and the remaining aqueous phase is washed twice with 5 mL of 
dichloromethane. The PAP is obtained in satisfactory purity after drying 
(MgSO4) and evaporation of the solvent under reduced pressure. In order to 
have the PAP’s at higher purity, an acid/base extraction can be performed. 
Also column chromatography with silica gel as a stationary phase and a 
mixture of CH3CN, EtOAc and MeOH (50/47/3) as a mobile phase is 
appropriate. 
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Tetramethyl 3-benzylamino-1-phenyl-3-phosphonopropyl phosphonate 
(196c) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 19/81). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 1.71 (1H, s (br.), NH); 2.08-2.50 
(2x 2H, multiplet, CHPCH2CHP, m+M); 2.58 (1H, ~td, J = 
12.1 Hz, J = 2.3 Hz, PCHN, M); 2.89 (1H, ~quintet, J = 6.9 Hz, 
PCHN, m); 3.43-4,04 (2x 15H, multiplet, 4x OCH3, PCHPh, 
CH2Ph, m+M); 7.01-7.08 (2x 10H, multiplet, CHarom, m+M). 
13C NMR δ (75 MHz, ppm): 30.18 (d, JCP = 8.1 Hz, CH2, M); 30.58 (CH2, m); 39.18 
(dd, JCP = 139.6 Hz, JCP = 13.8 Hz, PCHPh, M); 39.73 (d, JCP = 137.3 Hz, PCHPh, m); 
49.94 (dd, JCP = 148.8 Hz, JCP = 16.1 Hz, PCHNH, M); 50.57 (dd, JCP = 145.4 Hz, JCP 
= 12.7 Hz, PCHNH, m); 50.96 (OCH3); 50.98 (d, JCP = 6.9 Hz, CH2Ph, m); 51.41 
(OCH3); 51.52 (CH2Ph, M); 51.65 (OCH3); 52.05 (OCH3); 52.75 (OCH3); 126.54, 
126.62, 126.92, 127.76, 127.88, 128.19, 128.71, 128.86, 128.94 (CHarom); 134.11 (d, 
JCP = 5.8 Hz, Cq,arom, M); 135.32 (d, JCP = 6.9 Hz, Cq,arom, m); 139.01 (Cq,arom, m); 
139.53 (Cq,arom, M). 31P NMR δ (121 MHz, ppm): 30.41 (m); 31.23 (m); 31.27 (d, JPP = 
9.7 Hz, M); 32.08 (d, JPP = 9.7 Hz, M). IR ν (cm-1): 3467 (N-H); 1243 (br, P=O); 1030 
(br., P-O). MS: m/z (%) : 333 (8, [M+H-PO(OCH3)2]+); 442 (100, [M+H]+);. Yield: 70%. 
Pale yellow oil. 
 
Tetraethyl 3-benzylamino-1-phenyl-3-phosphonopropyl phosphonate 
(196d) 
The product was obtained as a mixture of two diastereomeric 
pairs (ratio: 29/71). Signals of the major and minor isomers are 
indicated as ‘m’ and ‘M’ whenever possible. 
 1H NMR δ (300 MHz, ppm): 1.07 (3H, t, J = 6.6 Hz, CH3, m); 
1.09 (3H, t, J = 7.2 Hz, CH3, M); 1.26-1.36 (2 x 9H, multiplet, 
CH3, m+M); 2.04-2.48 (2 x 2H, multiplet, CH2, m+M); 2.55 (1H, td, J = 11.8 Hz, 
JHP = 2.2 Hz, NCHP, M); 2.81-2.94 (1H, multiplet, NCHP, m); 3.53-4.19 (2 x 7H, 
multiplet, CH2N, CHP, OCH2, m+M); 7.12-7.36 (2 x 10H, multiplet, CHarom, m+M). 
13C NMR δ (75 MHz, ppm): 16.20, 16.28, 16.37, 16.46, 16.52, 16.60 (CH3); 30.68 (d, 
JCP = 8.1 Hz, CH2, M); 31.15 (CH2, m); 40.32 (dd, JCP = 139.6 Hz, JCP = 14.4 Hz, CHP, 
M); 40.89 (dd, JCP = 137.3 Hz, JCP = 5.8 Hz, CHP, m); 51.17 (dd, JCP = 141.9 Hz, 
JCP = 16.2 Hz, NCHP, M); 51.57 (d, JCP = 8.1 Hz, NCH2, m); 51.74 (dd, JCP = 150.0 Hz, 
JCP = 13.3 Hz, NCHP, m); 52.03 (NCH2, M); 61.82, 61.91, 62.03, 62.31, 62.42, 62.49, 
62.58, 62.68 (OCH2); 126.99, 127.09, 127.28, 127.31, 128.24, 128.37, 128.42, 
128.56, 128.59, 129.35, 129.44, 129.50, 129.60 (CHarom, m + M); 135.07 (d, 
JCP = 5.8 Hz, Cq,arom, M); 136.21 (d, JCP = 6.9 Hz, Cq,arom, m); 139.72 (Cq,arom, m); 
140.31 (Cq,arom, M). 31P NMR δ (121 MHz, ppm): 28.16 (m); 28.91 (d, JPP = 9.7 Hz, 
M); 28.99 (m); 29.86 (d, JPP = 9.7 Hz, M). IR ν (cm-1): 3306 (NH); 1243 (P=O); 1051, 
1026 (P-O). MS m/z (%):360 (37, [M+H-PO(OCH2CH3)2]+); 498 (100, [M+H]+). Yield: 
80%. Pale yellow oil. 
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Tetramethyl 3-allylamino-1-phenyl-3-phosphonopropyl phosphonate 
(196e) 
The product was obtained as a mixture of two diastereomeric 
pairs (ratio: 71/29). Signals of the major and minor isomers 
are indicated as ‘m’ and ‘M’ whenever possible. 
1H NMR δ (300 MHz, ppm): 1.79 (2x 1H, s (br.), NH); 2.02-
2.28 (2x 1H, multiplet, CHAHB, m+M); 2.30-2.46 (2x 1H, 
multiplet, CHAHB, m+M); 2.53 (1H, td, J = 12.4 Hz, J = 2.5 Hz, NCHP, M); 2.85 (2x 
1H, ddd, J = 14.0 Hz, J = 8.0 Hz, J = 6.1 Hz, NCHP, m); 3.01 (1H, ddd, JAB = 13.8 Hz, 
J = 6.1 Hz, J = 1.4 Hz, CHAHBN, M); 3.13 (1H, dd, J = 14.0 Hz, J = 6.3 Hz, CHAHBNH, 
m); 3.25 (1H, ddd, J = 14.0 Hz, J = 6.3 Hz, J = 1.4 Hz, CHAHBNH, m); 3.41 (1H, dd, 
JAB = 13.8 Hz, J = 5.9 Hz, J = 1.4 Hz, CHAHBNH, M);  3.46-3.87 (2x 1H, multiplet, 
CHP, m+M); 3.47 (3H, d, JHP = 10.5 Hz, OCH3, m); 3.49 (3H, d, JHP = 10.5 Hz, OCH3, 
M); 3.70 (6H, d, JHP = 10.2 Hz, 2x OCH3, M); 3.71 (3H, d, JHP = 12.0 Hz, OCH3, m); 
3.72 (3H, d, JHP = 11.9 Hz, OCH3, m); 3.73 (3H, d, JHP = 10.2 Hz, OCH3, M); 3.79 (3H, 
d, JHP = 10.7 Hz, m); 4.93-5.14 (2x 2H, multiplet, =CH2, m+M); 5.62-5.82 (2x 1H, 
multiplet, CH=, m+M); 7.24-7.40 (2x 5H, multiplet, CHarom, m+M). 13C-NMR δ (75 
MHz, ppm): 30.28 (d, JCP = 8.1 Hz, CH2, M); 30.90 (CH2, m); 39.66 (dd, JCP = 139.6 
Hz, JCP = 15.0 Hz, CHP, M); 40.37 (dd, JCP = 137.3 Hz, JCP = 5.8 Hz, CHP, m); 50.36 
(dd, JCP = 141.9 Hz, JCP = 16.2 Hz, NCHP, M); 50.07 (d, J = 9.2 Hz, CH2NH, m); 50.63 
(CH2N, M); 51.12 (dd, JCP = 152.3 Hz, JCP = 13.9 Hz, NCHP, m); 52.55, 52.66, 52.78, 
53.24, 53.34, 53.41, 53.51 (OCH3, m+M); 116.05 (=CH2, M); 116.54 (=CH2, m); 
127.53, 127.58, 128.73, 129.27, 129.37, 129.49, 129.58 (CHarom); 134.58 (d, JCP = 
5.8 Hz, Cq,arom, M); 135.69 (d, JCP = 6.9 Hz, Cq,arom, m); 136.04 (CH=, m); 136.51 (CH=, 
M). 31P-NMR δ (121 MHz, ppm): 30.41 (m); 31.20 (m); 31.37 (d, JPP = 9.7 Hz, M); 
32.14 (d, JPP = 8.9 Hz, M). IR ν (cm-1): 3455 (NH); 1242 (br., P=O); 1183, 1031 (br., 
P-O). MS: m/z (%) : 392 (100, [M+H]+). Yield: 36%. Yellow oil. 
 
Tetraethyl 3-allylamino-1-phenyl-3-phosphonopropyl phosphonate (196f) 
The product was obtained as a mixture of two diastereomeric 
pairs (ratio: 33/67). Signals of the major and minor isomers are 
indicated as ‘m’ and ‘M’ whenever possible. 
1H NMR δ: (300 MHz, ppm): 1.06-1.36 (2x 6H, multiplet, CH3, 
m+M); 1.60 (2x1H, s(br.), NH, m+M); 2.01-2.28 (2x1H, 
multiplet, CHAHB, m+M); 2.37-2.55 (2H + 1H, CHAHB, m+M, NCHP, m); 2.80 (1H, 
ddd, J = 14.0 Hz, J = 8.0 Hz, J = 5.8 Hz, CHPNH, M); 3.00-3.06 (1H, multiplet, 
CHAHBN, m); 3.14 (1H, dd, JAB = 13.8 Hz, J = 6.3 Hz, CHAHBN, M); 3.26 (1H, dd, JHP = 
13.8 Hz, J = 5.7 Hz, CHAHBNH, M); 3.40-3.47 (1H, multiplet, CHAHBN, m); 3.53-4.18 
(2x 9H, multiplet, CHP, OCH2, m+M); 4.93-5.16 (2x 2H, multiplet, =CH2, m+M); 5.62-
5.84 (2x 1H, multiplet, =CH, m+M); 7.25-7.39 (2x 5H, CHarom, m+M). 13C NMR δ (75 
MHz, ppm): 16.22, 16.29, 16.42, 16.52, 16.59, 16.65 (4x CH3, m+M); 30.56 (d, JCP = 
8.1 Hz, CH2, m); 31.06 (CH2, M); 40.29 (dd, JCP = 138.5 Hz, JCP = 13.8 Hz, CHP, m); 
41.00 (dd, JCP = 137.3 Hz, JCP = 5.8 Hz, CHP, M); 50.22 (d, JCP = 8.0 Hz, CH2N, M); 
50.71 (CH2N, m); 50.97 (dd, JCP = 152.3 Hz, JCP = 16.2 Hz, NCHP, m); 51.70 (dd, JCP 
= 151.1 Hz, JCP = 13.8 Hz, NCHP, M); 61.89, 61.98, 62.4, 62.43, 62.52, 62.67, 62.76, 
62.93 (OCH2, m+M); 115.94 (=CH2, m); 116.46 (=CH2, M); 127.39, 127.96, 128.61, 
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129.45, 129.53, 129.65, 129.74 (CHarom, m+M); 135.10 (d, JCP = 6.9 Hz, Cq,arom, m); 
136.14 (d, JCP = 6.9 Hz, Cq,arom, M); 136.25 (=CH, M); 136.78 (=CH, m). 31P NMR δ 
(121 MHz, ppm): 28.25 (M); 28.98 (M); 29.02 (d, JPP = 9.7 Hz, m); 29.89 (d, JPP = 9.7 
Hz, m). IR ν (cm-1): 3469 (NH); 1239 (br., P=O); 1028 (br., P-O). MS m/z (%): 448 
(100, [M+H]+). Yield: 40%. Yellow oil. 
 
Tetraethyl 3-[2-(1H-indol-3-yl)ethylamino]-1-phenyl-3-phosphonopropyl 
phosphonate (196g) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 29/71). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 1.04-1.27 (2 x 12H, 
multiplet, CH3, m+M); 2.11-2.41 (2H, multiplet, CH2CH, 
m+M); 2.43-2.54 (1H, ~t, NCH, M); 2.63-2.71 (1H, 
multiplet, CHAHBN, M); 2.78 (2H, t, J = 6.6 Hz, CH2Cq=, 
m); 2.84 (2H, t, J = 6.6 Hz, CH2Cq=, M); 2.89-2.98 (3H, 
multiplet, CH2N, NCH, m); 3.16-3.24 (1H, multiplet, 
CHAHBN, M); 3.45-3.56 (2 x 1H, multiplet, CHPh, m+M); 3.59-4.13 (2 x 8H, multiplet, 
OCH2, m+M); 6.85 (1H, d, J = 2.2 Hz, =CH, m); 6.91 (1H, d, J = 2.2 Hz, =CH; M); 
7.00-7.41 (2 x 8H, multiplet, CHarom, m+M, 3 x CHindole, m+M); 7.49 (1H, d, 
J = 7.7 Hz, CHCq,indole, m); 7.56 (1H, d, J = 7.7 Hz, CHCq,indole, M); 9.58 (2 x 1H, s(br.), 
NHindole, m+M). 13C NMR δ (75 MHz, ppm): 16.13 (CH3, m); 16.22 (CH3, m); 16.34 
(CH3, M); 16.42 (CH3, M); 25.92 (CH2Cq=, m); 26.44 (CH2Cq=, M); 30.15 (d, 
JCP = 6.9 Hz, CH2CH, M); 30.94 (CH2CH, m); 39.89 (dd, JCP = 138.5 Hz, JCP = 13.9 Hz, 
CHPh, M); 40.67 (dd, JCP = 136.2 Hz, JCP = 6.9 Hz, CHPh, m); 48.04 (d, JCP = 6.9 Hz, 
CH2N, m); 48.35 (CH2N, M); 51.70 (dd, JCP = 144.2 Hz, JCP = 16.2 Hz, NCH, M); 52.75 
(dd, JCP = 150.0 Hz, JCP = 12.7 Hz, NCH, m); 61.74, 61.83, 61.87, 61.93, 62.29, 
62.38, 62.47, 62.61 (OCH2, m+M); 111.39 (CHCqNindole); 112.62 (=Cq, m); 112.93 (=Cq, 
M); 118.63, 118.66 (CHindole); 121.37 (CHCHCqC=); 122.41 (=CH); 127.30 (CHarom); 
127.42 (Cq,indole); 128.55 (2 x CHarom); 129.28 (d, JCP = 6.9 Hz, 2 x CHarom, m); 129.48 
(d, JCP = 6.9 Hz, 2 x CHarom, M); 134.84 (d, JCP = 6.9 Hz, Cq,arom, M); 136.17 (d, 
JCP = 6.9 Hz, Cq,arom, m); 136.64 (CqN). 31P NMR δ (121 MHz, ppm): 28.22 (m); 29.04 
(m); 29.04 (d, JPP = 9.7 Hz, M); 29.99 (d, JPP = 9.7 Hz, M). IR ν (cm-1): 1232 (P=O); 
1030 (br., P-O). MS m/z (%): 551 (100, [M+H]+). Yield: 82%. Yellow oil. 
 
Tetramethyl 3-isopropylamino-1-phenyl-3-phosphonopropyl 
phosphonate (196h) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 32/68). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 0.67 (3H, d, J = 6.1 Hz, CH3, M); 
0.73 (3H, d, J = 6.1 Hz, CH3, m); 0.94 (3H, d, J = 6.3 Hz, CH3, 
m); 0.98 (3H, d, J = 6.3 Hz, CH3, M); 1.55 (1H, s(br), NH); 2.02-
2.20 (2x 1H, multiplet, CHAHB, m+M); 2.41-2.52 (2x 1H, 
multiplet, CHAHB, m+M); 2.64 (1H, td, J = 11.6 Hz, JHP = 2.8 
Hz, PCHNH, M); 2.76-2.84 (1H, multiplet, PCHNH, m); 2.81 (1H, septet, J = 6.3 Hz, 
CH(CH3)2, m); 3.01 (1H, septet x d, J = 6.1 Hz, JHP = 2.8 Hz, CH(CH3)2, M); 3.47 (3H, 
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d, JHP = 10.5 Hz, OCH3, m); 3.49 (3H, d, JHP = 10.5 Hz, OCH3, M); 3.69 (3H, d, JHP = 
10.5 Hz, OCH3, M); 3.71 (3H, d, JHP = 10.5 Hz, OCH3, M); 3.72 (3H, d, JHP = 10.5 Hz, 
OCH3, m); 3.74 (3H, d, JHP = 10.5 Hz, OCH3, M); 3.75 (3H, d, JHP = 10.5 Hz, OCH3, 
m); 3.77- 3.81 (2x1H, multiplet, CHP(Ph), m+M); 3.80 (3H, d, JHP = 10.5 Hz, OCH3, 
m); 7.26-7.36 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 22.11 (CH3, M); 
22.37 (CH3, m); 23.15 (CH3, m); 24.01 (CH3, M); 30.53 (d, JCP = 8.1 Hz, CH2, M); 
31.33 (s(br.), CH2, m); 39.63 (dd, JCP = 141.9 Hz, JCP = 10.4 Hz, PCHPh, M); 40.47 (d 
(br.), JCP = 137.3 Hz, PCHPh, m); 46.04 (d, JCP = 9.2 Hz, CH(CH3)2,  m); 46.28 
(CH(CH3)2, M); 48.55 (dd, JCP = 145.4 Hz, JCP = 12.7 Hz, PCHNH, M); 49.27 (dd, JCP = 
153.5 Hz, JCP = 13.9 Hz, PCHNH, m); 52.59 (OCH3); 52.68 (OCH3); 52.83 (OCH3); 
53.26 (OCH3); 53.37 (OCH3); 53.67 (OCH3); 127.50 128.66, 129.30, 129.38, 129.61, 
129.69 (CHarom); 134.50 (d, JCP = 6.9 Hz, Cq,arom, M); 135.58 (d, JCP = 6.9 Hz, Cq,arom, 
m). 31P NMR δ (121 MHz, ppm): 30.66 (m); 31.28 (m); 31.62 (d, JPP = 9.7 Hz, M); 
32.10 (d, JPP = 9.7 Hz, M). IR ν (cm-1): 3477 (N-H); 1245 (br., P=O); 1051 (br., P-O). 
MS m/z (%):176 (2, [M+H-2PO(OCH3)2]+); 285 (12, [M+H-PO(OCH3)2]+); 394 (100, 
[M+H]+). Yield: 77%. Pale yellow oil. 
 
Tetraethyl 3-isopropylamino-1-phenyl-3-phosphonopropyl phosphonate 
(196i) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 33/67). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 0.70 (3H, d, J = 6.1 Hz, CH3CH, 
M); 0.72 (3H, d, J = 6.1 Hz, CH3CH, m); 0.94 (3H, d, J = 6.3 Hz, 
CH3CH, m); 0.99 (3H, d, J = 6.3 Hz, CH3CH, M); 1.08 (3H, t, J 
= 6.9 Hz, CH3, m); 1.12 (3H, t, J = 7.3 Hz, CH3, M); 1.26-1.36 (2 
x 9H, multiplet, CH3, m+M); 1.97-2.53 (2 x 2H, multiplet, CH2, 
m+M); 2.60 (1H, td, J = 11.6 Hz, J = 2.5 Hz, NCHP, M); 2.71-2.81 (1H, multiplet, 
NCHP, m); 2.86 (1H, septet, J = 6.3 Hz, NCH, m); 3.06 (1H, septet x d, J = 6.3 Hz, JHP 
= 2.6 Hz, NCH, M); 3.54-3.79 (2 x 1H, multiplet, CHP, m+M); 2.81-4.21 (2 x 8H, 
multiplet, OCH2, m+M); 7.22-7.41 (2 x 5H, multiplet, CHarom, m+M). 13C NMR δ (75 
MHz, ppm): 16.21, 16.29, 16.37, 16.46, 16.50, 16.58 (CH3, m+M); 22.16 (CH3CH, 
M); 22.43 (CH3CH, m); 23.16 (CH3CH, m); 24.05 (CH3CH, M); 30.58 (d, JCP = 6.9 Hz, 
CH2, M); 31.51 (CH2, m); 40.98 (dd, JCP = 136.7 Hz, JCP = 4.0 Hz, CHP, m); 41.19 (dd, 
JCP = 136.2 Hz, JCP = 15.0 Hz, CHP, M); 46.02 (d, JCP = 4.0 Hz, NCH, m); 46.19 (NCH, 
M); 49.03 (dd, JCP = 140.8 Hz, JCP = 17.3 Hz, NCHP, M); 49.64 (dd, JCP = 152.9 Hz, 
JCP = 14.4 Hz, NCHP, m); 61.71, 61.75, 61.81, 61.85, 61.94, 62.37, 62.46, 62.54, 
62.58, 62.63 (OCH2, m+M); 127.29, 128.47, 128.49 (CHarom, M); 129.49 (d, JCP 
= 6.9 Hz, CHarom, m); 129.78 (d, JCP = 6.9 Hz, CHarom, M); 135.05 (d, JCP = 6.9 Hz, 
Cq,arom, M); 136.10 (d, JCP = 6.9 Hz, Cq,arom, m). 31P NMR δ (121 MHz, ppm): 28.41 
(m); 28.94 (m); 29.09 (d, JPP = 9.7 Hz, M); 29.70 (d, JPP = 9.7 Hz, M). IR ν (cm-1): 
3300 (NH); 1243 (P=O); 1047 (br., P-O). MS m/z: 312 (65, [M+H-PO(OCH2CH3)2]+); 
450 (100, [M+H]+). Yield: 78%. Pale yellow oil. 
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Tetramethyl 3-tert-butylamino-1-phenyl-3-phosphonopropyl 
phosphonate (196j) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 49/51). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 0.89 (3H, s, CH3, m); 0.96 (3H, s, 
CH3, M); 2.11-2.38 (2x 1H, multiplet, CHAHB, m+M); 2.39-2.56 
(2x 1H, multiplet, CHAHB, m+M); 2.72 (1H, ddd, J = 15.1 Hz, J 
= 11.3 Hz, J = 3.3 Hz, NHP, m); 3.02 (1H, ddd, J = 16.0 Hz, J = 
8.3 Hz, J = 4.7 Hz, NHP, M); 3.45 (3H, d, JHP = 10.5 Hz, OCH3, 
m); 3.48 (3H, d, JHP = 10.5 Hz, OCH3, m); 3.51-3.84 (2x 1H, multiplet, CHP, m+M); 
3.68 (3H, d, JHP = 10.7 Hz, OCH3, m); 3.73 (3H, d, JHP = 10.5 Hz, OCH3, M); 3.74 (3H, 
d, JHP = 10.7 Hz, OCH3, M); 3.75 (3H, d, JHP = 10.2 Hz, OCH3, M); 3.76 (3H, d, JHP = 
10.2 Hz, OCH3, M); 3.81 (3H, d, JHP = 10.2 Hz, OCH3, m); 7.25-7.44 (2x 5H, 
multiplet, CHarom, m+M). 13C NMR δ (75 MHz, ppm): 29.78 (CH3, M); 30.32 (CH3, m); 
32.98 (CH2, m); 35.19 (CH2, M); 40.00 (d, JCP = 140.8 Hz, CHP, m); 40.42 (d, JCP = 
138.5 Hz, CHP, M); 46.78 (dd, JCP = 160.4 Hz, JCP = 17.3 Hz, CHPN, m); 47.48 (dd, 
JCP = 151.1 Hz, JCP = 13.8 Hz, CHPN, M); 50.99 (Cq, M); 51.84 (Cq, m); 52.68, 53.34, 
54.25 (OCH3, m+M); 127.42, 127.56, 128.61, 129.65, 129.71 (CHarom, m+M); 135.13 
(d, JCP = 6.9 Hz, Cq,arom, M); 135.45 (d, JCP = 6.9 Hz, Cq,arom, m). 31P NMR δ (121 MHz, 
ppm): 30.60 (M); 31.00 (d, JPP = 5.9 Hz, m); 31.14 (M); 31.88 (d, JPP = 5.6 Hz, m). IR 
ν (cm-1): 3469 (NH); 1235 (br., P=O); 1051 (br., P-O). MS: m/z (%): 408 (100, 
[M+H]+). Yield: 82%. Colourless oil. 
 
Tetraethyl 3-tert-butylamino-1-phenyl-3-phosphonopropyl phosphonate 
(196k) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 36/64). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 0.89 (3H, s, CH3Cq, m); 0.97 (3H, 
s, CH3Cq, M); 1.05 (3H, t, 3J(H,H) = 7.1 Hz, CH3, m); 1.12 (3H, t, 
3J(H,H) = 7.1 Hz, CH3, M); 1.26-1.36 (2 x 9H, multiplet, CH3, 
m+M); 2.10-2.33 (2 x 1H, multiplet, CHAHB, m+M); 2.39-2.60 
(2 x 1H, multiplet, CHAHB, m+M); 2.70 (1H, ddd, J = 16.1 Hz, 
J = 11.3 Hz, J = 3.3 Hz, NCHP, m); 3.00 (1H, ddd, J = 16.0 Hz, J = 8.3 Hz, 
J = 4.7 Hz, NCHP, M); 3.63-4.28 (2 x 9 H, multiplet, OCH2, CHP, m+M); 7.22-7.46 (2 
x 5H, multiplet, CHarom, m+M). 13C NMR δ (75 MHz, ppm): 16.21, 16.27, 16.38, 
16.46, 16.55 (CH2CH3); 29.56 (CH3, m); 30.12 (CH3, M); 32.87 (d, JCP = 6.9 Hz, 
CH2,M); 35.10 (CH2, m); 40.28 (dd, JCP = 136.1 Hz, JCP = 9.2 Hz, CHP, M); 41.04 (d, 
JCP = 136.1 Hz, CHP, m); 46.88 (dd, JCP = 159.2 Hz, JCP = 17.9 Hz, NCHP, m); 47.84 
(dd, JCP = 152.29 Hz, JCP = 13.9 Hz, NCHP, M); 51.01 (NCq, m); 51.81 (d, JCP = 9.2 Hz, 
NCq, M); 61.76, 61.85, 62.31, 62.41, 62.51, 63.02, 63.12 (OCH2); 127.23, 127.38, 
128.45, 129.75, 129.84, 129.95 (CHarom); 135.58 (d, JCP = 6.9 Hz, Cq,arom, m); 135.93 
(d, JCP = 8.1 Hz, Cq,arom, M). 31P NMR δ (121 MHz, ppm): 28.74 (s(br.), m); 28.84 (d, 
JPP = 6.0 Hz, M); 28.91 (s(br.), m); 29.64 (dd, JPP = 6.0 Hz, M). IR ν (cm-1): 3308 (NH); 
1243 (P=O); 1049, 1028 (P-O). MS m/z: 326 (56, [M+H-PO(OCH2CH3)2]+); 464 (100, 
[M+H]+). Yield: 85%. Pale yellow oil. 
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Tetramethyl 3-tert-butylamino-1-methyl-3-phosphonopropyl 
phosphonate (196l) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 36/64). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 0.95 (9H, s, 3x CH3, m); 0.96 (9H, 
s, 3x CH3, M); 0.99-1.23 (2x 3H, multiplet, CH3, m+M); 1.32-
2.00 (2x 3H, multiplet, CH2, NH, m+M); 2.02-2.32 (1H, 
multiplet, CHP, m+M); 2.98 (1H, ddd, J = 15.4 Hz, J = 9.9 Hz, 
J = 5.5 Hz, NCHP, m); 3.13 (1H, dt, J = 16.2 Hz, J = 7.4 Hz, 
NCHP, M); 3.75 (3H, d, JHP = 10.5 Hz, OCH3, m); 3.61 (3H, d, JHP = 10.5 Hz, OCH3, 
m); 3.75 (3H, d, JHP = 10.5 Hz, OCH3, M); 3.76 (3H, d, JHP = 10.5 Hz, OCH3, M). 
13C NMR δ (75 MHz, ppm): 13.39 (d, JCP = 4.6 Hz, CH3, m); 14.72 (d, JCP = 4.6 Hz, 
CH3, M); 26.34 (dd, JCP = 141.9 Hz, JCP = 6.9 Hz, CHP,  M); 27.03 (d, JCP = 139.6 Hz, 
CHP, m); 29.71 (3x CH3, m); 29.97 (3x CH3, M); 34.72 (CH2, s (br.), m); 35.02 (CH2, s 
(br.), M); 46.94 (d, JCP  = 145.4 Hz, NCHP, M); 47.00 (d, JCP = 163.8 Hz, NCHP, m); 
51.37 (d, JCP = 5.8 Hz, NCq, m); 51.79 (d, JCP = 8.1 Hz, NCq, M); 52.41 (d, JCP = 8.1 
Hz, OCH3, M); 52.66 (d, JCP = 12.7 Hz, OCH3, M); 53.74 (d, JCP = 6.9 Hz, OCH3, m); 
54.29 (s(br.), OCH3, m). 31P NMR δ (121 MHz, ppm): 30.61 (d, JPP = 2.2 Hz, m); 
31.75 (d, JPP = 5.2 Hz, M); 37.11 (d, JPP = 2.2 Hz, m); 37.99 (d, JPP = 5.2 Hz, M). IR ν 
(cm-1): 3470 (NH); 1231 (br., P=O); 1034 (br., P-O). MS m/z (%):  346 (100, [M+H]+). 
Yield: 74%. Yellow oil. 
 
Tetramethyl 3-tert-butylamino-1,1-dimethyl-3-phosphonopropyl 
phosphonate (196m) 
1H NMR δ (300 MHz, ppm): 1.15 (9H, s, 3x CH3); 1.26 (3H, d, 
JHP = 5.2 Hz, CH3); 1.32 (3H, d, JHP = 5.2 Hz, CH3); 1.65-1.82 
(1H, multiplet, CHAHB); 1.91 (1H, s(br.), NH); 2.15-2.30 (1H, 
multiplet, CHAHB); 3.36 (1H, dt, J = 13.5 Hz, J = 6.3 Hz, CHP); 
3.75 (3H, d, JHP = 10.2 Hz, OCH3); 3.76 (3H, d, JHP = 10.2 Hz, 
OCH3); 3.77 (3H, d, JHP = 10.2 Hz, OCH3); 3.80 (3H, d, JHP = 10.2 Hz, OCH3). 
13C NMR δ (75 MHz, ppm): 20.67 (CH3); 20.73 (CH3); 28.81 (3x CH3); 34.98 (dd, JCP 
= 139.6 Hz, JCP = 8.1 Hz, CqP); 38.43 (d, JCP = 6.9 Hz, CH2); 45.11 (dd, JCP = 
150.0 Hz, JCP = 12.1 Hz, CHP); 50.28 (d, JCP = 4.6 Hz, NCq); 51.25 (d, JCP = 8.1 Hz, 
OCH3); 51.72 (d, JCP = 8.1 Hz, OCH3); 51.82 (d, JCP = 8.1 Hz, OCH3); 52.18 (d, JCP = 
8.1 Hz, OCH3). 31P NMR δ (121 MHz, ppm): 31.36 (d, JPP = 3.0 Hz); 38.85 (d, JPP = 
3.0 Hz). IR ν (cm-1): 3429 (NH); 1242 (P=O); 1049 (br., P-O). MS m/z (%): 250 (7, 
[M+H-PO(OCH3)2]+); 360 (100, [M+H]+). Yield: 60%. Yellow oil. 
 
Tetramethyl {2-[isopropylaminophosphonomethyl]-6,6-dimethyl-
bicyclo[3.1.1]hept-3-yl} phosphonate (196n) 
The product was obtained as a mixture of two diastereomeric 
pairs (ratio: 22/78). Signals of the major and minor isomers are 
indicated as ‘m’ and ‘M’ whenever possible. 
 1H NMR δ (300 MHz, ppm): 0.98-1.22 (2 x 13H, multiplet, 
CH3Cq, CH3CH, CHAHB, m+M); 1.73 (2 x 1H, s(br.), NH, m+M); 
1.88-1.95 (2 x 1H, multiplet, CqCHCH2, m+M); 2.10-2.20 (2 x 
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2H, multiplet, CH2CHP, m+M); 2.23-2.32 (1H, multiplet, CHAHB, M); 2.34-2.40 (2 x 
1H, multiplet, CqCHCH, m+M); 2.41-2.49 (1H, multiplet, CHAHB, m); 2.56-2.79 (2 x 
1H, multiplet, NCHP, m+M); 2.90-2.95 (1H, multiplet, CHPCH2, m); 2.98-3.04 (2H, 
multiplet, CHPCH2, NCHP, M); 3.13 (2 x 1H, septet x d, J = 6.3 Hz, JHP = 2.5 Hz, 
CHCH3, m+M); 3.52 (1H, dd, J = 17.6 Hz, J = 3.3 Hz, NCHPm); 3.72-3.84 (2 x 12H, 
multiplet, OCH3, m+M). 13C NMR δ (75 MHz, ppm): 21.69 (CH3Cq); 22.64 (CH3CH, 
M); 23.71 (CH3CH, M); 24.06 (CH3, m); 25.06 (dd, JCP = 139.6 Hz, JCP = 11.5 Hz, 
CHPCH2, M); 25.60 (CH3, m); 26.44 (dd, JCP = 139.6 Hz, JCP = 16.2 Hz, CHPCH2, m); 
26.51 (d, JCP = 4.6 Hz, CH2CHP); 27.06 (CH3Cq); 28.35 (CH3, m); 29.51 (CH2, M); 
34.59 (CH2, m); 37.68 (Cq, M); 37.84 (Cq, m); 38.73 (d, JCP = 4.6 Hz, CqCHCH2, M); 
40.41 (CqCHCH2, m); 40.59 (CHCHP); 40.67 (CHCHP); 43.42 (d, JCP = 5.8 Hz, 
CqCHCHM); 43.80 (d, JCP = 11.5 Hz, CqCHCHm); 46.74 (CHCH3, m+M); 51.74 (OCH3, 
m); 51.91 (d, JCP = 8.1 Hz, OCH3, M); 52.61 (d, JCP = 6.9 Hz, OCH3, M); 52.87 d, JCP 
= 6.9 Hz, OCH3, M); 53.18 (d, JCP = 132.7 Hz, NCHPm); 53.48 (d, JCP = 6.9 Hz, OCH3, 
M); 55.30 (d, JCP = 148.8 Hz, NCHPM). 31P NMR δ (121 MHz, ppm): 31.59 (d, 
JPP = 3.0 Hz, M); 32.87 (d, JPP = 2.2 Hz, m); 37.83 (d, JPP = 2.2 Hz, m); 39.02 (d, 
JPP = 3.0 Hz, M). IR ν (cm-1): 3311 (NH); 1235 (P=O); 1054 (br., P-O). MS m/z: 302 
(7, [M+H-PO(OCH3)2]+); 412 (100, [M+H]+). Yield: 46%. Yellow oil. 
 
Tetramethyl {2-[ tert-butylaminophosphonomethyl]-6,6-dimethyl-
bicyclo[3.1.1]hept-3-yl} phosphonate (196o) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 12/88). 
Due to the low abundance of the minor isomer, peak identification in 1H and 
13C NMR was limited to the major (M) isomer. 
1H NMR δ (300 MHz, ppm): 0.99 (3H, s, CH3); 1.13 (9H, s, 
CH3); 1.13-1.15 (1H, multiplet, CHAHB); 1.19 (3H, s, CH3, M); 
1.90 (1H, s(br.), CqCHCH2); 2.08-2.32 (3H, multiplet, CH2CHP, 
CHAHB, m+M); 2.42 (1H, s (br.), CqCHCH); 2.55-2.88 (2x 1H, 
multiplet, CHCHP, CHP); 3.20 (1H, ~t, J = 10.3 Hz, NCHP). 
13C NMR δ (75 MHz, ppm): 22.99 (CH3Cq, M); 25.93 (dd, JCP = 
139.6 Hz, JCP = 13.9 Hz, CHP); 27.21 (CH3Cq); 29.96 (br, CH2); 30.49 (3x CH3); 37.74 
(Cq); 39.80 (d, JCP = 4.6 Hz, CqCHCH2); 41.68 (s (br.), CHCHCHP); 43.12 (d, JCP = 
5.8 Hz, CqCHCH); 50.78 (NCq); 51.90  (d, JCP = 8.1 Hz, OCH3); 52.72 (d, JCP = 6.9 Hz, 
OCH3); 53.18 (d, JCP = 6.9 Hz, OCH3); 54.23 (d, JCP = 6.9 Hz, OCH3); 54.22 (dd, JCP = 
148.8 Hz, NCHP). 31P NMR δ (121 MHz, ppm): 31.59 (d, JPP = 3.7 Hz, M); 34.07 (m); 
37.79 (m); 38.95 (d, JPP = 3.7 Hz, M). IR ν (cm-1): 3320 (NH); 1227 (br., P=O); 1051 
(br., P-O). MS m/z (%) : 426 (100,  [M+H+]). Yield: 20%. Yellow oil. 
 
3.2.3 Preparation of 2-isopropylamino-4-phenylbut-3-ene nitrile (198) 
The imine 19g (5 mmol) was dissolved in 10 ml of dry dichloromethane and 
stirred under a nitrogen atmosphere at room temperature. Then 10 mmol of 
TMSCN and 2.5 mmol of sulphuric acid were added consecutively using a 
syringe. CAUTION: HCN may escape from the reaction vessel during this 
procedure. Therefore, the exhaust of the nitrogen flow was passed through 
two consecutive washbottles containing a 3 M NaOH(aq) solution prior to 
P(OMe)2
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O
O
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discharge directly to the hood ventilation system. Stirring was continued for 
24 h at room temperature. Then 10 ml of a saturated NaHCO3(aq) solution was 
added. After 30 minutes, the mixture was poured into a separatory funnel 
and extracted twice with 10 ml of dichlormethane. After drying (MgSO4) and 
evaporation of the solvent under reduced pressure, the resulting oil was kept 
at -32°C until crystallization occurred. Nitrile 198 was obtained in pure form 
by recrystallization from ethanol/hexane. 
 
1H NMR δ (300 MHz, ppm): 1.12 (3H, d, J = 6.3 Hz, CH3); 1.17 
(3H, d, J = 6.3 Hz, CH3); 1.33 (1H, s(br.), NH); 3.20 (1H, septet, J = 
6.3 Hz, CH(CH3)2); 4.43 (1H, dd, J = 5.2 Hz, J = 1.1 Hz,  CHCN); 
6.20 (1H, dd, J = 16.0 Hz, J = 5.2 Hz, =CHCHCN); 6.92 (1H, dd, 
J = 16.0 Hz, J = 1.4 Hz, PhCH=); 7.29-7.43 (5H, multiplet, CHarom). 
13C NMR δ (75 MHz, ppm): 21.39 (CH3); 23.72 (CH3); 46.98 (CH(CH3)2); 49.85 
(CHCN); 118.51 (CN); 122.81 (CHCHCN); 126.83 (2x CHarom); 128.60 (CHarom); 128.77 
(2x CHarom); 133.79 (PhCH=); 135.38 (Cq,arom). MS m/z (%): 174 (100, [M-CN]+). IR ν 
(cm-1): 3358 (N-H); 2224 (CN); 1627 (CH=CH). Mp.: 40-41°C. Yield: 81%. Yellow 
crystals. 
 
3.2.4 Preparation of dimethyl 3-phenyl-2-propenyl phosphonate (210) 
Cinnamyl bromide (5 mmol) was mixed with 5 mmol of trimethyl phosphite in 
a roundbottom flask under a nitrogen atmosphere. The mixture was heated 
at 80°C for 6 h. CAUTION: the reaction should be performed in a properly 
working hood since gaseous methyl bromide is deliberated from the reaction 
mixture. Phosphonate 210 was obtained after evaporation of the volatiles.  
 
1H NMR δ (300 MHz, ppm): 2,77 (2H, dd, JHP = 22,3 Hz, J = 
7,4 Hz, CH2); 3,75 (3H, d, JHP = 11,0 Hz, OCH3); 3,76 (3H, d, 
JHP = 10,7 Hz, OCH3); 6,09-6,22 (1H, multiplet, CHCH2); 6,53 
(1H, dd, J = 15,9 Hz, JHP = 4,7 Hz, CH); 7,19-7,37 (5H, multiplet, CHarom). 13C NMR δ 
(75 MHz, ppm): 30,11 (d, JCP = 39,6 Hz, CH2P); 52,78 (OCH3); 52,84 (OCH3); 118,36 
(d, JCP = 12,7 Hz, =CHCH2); 126,28 (2x CHarom); 127,70 (CHarom); 128,59 (2x CHarom); 
134,90 (d, JCP = 15,0 Hz, =CH); 136,68 (d, JCP = 3,5 Hz, Cq,arom). 31P NMR δ (121 
MHz, ppm): 29,99. IR ν (cm-1): 1651, 1598, 1251 (br, P=O); 1048 (br, P-O). MS m/z 
(%): 227 (100, [M+H]+). Yield: 98%. Orange oil. 
 
3.2.5 Preparation of diethyl (3-oxo-1-phenylpropyl) phosphonate (217) 
Imine 19h (10 mmol) was mixed with 9.6 mmol of triethyl phosphite in 10 ml 
of dry ethanol (20 ml) under a nitrogen atmosphere. Then 10.4 mmol of 
formic acid was added dropwise to the reaction mixture. Stirring was 
continued for 10 minutes and then the solvent was evaporated under 
reduced pressure. The resulting oil was dissolved in 4 ml of dichloromethane 
and 6 ml of diethyl ether. Then 8 ml of a 1 M aqueous oxalic acid solution 
CN
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was added and the resulting biphasic system was mixed very vigorously 
during 30 minutes. Both phases were separated and the aqueous phase was 
extracted twice with 5 ml of dichloromethane. The combined organic phases 
were then washed twice with 10 ml of water and twice with 10 ml of a 
saturated NaHCO3(aq) solution. After drying (MgSO4) and evaporation of the 
solvent, the β-phosphono aldehyde 217 was obtained in 82% yield. Further 
purification could be performed using vacuum distillation (120-123°C/1 
mbar). 
 
1H NMR δ (300 MHz, ppm): 1.11 (3H, t, J = 7.2 Hz, CH3);  1.28 (3H, 
t, J = 7.2 Hz, CH3); 3.05-3.26 (2H, multiplet, CH2); 3.67-4.14 (5H, 
multiplet, OCH2, CHP); 7.23-7.39 (5H, multiplet, CHarom); 9.66-9.69 
(1H, multiplet, CHO). 13C NMR δ (75 MHz, ppm): 16.18, 16.26, 
16.34, 16.41 (CH3); 37.96 (d, JCP = 140.8 Hz, CHP); 44.02 (d, 
JCP = 2.3 Hz, CH2); 62.16, 62.25, 62.94, 63.03 (OCH2); 127.57 (d, JCP = 2.3 Hz, 
CHarom); 128.70 (d, JCP = 2.3 Hz, CHarom); 129.13 (d, JCP = 5.7 Hz, CHarom); 135.20 (d, 
JCP = 6.9 Hz, Cq,arom); 198.97 (d, JCP = 15.0 Hz, CHO). 31P NMR δ (121 MHz, ppm): 
27.64. IR ν (cm-1): 1725 (C=O); 1243 (P=O); 1050, 1027 (P-O). MS m/z (%): 271 
(100, [M+H]+). Yield: 42% (after distillation). Pale yellow oil. 
 
3.2.6 Preparation of PAP’s using trialkyl phosphites 
To a solution of 5 mmol of a suitable imine in 10 ml of methanol (or ethanol, 
depending on the phosphite used) 10 mmol of trialkyl phosphite was added. 
Then 10 mmol of formic acid was added dropwise to the reaction mixture. 
CAUTION: the reaction may proceed highly exothermic upon addition of 
formic acid. After stirring for 30 minutes at room temperature, the solvent 
was evaporated under reduced pressure. The residual oil was dissolved in 
10 ml of diethyl ether and mixed with 10 ml of 1 M HCl(aq) in a separatory 
funnel. The aqueous phase was washed two times more with 5 ml of diethyl 
ether. Then 10 ml of dichloromethane was added to the aqueous phase 
together with 3 M NaOH(aq) until the pH reached 9-10. The aqueous layer was 
then extracted two times more with 5 ml of dichloromethane and the 
combined organic phases were dried using MgSO4. The PAP’s were found in 
high purity after evaporation of the solvent under reduced pressure. 
 
Tetramethyl 1-phenyl-3-anilino-3-phosphonopropyl phosphonate (196a) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 34/66). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 2.29 (2x 1H, multiplet, CHAHB, 
m+M); 2.52-2.71 (2x 1H, multiplet, CHAHB, m+M); 3.38-3.83 
(2x 2H, NCHP, CHP, m+M); 3.48 (3H, d, JHP = 10.5 Hz, OCH3, 
M); 3.49 (3H, d, JHP = 10.5 Hz, OCH3, m); 3.54 (3H, d, JHP = 
10.2 Hz, OCH3, M); 3.65 (3H, d, JHP = 11.0 Hz, OCH3, M); 3.68 
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(3H, d, JHP = 10.5 Hz, OCH3, m);  3.69 (3H, d, JHP = 10.5 Hz, OCH3, M); 3.71 (3H, d, 
JHP = 9.1 Hz, OCH3, m); 3.78 (3H, d, JHP = 10.2 Hz, OCH3, m); 6.34 (2H, d, J = 
8.3 Hz, CHarom(a), M); 6.43 (2H, d, J = 8.3 Hz, CHarom(a), m); 6.46-6.61 (2x 1H, 
multiplet, CHarom(c), m+M); 6.78-7.15 (2x 2H, CHarom,(b), m+M); 7.16-7.37 (2x 5H, 
multiplet, CHarom, m+M). 13C NMR δ (75 MHz, ppm): 31.05 (d, J = 8.1 Hz, CH2, M); 
32.01 (CH2, m); 39.88 (dd, JCP = 139.6 Hz, JCP = 13.8 Hz, CHP, M); 40.12 (dd, JCP = 
137.3 Hz, JCP = 8.1 Hz, CHP, m); 48.09 (dd, JCP = 154.6 Hz, JCP = 16.2 Hz, NCHP, M); 
48.63 (dd, JCP = 155.9 Hz, JCP = 11.5 Hz, NCHP, m); 52.56 (d, JCP = 6.9 Hz, OCH3, M); 
52.77 (d, JCP = 6.9 Hz, OCH3, M); 53.36 (d, JCP = 5,8 Hz, OCH3, M); 53,51 (d, JCP = 
5,8 Hz, OCH3, M); 113,63 (2x CHarom(a), M); 113.87 (d, JCP = 10.4 Hz, 2x CHarom(a), 
m); 118.12 (CHarom(c), m); 118.49 (CHarom(c), M); 127.62, 127.69, 127.74, 128.56, 
128.59, 128.72, 128.82, 128.98, 129.17, 129.25, 129.28, 129.33, 129.37, 129.51, 
129.57, 129.63, 129.72 (CHarom, m+M); 134.17 (d, J = 6.9 Hz, Cq,arom, M); 135.88 
(Cq,arom, m); 146.12 (Cq,aromN, m); 146.63 (Cq,aromN, M). 31P NMR δ (121 MHz, ppm): 
28.47 (m); 28.74 (d, JPP = 9.7 Hz, M); 30.76 (m); 31.30 (d, JPP = 9.7 Hz, M). IR ν 
(cm-1): 3301 (NH); 1243 (br., P=O); 1043 (br., P-O). MS m/z (%): 428 (100, [M+H]+); 
318 (10, [M+H-PO(OMe)2]+). Yield: 86%. Yellow oil. 
 
Tetraethyl 1-phenyl-3-anilino-3-phosphonopropyl phosphonate (196b) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 44/76). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 1.03-1.39 (2x 12H, multiplet, 4x 
CH3, m+M); 2.11-2.44 (2x 1H, multiplet, CHAHB, m+M); 2.55-
2.80 (2x 1H, multiplet, CHAHB); 3.40-3.51 (2x 2H, multiplet, 2x 
CHP, m+M); 3.67-4.20 (2x 8H, multiplet, OCH2, m+M); 6.34 
(2H, d, J = 8.0 Hz, CHarom(a), M); 6.44 (2x 1H, d, J = 8.0 Hz, 
CHarom, m); 6.65-6.72 (2x 1H, multiplet, CHarom(c), m+M); 7.03-
7.13 (2x 2H, multiplet, CHarom(b), m+M); 7.14-7.33 (2x 5H, multiplet, CHarom, m+M). 
13C NMR δ (75 MHz, ppm): 16.27 (CH3, M); 16.36 (CH3, m); 31.01 (d, JCP = 8.1 Hz, 
CH2, M); 32.0 (CH2, m); 40.45 (dd, JCP = 139.6 Hz, JCP = 13.8 Hz, PhCHP, M); 40.74 
(dd, JCP = 145.4 Hz, JCP = 8.1 Hz, PhCHP, m); 48.41 (dd, JCP = 154.6 Hz, JCP = 16.2 
Hz, NCHPN, M); 48.99 (dd, JCP = 166.1 Hz, JCP = 11.5 Hz, NCHP, m); 61.74, 61.80, 
61.89, 62.00, 62.09, 62.24, 62.56, 62.69, 62.78, 62.93, 63.02 (OCH2, m+M); 113.63 
(2x CHarom(a), m); 113.73 (2x CHarom(a), M); 118.29 (CHarom(c), M); 118.50 (CHarom(c), 
m); 127.42, 127.56, 128.57, 128.66 (CHarom, m+M); 129.06 (2x CHarom(b)); 129.15, 
129.41, 129.50, 129.76, 129.85 (CHarom); 134.66 (d, JCP = 6.9 Hz, Cq,aromCH, M); 
136.32 (d, JCP = 6.9 Hz, Cq,aromCH, m); 146.41 (d, JCP = 6.9 Hz, Cq,aromN, m); 146.94 
(Cq,aromN, M). 31P NMR δ (121 MHz, ppm): 26.20 (m); 26.29 (d, JPP = 9.7 Hz, M); 
28.60 (m); 29.05 (d, JPP = 9.7 Hz, M). IR ν (cm-1): 3296 (N-H); 1243 (br, P=O); 1027 
(br, P-O). MS: m/z (%): 484 (100, [M+H]+). Yield: 86%. Yellow oil. 
 
Tetraethyl 3-benzylamino-1-phenyl-3-phosphonopropyl phosphonate 
(196d) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 33/67). 
Spectral data can be found in chapter 4, section 3.2.2. 
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Tetraethyl 3-allylamino -1-phenyl-3-phosphonopropyl phosphonate 
(196f) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 72/28). 
Spectral data can be found in chapter 4, section 3.2.2. 
 
Tetraethyl 3-isopropylamino-1-phenyl-3-phosphonopropyl phosphonate 
(196i) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 38/62). 
Spectral data can be found in chapter 4, section 3.2.2. 
 
3.2.7 Preparation of diphosphonic acids 
Method A: Dealkylation of the corresponding PAP esters 
To a solution of 5 mmol of PAP ester in 10 ml of dry dichloromethane, 
25 mmol of TMSBr was added under a nitrogen atmosphere. After stirring for 
1 h at room temperature, 2 ml of water was added to the reaction mixture. 
Stirring was continued for 1 h. When a precipitate had formed in the mean 
time, it could be easily isolated using filtration. Otherwise, the solvent was 
evaporated under reduced pressure. Residual water wass conveniently 
removed under high vacuum. 
 
Method B: Tandem addition of P(OTMS)3 
Preparation of P(OTMS)3 
Phosphoric acid (10 mmol) was added to 10 ml of dry dichloromethane under 
a nitrogen atmosphere. The mixture was stirred for 30 minutes while the 
phosphoric acid only partially dissolved in the organic solvent. Then the 
mixture is cooled to 0°C and 22 mmol of TMSCl was added using a syringe. 
After stirring for 15 minutes, 33 mmol of triethyl amine was added, causing 
immediate precipitation of ammonium salts. Care should be taken to avoid 
solidifying of the reaction medium (extra solvent may be added to assure 
proper stirring of the mixture). Then 11 mmol of TMSCl was added and the 
reaction was monitored using 31P NMR. Additional TMSCl may be added if 
necessary in order to obtain complete conversion.   
 
The imine of choice was added to the crude mixture of P(OTMS)3 and triethyl 
ammonium chloride in dichloromethane at room temperature. Then the 
reaction mixture was heated under reflux. The reaction could be easily 
monitored using 31P NMR. After complete conversion, the ammonium salts 
were removed by filtration and the solvent was evaporated under reduced 
pressure. The residual oil was dissolved in diethyl ether and filtered again in 
order to remove all ammonium salts. Then, 10 ml of methanol was added to 
the filtrate and the mixture was stirred during an overnight period. When a 
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precipitate had formed in the mean time, it could be easily isolated using 
filtration. Otherwise, the solvent was evaporated under reduced pressure.  
 
3-Isopropylamino-1-phenyl-3-phosphonopropyl phosphonic acid (226a)     
The product was obtained as a mixture of two diastereomeric pairs (ratio: 31/69). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (D2O, 300 MHz, ppm): 0.84 (3H, d, J = 6.3 Hz, CH3, 
M); 1.04 (3H, d, J = 6.3 Hz, CH3, m); 1.05 (3H, d, J = 6.3 Hz, 
CH3, M); 1.16 (3H, d, J = 6.3 Hz, CH3, m); 2.19-2.39 (2x 1H, 
multiplet, CHAHB, m+M); 2.47-2.56 (2x 1H, multiplet, CHAHB, 
m+M); 2.76 (1H, ~t, J = 11.3 Hz, PCHN, m); 2.07 (1H, ddd, J = 
12.9 Hz, J= 9.1 Hz, JHP = 3.3 Hz, PCHN, M); 3.30-3.58 (4H, multiplet, CH(CH3)2, 
CHPPh, m+M); 7.23-7.31 (5H, multiplet, CHarom, m+M). 13C NMR δ (D2O, 75 MHz, 
ppm): 17.56 (CH3, M); 18.04 (CH3, m); 18.49 (CH3, M); 18.86 (CH3, m); 28.06 (CH2); 
41.42 (dd, JCP = 133.8 Hz, JCP = 12.7 Hz, PCHPh, M); 42.03 (d, JCP = 135.0 Hz, 
PCHPh, m); 49.97 (dd, JCP = 143.1 Hz, JCP = 18.5 Hz, PCHN, m); 50.26 (CHCH3, M); 
51.00 (d, JCP = 111.9 Hz, PCHN, M); 51.74 (CHCH3, m); 128.02, 128.18, 129.15, 
129.23 (CHarom); 134.28 (Cq,arom). 31P NMR δ (D2O, 121 MHz, ppm): 12.71 (M); 12.89 
(d, JPP = 3.7 Hz, m); 25.21 (d, JPP = 3.7 Hz, m); 25.72 (M).  IR ν (cm-1): 3414 (NH); 
1245 (br., P=O); 1026 (br., P-O). MS m/z (%): 336 (100, [M-H]-). Yield: 75%. Yellow, 
highly viscous oil. 
 
3-tert-Butylamino-1-phenyl-3-phosphonopropyl phosphonic acid (226b)     
The product was obtained as a mixture of two diastereomeric pairs (ratio: 47/53). 
Spectral data were collected from the corresponding triethyl amine salt, unless 
otherwise stated.  
1H NMR δ (D2O, 300 MHz, ppm): 1.11 (9H, s, CH3); 
1.18 (18H, t, J = 7.2 Hz, N(CH2CH3)3); 1.30 (9H, s, CH3); 
2.22-2.67 (2x 2H, multiplet, CH2); 2.76 (1H, ~t, J = 
11.6 Hz, NCHP); 2.84-3.40 (1H + 2x 1H, multiplet, 
NCHP, 2x CHP); 3.10 (12H, q, J = 7.2 Hz, N(CH2CH3)3); 
7.21-7.38 (2x 5H, multiplet, CHarom). 13C NMR δ (D2O, 75 MHz, ppm): 8.35 
(N(CH2CH3)3); 25.42 (CH3); 25.90 (CH3); 31.57 (CH2); 32.36 (CH2); 43.25 (dd, 
JCP = 125.8 Hz, JCP = 8.1 Hz, CHP); 43.44 (d, JCP = 128.1 Hz, CHP); 46.71 
(N(CH2CH3)3); 50.66 (dd, JCP = 132.1 Hz, JCP = 17.9 Hz, NCHP); 51.77 (dd, 
JCP = 131.5 Hz, JCP = 9.2 Hz, NCHP); 59.42 (NCq); 59.89 (d, JCP = 4.6 Hz, NCq); 
126.87, 127.10, 128.69, 129.33, 129.39, 129.64, 129.72 (CHarom); 138.16 (d, 
JCP = 6.9 Hz, Cq,arom); 138.78 (d, JCP = 6.9 Hz, Cq,arom). 31P NMR δ (D2O, 121 MHz, 
ppm): 12.38, 12.54, 21.37, 22.05. IR ν (cm-1): (acid): 1198 (br., P=O); 1005 (br., P-
O). MS m/z (%): (salt, neg. mode): 350 (100, [M-H]-). (salt, pos. mode): 102 (100, 
[Et3N+H]+); 352 (51, [M+H]+); 453 (8, [M+H+Et3N]+); 703 (48, [2M+H]+). (acid, neg. 
mode): 350 (100, [M-H]-). Mp.: (acid): decomposition above 230°C. Yield: 99%. 
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3-Benzylamino-1-phenyl-3-phosphonopropyl phosphonic acid (226c)     
The product was obtained as a mixture of two diastereomeric pairs (ratio: 20/80). 
Spectral data were collected from the corresponding triethyl amine salt, unless 
otherwise stated.  
1H NMR δ (D2O, 300 MHz, ppm): 1.10 (27H, t, 
J = 7.2 Hz, N(CH2CH3)3); 2.22-2.81 (2H, multiplet, CH2, 
M); 2.44-2.53 (1H, multiplet, CH2, m); 2.67 (1H, dt, JHP = 
20.4 Hz, J = 6.9 Hz, NCHP, M); 2.76-2.95 (1H + 2x 1H, 
multiplet, NCHP, m, 2x CHP, m+M); 2.99 (18H, q, 
J =7.2 Hz, N(CH2CH3)3); 4.01 (1H, d, JAB = 13.2 Hz, NCHAHB, m); 4.11 (1H, d 
JAB = 13.2 Hz, NCHAHB, m); 4.21 (d, JAB = 12.9 Hz, NCHAHB, M); 4.44 (1H, d, 
JAB = 12.9 Hz, NCHAHB, M); 7.05-7.44 (2x 10H, multiplet, CHarom). 13C NMR δ (D2O, 
75 MHz, ppm): 8.35 (N(CH2CH3)3); 30.45 (CH2, m); 31.29 (CH2, M); 46.30 (dd, 
JCP = 122.3 Hz, JCP = 11.5 Hz, CHP, M); 46.50 (N(CH2CH3)3); 49.42 (NCH2, m); 50.46 
(NCH2, M); 54.84 (dd, JCP = 128.7 Hz, JCP = 13.3 Hz, NCHP, m); 57.40 (dd, 
JCP = 130.4 Hz, JCP = 5.8 Hz, NCHP, M); 125.97, 126.52, 128.35, 128.70, 128.87, 
129.15, 129.22, 129.33, 129.44, 129.60, 129.70, 129.93, 130.20 (CHarom); 131.54 
(Cq,arom, m); 132.22 (Cq,arom, m) 140.25 (d, JCP = 5.8 Hz, Cq,arom, m); 141.83 (d, 
JCP = 6.9 Hz, Cq,arom, M). 31P NMR δ (D2O, 121 MHz, ppm): 11.47 (m); 11.78 (M); 
19.72 (M); 20.26 (m). MS m/z (%): (salt, neg. mode): 384 (100, [M-H]-). (salt, pos. 
mode): 102 (100); 285 (67) ; 386 (29, [M+H]+); 487 (7, [M+H+Et3N]+); 771 (12, 
[2M+H]+). Yield: 99%. 
 
3.3 Phosphonylation using dialkyl phosphite 
To a solution of an aldimine (5 mmol) in methanol (10 ml), 2 equivalents of 
dimethyl phosphite was added and the resulting mixture was refluxed for 2 
to 3 hours shielded from moisture using a CaCl2 tube. After evaporation of 
the solvent, the residue was dissolved in 10 ml of diethyl ether and added to 
an equal amount of 1M HCl(aq) in a separatory funnel. The mixture was then 
shaken very vigorously and the organic phase was discarded. The water 
phase was washed twice with a small amount of diethyl ether, neutralized 
using 3M NaOH(aq) and extracted with dichloromethane. The α-aminoalkyl 
phosphonates are obtained in high purity after drying with MgSO4 and 
evaporation of the solvent under reduced pressure.  
 
Dimethyl (2E)-1-benzylamino-3-phenylprop-2-enyl phosphonate (22b)  
1H NMR δ (300 MHz, ppm): 1.94 (1H, s (br.), NH); 3.65-3.77 
(2H, multiplet, CHP, CHAHBN); 3.76 (3H, d, JHP = 10.5 Hz, 
OCH3); 3.80 (3H, d, JHP = 10.5 Hz, OCH3); 3.97 (1H, d, JAB = 
13.6 Hz, CHAHBPh); 6.15 (1H, ddd, JAB = 16.0 Hz, J = 8.5 Hz, 
JHP = 5.8 Hz, =CH); 6.62 (1H, dd, JAB = 16.0 Hz, J = 4.7 Hz, 
=CHPh); 7.21-7.42 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 51.22 (d, JCP 
= 16.2 Hz, NCH2); 53.42 (d, JCP = 6.9 Hz, OCH3); 53.67 (d, JCP = 6.9 Hz, OCH3);  
57.41 (d, JCP = 156.9 Hz, CHP); 123.82 (d, JCP = 5.8 Hz, =CH); 126.56, 127.17, 
128.01, 128.28, 128.45, 128.62 (CHarom); 134.50 (d, JCP = 13.9 Hz, =CHPh); 136.24 
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(d, JCP = 2.3 Hz, Cq,arom); 139.24 (Cq,arom). 31P NMR δ (121 MHz, ppm): 26.70. IR ν 
(cm-1): 3305 (NH); 1243 (P=O); 1050, 1028 (P-O). MS m/z (%): 332 (100, [M+H]+); 
222 (60, [M+H-P(O)(OMe)2]+); Yield: 96%. Yellow oil. 
 
Diethyl (2E)-1-benzylamino-3-phenylprop-2-enyl phosphonate (22c)  
1H NMR δ (300 MHz, ppm): 1.29 (3H, t, J = 6.9 Hz, CH3); 1.31 
(3H, t, J = 6.9 Hz, CH3); 2.28 (1H, s (br.), NH); 3.67 (1H, ddd, 
JHP = 19.3 Hz, J = 8.5 Hz, J = 0.8 Hz, CHP); 3.75 (1H, d, JAB = 
13.6 Hz, CHAHBPh); 3.97 (1H, d, JAB = 13.6 Hz, CHAHBPh);  
4.06-4.25 (4H, multiplet, CH2O); 6.15 (1H, ddd, JAB = 16.0 Hz, 
J = 8.5 Hz, JHP = 5.8 Hz, =CH); 6.61 (1H, dd, JAB = 16.0 Hz, J = 4.7 Hz, =CHPh); 7.22-
7.42 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 16.28; 16.36; 16.46; 16.54 
(CH3); 51.27 (d, JCP = 16.2 Hz, NCH2);  57.72 (d, JCP = 154.6 Hz, CHP); 62.71; 62.82; 
62.86; 62.95 (CH2O); 124.19 (d, JCP = 6.9 Hz, =CH); 126.55; 127.13; 127.90; 128.30; 
128.42; 128.62 (CHarom); 133.49 (d, JCP = 13.8 Hz, =CHPh); 136.41 (d, JCP = 2.3 Hz, 
Cq,arom); 139.37 (Cq,arom). 31P NMR δ (121 MHz, ppm): 24.42. IR ν (cm-1): 3305 (NH); 
1243 (P=O); 1050, 1028 (P-O). MS m/z (%): 222 (100, [M+H-P(O)(OEt)2]+); 360 (16, 
[M+H]+). Yield: 95%. Yellow oil. 
 
Dimethyl (2E)-1-(4-methoxybenzylamino)-3-phenylprop-2-enyl 
phosphonate (22d)  
1H NMR δ (300 MHz, ppm): 1.91 (1H, s (br.), NH); 3.64-3.75 
(1H, multiplet, CHP); 3.69 (1H, d, JAB = 13.5 Hz, CHAHBPh); 
3.77 (3H, d, JHP = 10.7 Hz, OCH3); 3.80 (3H, s, OCH3(Ph)); 3.80 
(3H, d, JHP = 10.5 Hz, OCH3); 3.91 (1H, d, JAB = 13.2 Hz, 
CHAHBPh);  6.14 (1H, ddd, JAB = 16.0 Hz, J = 8.5 Hz, JHP = 5.8 
Hz, =CH); 6.61 (1H, dd, JAB = 16.0 Hz, J = 4.7 Hz, =CHPh); 6.83-6.90 (2H, multiplet, 
CHarom); 7.21-7.45 (7H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 50.72 (d, 
JCP = 17.31 Hz, NCH2); 53.52 (d, JCP = 6.9 Hz, OCH3); 53.77 (d, JCP = 6.9 Hz, OCH3); 
55.31 (OCH3(Ph)); 57.30 (d, JCP = 155.8 Hz, CHP); 113.92 (=CHo,PMB); 123.97 (d, JCP = 
6.9 Hz, =CH); 126.66, 128.11, 128.74, 129.62 (CHarom); 131.36 (Cq,arom,PMB); 134.76 
(d, JCP = 15.0 Hz, =CHPh); 136.35 (d, JCP = 2.3 Hz, Cq,arom); 158.87 (OCq,arom). 31P 
NMR δ (121 MHz, ppm): 26.79. IR ν (cm-1): 3462 (NH); 1247 (P=O); 1037 (br., P-O). 
MS m/z (%): 362 (100, [M+H]+); 252 (19, [M+H-P(O)(OMe)2]+); Yield: 86%. Orange oil. 
 
Dimethyl (2E)-1-allylamino-3-phenylprop-2-enyl phosphonate (22e) 
1H NMR δ (300 MHz, ppm): 1.69 (1H, s (br.), NH); 3.21 (1H, 
dd, JAB = 14.0 Hz, J = 6.3 Hz, CHAHBN); 3.41 (1H, dd, JAB = 
14.0 Hz, J = 5.2 Hz, CHAHBN); 3.72-3.84 (7H, multiplet, CHP, 
OCH3); 5.12-5.22 (2H, multiplet, =CH2); 5.86 (1H, dddd, J = 
17.2 Hz, J = 10.3 Hz, J = 6.7 Hz, J = 5.2 Hz, CH2=CH); 6.10 (1H, ddd, J = 15.8 Hz, J2 
= 8.7 Hz, JHP = 5.8 Hz, PhCH=CH); 6.62 (1H, dd, J = 16.0 Hz, J = 4.7 Hz, PhCH=); 
7.23-7.42 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 50.09 (d, JCP = 16.2 
Hz, CH2N); 53.57 (d, JCP = 6.9 Hz, OCH3); 53.73 (d, JCP = 8.1 Hz, OCH3); 57.72 (d, 
JCP = 156.9 Hz, CHP); 116.96 (=CH2); 123.91 (d, JCP = 6.9 Hz, PhCH=CH); 126.64; 
128.09; 128.72 (CHarom); 134.70 (d, JCP = 6.9 Hz, PhCH=); 135.97 (CH=CH2); 136.34 
(Cq,arom). 31P NMR δ (121 MHz, ppm): 26.77. MS m/z (%): 282 (100, [M+H]+). IR ν 
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(cm-1): 3308 (NH); 1247 (P=O); 1053, 1033 (P-O). Mp.: 54.1°C. Yield: 95%. Green 
solid. 
 
Dimethyl (2E)-[1-(2-methylprop-2-enyl)amino]-3-phenylprop-2-enyl 
phosphonate (22f)  
1H NMR δ (300 MHz, ppm): 1.75 (4H, s (br.), NH + CH3); 3.16 
(1H, d, JAB = 14.3 Hz, NCHAHB); 3.29 (1H, d, JAB = 14.3 Hz, 
NCHAHB); 3.71 (1H, ddd, JHP = 19.5 Hz, J = 8.5 Hz, J = 0.8 Hz, 
CHP); 3.80 (3H, d, JHP = 9.6 Hz, OCH3); 3.83 (3H, d, JHP = 9.6 
Hz, OCH3); 4.88 (1H, s, C=CHAHB); 4.90 (1H, s, C=CHAHB); 
6.11 (1H, ddd, J = 15.8 Hz, J = 8.5 Hz, JHP = 5.6 Hz, CHCHP); 6.62 (1H, dd, J = 15.8 
Hz, JHP = 4.5 Hz, =CHPh); 7.23-7.42 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, 
ppm): 20.68 (CH3); 53.22 (d, JCP = 16.1 Hz, NCH2); 53.51 (d, JCP = 6.9 Hz, OCH3); 
53.80 (d, JCP = 7.0 Hz, OCH3); 57.45 (d, JCP = 156.9 Hz, CHP); 111.99 (C=CH2); 
124.02 (d, JCP = 6.9 Hz, CHCHP); 126.64 (2 x CHarom); 128.05 (CHarom); 128.70 (2 x 
CHarom); 134.64 (d, JCP = 13.8 Hz, PhCH); 136.37 (Cq,arom); 143.03 (=Cq). 31P NMR δ 
(121 MHz, ppm): 26.90. IR ν (cm-1): 3460 (NH); 1244 (P=O); 1057 (P-O). MS m/z 
(%): 296.7 (100, [M+H]+). Yield: 74%. Yellow oil. 
 
Dimethyl (2E)-1-isopropylamino-3-phenylprop-2-enyl phosphonate (22h) 
1H NMR δ (300 MHz, ppm): 1.03 (3H, d, J = 6.3 Hz, CH3); 
1.09 (3H, d, J = 6.3 Hz, CH3); 1.53 (1H, s (br.), NH); 2.95 (1H, 
septet, J = 6.3 Hz, NCH); 3.78 (3H, d, JHP = 10.5 Hz, OCH3); 
3.83 (3H, d, JHP = 10.5 Hz, OCH3); 3.82 (1H, ddd, JHP = 20.0 
Hz, J = 8.5 Hz, J = 1.1 Hz, CHP); 6.12 (1H, ddd, J = 16.0 Hz, J 
= 8.5 Hz, JHP = 5.8 Hz, PhCH=CH); 6.61 (1H, dd, J = 16.0 Hz, JHP = 4.7 Hz, =CHPh); 
7.23-7.42 (5H, multiplet, CHarom).  13C NMR δ (75 MHz, ppm): 21.56 (CH3); 23.93 
(CH3)); 46.05 (d, JCP = 16.2 Hz, NCH); 53.44 (d, JCP = 6.9 Hz, OCH3); 53.89 (d, JCP = 
8.1 Hz, OCH3); 56.26 (d, JCP = 156.9 Hz, CHP); 124.69 (d, JCP = 5.8 Hz, PhCH=CH); 
126.56; 127.92; 128.60 (CHarom); 133.84 (d, JCP = 13.9 Hz, PhCH=CH); 136.31 
(Cq,arom). 31P NMR δ (121 MHz, ppm): 27.04. IR ν (cm-1): 3316 (NH); 1242 (P=O); 
1061, 1033 (P-O). MS m/z (%): 174 (100, [M+H-P(O)(OMe)2]+). Mp.: 67.3°C. Yield: 
94%. Yellow solid. 
 
Diethyl (2E)-1-(isopropylamino)-3-phenyl-prop-2-enyl phosphonate (22i) 
See chapter 4, section 3.1 for spectral data. Yield: 95%. 
 
Dimethyl (2E)-1-(tert-butylamino)-3-phenylprop-2-enyl phosphonate 
(22j) 
1H NMR δ (300 MHz, ppm): 1.12 (9H, s, CH3); 1.40 (1H, s 
(br.), NH); 3.76 (3H, d, JHP = 10.5 Hz, OCH3); 3.84 (3H, d, JHP = 
10.5 Hz, OCH3); 3.90 (1H, dd, JHP = 24.2 Hz, J = 8.0 Hz, CHP); 
6.21 (1H, ddd, JAB = 16.0 Hz, J = 8.0 Hz, JHP = 5.8 Hz, 
PhCH=CH); 6.63 (1H, dd, J = 16.0 Hz, J = 5.2 Hz, =CHPh); 
7.21-7.44 (5H, multiplet, CHarom).  13C NMR δ (75 MHz, ppm): 30.00 (CH3); 52.18 
(NCq, JCP = 15.0 Hz); 53.29 (d, JCP = 6.9 Hz, OCH3); 53.89 (d, JCP = 158.1 Hz, CHP); 
54.43 (d, JCP = 6.9 Hz, OCH3); 126.45 (d, JCP = 2.3 Hz, CHarom); 127.70 (CHarom); 
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127.96 (d, JCP = 4.6 Hz, PhCH=CH); 128.59 (CHarom); 132.30 (d, JCP = 13.8 Hz, 
PhCH=CH); 136.64 (Cq,arom); 31P NMR δ (121 MHz, ppm): 27.02. IR ν (cm-1): 3298 
(NH); 1240 (P=O); 1060, 1030 (P-O). MS m/z (%): 188 (100, [M+H-P(O)(OMe)2]+); 298 
(19, [M+H]+). Mp.: 54.7°C. Yield: 97%. Yellow solid. 
 
Diethyl (2E)-1-(tert-butylamino)-3-phenylprop-2-enyl phosphonate (22k) 
1H NMR δ (300 MHz, ppm): 1.12 (9H, s, CH3); 1.29 (3H, t, 
J = 7.2 Hz, CH2CH3); 1.32 (3H, t, J = 7.2 Hz, CH2CH3); 1.42 
(1H, s (br.), NH); 3.86 (1H, ddd, JHP = 24.8 Hz, J = 8.0 Hz, 
J = 0.8 Hz, CHP); 4.06-4.24 (4H, multiplet, OCH2); 6.21 (1H, 
ddd, J = 16.0 Hz, J = 8.0 Hz, JHP = 5.8 Hz, =CH); 6.62 (1H, dd, 
J = 16.0 Hz, J = 5.2 Hz, =CHPh); 7.21-7.36 (5H, multiplet, CHarom).  13C NMR δ (75 
MHz, ppm): 16.48 (d, JCP = 5.8 Hz, CH2CH3); 16.56 (d, JCP = 5.8 Hz, CH2CH3); 30.03 
(CH3); 52.08 (NCq, JCP = 13.9 Hz); 54.16 (d, JCP = 155.8 Hz, CHP); 62.51 (d, JCP = 6.9 
Hz, OCH3); 63.35 (d, JCP = 6.9 Hz, OCH3); 126.40, 127.56 (CHarom); 128.47 (d, JCP = 
5.8 Hz, PhCH=CH); 128.56 (CHarom); 132.05 (d, JCP = 12.7 Hz, PhCH=CH); 136.84 (d, 
JCP = 3.5 Hz, Cq,arom); 31P NMR δ (121 MHz, ppm): 26.42. IR ν (cm-1): 3288 (NH); 
1238 (P=O); 1053, 1029 (P-O). MS m/z (%): 188 (100, [M+H-P(O)(OEt)2]+); 326 (12, 
[M+H]+). Mp.: 69.6°C. Yield: 93%. Yellow solid. 
 
Dimethyl (2E)-1-allylamino-2-methyl-3-phenylprop-2-enyl phosphonate 
(22l) 
1H NMR δ (300 MHz, ppm): 1.90 (1H, s (br.), NH); 1.99 (3H, 
dd, JHP = 3.3 Hz, J = 1.4 Hz, CH3); 3.13 (1H, dd, JAB = 14.0 Hz, 
J = 6.9 Hz, CHAHBN); 3.33 (1H, dd, JAB = 13.8 Hz, J = 5.2 Hz, 
CHAHBN); 3.70 (1H, d, JHP = 21.5 Hz, CHP); 3.78 (3H, d, JHP = 
10.5 Hz, OCH3); 3.83 (3H, d, JHP = 10.7 Hz, OCH3); 5.12-5.29 (2H, multiplet, =CH2); 
5.81-5.94 (1H, multiplet, =CH); 6.55 (1H, d, JHP = 4.1 Hz, =CHPh); 7.21-7.37 (5H, 
multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 15.40 (CH3); 49.86 (d, JCP = 18.5 Hz, 
NCH2); 53.48 (d, JCP = 6.9 Hz, OCH3); 53.65 (d, JCP = 8.1 Hz, OCH3); 62.97 (d, JCP = 
153.5 Hz, CHP); 116.99 (=CH2); 126.84, 128.28, 129.07 (CHarom); 130.48 (d, JCP = 
12.7 Hz, =CHPh); 132.67 (d, JCP = 4.6 Hz, =Cq); 136.05 (=CH); 137.28 (d, 
JCP = 2.3 Hz, Cq,arom).   31P NMR δ (121 MHz, ppm): 26.98. IR ν (cm-1): 3470 (NH); 
1248 (P=O); 1039 (br., P-O). MS m/z (%): 296 (81, [M+H]+); 186 (100, [M+H-
PO(OMe)2]+). Yield: 90%. Yellow oil. 
 
Dimethyl 1-allylamino-2-isopentyl-3-phenylprop-2-enyl phosphonate 
(22m) 
Mixture of two isomers: 79% E and 21% Z. 
The major isomer is indicated as M, the minor isomer as m whenever possible. 
1H NMR δ (300 MHz, ppm): 0.85-0.96 (2x3H, multiplet, CH3, 
m+M); 1.27-1.49 (2x5H, multiplet, CH3, CH, CHAHB, m+M); 
1.53-1.71 (2x1H, multiplet, CHAHB, m+M); 1.89 (2x1H, s (br.), 
NH, m+M); 2.11-2.20 (1H, multiplet, CHAHBC=, M); 2.22-2.37 
(2H, multiplet, CHAHBC=, m); 2.50-2.60 (1H, multiplet, 
CHAHBC=, M); 2.84 (1H, dd, JAB = 13.8 Hz, J = 6.3 Hz, 
NCHAHB, m); 3.17 (1H, dd, JAB = 14.0 Hz, J = 5.5 Hz, CHAHBN, M); 3.13-3.20 (1H, 
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multiplet, CHAHBN, m); 3.40 (1H, dd, JAB = 13.8 Hz, J = 3.9 Hz, CHAHBN, M); 3.66 
(1H, d, JHP = 20.6 Hz, CHP, M); 3.77 (2x3H, d, JHP = 10.5 Hz, OCH3, m+M); 3.78 (3H, 
d, JHP = 10.5 Hz, OCH3, m); 3.83 (3H, d, JHP = 10.5 Hz, OCH3, M); 4.25 (1H, d, 
JHP = 22.6 Hz, CHP, m); 4.83-4.90 (2H, multiplet, =CH2, m); 5.11-5.25 (2H, multiplet, 
=CH2, M); 5.61-5.74 (1H, multiplet, =CH, m); 5.81-5.94 (1H, multiplet, =CH, M); 6.67 
(1H, d, JHP = 5.5 Hz, =CHPh, M); 6.70 (1H, s (br.), =CHPh, m); 7.20-7.36 (2x5H, 
multiplet, CHarom, m+M).   13C NMR δ (75 MHz, ppm): 13.99 (CH3, M); 14.08 (CH3, 
m); 22.34 (CH3, M); 22.74 (CH3, m); 27.83 (d, JCP = 2.3 Hz, CH2, M); 28.08 (CH2, m); 
30.58 (CH2C=, m); 30.89 (d, JCP = 2.3 Hz, CH2, M); 31.85 (CH, m); 32.00 (CH, M); 
49.62 (d, JCP = 16.2 Hz, CH2N, m); 49.84 (d, JCP = 16.2 Hz, CH2N, M); 52.95 (d, 
JCP = 6.9 Hz, OCH3, m); 53.26 (d, JCP = 6.9 Hz, OCH3, M); 53.45 (d, JCP = 6.9 Hz, 
OCH3, m); 53.87 (d, JCP = 6.9 Hz, OCH3, M); 54.78 (d, JCP = 156.9 Hz, CHP, m); 59.74 
(d, JCP = 152.3 Hz, CHP, M); 116.60 (=CH2, m + M); 126.63, 128.18, 128.22, 128.48 
(CHarom); 128.60 (d, JCP = 13.9 Hz, =CHPh, M); 130.53 (d, JCP = 13.9 Hz, =CHPh, m); 
135.75 (=CH, m); 136.24 (=CH, M); 136.42, 137.34, 137.38, 137.43, 137.49 (Cq).    
31P NMR δ (121 MHz, ppm): 26.94 (M); 27.64 (m). IR ν (cm-1): 3329 (NH); 1246 
(P=O); 1052, 1035 (P-O). MS m/z (%): 352 (53, [M+H]+); 242 (100, [M+H-PO(OMe)2]+, 
100). Yield: 88%. Yellow oil. 
 
Dimethyl (2E)-1-allylamino-2-chloro-3-phenylprop-2-enyl phosphonate 
(22n)  
1H NMR δ (300 MHz, ppm): 2.17 (1H, s (br.), NH); 3.14 (1H, 
d, JAB = 13.5 Hz, NCHAHB); 3.38-3.45 (1H, multiplet, NCHAHB); 
3.81 (3H, d, JHP = 10.7 Hz, OCH3); 3.87 (3H, d, JHP = 10.5 Hz, 
OCH3); 3.93 (1H, d, JHP = 24.2 Hz, CHP); 5.08-5.26 (=CH2); 
5.80-5.93 (1H, multiplet, =CH); 6.73 (1H, d, JHP = 3.9 Hz, =CHPh); 7.29-7.42 (3H, 
multiplet, CHarom); 7.66-7.69 (2H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 
49.41 (d, JCP = 18.5 Hz, NCH2); 53.70 (d, JCP = 6.9 Hz, OCH3); 53.98 (d, JCP = 7.0 Hz, 
OCH3); 62.69 (d, JCP = 162.7 Hz, CHP); 117.57 (=CH2);  128.41, 128.49, 128.57, 
128.66, 129.42 (CHarom, =CCl); 129.60 (d, JCP = 13.8 Hz, PhCH=);  134.08 ((Cq,arom); 
135.53 (=CH). 31P NMR δ (121 MHz, ppm): 23.84. Yield: 54%. Yellow oil (purity 
~90%). 
 
Dimethyl (2E)-1-allylamino-2-phenylbut-2-enyl phosphonate (E-(22o)) 
1H NMR δ (300 MHz, ppm): 1.66 (3H, dd, J = 6.6 Hz, J = 5.2 Hz, 
CH3); 1.84 (1H, s (br.), NH); 3.23 (1H, dd, JAB = 13.8 Hz, 
J = 6.6 Hz, CHAHBN); 3.44 (1H, dd, JAB = 13.6 Hz, J = 5.2 Hz, 
CHAHBN); 3.64 (3H, d, JHP = 10.5 Hz, OCH3); 3.66 (3H, d, 
JHP = 10.7 Hz, OCH3); 3.80 (1H, d, JHP = 22.6 Hz, CHP); 5.10-5.22 
(2H, multiplet, =CH2); 5.80-5.97 (2H, multiplet, =CH, =CHCH3);  
7.22-7.40 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 14.79 (d, JCP = 2.3 Hz, 
CH3); 49.70 (d, JCP = 17.3 Hz, NCH2); 52.88 (d, JCP = 6.9 Hz, OCH3); 53.35 (d, 
JCP = 6.9 Hz, OCH3); 60.82 (d, JCP = 156.9 Hz, CHP); 116.69 (=CH2); 127.86 (CHarom); 
127.24 (d, JCP = 10.4 Hz, =CHCH3); 127.97 (2 x CHarom); 129.01 (2 x CHarom); 135.68 
(br., =Cq); 136.05 (=CH); 138.83 (d, JCP = 3.5 Hz, Cq,arom). 31P NMR δ (121 MHz, 
ppm): 26.87. IR ν (cm-1): 3469 (NH); 1244 (P=O); 1039 (br., P-O). MS m/z (%): 296.3 
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([M+H]+, 100); 186.2 ([M+H-PO(OMe)2]+, 84). Chromatography: Hex/EtOAc (2/8) Rf = 
0.20. Yield: 52%. Yellow oil. 
 
Dimethyl (2Z)-1-allylamino-2-phenylbut-2-enyl phosphonate (Z-(22o)) 
1H NMR δ (300 MHz, ppm): 1.86 (3H, dd, J = 7.2 Hz, J = 4.7 Hz, 
CH3); 1.89 (1H, s (br.), NH); 3.00 (1H, dd, JAB = 13.5 Hz, J = 6.9 Hz, 
CHAHBN); 3.18 (1H, dd, JAB = 13.8 Hz, J = 5.2 Hz, CHAHBN); 3.73 
(3H, d, JHP = 10.5 Hz, OCH3); 3.79 (3H, d, JHP = 10.5 Hz, OCH3); 4.29 
(1H, d, JHP = 26.4 Hz, CHP); 5.05-5.12 (2H, multiplet, =CH2); 5.71-
5.84 (1H, multiplet, =CH); 5.97 (1H, dq, J = 7.2 Hz, J = 4.1 Hz, 
=CHCH3); 7.20-7.36 (3H, multiplet, CHarom); 7.55-7.59 (2H, multiplet, CHarom). 13C 
NMR δ (75 MHz, ppm): 14.34 (CH3); 50.17 (d, JCP = 18.5 Hz, NCH2); 53.35 (d, 
JCP = 8.1 Hz, OCH3); 53.82 (d, JCP = 6.9 Hz, OCH3); 54.62 (d, JCP = 160.4 Hz, CHP); 
117.11 (=CH2); 127.17 (CHarom); 127.25 (2 x CHarom); 128.36 (2 x CHarom); 130.56 (d, 
JCP = 11.5 Hz, =CHCH3); 136.14 (=CH); 136.76 (=Cq); 140.86 (Cq,arom). 31P NMR δ 
(121 MHz, ppm): 27.40. IR ν (cm-1): 3469 (NH); 1246 (P=O); 1058, 1032 (br., P-O). 
MS m/z (%): 296.3 ([M+H]+, 100); 186.2 ([M+H-PO(OMe)2]+, 39). Chromatography: 
Hex/EtOAc (2/8) Rf = 0.24. Yield: 10%. Yellow oil. 
 
Dimethyl (2E)-1-allylamino-2-benzylbut-2-enyl phosphonate (22p) 
1H NMR δ (300 MHz, ppm): 1.54 (1H, s (br.), NH); 1.87 (3H, dd, 
J = 6.3 Hz, J = 5.8 Hz, CH3); 2.68 (1H, dd, JAB = 14.0 Hz, 
J = 6.6 Hz, NCHAHB); 2.99 (1H, dd, JAB = 14.0 Hz, J = 5.5 Hz, 
NCHAHB); 3.34-3.40 (1H, multiplet, CHAHBPh); 3.41 (1H, d, 
JHP = 21.7 Hz, CHP); 3.68-3.82 (1H, multiplet, CHAHBPh); 3.73 
(3H, d, JHP = 10.5 Hz, OCH3); 3.78 (3H, d, JHP = 10.5 Hz, OCH3); 
4.75-7.90 (2H, multiplet, =CH2); 5.49-5.63 (1H, multiplet, =CH); 5.81 (1H, ~quintet, J 
≈ 6.3 Hz, =CHCH3); 7.15-7.30 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 
14.15 (CH3); 35.23 (CH2); 49.57 (d, JCP = 16.2 Hz, NCH2); 53.05 (d, JCP = 6.9 Hz, 
OCH3); 53.86 (d, JCP = 6.9 Hz, OCH3); 58.90 (d, JCP = 154.6 Hz, CHP); 116.32 (=CH2); 
124.93 (d, JCP = 11.5 Hz, =CHCH3); 126.25, 128.46, 128.90 (CHarom); 133.31 (d, 
JCP = 3.5 Hz, =Cq); 136.09 (=CH); 139.41 (Cq,arom). 31P NMR δ (121 MHz, ppm): 
27.40. IR ν (cm-1): 3321 (NH); 1238 (P=O); 1074, 1026 (P-O). MS m/z (%): 310 (100, 
[M+H]+); 200 (19, [M+H-PO(OMe)2]+). Mp.: 78-80°C. Yield: 29% (from the 
corresponding aldehyde). Colourless crystals. 
 
Dimethyl (2E)-1-allylamino-2-(2-phenylethyl)but-2-enyl phosphonate 
(22q) 
1H NMR δ (300 MHz, ppm): 1.71 (3H, t, J = 6.05 Hz, CH3); 1.76 
(1H, s, NH); 2.28-2.81 (4H, m, CH2CH2); 3.07 (1H, dd, JAB = 14.1 
Hz, J = 6.3 Hz, NCHAHB); 3.27 (1H, dd, JAB = 14.1 Hz, J = 5.1 Hz, 
NCHAHB); 3.50 (1H, d, JHP = 21.5 Hz, CHP); 3.74 (3H, d, JHP = 10.5 
Hz, OCH3); 3.80 (3H, d, JHP = 10.2 Hz, OCH3); 5.09-5.22 (2H, 
multiplet, =CH2); 5.66 (1H, dq, J = 6.6 Hz, J = 6.2 Hz, CH3CH); 5.77-5.88 (1H, 
multiplet, HC=CH2); 7.16-7.32 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 
13.43 (CH3); 31.42 (CH2Ph); 34.42 (CCH2); 49.68 (d, JCP = 16.2 Hz, NCH2); 52.90 (d, 
JCP = 6.9 Hz, OCH3); 53.55 (d, JCP = 6.9 Hz, OCH3); 60.17 (d, JCP = 154.6 Hz, CHP); 
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116.26 (=CH2); 125.16 (d, JCP = 11.5 Hz, CH3CH); 125.82 (2 x CHarom); 128.28 (2 x 
CHarom); 133.73 (d, JCP = 3.5 Hz, HC=CH2); 136.29 (Cq arom); 141.97 (=Cq). 31P NMR δ 
(121 MHz, ppm): 27.56. IR ν (cm-1): 3324 (NH); 1246 (P=O); 1031 (P-O). MS m/z 
(%): 324.2 (100, [M+H]+). Chromatography: Rf = 0,32 (Hex/EtOAc 20/80). Yield: 
44% (from the corresponding aldehyde). Yellow oil. 
 
Dimethyl 3-(2-Nitrophenyl)-1-prop-2-ynylaminoprop-2-enyl phosphonate 
(22r) 
Isolated as the hydrochloride salt. 
1H NMR δ (300 MHz, ppm): 3.88 (3H, d, JHP = 11.0 Hz, 
OCH3); 3.92 (3H, d, JHP = 11.0 Hz, OCH3); 3.90-3.99 (1H, 
multiplet, CHP); 4.16 (1H, d, JAB = 13.5 Hz, NCHAHB); 4.75 
(1H, dd, JAB = 13.5 Hz, J = 1.7 Hz, NCHAHB); 6.54 (1H, ddd, 
J = 15.7 Hz, J = 9.9 Hz, J = 5.5 Hz, =CHCHP); 7.19 (dd, 
J = 15.7 Hz, JHP = 4.4 Hz, =CHPh); 7.39-7.80 (8H, multiplet, CHarom); 7.97 (1H, dd, 
J = 8.2 Hz, J = 1.1 Hz, =CHCqNO2). 13C NMR δ (75 MHz, ppm): 19.39 (d, 
JCP = 8.1 Hz, NCH2); 54.09 (d, JCP = 154.6 Hz, CHP); 54.70 (d, JCP = 6.9 Hz, OCH3); 
54.94 (d, JCP = 6.9 Hz, OCH3); 120.85 (d, JCP = 8.1 Hz, =CHCHP); 124.87 (=CHCqNO2); 
129.56, 129.73, 129.85, 129.91, 130.75 (CHarom, Cq,arom); 131.16 (d, JCP = 2.3 Hz, 
=CqNO2); 133.97 (CHarom); 136.01 (d, JCP = 12.7 Hz, =CH); 147.53 (CqNO2). 31P NMR δ 
(121 MHz, ppm): 18.28. Yield: 77%. Brown solid. 
 
Dimethyl 3-(2-Nitrophenyl)-1-prop-2-ynylaminoprop-2-enyl phosphonate 
(22s) 
1H NMR δ (300 MHz, ppm): 2.17 (1H, s(br.), NH); 2.31 (1H, t, 
J = 2.2 Hz, ≡CH); 3.47 (1H, dd, J = 17.2 Hz, J = 2.2 Hz, 
CHAHB); 3.62 (1H, ddd, J = 17.2 Hz, J  = 2.2 Hz, JHP  = 2.0 Hz, 
CHAHB); 3.85 (6H, d, JHP  = 10.7 Hz, OCH3); 4.12 (1H, dd, 1H, 
JHP  = 18.1 Hz, J = 8.3 Hz, CHP); 6.09 (1H, ddd, J = 15.7 Hz, 
J = 8.3 Hz, JHP = 5.5 Hz, =CHCHP); 7.21 (1H, dd, J = 16.7 Hz, JHP = 4.7 Hz, =CH);  
7.44 (1H, ddd, J  = 8.2 Hz, J = 6.4 Hz, J = 2.1 Hz, =CHCHCqNO2); 7.57-7.65 (2H, 
multiplet, CHarom); 7.97 (1H, d, J = 8.2 Hz, =CHCqNO2). 13C NMR δ (75 MHz, ppm): 
36.21 (d, JCP = 17.3 Hz, CH2); 53.64 (d, JCP = 8.1 Hz, OCH3); 53.74 (d, JCP = 6.9 Hz, 
OCH3); 56.50 (d, JCP = 155.8 Hz, CHP); 72.75 (≡CH); 80.65 (≡Cq); 124.63 (=CHCqNO2); 
128.24 (d, JCP = 9.2 Hz, =CHCHP); 128.62 (=CHCHCqNO2) 129.00 (d, JCP = 2.3 Hz, 
=CHCq,arom); 130.71 (d, JCP = 13.9 Hz, =CH); 132.16 (d, JCP = 2.3 Hz, =Cq,arom); 133.31 
(=CHCHCq,arom); 147.66 (CqNO2). 31P NMR δ (121 MHz, ppm): 25.70. IR ν (cm-1): 
1249 (P=O); 1028, 1055 (P-O). MS: m/z (%): 325 (21, [M+H]+); 215 (100, [M+H-
PO(OMe)2]+). Mp.: 87-88°C. Yield: 58%. 
 
Dimethyl benzylamino[(1R,5S)-6,6-dimethylbicyclo-[3.1.1]hept-2-en-2-
yl]methyl phosphonate (22t) 
The product was obtained as a mixture of two diastereomeric 
pairs (ratio: 31/69). Signals of the major and minor isomers are 
indicated as ‘m’ and ‘M’ whenever possible. 
1H NMR δ (300 MHz, ppm): 0.90 (3 H, s, CH3, M); 0.93 (3 H, s, 
CH3,minor); 1.19-1.26 (2 x 1 H, multiplet, CHAHB, m+M); 1.31 (2 x 
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3 H, s, CH3, m+M); 2.08-2.15 (2 x 1 H, multiplet, CH, m+M); 2.18 (2 x 1 H, s (br), NH, 
m+M); 2.31-2.50 (2 x 4 H, multiplet, CHAHB, CH2CH=, CHCq=, m+M); 3.46 (1H, d, 
JHP = 21.2 Hz, CHP, m); 3.49 (1H, d, JHP = 20.9 Hz, CHP, M); 3.60 (1 H, d, 
JAB = 13.2 Hz, CHAHBN, m); 3.63 (1H, d, JAB = 13.2 Hz, CHAHBN, M); 3.70 (2 x 3H, d, 
JHP = 10.5 Hz, OCH3, m+M); 3.77 (2 x 3H, d, JHP = 10.5 Hz, OCH3, m+M); 3.86 
(2 x 1 H, d, JAB = 13.2 Hz, CHAHBN, m+M); 5.56 (2 x 1H, s (br.), =CH, m+M); 7.21-
7.41 (2 x 5 H, multiplet, CHarom, m+M). 13C NMR δ (75 MHz, ppm): 21.07 (CH3, M); 
21.54 (CH3, m); 26.26 (CH3, m); 26.37 (CH3, M); 31.62 (CH2CH=, m); 31.68 (CH2CH=, 
M); 32.06 (CH2); 37.85 (Cq, m); 38.34 (Cq, M); 40.,67 (CH, m); 40.84 (CH, M); 42.95 
(CHCq=, M); 43.35 (CHCq=, m); 51.36 (d, JCP = 13.9 Hz CH2N, M); 51.61 (d, 
JCP = 13.9 Hz, CH2N, m); 52.69 (d, JCP = 6.9 Hz, CH3O, m+M); 52.78 (d, JCP = 6.9 Hz, 
CH3O, m); 53.44 (d, JCP = 6.9 Hz, CH3O, M); 53.51 (d, JCP = 6.9 Hz CH3O, m); 59.56 
(d, JCP = 156.9 Hz, CHP, m); 60.00 (d, JCP = 156.9 Hz, CHP, M); 123.05 (d, 
JCP = 13.8 Hz, =CH, m); 123.50 (d, JCP = 13.8 Hz, =CH, M); 127.09, 128.33, 128.37 
(CHarom, m+M); 139.61 (Cq,arom); 142.16 (d, JCP = 5.8 Hz, =Cq, M); 142.34 (d, 
JCP = 5.8 Hz, =Cq, m). 31P NMR δ (121 MHz, ppm): 26.60 (m); 26.87 (M). IR ν (cm-1): 
3318 (NH); 1677 (C=C); 1244 (P=O); 1060, 1033 (P-O). MS m/z (%): 240 (100, [M+H-
P(O)(OMe)2]+); 350 (14, [M+H]+). Chromatography: Rf = 0.35 (EtOAc). Yield: 80%. 
Colourless oil. 
 
Diethyl benzylamino[(1R,5S)-6,6-dimethylbicyclo-[3.1.1]hept-2-en-2-
yl]methyl phosphonate (22u) 
See chapter 4, section 3.1 for spectral data. Yield: 88%. 
 
Dimethyl allylamino[(1R,5S)-6,6-dimethylbicyclo-[3.1.1]hept-2-en-2-
yl]methyl phosphonate (22v) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 30/70). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 0.88 (2x3H, s, CH3, m+M); 1.15 
(1H, d, J = 8.5 Hz, CHAHB, m); 1.21 (1H, d, J = 8.5 Hz, CHAHB, 
M); 1.29 (2x3H, s, CH3, m+M); 1.58 (1H, s (br.), NH); 2.06-2.14 
(2x 1H, multiplet, CqCHCH2, m+M); 2.27-2.35 (2x 3H, multiplet, 
CH2CH=, CHCq=, m+M); 2.41-2.48 (2x 1H, multiplet, CHAHB, 
m+M); 3.11 (2x 1H, dd, JAB = 14.0 Hz, J = 6.9 Hz, NCHAHB, M); 3.28-3.35 (2x 1H, 
multiplet, NCHAHB, m+M);  3,50 (1H, d, JHP = 21.2 Hz, CHP, M); 3,54 (1H, d, JHP = 
20.9 Hz, CHP, m); 3.74 (3H, d, JHP = 10.7 Hz, OCH3, m); 3.75 (3H, d, JHP = 10.7 Hz, 
OCH3, M); 3.78 (3H, d, JHP = 10.5 Hz, OCH3, m); 3.79 (3H, d, JHP = 10.5 Hz, OCH3, 
M); 5.08-5.30 (2x 2H, multiplet, =CH2, m+M); 5.53 (2x 1H, s (br.), =CH, m+M); 5.76-
5.90 (2x 1H, multiplet, CH=CH2, m+M). 13C NMR δ (75 MHz, ppm): 21.01 (CH3, m); 
21.38 (CH3, M); 26.23 (CH3, M); 26.35 (CH3, m); 31.52 (CH2CH=, M); 31.60 (CH2CH=, 
m); 31.97 (CHCH2CH, m+M); 37.76 (Cq(CH3)2, M); 38.23 ((Cq(CH3)2, m); 40.63 
(CHCH2, M); 40.78 (CHCH2, m); 42.87 (CHCq=, m); 43.33 (CHCq=, M); 49.98 (d, JCP = 
17.3 Hz, NCH2, M); 50.08 (d, JCP = 18.5 Hz, NCH2, m); 52.51 (d, JCP = 8.1 Hz, OCH3, 
m); 52.62 (d, JCP = 8.1 Hz, OCH3, M); 53.38 (d, JCP = 6.9 Hz, OCH3, m+M); 59.55 (d, 
JCP = 156.9 Hz, CHP, M); 59.96 (d, JCP = 156.9 Hz, CHP, m); 116.47 (s (br.), =CH2); 
122.57 (d, JCP = 13.9 Hz, =CH, M); 123.05 (d, JCP = 13.9 Hz, =CH, m); 136.18 
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(CH=CH2, m+M); 142.23 (d, JCP = 5.8 Hz, =Cq, m); 142.38 (d, JCP = 4.6 Hz, =Cq, M).  
31P NMR δ (121 MHz, ppm): 26.76 (m); 27.04 (M). IR ν (cm-1): 3466 (NH); 1240 
(P=O); 1038 (br., P-O). MS m/z (%): 300 (100, [M+H]+); 191 (51, [M+H-PO(OCH3)2]+, 
33). Yield: 85%. Yellow oil. 
 
Dimethyl isopropylamino[(1R,5S)-6,6-dimethylbicyclo-[3.1.1]hept-2-en-
2-yl]methyl phosphonate (22w) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 26/74). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 0.85 (3H, s, CH3, M); 0.87 (3H, s, 
CH3, m); 0.96 (3H, d, J = 6.1 Hz, CH(CH3)2, m); 0.97 (3H, d, J = 
6.1 Hz, CH(CH3)2, M); 1.03 (3H, d, J = 6.3 Hz, CH(CH3)2, M); 1.05 
(3H, d, J = 6.3 Hz, CH(CH3)2, m); 1.12 (1H, d, J = 8.5 Hz, CHAHB, 
m); 1.20 (1H, d, J = 8.5 Hz, CHAHB, M); 1.29 (3H, s, CH3, M); 
1.30 (3H, s, CH3, m); 1.44 (1H, s(br), NH); 2.10 (2x 1H, s(br), CqCHCH2, m+M); 2.29-
2.48 (2x 4H, multiplet, CH2CH=, CHCq=, CHAHB, m+M); 2.81 (1H, septet, J = 6.3 Hz, 
CH(CH3)2); 3.55 (1H, d, JHP = 23.1 Hz, CHP, M); 3.58 (1H, d, JHP = 23.1 Hz, CHP, m); 
3.72 (3H, d, JHP = 10.7 Hz, OCH3, m); 3.73 (3H, d, JHP = 10.7 Hz, OCH3, M); 3.80 (3H, 
d, JHP = 10.5 Hz, OCH3, m); 3.81 (3H, d, JHP = 10.5 Hz, OCH3, M); 5.50 (2x 1H, s (br.), 
=CH, m+M). 13C NMR δ (75 MHz, ppm): 20.97 (CH3, m); 21.21 (CH3, M); 21.21 
(CH(CH3)2, m); 21.33 (CH(CH3)2, M); 23.82 (CH(CH3)2, M); 24.00 (CH(CH3)2, m); 26.22 
(CH3, M); 26.34 (CH3, m); 31.51 (CH2CH=, m+M); 31.84 (CHCH2CH, m); 32.04 
(CHCH2CH, M); 38.00 (Cq(CH3)2, M); 38.30 ((Cq(CH3)2, m); 40.62 (CHCH2, M); 40.81 
(CHCH2, m); 43.03 (CHCq=, m); 43.20 (CHCq=, M); 45.70 (d, JCP = 17.3 Hz, CH(CH3)2, 
M); 45.76 (d, JCP = 17.3 Hz, CH(CH3)2, m); 52.47 (OCH3, m); 52.60 (d, JCP = 8.1 Hz, 
OCH3, M); 53.76 (OCH3, m); 53.91 (d, JCP = 6.9 Hz, OCH3, M); 58.07 (d, JCP = 
159.2 Hz, CHP, M); 58.39 (d, JCP = 156.9 Hz, CHP, m); 122.33 (d, JCP = 15.0 Hz, =CH, 
M); 122.59 (d, JCP = 16.2 Hz, =CH, m); 142.54 (d, JCP = 5.8 Hz, =Cq, m); 142.66 (d, JCP 
= 3.5 Hz, =Cq, M). 31P NMR δ (121 MHz, ppm): 26.82 (m); 26.96 (M). IR ν (cm-1): 
3299 (NH); 1252 (P=O); 1038 (br., P-O). MS m/z (%): 302 (100, [M+H]+); 193 (33, 
[M+H-PO(OCH3)2]+, 33). Yield: 39%. Yellow oil. 
 
Dimethyl t-butylamino[(1R,5S)-6,6-dimethylbicyclo-[3.1.1]hept-2-en-2-
yl]methyl phosphonate (22x) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 44/56). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 0.85 (3H, s, CH3, M); 0.86 (3H, s, 
CH3, m); 1.06 (9H, s, 3x CH3, m); 1.07 (9H, s, 3x CH3, M); 1.16 
(1H, d, J = 8.5 Hz, CHAHB, m); 1.17 (1H, d, J = 8.5 Hz, CHAHB, 
M); 1.28 (3H, s, CH3, m); 1.30 (3H, s, CH3, M); 1.41 (1H, s(br), 
NH); 2.07 (2x 1H, s(br), CqCHCH2, m+M); 2.27-2.30 (2x 2H, 
multiplet, CH2CH=, m+M); 2.34 (2x 1H, t, J = 5.5 Hz, CHCq=, m+M); 2.41-2.47 (2x 
1H, multiplet, CHAHB, m+M); 3.45 (1H, d, JHP = 24.7 Hz, CHP, m); 3.57 (1H, d, JHP = 
25.3 Hz, CHP, M); 3.68 (3H, d, JHP = 10.5 Hz, OCH3, M); 3.69 (3H, d, JHP = 10,5 Hz, 
OCH3, M); 3.82 (6H, d, JHP = 10.2 Hz, 2x OCH3, m); 5.50-5.61 (2x 1H, multiplet, =CH, 
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m+M). 13C NMR δ (75 MHz, ppm): 21.12 (CH3, M); 21.43 (CH3, m); 26.18 (CH3, M); 
26.28 (CH3, m); 29.62 (3x CH3, m); 29.79 (3x CH3, M); 31.57, 31.69, 32.00, 32.44 
(CH2CH=, CH2); 37.95 (Cq(CH3)2, m+M); 40.46 (CHCH2, M); 40.54 (CHCH2, m); 43.66 
(CHCH2CH=, m+M); 45.37 (Cq(CH3)3, M+m); 54.77, 51.97, 52.21, 52.31, 54.68, 54.78 
(OCH3, m+M); 55.22 (d, JCP = 161.5 Hz, CHP, m); 55.68 (d, JCP = 161.5 Hz, CHP, M); 
120.37 (d, JCP = 12.7 Hz, CH=, m); 121.04 (d, JCP = 13.8 Hz, CH=, M); 144.82 (Cq=, 
m); 144.93 (CHq=, M).  31P NMR δ (121 MHz, ppm): 26.49 (m); 27.02 (M). IR ν (cm-
1): 3310 (NH); 1243 (br., P=O); 1037 (br, P-O). MS m/z (%): 316 (100, [M+H]+). Mp.: 
56-57°C. Yield: 60%. Yellow crystals. 
 
Dimethyl benzylaminofuran-2-ylmethyl phosphonate (22y) 
1H NMR δ (300 MHz, ppm): 2.17 (1H, s (br.), NH); 3.60 (1H, d, JAB 
= 13.2 Hz, CH2); 3.63 (3H, d, JHP = 10.7 Hz, CH3O); 3.81 (3H, d, JHP 
= 10.5 Hz, CH3O); 3.87 (1H, d, JAB = 13.2 Hz, CH2); 4.12 (1H, d, JHP 
= 22.3 Hz, CHP); 6.37 (2H, multiplet, =CH); 7.22-7.35 (5H, 
multiplet, CHarom); 7.45-7.47 (1H, multiplet, CHOarom). 13C NMR δ (75 MHz, ppm): 
51.32 (d, JCP = 16.2 Hz, CH2); 52.71 (d, JCP = 161.5 Hz, CHP); 53.42 (d, JCP = 6.9 Hz, 
OCH3); 53.94 (d, JCP = 6.9 Hz, OCH3); 109.57 (d, JCP = 8.1 Hz, =CHCqO); 110.66 
(CH=CHO); 127.26; 128.42 (CHarom); 138.86 (Cq,arom)); 142.80 (=CHO); 149.37 (=CqO). 
31P NMR δ (121 MHz, ppm): 24.01. IR ν (cm-1): 3311, 3470 (NH); 1251 (P=O); 1037 
(br., P-O). MS m/z (%): 296 (100, [M+H]+). Yield: 89%. Yellow oil. 
 
Dimethyl allylaminofuran-2-ylmethyl phosphonate (22z) 
1H NMR δ (300 MHz, ppm): 2.04 (1H, s (br.), NH); 2.95 (1H, dd, 
JAB = 13.8 Hz, J = 6.7 Hz, CH2); 3.17 (1H, d, JAB = 13.8 Hz, J = 5.4 
Hz, J = 1.4 Hz, CH2); 3.53 (3H, d, JHP = 10.7 Hz, CH3O); 3.69 (3H, d, 
JHP = 10.7 Hz, CH3O); 4.06 (1H, d, JHP = 22.3 Hz, CHP); 4.96-5.18 
(2H, multiplet, =CH2); 5.68 (1H, dddd, J = 17.1 Hz, J = 10.2 Hz, J = 6.8 Hz, J = 5.5 
Hz, CH2CH=); 6.23-6.27 (2H, multiplet, =CH); 7.30-7.32 (1H, multiplet, CHO). 13C 
NMR δ (75 MHz, ppm): 50.13 (d, JCP = 16.2 Hz, CH2); 52.80 (d, JCP = 162.7 Hz, 
CHP); 53.46 (d, JCP = 5.8 Hz, OCH3); 53.84 (d, JCP = 6.9 Hz, OCH3); 109.43 (d, JCP = 
8.1 Hz, =CHCqO); 110.65 (CH=CHO); 117.20 (=CH2); 135.58 (CH2CH=); 142.71 (d, JCP 
= 2.3 Hz, =CHO); 149.37 (d, JCP = 2.3 Hz, =CqO).  IR ν (cm-1): 3317 (NH); 1643 (C=C); 
1248 (P=O); 1044 (br., P-O).  31P NMR δ (121 MHz, ppm): 24.16. MS m/z (%): 246 
(100, [M+H]+). Yield: 89%. Brown oil. 
 
Dimethyl t-butylaminofuran-2-ylmethyl phosphonate (22ab) 
1H NMR δ (300 MHz, ppm): 1.01 (9H, s, 3x CH3); 1.71 (1H, s (br.), 
NH); 3.62 (3H, d, JHP = 10.5 Hz, OCH3); 3.85 (3H, d, JHP = 10.5 Hz, 
OCH3); 4.26 (1H, d, JHP = 25.6 Hz, CHP); 6.30-6.39 (1H, multiplet, 
CH=Cq, CH=CHO); 7.40 (1H, multiplet, CHO). 13C NMR δ (75 MHz, 
ppm): 29.47 (3x CH3); 49.27 (d, JCP = 167.3 Hz, CHP); 51.89 (Cq, d, 
JCP = 16.2 Hz); 53.34 (d, JCP = 6.9 Hz, OCH3); 54.79 (d, JCP = 6,9 Hz, OCH3); 107.96 
(d, JCP = 8.0 Hz, CH=Cq); 110.99 (d, JCP = 2,3 Hz, CH=CHO); 141.95 (d, CHO, 
JCP = 3.4 Hz); 152.20 (CqO). 31P NMR δ (121 MHz, ppm): 24.27. IR ν (cm-1): 3298 
(NH); 1246 (P=O); 1064, 1032 (P-O). MS m/z (%): 262 (MH+, 100); Mp.: 41°C. Yield: 
63%. Yellow crystals. 
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Dimethyl benzylaminophenylmethyl phosphonate (22ac) 
1H NMR δ (300 MHz, ppm): 2.41 (1H, br. s, NH); 3.54 (3H, d, JHP = 
10.5 Hz, CH3O); 3.74 (3H, d, JHP = 10.5 Hz, OCH3); 3.55 (1H, d, JAB 
= 13.2 Hz, NCHAHB); 3.82 (1H, d, JAB = 13.2 Hz, NCHAHB); 4.05 
(1H, d, JHP = 20.1 Hz, CHP); 7.22-7.45 (5H, multiplet, CHarom); 13C 
NMR δ (75 MHz, ppm): 51.14 (d, JCP = 17.3 Hz, NCH2); 53.40 (d, JCP = 5.8 Hz, 
OCH3); 53.71 (d, JCP = 6.9 Hz, OCH3); 59.29 (d, JCP = 154.6 Hz, CHP); 128.02; 
128.07; 128.33; 128.39; 128.56; 128.59; 128.63 (CHarom); 135.50 (d, JCP = 3.5 Hz, 
Cq); 139.18 (CqCH2). IR ν (cm-1): 3437 (NH); 1230 (P=O); 1034 (br., P-O). 31P NMR δ 
(121 MHz, ppm): 26.44. MS m/z (%): 306 (100, [M+H]+). Yield: 89%. Colourless oil. 
 
Dimethyl isopropylaminophenylmethyl phosphonate (22ad) 
1H NMR δ (300 MHz, ppm): 1.00 (3H, d, J = 6.1 Hz, CH3); 1.02 
(3H, d, J = 6.3 Hz, CH3); 1.85 (1H, s (br.), NH); 2.68 (1H, septet, J = 
6.3 Hz, NCH); 3.51 (3H, d, JHP = 10.5 Hz, CH3O); 3.78 (3H, d, JHP = 
10.5 Hz, CH3O); 4.17 (1H, d, JHP = 22.3 Hz, CHP); 7.27-7.43 (5H, 
multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 21.31 (CH3); 24.04 
(CH3); 45.71 (d, JCP =16,2 Hz, NCH); 53,51 (d, JCP = 6.9 Hz, OCH3); 54.00 (d, JCP = 
6.9 Hz, OCH3); 57.98 (d, JCP = 154.6 Hz, CHP); 127.99, 128.43, 128.51, 128.61 
(CHarom); 136.29 (Cq,arom). 31P NMR δ (121 MHz, ppm): 27.00. IR ν (cm-1): 3303 (NH); 
1241 (P=O); 1066, 1026 (P-O). MS m/z (%): 258 (100, [M+H]+). Mp.: 72.7 °C. Yield: 
94%. White solid. 
 
Diethyl isopropylaminophenylmethyl phosphonate (22ae) 
1H NMR δ (300 MHz, ppm): 0.99 (3H, d, J = 6.1 Hz, CHCH3); 1.01 
(3H, d, J = 6.3 Hz, CHCH3); 1.11 (3H, t, J = 7.0 Hz, CH3CH2); 1.30 
(3H, t, J = 7.0 Hz, CH3CH2); 1.80 (1H, s (br.), NH); 2.68 (1H, septet, 
J = 6.2 Hz, NCH); 3.70-3.83 (1H, multiplet, CH2O); 3.88-4.04 (1H, 
multiplet, CH2O); 4.06-4.22 (3H, multiplet, CH2O, CHP); 7.25-7.42 
(5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 16.24 (d, JCP = 5.8 Hz, CH3CH2); 
16.47 (d, JCP = 5.8 Hz, CH3CH2); 21.33 (CHCH3); 24.00 (CHCH3); 45.74 (d, JCP =16,2 
Hz, NCH); 58.30 (d, JCP = 153.5 Hz, CHP); 62.68 (d, JCP = 6.9 Hz, OCH2); 63.12 (d, JCP 
= 6.9 Hz, OCH2); 127.72, 128.42, 128.50 (CHarom); 136.63 (Cq,arom). 31P NMR δ (121 
MHz, ppm): 24.74. IR ν (cm-1): 3294 (NH); 1240 (P=O); 1061, 1028 (P-O). MS m/z 
(%):  286 (100, [M+H]+). Mp.: 36.3 °C. Yield: 84%. White solid. 
 
Dimethyl cyclohexyl-isopropylaminomethyl phosphonate (22af) 
1H NMR δ (300 MHz, ppm): 0.99 (3H, d, J = 6.3 Hz, CH3); 1.04 
(3H, d, J = 6.1 Hz, CH3); 1.07-1.46 (6H, multiplet, CHCH2, 2xCH2, 
NH); 1.61-1.87 (6H, multiplet, 3xCH2); 2.78 (1H, dd, JHP = 16.8 Hz, 
J = 3.3 Hz, CHP); 2.98 (1H, septet x d, J = 6.1 Hz, JHP = 1.3 Hz, 
NCH); 3.75 (3H, d, JHP = 10.5 Hz, OCH3); 3.78 (3H, d, JHP = 10.5 Hz, 
OCH3). 13C NMR δ (75 MHz, ppm): 22.85 (CH3); 23.36 (CH3); 26.19, 26.50, 26.68 (3 
x CH2); 28.35 (d, JCP = 3.5 Hz, CH2); 30.90 (d, JCP = 11.64 Hz, CH2); 39.62 (d, JCP = 
5.8 Hz, CHCH2); 47.72 (d, JCP = 5.8 Hz, NCH);  52.36 (d, JCP = 8.1 Hz, OCH3); 52.87 
(d, JCP = 8.1 Hz, OCH3); 57.59 (d, JCP = 144.2 Hz, CHP). 31P NMR δ (121 MHz, ppm): 
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31.77. IR ν (cm-1): 3294; 3309; 3325 (NH); 1243 (P=O); 1067, 1030 (P-O). MS m/z 
(%): 264 (100, [M+H]+). Mp.: 54.2 °C. Yield: 93%. White solid. 
 
Dimethyl 1-benzylamino-2-methylpropyl phosphonate (22ag) 
1H NMR δ (300 MHz, ppm): 1.01 (3H, d, J = 6.9 Hz, CH3); 1.02 (3H, 
dd, J = 6.7 Hz, JHP = 1.0 Hz, CH3); 1.50 (1H, s (br.), NH); 2.05-2.22 
(1H, multiplet, CH); 2.78 (1H, dd, JHP = 14.5 Hz, J = 3.7 Hz, CHP); 
3.76 (3H, d, JHP = 10.5 Hz, OCH3); 3.79 (3H, d, JHP = 10.2 Hz, OCH3); 
3.83 (1H, dd, JAB = 12.6 Hz, JHP = 1.4 Hz, CHAHBN); 4.01 (1H, d, JAB = 12.6 Hz,  
CHAHBPh); 7.22-7.38 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 17.92 (d, 
JCP = 3.5 Hz, CH3); 20.63 (d, JCP = 12.7 Hz, CH3); 29.03 (d, JCP = 5.8 Hz, CH); 52.35 
(d, JCP = 6.9 Hz, OCH3); 52.39 (d, JCP = 8.1 Hz, OCH3); 53.26 (d, JCP = 3.5 Hz, CH2N); 
59.25 (d, JCP = 142.0 Hz, CHP); 127.09; 128.27; 128.44 (CHarom); 140.08 (Cq,arom). 31P 
NMR δ (121 MHz, ppm): 31.75. IR ν (cm-1): 3469 (NH); 1246 (P=O); 1057, 1031 (P-
O). MS m/z (%): 271 (100, [M+H]+). Yield: 84%. Colourless oil. 
 
Dimethyl 1-isopropylamino-2-methylpropyl phosphonate (22ah) 
1H NMR δ (300 MHz, ppm): 0.98-1.06 (12H, multiplet, 4xCH3); 2.02 
(1H, multiplet, CH); 2.81 (1H, dd, JHP = 16.5 Hz, J = 3.6 Hz, CHP); 
3.00 (1H, septet x d, J = 6.3 Hz, JH-P = 1.4 Hz, NCH); 3.75 (3H, d, JHP 
= 9.9 Hz, OCH3); 3.79 (3H, d, JHP = 10.2 Hz, OCH3). 13C NMR δ (75 
MHz, ppm): 17.91 (d, JCP = 2.3 Hz, CH3);  20.55 (d, JCP = 13.8 Hz, CH3); 22.72 
(CH3CHN);  23.45 (CH3CHN);  29.26 (d, JCP = 5.8 Hz, CH); 47.51 (d, JCP = 5.8 Hz, 
NCH); 52.30 (d, JCP = 8.1 Hz, OCH3); 52.81 (d, JCP = 6.9 Hz, OCH3); 57.39 (d, JCP = 
144.2 Hz, CHP). IR ν (cm-1): 1054 (P-O); 1247 (P=O); 1465; 3326 (NH); 31P NMR δ 
(121 MHz, ppm): 31.84; MS m/z (%): 114 (100, [M+H-P(O)(OMe)2]+). Yield: 86%. 
Colourless oil. 
 
 
3.4 Preparation of monoalkyl aminoalkyl phosphonates 
A solution of dialkyl aminoalkyl phosphonate (2 mmol) in 5 ml dry diethyl 
ether was stirred at room temperature protected from moisture using a CaCl2 
tube. Then, 3 mmol of potassium silanolate (KOTMS) was added in solid form 
and stirring was continued until precipitation occurred. The precipitate was 
collected by filtration and washed three times with 2 ml of dry diethyl ether. 
Finally the powder was dried under vacuum. 
 
Potassium methyl isopropylaminophenylmethyl phosphonates (237a) 
1H NMR δ (D2O, 300 MHz, ppm): 0.99 (3H, d, J = 6.3 Hz, CH3); 
1.01(3H, d, J = 6.3 Hz, CH3); 2.71 (1H, septet, J = 6.3 Hz, CH); 
3.51(3H, JHP = 10.2 Hz, OCH3); 4.08 (1H, JHP = 19.8 Hz, CHP); 
7.33-7.43 (5H, multiplet, CHarom).  13C NMR δ (D2O, 75 MHz, 
ppm): 20.54 (CH3); 22.70 (CH3); 46.30 (d, JCP = 12.7 Hz, CH); 
52.44 (d, JCP = 5.8 Hz, OCH3); 57.84 (d, JCP = 143.1 Hz, CHP); 127.98 (CHarom); 
129.09 (CHarom); 129.17 (CHarom); 138.50 (Cquat,arom). 31P NMR δ (D2O, 121 MHz, 
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ppm): 22.32. IR ν (cm-1): 3369 (br., NH); 1242, 1214, 1197, 1075 (P-O); 1048 (P-O). 
MS m/z (%): 244 (68, [M-K+2H]+); 282 (43, [M+H]+); 487 (100, [2M-2K+3H]+); 525 
(100, [2M-K+2H]+); 563 (21, [2M+H]+); 844 (13, [3M+H]+); 882 (8, [3M+K]+). Mp.: 204-
205°C. Yield: 95%. White crystals. 
 
Potassium methyl cyclohexyl-isopropylaminomethyl phosphonates 
(237c) 
1H NMR δ (D2O, 300 MHz, ppm): 0.99 (3H, d, J = 6.3 Hz, CH3); 
1.05 (3H, d, J = 6.3 Hz, CH3); 1.12-2.05 (11H, multiplet, CH2ring, 
CHring); 2.64 (1H, dd, JHP = 16.0 Hz, J = 2.5 Hz, CHP); 3.02 (1H, 
septet, J = 6.3 Hz, CH); 3.53 (3H, JHP = 10.2 Hz, OCH3).  13C NMR 
δ (D2O, 75 MHz, ppm): 21.29 (CH3); 22.81 (CH3); 26.31, 26.83, 27.03, 28.66 
(CH2ring); 31.03 (d, JCP = 11.5 Hz, CH2ring); 40.34 (CHring); 48.14 (NCH); 51.47 (d, 
JCP = 6.9 Hz, OCH3); 57.59 (d, JCP = 133.8 Hz, CHP). 31P NMR δ (D2O, 121 MHz, 
ppm): 27.81. IR ν (cm-1): 3308 (br., NH); 1380, 1194, 1068 (P-O); 1052 (P-O).  MS 
m/z (%): 250 (76, [M-K+2H]+); 288 (43, [M+H]+); 499 (100, [2M-2K+3H]+); 537 (70, 
[2M-K+2H]+); 575 (6, [2M+H]+); 786 (15, [3M-2K+3H]+); 824 (15, [3M-K+2H]+). Yield: 
98%. White crystals (very hydroscopic). 
 
Potassium methyl allylaminofuran-2-ylmethyl phosphonates (237b) 
Was formed as an oil, giving a biphasic system with diethyl ether. The solvent was 
easily decanted and the potassium salts were obtained in pure form after washing 
three times with ether and drying under vacuum.  
1H NMR δ (D2O, 300 MHz, ppm): 3.03 (1H, dd, JAB = 14.0 Hz, 
J = 7.2 Hz, CHAHB); 3.20 (1H, dd, JAB = 14.0 Hz, J = 5.3 Hz, 
CHAHB); 3.54 (3H, d, JHP = 10.2 Hz, OCH3); 4.08 (1H, d, 
JHP = 19.5 Hz, CHP); 5.12-5.19 (2H, multiplet, =CH2); 5.77-5.90 
(1H, multiplet, =CH); 6.38-6.40 (1H, multiplet, =CHring); 6.46-6.48 (1H, multiplet, 
=CHring); 7.51-7.53 (1H, multiplet, =CHO). 13C NMR δ (D2O, 75 MHz, ppm): 50,02 (d, 
JCP = 12.7 Hz); 52.68 (d, JCP = 5.8 Hz, OCH3); 53.01 (d, JCP = 148.8 Hz, CHP); 109.62 
(d, JCP = 6.9 Hz, =CH-Cq); 110.12 (=CHring); 117.18 (=CH2); 135.53 (=CH); 143.07 (d, 
JCP = 2.3 Hz, =CHO); 151.25 (d, JCP = 4.6 Hz, =CqO). 31P NMR δ (D2O, 121 MHz, 
ppm): 19.24. MS m/z (%): 232 (13, [M-K+2H]+); 270 (67, [M+H]+); 308 (100, [M+K]+); 
463 (10, [2M-2K+3H]+); 501 (73, [2M-K+2H]+); 539 (59, [M+H]+); 577 (22, [2M+K]+); 
769 (7, [3M-K+2H]+); 808 (25 [3M+H]+); 846 (23, [3M+K]+). Yield: 63%. Orange oil. 
 
 
4 Synthesis of 4-phosphono β-lactams 
4.1 Acylation of 1-aminoalkyl phosphonates 
To a solution of 5 mmol of 1-aminoalkyl phosphonate in 10 ml of dry THF, a 
specified amount of base and/or nucleophilic catalyst was added at room 
temperature under a nitrogen atmosphere. Then a solution of the acid 
chloride of choice in 2 ml of dry THF was added dropwise using a syringe at 
room temperature. The reaction mixture was then allowed to react for a 
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specified time at the specified temperature (see Table 8). The reaction mixture 
was then mixed with a saturated NaHCO3(aq) solution (10 ml) and diethyl 
ether (10 ml) in a seperatory funnel. The organic phase was collected an the 
remaining aqueous phase was whashed twice with 5 ml of diethyl ether. The 
combined organic phases were then mixed with a 1 M HCl(aq) solution (10 ml) 
in a seperatory funnel. The organic phase was collected and the remaining 
aqueous phase was washed twice with 5 ml of diethyl ether. The combined 
organic phases were dried using MgSO4 and the solvent was evaporated 
under vacuum.  
 
Dimethyl (2E)-1-[benzyl(chloroacetyl)amino]-3-phenylprop-2-enyl 
phosphonate (21b) 
1H NMR δ (300 MHz, ppm): 3.79 (3H, d, JHP = 10.9 Hz, 
OCH3); 3.80 (3H, d, JHP = 10.6 Hz, OCH3); 3.93 (1H, d, 
JAB = 12.5 Hz, CHAHBCl); 4.01 (1H, d, JAB = 12.5 Hz, CHAHBCl); 
4.87 (1H, d, JAB = 18.2 Hz, NCHAHB); 5.05 (1H, d, 
JAB = 17.8 Hz, NCHAHB); 5.66 (1H, dd, JHP = 20.5 Hz, 
J = 9.2 Hz, NCHP); 6.18 (1H, multiplet, CH=); 6.76 (1H, dd, Jtrans = 15.7 Hz, 
J = 3.0 Hz, PhCH=); 7.20-7.40 (10H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 
41.51 (CH2Cl); 49.78 (NCH2); 53.17 (d, JCP = 7.3 Hz, OCH3); 54.00 (d, JCP = 7.3 Hz, 
OCH3); 54.74 (d, JCP = 157.5 Hz, NCHP); 119.03 (=CH); 125.98, 126.68, 126.99, 
127.11, 127.71, 128.44, 128.55, 129.02 (CHarom); 135.72; 136.64 (Cq,arom); 137.32 (d, 
JCP= 13.4 Hz, =CHPh); 167.38 (d, JCP = 2.5 Hz, C=O).  31P NMR δ (121 MHz, ppm): 
23.33. IR ν (cm-1): 1661 (C=O); 1249 (P=O). MS m/z (%): 91(100); 116(18); 207(12); 
209(25); 299(39); 301(14). Chromatography: Rf = 0.29 (Hex/EtOAc/MeOH 
20/78/2). Yield: 97%. Yellow oil. 
 
Dimethyl (2E)-1-[(4-methoxybenzyl)(chloroacetyl)amino]-3-phenylprop-2-
enyl phosphonate (21d) 
1H NMR δ (300 MHz, ppm): 3.76 (3H, s, OCH3(Ph)); 3.77 (3H, 
d, JHP = 10.7 Hz, OCH3); 3.80 (3H, d, JHP = 10.7 Hz, OCH3); 
3.93 (1H, d, JAB = 12.7 Hz, CHAHBCl); 4.04 (1H, d, 
JAB = 12.7 Hz, CHAHBCl); 4.79 (1H, d, JAB = 17.6 Hz, NCHAHB); 
4.96 (1H, d, JAB = 17.6 Hz, NCHAHB); 5.58 (1H, dd, 
JHP = 20.6 Hz, J = 9.4 Hz, CHP); 6.15-6.29 (1H, multiplet, =CH); 6.73 (1H, dd, 
J = 15.7 Hz, JHP = 3.0 Hz, =CHPh); 6.85 (2H, d, J = 8.8 Hz, CHCqOMe); 7.13-7.33 
(7H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 41.58 (CH2Cl); 49.50 (NCH2); 
53.16 (d, JCP = 6.9 Hz, OCH3); 54.05 (d, JCP = 6.9 Hz, OCH3); 54.90 (d, 
JCP = 158.1 Hz, CHP); 55.29 (OCH3(Ph)); 114.43 (CHarom,PMB); 119.14 (=CH); 126.74, 
127.38 (CHarom); 128.47 (CH2Cq,arom); 128.59 (CHarom); 135.78 (Cq,arom); 137.37 (d, 
JCP = 13.9 Hz, =CHPh); 159 (OCq,arom); 167.41 (d, JCP = 3.5 Hz, C=O). 31P NMR δ 
(121 MHz, ppm): 23.74. IR ν (cm-1): 1663 (C=O, C=C); 1249 (P=O); 1033 (br., P-O). 
MS m/z (%): 229 (100); 436 (60, [M-H]-); 338 (21, [M-H+2]-). Chromatography: Rf = 
0.21 (EtOAc). Yield: 91%. Orange oil. 
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Dimethyl (2E)-1-[allyl(acetyl)amino]-3-phenylprop-2-enyl phosphonate 
(255a) 
1H NMR δ (300 MHz, ppm): 2.15 (3H, s, CH3); 3.77 (3H, d, 
JHP = 10.7 Hz, OCH3); 3.79 (3H, d, JHP = 10,7 Hz, OCH3);  4.10–
4.18 (1H, multiplet, NCHAHB); 4.28-4.36 (1H, multiplet, 
NCHAHB); 5.16-5.23 (2H, multiplet, =CH2); 5.73 (1H, dd, 
JHP = 20.9 Hz, J = 8.8 Hz, CHP); 5.83-5.94 (1H, multiplet, 
CH2CH=); 6.28 (1H, ddd, Jtrans = 15.7 Hz, JHP =  8.8 Hz, J = 8.8 Hz, =CHCHP); 6.83 
(1H, dd, Jtrans = 15.7 Hz, JHP = 2.8 Hz, =CHPh); 7.25-7.39 (5 H, multiplet, CHarom). 13C 
NMR δ (75 MHz, ppm): 21.74 (CH3); 49.33 (NCH2); 53.13 (d, JCP = 156.9 Hz, CHP); 
53.17 (d, JCP = 6.9 Hz, OCH3); 53.92 (d, JCP = 6.9 Hz, OCH3); 117.09 (=CH2); 119.96 
(HC=CHPh); 126.78 (2 x CHarom); 128.43 (CHarom); 128.73 (2 x CHarom); 134.23 (=CH); 
136.11 (Cq,arom); 136.72 (d, JCP = 13.9 Hz, =CHPh); 171.34 (d, JCP =3.5 Hz, C=O).  31P 
NMR δ (121 MHz, ppm): 24.48. IR ν (cm-1): 1651 (C=O, C=C); 1252 (P=O); 1040 
(br., P-O). MS m/z (%): 324 (100, [M+H]+). Yield: 78%. Yellow oil. 
 
Dimethyl (2E)-1-[allyl(chloroacetyl)amino]-3-phenylprop-2-enyl 
phosphonate (21e) 
1H NMR δ (300 MHz, ppm): 3.789 (3H, d, JHP = 10.7 Hz, 
OCH3); 3.791 (3H, d, JHP = 10,7 Hz, OCH3);  4.08 (1H, d, 
JAB = 12.7 Hz, CHAHBCl); 4.16 (1H, d, JAB = 12.4 Hz, 
CHAHBCl); 4.19-4.44 (2 H, multiplet, NCH2); 5.19-5.29 (2H, 
multiplet, =CH2); 5.67 (1H, dd, JHP = 21.1 Hz, J = 8.9 Hz, 
CHP); 5.83-5.94 (1H, multiplet, CH2CH=); 6.27 (1H, ddd, Jtrans = 15.7 Hz, JHP =  8.8 
Hz, J = 8.8 Hz, =CHCHP); 6.79 (1H, dd, Jtrans = 15.7 Hz, JHP = 2.8 Hz, =CHPh); 7.28-
7.39 (5 H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 41.41 (CH2Cl); 48.48 
(NCH2); 53.22 (d, JCP = 6.9 Hz, OCH3); 53.79 (d, JCP = 6.4 Hz, OCH3); 53.84 (d, 
JCP = 159.9 Hz, CHP); 117.38 (=CH2); 119.13 (HC=CHPh); 126.71 (2 x CHarom); 128.51 
(CHarom); 128.69 (2 x CHarom); 134.05 (=CH); 135.82 (Cq,arom); 136.99 (d, JCP = 12.7 Hz, 
=CHPh); 167.13 (C=O).  31P NMR δ (121 MHz, ppm): 23.64. IR ν (cm-1): 1663 (C=O, 
C=C); 1251 (P=O); 1033 (P-O). MS m/z (%): 225 (100); 248 (18); 358 (13, [M+H]+); 
360 (4, [M+H+2]+). Chromatography: Rf = 0.21 (EtOAc/MeOH 99/1). Yield: 96%. 
Yellow oil. 
 
Dimethyl (2E)-1-[allyl(chlorobutyryl)amino]-3-phenylprop-2-enyl 
phosphonate (25b) 
1H NMR δ (300 MHz, ppm): 2,05-2,22 (2H, multiplet, CH2); 
2,46-2,67 (2H, multiplet, CH2CO); 3,64 (2H, ~t, J = 5,8 Hz, 
J = 6,3 Hz, CH2Cl); 3,76 (3H, d, JHP = 10,7 Hz, OCH3); 3,78 
(3H, d, JHP = 10,7 Hz, OCH3); 4,14-4,37 (2H, multiplet, 
CH2N); 5,23-5,16 (2H, multiplet, =CH2); 5,74 (1H, dd, 
JHP = 21,0 Hz, J = 8,8 Hz, CHP); 5,92-5,80 (1H, multiplet, =CH); 6,28 (1H, ddd, 
J = 16,0 Hz, JHP = 8,8 Hz, J = 8,8 Hz, =CH-CHP); 6,76 (1H, dd, J = 16,0 Hz, 
JHP = 2,8 Hz, =CHPh); 7,25-7,40 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 
27,91 (CH2); 29,93 (CH2C=O); 44,55 (CH2Cl); 48,45 (CH2N); 53,00 (JCP = 8,1 Hz, 
OCH3); 53,27 (JCP = 156,9 Hz, CHP); 53,73 (JCP = 6,9 Hz, OCH3); 117,01 (=CH2); 
119,84 (=CHCHP); 126,66 (2 x CHarom); 128,34 (CHarom); 128,63 (2 x CHarom); 134,18 
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(CH=CH2); 135,96 (Cquat,arom); 136,50 (JCP = 12,7 Hz, =CHPh); 172,38 (C=O).  31P NMR 
δ (121 MHz, ppm): 24,49. IR ν (cm-1): 1651 (br, C=O, C=C); 1249 (P=O); 1030 (br, P-
O). MS m/z (%): 225 (100); 276 (34, [M+H-P(O)(OMe)2]+); 386 (42, [M+H]+); 360 (13, 
[M+H+2]+). Chromatography: Rf = 0.28 (EtOAc). Yield: 98%. 
 
Dimethyl (2E)-1-[(chloroacetyl)(isopropyl)amino]-3-phenyl-prop-2-enyl 
phosphonate (21f) 
1H NMR δ (300 MHz, ppm): 1.26 (3 H, d, J = 6.5 Hz, CH3); 
1.39 (3 H, d, J = 6.5 Hz, CH3); 3.71 (3 H, d, JHP = 11.0 Hz, 
OCH3); 3.89 (3 H, d, JHP = 11.0 Hz, OCH3); 4.09-4.27 (4 H, 
multiplet, CHP, CH, CH2); 6.47-6.60 (2 H, multiplet, HC=CH); 
7.23-7.41 (5 H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 
21.03 (CH3); 21.62 (CH3); 41.57 (CH2Cl); 50.90 (NCH); 52.30 (d, JCP = 6.9 Hz, OCH3); 
54.86 (d, JCP = 161.0 Hz, CHP); 54.91 (d, JCP = 5.8 Hz, OCH3); 121.82 (=CH); 126.80 
(2 x CHarom); 128.19 (CHarom); 128.66 (2 x CHarom); 133.97 (d, JCP = 12.1 Hz, =CH-Ph); 
136.29 (Cq,arom); 165.97 (C=O). 31P NMR δ (121 MHz, ppm): 25.86. IR ν (cm-1): 1651 
(C=O, C=C); 1250 (P=O); 1055 (br., P-O). MS m/z (%): 225 (100); 360 (14, [M+H]+); 
362 (4, [M+H+2]+). Chromatography: Rf = 0.10 (Hex/EtOAc 20/80). Yield: 97%. 
Yellow oil. 
 
Dimethyl [benzyl(chloroacetyl)amino]furan-2-ylmethyl phosphonate 
(21h) 
1H NMR δ (300 MHz, ppm): 3.72 (3H, d, JHP = 10.7 Hz, OCH3); 
3.82 (1H, d, JAB = 12.8 Hz, CHAHBCl); 3.85 (3H, d, JHP = 10.9 Hz, 
OCH3); 3.94 (1H, d, JAB = 12.8 Hz, CHAHBCl); 4.78 (1H, d, 
JAB = 18.0 Hz, CHAHBN); 5.13 (1H, d, JAB = 18.0 Hz, CHAHBN); 
6.24 (1H, dd, J = 2.9 Hz, J = 2.1 Hz, =CH); 6.55 (1H, d, 
JHP = 22.8 Hz, CHP); 6.68 (1H, d, J = 3.3 Hz, =CHCq); 6.83 (2H, ~d, J ≈ 6.6 Hz, 
CHarom); 7.14-7.28 (3H, multiplet, CHarom); 7.31 (1H, d, J = 1.1 Hz, =CHO).  13C NMR 
δ (75 MHz, ppm): 41.71 (CH2Cl); 48.00 (d, JCP = 162.7 Hz, CHP); 49.16 (CH2N); 
53.71 (d, JCP = 6.9 Hz, OCH3); 54.05 (d, JCP = 5.8 Hz, OCH3); 111.02 (=CH); 113.29 
(d, JCP = 3.5 Hz, =CHCq); 125.25 (2 x CHarom); 127.35 (CHarom); 128.83 (2 x CHarom); 
136.83 (Cq,arom); 143.62 (=CHO); 145.42 (d, JCP = 9.2 Hz, =Cq); 167.79 (C=O).   31P 
NMR δ (121 MHz, ppm): 20.84. IR ν (cm-1): 1651 (C=O); 1252 (P=O); 1057, 1043 (P-
O). MS m/z (%): 189 (15); 372 (100, [M+H]+); 374 (25, [M+H+2]+). Chromatography: 
Rf = 0.26 (Hex/EtOAc 30/70). Yield: 99%. Yellow oil. 
 
Dimethyl [benzyl(chlorobutyryl)amino]furan-2-ylmethyl phosphonate 
(25c) 
1H NMR δ (300 MHz, ppm): 1.92-2.29 (3H, multiplet, CH2, 
CHAHBCO); 2.46-2.58 (1H, multiplet, CHAHBCO); 3.47-3.62 
(2H, multiplet, CH2Cl); 3.71 (3H, d, JHP = 11.0 Hz, OCH3); 
3.91 (3H, d, JHP = 11.0 Hz, OCH3); 4.73 (1H, d, JAB = 18.2 Hz, 
NCHAHB); 5.07 (1H, d, JAB = 18.2 Hz, NCHAHB); 6.21 (1H, dd, 
J = 3.0 Hz, J = 1.9 Hz, CH=); 6.63 (1H, d, J = 3.0 Hz, =CHCq); 6.66 (1H, d, 
JHP = 23.1 Hz, CHP); 6.81-6.86 (2H, multiplet, CHarom); 7.10-7.21 (3H, multiplet, 
Charom); 7.29 (1H, d, J = 1.9 Hz, CHO). 13C NMR δ (75 MHz, ppm): 27.83 (CH2); 
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30.26 (CH2CO); 44.28 (CH2Cl); 47.05 (d, JCP = 162.7 Hz, CHP); 49.12 (CH2N); 53.32 
(d, JCP = 6.9 Hz, OCH3); 53.83 (d, JCP = 5.8 Hz, OCH3); 110.83 (=CH); 112.79 (d, 
JCP = 2.3 Hz, =CHCq); 125.26, 126.79, 128.42 (Charom); 137.31 (Cq,arom); 143.26 
(=CHO); 145.87 (d, JCP = 9.2 Hz, =CqO); 173.00 (C=O).  31P NMR δ (121 MHz, ppm): 
21.70. IR ν (cm-1): 1651 (br., C=O, C=C); 1250 (P=O); 1041 (br., P-O). MS m/z (%): 
400 (100, [M+H]+); 402 (35, [M+H+2]+). Chromatography: Rf = 0.29 (Hex/EtOAc 
20/80). Yield: 92%. Yellow oil. 
 
Dimethyl [allyl(chloroacetyl)amino]furan-2-ylmethyl phosphonate 
(21i/36a) 
1H NMR δ (300 MHz, ppm): 3.73 (3H, d, JHP = 10.7 Hz, OCH3); 
3.83 (3H, d, JHP = 10.7 Hz, OCH3); 4.07 (1H, d, JAB = 12.7 Hz, 
CHAHBCl); 4.11-4.19 (1H, multiplet, CHAHBN); 4.17 (1H, d, 
JAB = 12.7 Hz, CHAHBCl); 4.37-4.45 (1H, multiplet, CHAHBN); 
4.91-5.01 (2H, multiplet, =CH2); 5.30-5.43 (1H, multiplet, 
CH=CH2); 6.38 (1H, s (br.), CH=); 6.41 (1H, d, JHP = 26.4 Hz, CHP); 6.70 (1H, d, 
J = 3.0 Hz, =CHCq); 7.42 (1H, d, J = 1.7 Hz, =CHO). 13C NMR δ (75 MHz, ppm): 
41.37 (CH2Cl); 47.34 (d, JCP = 162.7 Hz, CHP); 47.88 (CH2N); 53.63 (d, JCP = 8.1 Hz, 
OCH3); 53.80 (d, JCP = 6.9 Hz, OCH3); 110.94 (=CH); 112.81 (d, JCP = 3.5 Hz, =CHCq); 
116.31 (=CH2); 133.12 (CH=CH2); 143.49 (=CHO); 145.54 (d, JCP = 10.4 Hz, =Cq); 
167.25 (d, JCP = 3.5 Hz, C=O).  31P NMR δ (121 MHz, ppm): 20.77. IR ν (cm-1): 1665 
(br., C=O, C=C); 1251 (P=O); 1041 (br., P-O). MS m/z (%): 189 (100); 322 (26, 
[M+H]+); 324 (9, [M+H+2]+). Chromatography: Rf = 0.42 (Hex/EtOAc 20/80). Yield: 
99%. Yellow oil. 
 
Diethyl [allyl(chloroacetyl)amino]furan-2-ylmethyl phosphonate (21j) 
1H NMR δ (300 MHz, ppm): 1.22 (3H, d, J = 7.2 Hz, CH3); 1.35 
(3H, d, J = 7.2 Hz, CH3); 3.98-4.23 (7H, multiplet, 2x OCH2, 
CH2Cl, NCHAHB); 4.40-4.49 (1H, multiplet, NCHAHB);  4.87-5.00 
(2H, multiplet, =CH2); 5.27-5.42 (1H, multiplet, CH=CH2); 6.33-
6.39 (1H, multiplet, CH=); 6.40 (1H, d, JHP = 22.6 Hz, CHP); 6.71 
(1H, d, J = 2.8 Hz, =CHCq); 7.42 (1H, ~d, J = 1.4 Hz, =CHO). 13C NMR δ (75 MHz, 
ppm): 16.24 (d, JCP = 5.8 Hz, CH3); 16.42 (d, JCP = 5.8 Hz, CH3); 41.34 (CH2Cl); 47.68 
(d, JCP = 161.5 Hz, CHP); 47.85 (CH2N); 63.21 (d, JCP = 6.9 Hz, OCH2); 63.43 (d, 
JCP = 6.9 Hz, OCH2); 110.89 (=CH); 112.72 (d, JCP = 3.5 Hz, =CHCq); 116.21 (=CH2); 
133.29 (CH=CH2); 143.34 (=CHO); 145.80 (d, JCP = 10.4 Hz, =Cq); 167.19 (d, 
JCP = 3.5 Hz, C=O).  31P NMR δ (121 MHz, ppm): 18.12. IR ν (cm-1): 1661 (br., C=O, 
C=C); 1249 (P=O); 1034 (br., P-O). MS m/z (%): 217 (100); 350 (20, [M+H]+); 352 (7, 
[M+H+2]+). Yield: 99%. Yellow oil. 
 
Dimethyl [allyl(chlorobutyryl)amino]furan-2-ylmethyl phosphonate 
(25d/36b) 
1H NMR δ (300 MHz, ppm): 2.04-2.26 (2H, multiplet, CH2); 
2.45-2.66 (2H, multiplet, CH2CO); 3.64 (2H, t, J = 6.4 Hz, 
CH2Cl); 3.72 (3H, d, JHP = 10.7 Hz, OCH3); 3.80 (3H, d, 
JHP = 10.7 Hz, OCH3); 4.09 (1H, dd (br.), JAB = 18.1 Hz, 
J = 5.2 Hz, NCHAHB); 4.32 (1H, ddd, JAB = 18.1 Hz, 
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J = 5.2 Hz, J = 2.2 Hz, NCHAHB); 4.87-4.99 (2H, multiplet, =CH2) 5.35 (1H, multiplet, 
=CH); 6.36 (1H, dd, J = 3.3 Hz, J = 1.8 Hz, CH=CHO); 6.52 (1H, d, JHP = 23.1 Hz, 
CHP); 6.67 (1H, d, J = 3.3 Hz, CH=Cq); 7.41 (1H, d, J = 1.8 Hz, CHO). 13C NMR δ (75 
MHz, ppm): 27.99 (CH2); 30.09 (CH2CO); 44.54 (CH2Cl); 46.80 (d, JCP = 163.8 Hz, 
CHP); 47.97 (CH2N); 53.50 (d, JCP = 6,9 Hz, OCH3); 53.84 (d, JCP = 6,9 Hz, OCH3); 
110.92 (CH=CHO); 112.55 (d, JCP = 3.5 Hz, CH=Cq); 116.05 (=CH2); 133.35 (=CH); 
143.32 (CHO); 146.14 (d, JCP = 10,4 Hz, CqO); 172.67 (d, JCP = 3.5 Hz, C=O).  31P 
NMR δ (121 MHz, ppm): 21.70. IR ν (cm-1): 1651 (C=O); 1252 (P=O); 1040 (br., P-
O). MS m/z (%): 350 (100, [M+H]+); 352 (18, [M+H+2]+). Chromatography: Rf = 0.34 
(EtOAc). Yield: 88%. Yellow oil. 
 
Dimethyl (allylisobutyrylamino)furan-2-ylmethyl phosphonate (36c) 
 1H NMR δ (300 MHz, ppm): 1.11 (d, 3H, J = 6.6 Hz, CH3); 1.15 (d, 
3H, J = 6.6 Hz, CH3); 2.76 (septet, 1H, J = 6.6 Hz, CH); 3.71 (d, 3H, 
JHP = 10.7 Hz, OCH3); 3.79 (d, 3H, JHP = 10.7 Hz, OCH3); 4.08 (dd, 
1H, JAB = 18.3 Hz, J = 4.9 Hz, NCHAHB); 4.35 (ddd, 1H, 
JAB = 18.3 Hz, J = 4.9 Hz, J = 1.7 Hz NCHAHB); 4.84 (dd, 1H, 
J = 17.1 Hz, Jgem = 1,1 Hz, =CHcisHtrans); 4.90 (dd, 1H, J = 10.5 Hz, J = 1.1 Hz, 
=CHcisHtrans); 5.40 (ddt, 1H, Jtrans = 17.1 Hz, Jcis = 10.5 Hz, J = 4.9 Hz, =CH); 6.34 (dd, 
1H, J = 3.3 Hz, J = 1.9 Hz, CH=CHO); 6.58 (d, 1H, JHP = 23.1 Hz, CHP); 6.66 (d (br.), 
1H, Jvic = 3.3 Hz, CH=Cq); 7.39 (d, 1H, J = 1.8 Hz, CHO). 13C NMR δ (75 MHz, 
ppm): 19.04 (CH3); 19.97 (CH3); 30.77 (CH); 46.35 (d, CHP, JCP = 162.7 Hz); 47.65 
(CH2N); 53.53 (d, OCH3, JCP = 6.9 Hz); 53.81 (d, OCH3, JCP = 6.9 Hz); 110.82 
(CH=CHO); 112.44 (d, CH=Cq, JCP = 3.5 Hz); 115.11 (=CH2); 133.93 (=CH); 143.18 
(CHO); 146.22 (d, CqO, JCP = 10.4 Hz); 178.26 (d, Cq=O, JCP = 2.3 Hz). 31P NMR δ 
(121 MHz, ppm): 22.01. IR ν (cm-1):  1652 (C=O); 1222 (P=O); 1044 (P-O). MS m/z 
(%): 316 (100, [M+H]+). Mp.:  43-44°C. Chromatography: Rf = 0.34 (EtOAc). Yield: 
88%. Yellow crystals. 
 
Dimethyl [allyl(2,2-dichloro-acetyl)amino]furan-2-ylmethyl phosphonate 
(36d) 
1H NMR δ (300 MHz, ppm): 3.74 (3H, d, JHP = 10.7 Hz, OCH3); 
3.84 (3H, d, JHP = 11.0 Hz, OCH3); 4,15 (1H, dd (br.), 
JAB = 18,7 Hz, J = 5.0 Hz, NCHAHB); 4.48 (1H, ddd, JAB = 18.7 Hz, 
NCHAHB); J = 4.1 Hz, J = 2.0 Hz, 4.91-5.07 (2H, multiplet, =CH2); 
5.45 (1H, multiplet, =CH); 6.25 (1H, s, CHCl2); 6.36 (1H, d, 
JHP = 22.6 Hz, CHP); 6.38 (1H, dd, Jvic,CH=Cq = 3.1 Hz, J2 = 2.1 Hz, CH=CHO); 6.73 
(1H, d, Jvic = 3.1 Hz, CH=Cq); 7.43 (1H, d, J = 1.4 Hz, CHO); 13C NMR δ (75 MHz, 
ppm): 47.75 (CH2N); 48.13 (d, CHP, JCP = 161.5 Hz); 53.70 (d, OCH3, JCP = 6.9 Hz); 
53.98 (d, OCH3, JCP = 5.8 Hz); 64.20 (CHCl2); 111.00 (CH=CHO); 113.25 (d, CH=Cq, 
JCP = 3.4 Hz); 116.47 (=CH2); 132.80 (=CH); 143.77 (CHO); 144.97 (d, CqO, 
JCP = 9.2 Hz); 164.80 (d, Cq=O, JCP = 3.5 Hz). 31P NMR δ (121 MHz, ppm): 20.20. IR 
ν (cm-1): 1672 (C=O); 1261 (P=O); 1053, 1040 (P-O). MS m/z (%): 356 (100, [M+H]+); 
358 (68, [M+H+2]+); 360 (11, [M+H+4]+). Mp.: 59-60°C. Chromatography: Rf = 0.31 
(Hex/EtOAc 40/60). Yield: 96%. Yellow Crystals. 
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4.2 One-pot phosphonylation of N-acyliminium ions 
4.2.1 General procedure 
5 Mmol of imine was dissolved in 10 ml of THF in a round bottom flask under 
a nitrogen atmosphere at temperature T. Then, 0.57 g (1 eq., 5 mmol) of 
chloroacetyl chloride was added dropwise using a syringe. The mixture was 
stirred for t minutes at temperature T before 1 eq. (5 mmol) of trimethyl or 
triethyl phosphite was added. Then the mixture was heated very fast and 
refluxed for 2 more hours using a single tube cooler. CAUTION: during this 
reaction, methyl chloride is liberated from the reaction mixture. Therefore, 
the reaction should be performed in a properly working hood. Finally, the 
solvent was removed under reduced pressure and the N-chloroacetyl 
aminoalkyl phosphonates could be obtained in pure form after column 
chromatography. (Parameters t and T are given for each individual derivative 
in the section below). 
 
Dimethyl (2E)-1-[(chloroacetyl)anilino]-3-phenylprop-2-enyl phosphonate 
(21a) 
Procedure: T = 0°C; t = 10 minutes. 
1H NMR δ (300 MHz, ppm): 3.77 (3H, d, JHP = 10.7 Hz, 
OCH3); 3.78 (3H, d, JHP = 11.0 Hz, OCH3); 3.82 (2H, s, CH2Cl); 
5.59 (1H, dd,  JHP = 19.4 Hz, J = 9.8 Hz, CHP); 6.09 (1H, 
J = 15.8 Hz, J = 9.7 Hz, JHP = 6.3 Hz, =CH);  66.76 (1H, 
J = 15.8 Hz, JHP = 3.0 Hz, =CH); 7.22-7.51 (10 H, multiplet, 
CHarom). 13C NMR δ (75 MHz, ppm): 42.09 (CH2Cl); 52.89 (d, JCP = 8.1 Hz, OCH3); 
53.98 (d, JCP = 6.9 Hz, OCH3); 57.70 (d, JCP = 158.0 Hz, CHP); 119.34 (d, 
JCP = 2.3 Hz, =CH); 126.82, 128.50, 128.64, 129.56, 129.72, 129.86 (CHarom); 135.82 
(Cq,arom); 137.24 (d, JCP = 13.9 Hz, =CHPh); 138.49 (Cq,arom); 166.02 (d, JCP = 2.3 Hz, 
C=O).  31P NMR δ (121 MHz, ppm): 23.57. IR ν (cm-1): 1677, 1663 (C=O, C=C); 
1259 (P=O); 1047, 1023 (P-O). MS m/z (%): 225 (100); 284 (34); 394 (31, [M+H]+); 
396 (11, [M+H+2]+). Chromatography:  Rf = 0.25 (Hex/EtOAc 20/80). Mp.: 91-92°C. 
Yield: 43%. Brown crystals. 
 
Dimethyl (2E)-1-[benzyl(chloroacetyl)amino]-3-phenylprop-2-enyl 
phosphonate (21b) 
Procedure: T = -40°C; t = 10 minutes. Yield: 55%. Yellow oil. Spectral data can be 
found in chapter 4, section 4.1. 
 
Diethyl (2E)-1-[benzyl(chloroacetyl)amino]-3-phenylprop-2-enyl 
phosphonate (21c) 
Procedure: T = -40°C; t = 10 minutes. 
1H NMR δ (300 MHz, ppm): 1.27 (3H, t, J = 6.9 Hz, CH3);  1.32 
(3H, t, J = 6.9 Hz, CH3);  3.88 (1H, d, JAB = 12.7 Hz, CHAHBCl); 
3.98 (1H, d, JAB = 12.7 Hz, CHAHBCl); 4.06-4.23 (4H, multiplet, 
OCH2); 4.88 (1H, d, JAB = 18.2 Hz, CHAHBPh); 5.10 (1H, d, JAB = 
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18.2 Hz, CHAHBPh); 5.73 (1H, dd, JHP = 20.6 Hz, J = 9.2 Hz, CHP); 6.09-6.20 (1H, 
multiplet, =CH); 6.77 (1H, dd, J = 16.0 Hz, JHP = 2.8 Hz); 7.16-7.32 (10 H, multiplet, 
CHarom). 13C NMR δ (75 MHz, ppm): 16.48 (CH3); 16.53 (CH3); 41.61 (CH2Cl); 49.62 
(CH2Ph); 54.86 (d, JCP = 156.3 Hz, CHP); 62.84 (d, JCP = 6.4 Hz, OCH2); 63.42 (d, JCP 
= 5.8 Hz, OCH2); 119.43 (=CH); 126.03 (CHarom); 126.69 (CHarom); 127.69 (CHarom); 
128.25 (CHarom); 128.44 (CHarom); 128.62 (CHarom); 129.05 (CHarom); 135.93 (Cq,arom); 
137.03 (Cq,arom); 137.15 (d, JCP = 13.3 Hz, =CH); 167.44 (C=O). 31P NMR δ (121 MHz, 
ppm): 20.99. IR ν (cm-1): 1665 (C=O; C=C); 1248 (P=O); 1050 (P-O). MS m/z (%): 
253 (100); 436 (53, [M+H]+); 438 (15, [M+H+2]+). Chromatography:  Rf = 0.33 
(Hex/EtOAc/MeOH 78/20/2). Yield: 46%. Yellow oil. 
 
Dimethyl (2E)-1-[benzyl(chlorobutyryl)amino]-3-phenylprop-2-enyl-
phosphonate (25a) 
Procedure: T = -40°C; t = 10 minutes. 
1H NMR δ (300 MHz, ppm): 2.01-2.21 (2H, multiplet, CH2); 
2.30-2.62 (2H, multiplet, CH2CO); 3.42-3.60 (2H, multiplet, 
CH2Cl); 3.76 (3H, d, JHP = 11.0 Hz, OCH3); 3.79 (3H, 
JHP = 10.7 Hz, OCH3); 4.82 (1H, d, JAB = 17.9 Hz, CHAHBPh); 
4.99 (1H, d, JAB = 17.9 Hz, CHAHBPh); 5.71 (1H, dd, JHP = 
20.6 Hz, J = 9.4 Hz, CHP); 6.12-6.23 (1H, multiplet, =CH); 6.72 (1H, dd, J = 15.7 Hz, 
JHP = 3.0 Hz); 7.14-7.36 (10 H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 28.00 
(CH2); 30.22 (CH2CO); 44.45 (CH2Cl); 49.91 (NCH2); 53.04 (d, JCP = 6.9 Hz, OCH3); 
53.97 (d, JCP =6.9 Hz, OCH3); 54.41 (d, JCP = 156.3 Hz, CHP); 119.96 (=CH); 126.21, 
126.72, 127.12, 127.44, 127.74, 128.36, 128.60, 128.87 (CHarom); 136.00 (Cq,arom); 
136.95 (d, JCP = 13.9 Hz, =CH); 137.37 (Cq,arom); 162.83 (C=O). 31P NMR δ (121 MHz, 
ppm): 24.49. IR ν (cm-1): 1668 (C=O; C=C); 1250 (P=O); 1030 (br., P-O). MS m/z 
(%): 436 (100, [M+H]+); 438 (34, [M+H+2]+). Chromatography:  Rf = 0.22 (EtOAc). 
Yield: 38%. Yellow oil. 
 
Dimethyl (2E)-1-[allyl(chloroacetyl)amino]-3-phenylprop-2-enyl-
phosphonate (21e) 
Procedure: T = 20°C; t = 20 minutes. Yield: 41%. Spectral data can be found in 
chapter 4, section 4.1. 
 
Dimethyl (2E)-1-[allyl(chlorobutyryl)amino]-3-phenylprop-2-enyl-
phosphonate (25b) 
Procedure: T = rt; t = 10 minutes. Yield: 45%. Spectral data can be found in chapter 
4, section 4.1. 
 
Dimethyl (2E)-1-[(chloroacetyl)isopropylamino]-3-phenylprop-2-enyl 
phosphonate (21f) 
Dimethyl 3-[(chloroacetyl)isopropylamino]-1-phenylprop-2-enyl 
phosphonate (267a) 
Procedure: T = -20°C; t = 10 minutes. Yield: 27%. Yellow oil. Spectral data can be 
found in chapter, section 4.1. 
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The corresponding 1,4-adduct could be recovered from the reaction mixture in 8% 
yield using colum chromatography: 
1H NMR δ (300 MHz, ppm): 1.10 (3H, d, J = 8.3 Hz, CH3); 
1.12 (3H, d, J = 7.2 Hz, CH3); 3.07 (3H, d, JHP = 10.7 Hz, 
OCH3); 3.72 (3H, d, JHP = 10.7 Hz, OCH3); 3.99 (1H, dd, 
JHP = 24.9 Hz, J = 9.2 Hz, CHP); 4.10 (2H, s, CH2Cl); 4.35-
4.75 (1H, multiplet, CHN); 5.95-6.07 (1H, multiplet, =CH); 
6.24 (1H, dd, Jtrans = 13.8 Hz, JHP = 4.1 Hz, =CHN); 7.30-7.40 (5H, multiplet, CHarom). 
13C NMR δ (75 MHz, ppm): 19.89 (CH3); 20.00 (CH3); 42.32 (CH2Cl); 46.07 (d, 
JCP = 146.5 Hz, CHP); 46.94 (CHN); 53.25 (d, JCP = 6.9 Hz, OCH3); 53.83 (d, 
JCP = 6.9 Hz, OCH3); 127.93, 128.73, 128.82, 129.12 (CHarom, =CH); 134.31 (Cq,arom); 
165.71 (C=O). ).  31P NMR δ (121 MHz, ppm): 26.61. IR ν (cm-1): 1668, 1647 (C=O, 
C=C); 1252 (P=O); 1032 (P-O). MS m/z (%): 250 (23); 284 (15); 360 (100, [M+H]+); 
362 (34, [M+H+2]+). Chromatography: Rf = 0.19 (Hex/EtOAc 20/80). Yield: 8%. 
Yellow oil. 
 
Dimethyl (chloroacetyl)anilinofuran-2-ylmethyl phosphonate (21g) 
Procedure: T = 0°C; t = 10 minutes. 
1H NMR δ (300 MHz, ppm): 3.73 (3H, d, JHP = 3.7 Hz, OCH3); 
3.81 (3H, d, JHP = 11.0 Hz, OCH3); 3.81 (2H, s, CH2Cl); 6.26-6.28 
(1H, multiplet, =CH); 6.35-6.36 (1H, multiplet, =CHCqO); 6.57 
(1H, d, JHP = 22.6 Hz, CHP); 7.28-7.39 (6H, multiplet, CHarom, 
=CHO). 13C NMR δ (75 MHz, ppm): 42.23 (CH2Cl); 50.46 (d, 
JCP = 163.8 Hz, CHP); 53.28 (d, JCP = 8.1 Hz, OCH3); 53.96 (d, JCP = 5.8 Hz, OCH3); 
110.82 (=CH); 113.47 (d, JCP = 2.3 Hz, =CHCqO); 129.23 (CHarom); 129.44 (CHarom); 
137.63 (Cq,arom); 143.23 (=CHO); 145.32 (d, JCP = 9.2 Hz, =CqO); 166.32 (C=O).  31P 
NMR δ (121 MHz, ppm): 20.55. IR ν (cm-1): 1677 (C=O); 1238 (br., P=O); 1035 (br., 
P-O). MS m/z (%): 358 (100, [M+H]+); 360 (33, [M+H+2]+). Chromatography: Rf = 
0.24 (Hex/EtOAc 70/30). Yield: 35%. Brown oil. 
 
Dimethyl [benzyl(chloroacetyl)amino]furan-2-ylmethyl phosphonate 
(21h) 
Procedure: T = 0°C; t = 10 minutes. Yield: 57%. Spectral data can be found in 
chapter 4, section 4.1. 
 
Dimethyl [allyl(chloroacetyl)amino]furan-2-ylmethyl phosphonate 
(21i/36a) 
Procedure: T = 0°C; t = 10 minutes. Yield: 43%. Spectral data can be found in 
chapter 4, section 4.1. 
 
Diethyl [benzyl(chloroacetyl)amino]phenylmethyl phosphonate (21k) 
Procedure: T = 20°C; t = 30 minutes. 
1H NMR δ (300 MHz, ppm): 1.12 (3H, t, J = 7.2 Hz, CH3); 1.31 
(3H, t, J = 7.2 Hz, CH3); 3.79 (1H, d, JAB = 12.7 Hz, CHAHBCl); 3.90 
(1H, d, JAB = 12.7 Hz, CHAHBCl); 3.91-4.21 (4H, multiplet, OCH2); 
4.83 (1H, d, JAB = 18.2 Hz, CHAHBN); 5.08 (1H, d, JAB = 18.2 Hz, 
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CHAHBN); 6.35 (1H, d, JHP = 22.6 Hz, CHP); 6.77-6.79 (2H, multiplet, CHarom); 7.10-
7.12 (2H, multiplet, CHarom); 7.23-7.29 (4H, multiplet, CHarom); 7.62-7.65 (2H, 
multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 16.16 (CH3); 16.33 (CH3); 41.81 
(CH2Cl); 49.34 (CH2N); 54.53 (d, JCP = 158.1 Hz; CHP); 62.75, 63.23, 63.31 (OCH2); 
125.64, 127.20, 128.34, 128.56, 128.81, 130.41, 130.51 (CHarom); 132.99 (Cq,arom); 
136.77 (Cq,arom); 167.87 (C=O).  31P NMR δ (121 MHz, ppm): 20.45. IR ν (cm-1): 1663 
(C=O); 1251 (P=O); 1040 (br., P-O). Chromatography : Rf = 0.39 (Hex/EtOAc 80/20). 
Yield: 39%. Yellow oil. 
 
 
4.2.2 Side products 
N-benzyl-2-chloro-N-(2-methylprop-1-enyl) acetamide (265) 
This is the major component of the reaction mixture using the general 
procedure described above (T = -40°C, t = 10 minutes) with imine 19ah. 
However, the same product was obtained without adding trimethyl 
phosphite, but using the following procedure: 0.81 g (5 mmol) of imine 19ah 
was dissolved in 10 ml of dry THF in a round bottom flask under a nitrogen 
atmosphere at room temperature. Then, 0.57 g (5 mmol) of chloroacetyl 
chloride was added dropwise using a syringe. The mixture was stirred for 30 
minutes at room temperature and then refluxed for 2 more hours. Finally, 
the solvent was removed under reduced pressure and the enamide could be 
recovered as white crystals. 
 
1H NMR δ (300 MHz, ppm): 1.40 (3H, d, J = 1.2 Hz, CH3); 1.68 
(3H, d, J = 1.2 Hz, CH3); 4.03 (2H, s, CH2Cl); 4.61 (2H, s, CH2N); 
5.79-5.81 (1H, multiplet, =CH); 7.25-7.31 (5H, multiplet, CHarom). 
13C NMR δ (75 MHz, ppm): 17.34 (CH3); 21.74 (CH3); 42.23 
(CH2Cl); 51.37 (CH2N); 121.98 (=CH); 127.49 (CHarom); 128.39 (2 x 
CHarom); 128.80 (2 x CHarom); 136.41 (Cq,arom); 138.73 (=Cq); 166.42 (C=O). IR ν (cm-1): 
1661 (br. C=O, C=C). MS m/z (%): 238 (100, [M+H]+); 240 (39, [M+H+2]+). Mp.: 96-
97°C. Yield: 95%. White crystals. 
 
N-benzyl-2-chloro-N-{[(1R,5R)-6,6-dimethylbicyclo-[3.1.1]hept-3-en-2-
ylidene]methyl} acetamide (266) 
Formed as an undesired side product from imine 19u using the general procedure (T 
= 20°C; t = 45 minutes).  
1H NMR δ (300 MHz, ppm): 0.62 (3H, s, CH3); 1.24 (3H, s, CH3); 
1.34 (1H, d, J = 8.5 Hz, CHAHB); 2.31 (1H, ddd, J = 6.6 Hz, J = 
5.8 Hz, J = 5.5 Hz, CH-CH=); 2.45 (1H, ddd, J = 8.8 Hz, J = 5.5 
Hz, J = 5.5 Hz, CHAHB); 2.63 (1H, dd, J = 5.5 Hz, J = 5.8 Hz, CH-
Cquat=); 4.00 (1H, d, JAB = 13.2 Hz, CHAHBCl); 4.09 (1H, d, 
JAB = 13.2 Hz, CHAHBCl); 4.54 (1H, d, JAB = 14.1 Hz, CHAHBN); 
4.66 (1H, d, JAB = 14.1 Hz, CHAHBN); 5.82 (1H, s, =CHN); 5.99 (1H, d, J = 8.5 Hz, 
=CH-Cquat); 6.43 (1H, dd, J = 8.5 Hz, J = 6.6 Hz, =CH-CH); 7.22-7.33 (5H, m, CHarom). 
13C NMR δ (75 MHz, ppm): 22.03 (CH3); 25.88 (CH3); 35.96 (CH2); 41.97 (CH2Cl); 
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43.27 (CH-CH=); 44.66 (CH-Cquat=); 44.80 (Cquat); 51.91 (CH2N); 119.69 (=CHN); 
123.70 (=CH-Cquat); 127.51 (CHarom); 128.36 (2xCHarom); 128.88 (2xCHarom); 136.56 
(Cquat,arom); 140.99 (=CH-CH); 145.93 (=Cquat); 166.36 (C=O). IR ν (cm-1): 1671 (C=O); 
1639 (C=C). MS m/z (%): 316 (100, M++H); 318 (31, M++H+2). Chromatography: Rf 
= 0.80 (Hex/EtOAc 60/40). Yield: 44%. 
 
Dimethyl benzylamino[(1R,5S)-6,6-dimethylbicyclo-[3.1.1]hept-2-en-2-
yl]methylphosphonate 
Formed as an undesired side product from imine 19u using the general 
procedure (T = 20°C; t = 45 minutes). Mixture of two diastereomers (ratio 
47:53). Spectral data can be found in chapter 4, section 3.3. 
 
4.2.3 Preparation of 3-imino-1-phenylpropyl phosphonates 
To a mixture of 2.7 mmol of diethyl (3-oxo-1-phenyl-propyl) phosphonate 217 
(see chapter 4, section 3.2.5) in 7 ml of dry dichloromethane, 1 equivalent of 
amine (or 1.1 equivalent in case a volatile amine is used) wass added together 
with 2 equivalents of MgSO4. The resulting mixture was stirred for 14 hours 
at room temperature. The corresponding imines were obtained after filtration 
of the solids and evaporation of the solvent under reduced pressure.  
 
Diethyl 3-(isopropylimino)-1-phenylpropyl phosphonate (216a) 
 1H NMR δ (300 MHz, ppm): 0.96 (3H, d, J = 6.3 Hz, CHCH3); 1.04 
(3H, d, J = 6.3 Hz, CHCH3); 1.12 (3H, t, J = 7.2 Hz, CH3); 1.27 (3H, 
t, J = 7.2 Hz, CH3); 2.82-3.04 (2H, multiplet, CH2); 3.14 (1H, 
septet, J = 6.3 Hz, NCH); 3.41 (1H, ddd, JHP = 22.5 Hz, 
J = 10.5 Hz, J = 5.4 Hz, CHP); 3.72-4.12 (4H, multiplet, OCH2); 
7.21-7.39 (5H, multiplet, CHarom); 7.48 (1H, t, J = 4.8 Hz, N=CH). 13C NMR δ (75 
MHz, ppm): 16.26 (d, JCP = 5.8 Hz, CH3); 16.40 (d, JCP = 5.8 Hz, CH3); 23.85 
(CHCH3); 23.88 (CHCH3); 35.63 (d, JCP = 2.3 Hz, CH2); 41.99 (d, JCP = 138.5 Hz, 
CHP); 61.09 (NCH); 61.98 (d, JCP = 6.9 Hz, OCH2); 62.65 (d, JCP = 6.9 Hz, OCH2); 
127.23 (d, JCP = 2.3 Hz, CHp); 128.43 (d, JCP = 2.3 Hz, CHm); 129.46 (d, JCP = 6.9 Hz, 
CHo); 135.20 (d, JCP = 6.9 Hz, Cq); 159.01 (d, JCP = 17.3 Hz, N=CH). 31P NMR δ (121 
MHz, ppm): 28.13. IR ν (cm-1): 1666 (N=C); 1245 (P=O); 1054, 1027 (P-O). MS m/z 
(%): 312 (100, [M+H]+). Yield: 87%. Orange oil. 
 
Diethyl 3-(allylimino)-1-phenylpropyl phosphonate (216c) 
1H NMR δ (300 MHz, ppm): 1.11 (3H, t, J = 7.2 Hz, CH3); 1.28 
(3H, t, J = 7.2 Hz, CH3); 2.89-3.11 (2H, multiplet, CH2); 3.41 
(1H, ddd, JHP = 22.2 Hz, J = 10.2 Hz, J = 5.2 Hz, CHP); 3.71-
4.14 (6H, multiplet, OCH2, NCH2); 4.85-5.02 (2H, multiplet, 
=CH2); 5.76-5.90 (1H, multiplet, =CH); 7.24-7.38 (5H, multiplet, 
CHarom); 7.54 (1H, t, J = 4.7 Hz, N=CH). 13C NMR δ (75 MHz, ppm): 15.72 (d, 
JCP = 5.8 Hz, CH3); 15.87 (d, JCP = 5.8 Hz, CH3); 35.40 (CH2); 40.97 (d, 
JCP = 138.5 Hz, CHP); 61.38 (d, JCP = 6.9 Hz, OCH2); 62.12 (d, JCP = 6.9 Hz, OCH2); 
62.45 (NCH2); 114.99 (=CH2); 126.76 (CHp); 127.96 (CHm); 128.85 (d, JCP = 6.9 Hz, 
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CHo); 134.85 (d, JCP = 6.9 Hz, Cq); 135.05 (=CH); 162.33 (d, JCP = 16.2 Hz, N=CH). 31P 
NMR δ (121 MHz, ppm): 28.19. IR ν (cm-1): 1667 (N=C); 1245 (P=O); 1054, 1028 (P-
O). MS m/z (%): 310 (100, [M+H]+). Yield: 92%. Yellow oil. 
 
Diethyl 3-(benzylimino)-1-phenylpropyl phosphonate (216d) 
1H NMR δ (300 MHz, ppm): 1.11 (3H, t, J = 7.2 Hz, CH3); 1.26 (3H, 
t, J = 7.2 Hz, CH3); 2.89-3.09 (2H, multiplet, CH2); 3.41 (1H, ddd, 
JHP = 22.4 Hz, J = 9.9 Hz, J = 5.5 Hz, CHP); 3.69-4.09 (4H, 
multiplet, OCH2); 4.45 (2H, s, NCH2); 7.18-7.43 (10H, multiplet, 
CHarom); 7.64 (1H, t, J = 4.7 Hz, N=CH). 13C NMR δ (75 MHz, ppm): 
16.30 (d, JCP = 5.8 Hz, CH3); 16.44 (d, JCP = 5.8 Hz, CH3); 35.93 (d, JCP = 2.3 Hz, 
CH2); 40.70 (d, JCP = 139.6 Hz, CHP); 62.06 (d, JCP = 6.9 Hz, OCH2); 62.75 (d, 
JCP = 6.9 Hz, OCH2); 64.77 (NCH2); 126.80 (CHarom); 127.31 (d, JCP = 3.5 Hz, CHp); 
127.69 (CHarom); 128.34 (CHarom); 128.60 (d, JCP = 2.3 Hz, CHm); 129.50 (d, 
JCP = 6.9 Hz, CHo); 135.38 (d, JCP = 6.9 Hz, Cq); 138.95 (Cq,arom); 163.11 (d, 
JCP = 17.3 Hz, N=CH). 31P NMR δ (121 MHz, ppm): 28.21. IR ν (cm-1): 1665 (N=C); 
1243 (P=O); 1053, 1028 (P-O). MS m/z (%): 360 (100, [M+H]+). Yield: 96%. Yellow 
oil. 
 
4.2.4 Preparation of 3-(chloroacetylalkylamino)-1-phenylprop-2-enyl 
phosphonates (267b-d) 
A mixture of 2.4 mmol of imine and 7 ml of dry THF was stirred at room 
temperature under a nitrogen atmosphere. Then, 2.4 mmol of chloroacetyl 
chloride in 2 ml of dry THF was added dropwise using a syringe. After stirring 
for 10 more minutes at room temperature, 1 equivalent of triethyl amine was 
added resulting in immediate precipitation of ammonium salts. After stirring 
for 1 hour at room temperature, the mixture was poured into 10 ml of a 
saturated NaHCO3(aq) solution and extracted with 10 ml of diethyl ether. The 
remaining water phase was extracted two times more with 5 ml of diethyl 
ether. The combined organic phases were dried using MgSO4. The enamides 
were obtained in reasonable purity (80-90%) after filtration of the solids and 
evaporation of the solvent under reduced pressure. Further purification was 
performed using column chromatography. 
 
Diethyl 3-(chloroacetylisopropylamino)-1-phenylprop-2-enyl 
phosphonate (267b) 
1H NMR δ (300 MHz, ppm): 1.08-1.14 (4H, multiplet, CH3); 
1.16 (3H, t, J = 7.2 Hz, CH3); 1.28 (3H, t, J = 7.2 Hz, CH3); 
3.75-4.16 (5H, multiplet, OCH2, CHP); 4.10 (2H, s, CH2Cl); 
4.70 (1H, septet (br.), J = 6.3 Hz, NCH); 6.03 (1H, ddd, 
J = 13.8 Hz, J = 8.8 Hz, JHP = 8.8 Hz, =CH); 6.22 (1H, dd, J = 13.8 Hz, JHP = 4.1 Hz, 
=CHN); 7.26-7.41 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 16.28 (d, 
JCP = 5.8 Hz, CH3); 16.42 (d, JCP = 5.8 Hz, CH3); 19.81 (CHCH3); 19.92 (CHCH3); 
42.38 (CH2Cl); 46.43 (d, JCP = 138.5 Hz, CHP); 46.93 (NCH); 62.42 (d, JCP = 6.9 Hz, 
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OCH2); 63.06 (d, JCP = 6.9 Hz, OCH2); 127.45 (d, JCP = 15.0 Hz, =CHN); 127.69 (d, 
JCP = 3.5 Hz, =CH); 128.73, 128.80, 128.89 (CHarom); 134.65 (d, JCP = 6.9 Hz, Cq,arom); 
165.67 (C=O). 31P NMR δ (121 MHz, ppm): 24.29. IR ν (cm-1): 1678 (C=O); 1654 
(C=C); 1247 (P=O); 1029 (br., P-O). MS m/z (%): 388 (100, [M+H]+); 390 (32, 
[M+H+2]+). Mp.: 76-78°C. Chromatography: Rf = 0.27 (EtOAc). Yield: 45%. Yellow 
crystals. 
 
Spectral data of the corresponding dimethyl phosphonate 267a can be found in 
chapter 4, section 4.2.1. 
 
Diethyl 3-(allylchloroacetylamino)-1-phenylprop-2-enyl phosphonate 
(267c)  
The product was found as a mixture of two rotamers (ratio 37:63). From the (H,H) 
coupling constants it was found that 267c was exclusively formed in the (E)-
geometry. Peaks of the Major rotamer are indicated as ‘M’. Also most peaks of the 
minor ‘m’ isomer are indicated below. 
 1H NMR δ (300 MHz, ppm): 1.13 (3H, t, J = 7.2 Hz, CH3, M); 
1.26 (3H, t, J = 7.2 Hz, CH3, M); 3.66-4.15 (2x5H, multiplet, 
OCH2, CHP, m + M); 4.11 (2H, s, CH2Cl, m); 4.17 (2H, s, 
CH2Cl, M); 4.25-4.32 (2x2H,multiplet, NCH2, m+M); 5.11-
5.26 (2x2H, multiplet, =CH2, m + M); 5.42-5.51 (1H, 
multiplet, =CH, m); 5.55 (1H, ddd, J = 13.5 Hz, J = 9.1 Hz, 
JHP = 9.1 Hz, =CH, M); 5.70-5.91 (2x1H, multiplet, CH=CH2, m+M);  6.75 (1H, dd, 
J = 13.5 Hz, JHP = 3.9 Hz, =CHN, M); 7.22-7.42 (2x5+2H, multiplet, CHarom, m +M, 
=CHN, m). 13C NMR δ (75 MHz, ppm): 16.37 (d, JCP = 5.8 Hz, CH3); 16.54 (d, 
JCP = 5.8 Hz, CH3); 41.23 (CH2Cl, M); 41.57 (CH2Cl, m); 46.42 (NCH2, M); 46.52 (d, 
JCP = 139.6 Hz, CHP, M); 46.79 (d, JCP = 140.8 Hz, CHP, m); 47.72 (NCH2, m); 62.27 
(d, JCP = 6.9 Hz, OCH2, m); 62.58 (d, JCP = 6.9 Hz, OCH2, M); 63.00 (d, JCP = 8.1 Hz, 
OCH2, M); 108.46 (d, JCP = 8.1 Hz, =CH, m); 110.24 (d, JCP = 9.2 Hz, =CH, M); 117.15 
(CH=CH2, m); 117.24 (CH=CH2, M); 127.365, 127.59, 128.81, 128.95, 129.04 
(CHarom, m+M);  129.15 (d, JCP = 15.0 Hz, =CHN, m); 129.80 (d, JCP = 13.9 Hz, =CHN, 
M); 131.35 (CH=CH2, m); 131.41 (CH=CH2, M); 135.74 (d, JCP = 5.8 Hz, CqCHP, M); 
136.40 (d, JCP = 5.8 Hz, CqCHP, M); 164.97 (C=O, m); 165.16 (C=O, M). 31P NMR δ 
(121 MHz, ppm): 25.09 (M); 25.51 (m). IR ν (cm-1): 1679 (C=O); 1650 (C=C); 1240 
(P=O); 1053, 1028 (P-O). MS m/z (%): 386 (100, [M+H]+); 388 (28, [M+H]++2). 
Chromatography: Rf = 0.23 (EtOAc). Yield: 31%. Yellow oil. 
 
Diethyl 3-(benzylchloroacetylamino)-1-phenylprop-2-enyl phosphonate 
(267d)  
The product was found as a mixture of two rotamers (ratio 29:71). From the (H,H) 
coupling constants it was found that 267d was exclusively formed in the (E)-
geometry. Peaks of the Major rotamer are indicated as ‘M’. Also most peaks of the 
minor ‘m’ isomer are indicated below. 
 1H NMR δ (300 MHz, ppm): 1.07 (3H, t, J = 7.2 Hz, CH3, M); 
1.17 (3H, t, J = 7.2 Hz, CH3, M); 3.62-4.05 (5H, multiplet, 
OCH2, CHP, m + M); 4.07 (2H, s, CH2Cl, m); 4.24 (2H, s, 
CH2Cl, M); 4.89 (2H, s (br.), NCH2, M); 4.92 (2H, s (br.), 
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NCH2, m); 5.38-5.45 (1H, multiplet, =CH, m); 5.51 (1H, ddd, J = 13.8 Hz, J = 9.4 Hz, 
JHP = 9.4 Hz, =CH); 6.75 (1H, dd, J = 13.8 Hz, JHP = 3.9 Hz, =CHN, M); 7.15-7.39 
(10H, multiplet, CHarom); 7.50 (1H, dd, J = 14.5 Hz, JHP = 3.6 Hz, =CHN, m). 13C NMR 
δ (75 MHz, ppm): 16.22 (d, JCP = 5.8 Hz, CH3); 16.38 (d, JCP = 5.8 Hz, CH3); 41.24 
(CH2Cl, M); 41.68 (CH2Cl, m); 46.27 (d, JCP = 139.1 Hz, CHP, M); 46.53 (d, 
JCP = 139.1 Hz, CHP, m); 47.33 (NCH2, M); 48.92 (NCH2, m); 62.22 (d, JCP = 6.9 Hz, 
OCH2, m); 62.49 (d, JCP = 6.9 Hz, OCH2, M); 62.86 (d, JCP = 6.9 Hz, OCH2, M); 108.94 
(d, JCP = 9.2 Hz, =CH, m); 111.24 (d, JCP = 8.1 Hz, =CH, M); 127.15, 127.34, 128.65, 
128.79, 128.88 (CHarom, m + M);  129.12 (br., =CHN, m); 129.68 (d, JCP = 15.0 Hz, 
=CHN, M); 135.20 (Cq,arom, m); 135.52 (d, JCP = 6.9 Hz, CqCHP, M); 136.05 (Cq,arom, M); 
165.41 (C=O, m); 165.52 (C=O, M). 31P NMR δ (121 MHz, ppm): 24.83 (M); 25.35 
(m). Chromatography: Rf = 0.25 (EtOAc). Yield: 29%. Purity: ~90%. Yellow oil. 
 
 
4.3 Synthesis of 4-phosphono β-lactams 
4.3.1 Typical procedure for the synthesis of 4-phosphono-β-lactams 23 
Using NaH as a base 
0.24 g (6 mmol, 1.2 equiv.) of a NaH emulsion in mineral oil was washed 
three times with petroleum ether to remove the oil and then 15 ml of dry THF 
was added. Then 5 mmol of the corresponding N-chloroacetyl aminoalkyl 
phosphonate 21 in 5 ml of dry THF was added dropwise and the resulting 
mixture was refluxed for two or three hours, protected from moisture using a 
CaCl2 tube. After cooling, the mixture was poured into 25 ml of water and 
extracted with 20 ml of diethyl ether. The remaining water phase was then 
washed two times with 10 ml of diethyl ether. The combined organic phases 
were dried using MgSO4, and after filtration, the solvent was removed under 
reduced pressure.  
 
Using LiHMDS as a base 
A solution of 5 mmol of the N-chloroacetyl aminoalkyl phosphonate 21 in 
15 ml of dry THF was stirred at room temperature under a nitrogen 
atmosphere. Then, 5.5 ml of LiHMDS (1.0 M in hexane) was added dropwise 
using a syringe. Stirring was continued for 1 h at room temperature and the 
mixture was poured into 20 ml of 0.5 M HCl(aq) and extracted with 15 ml of 
diethyl ether. The remaining water phase was then washed two times with 
10 ml of diethyl ether. The combined organic phases were dried with MgSO4, 
and after filtration the solvent was removed under reduced pressure.  
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Dimethyl 4-oxo-1-phenyl-2-[(E)-2-phenylethenyl]-2-azetidinyl 
phosphonate (23a)  
1H NMR δ (300 MHz, ppm): 3.20 (1H, dd, JAB = 15.3 Hz, 
JHP = 5.8 Hz, CHAHB); 3.63 (1H, dd, JAB = 15.3 Hz, JHP = 8.0 Hz, 
CHAHB); 3.74 (3H, d, JHP = 10.7 Hz, OCH3); 3.82 (3H, d, JHP  
= 11.6 Hz, OCH3); 6.59 (1H, dd, Jtrans = 16.2 Hz, JHP = 9.4 Hz, =CH); 
6.84 (1H, dd, Jtrans = 16.2 Hz, JHP = 2.8 Hz, =CHPh); 7.11 (1H, td, 
J = 7.4 Hz, J = 1.1 Hz, CHpara,PhN); 7.24-7.39 (7H, multiplet, CHarom); 
7.80 (2H, d, J = 8.0 Hz, CHortho,PhN). 13C NMR δ (75 MHz, ppm): 
49.42 (CH2); 53.51 (d, JCP = 6.9 Hz, OCH3); 54.43 (d, JCP = 6.9 Hz, 
OCH3); 59.82 (d, JCP = 168.5 Hz, CqP); 118.08 (2 x CHortho,PhN); 122.21 (d, 
JCP = 6.9 Hz, =CH); 124.45 (CHpara,PhN); 126.80 (2 x CHarom); 128.65 (CHarom); 128.71 
(2 x CHarom); 129.06 (2 x CHarom); 134.25 (d, JCP = 9.2 Hz, =CHPh); 135.38 (Cq,arom); 
137.40 (Cq,arom); 163.41 (d, JCP = 8.1 Hz, C=O). 31P NMR δ (121 MHz, ppm): 24.19. 
IR ν (cm-1): 1760 (C=O); 1253 (P=O); 1059, 1032 (P-O). MS m/z (%): 358 (100, 
[M+H]+). Chromatography: Rf = 0.21 (EtOAc). Yield: 90%. Orange oil. 
 
Dimethyl 1-benzyl-4-oxo-2-[(E)-2-phenylethenyl]-2-azetidinyl 
phosphonate (23b)  
1H NMR δ (300 MHz, ppm): 3.08 (1H, dd, CHAHBCO, JAB = 14.6 Hz, 
JHP = 5.8 Hz); 3.47 (1H, dd, CHAHBCO, JAB = 14.6 Hz, JHP = 8.3 Hz); 
3.75 (3H, d, JHP = 10.5 Hz, OCH3); 3.76 (3H, d, JHP = 10.5 Hz, 
OCH3); 4.39 (1H, d, JAB = 15.3 Hz, CHAHBPh); 4.74 (1H, d, 
JAB = 15.3 Hz, CHAHBPh); 6.18 (1H, dd, J = 16.2 Hz, JHP = 8.5 Hz, 
=CH); 6.52 (1H, dd, J = 16.2 Hz, JHP = 3.3 Hz, =CHPh); 7.08-7.44 
(10H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 45.84 (CH2Ph); 
47.87 (CH2CO); 53.52, 53.62, 53.85, 53.94 (OCH3); 59.34 (d, JCP = 167.3 Hz, CqP); 
122.74 (d, JCP = 6.9 Hz, =CH); 126.58 (2 x CHarom); 127.70 (CHarom); 128.41 (CHarom); 
128.56 (2 x CHarom); 128.92 (2 x CHarom) 128.94 (2 x CHarom); 134.20 (d, JCP = 9.2 Hz, 
=CHPh); 135.40 (Cq,arom); 136.70 (Cq,arom); 166.06 (d, JCP = 6.9 Hz, C=O). 31P NMR δ 
(121 MHz, ppm): 24.01. IR ν (cm-1): 1754 (C=O); 1252 (P=O); 1056, 1022 (P-O). MS 
m/z (%): 372 (100, [M+H]+). Mp.: 115-116°C. Chromatography: Rf = 0.24 
(Hex/EtOAc/MeOH 20/78/2). Yield: 75%. Colourless crystals. 
 
Diethyl 1-benzyl-4-oxo-2-[(E)-2-phenylethenyl]-2-azetidinyl phosphonate 
(23c)  
1H NMR δ (300 MHz, ppm): 1.31 (6H, t, J = 7.2 Hz, CH3); 3.07 (1H, 
dd, JAB = 14.6 Hz, JHP = 5.8 Hz, CHAHBCO); 3.47 (1H, dd, 
JAB = 14.6 Hz, JHP = 8.3 Hz, CHAHBCO); 4.04-4.24 (4H, multiplet, 
OCH2); 4.39 (1H, d, JAB = 15.1 Hz, CHAHBPh); 4,77 (1H, d, 
JAB = 15.1 Hz, CHAHBPh); 6,19 (1H, dd, Jtrans = 16.2 Hz, JHP = 8.3 Hz, 
=CH); 6.50 (1H, dd, Jtrans = 16.2 Hz, JHP = 3.6 Hz, =CHPh); 7.07-7.44 
(10H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 16.58 (CH3); 
45.81 (CH2Ph); 47.81 (CH2CO); 59.47 (d, JCP = 166.7 Hz, CquatP); 63.13 (d, 
JCP = 7.5 Hz, OCH2); 63.43 (d, JCP = 6.9 Hz, OCH2); 123.07 (d, JCP = 6.3 Hz, =CH); 
126.57 (CHarom); 127.68 (CHarom); 128.35 (CHarom); 128.61 (CHarom); 128.94 (CHarom); 
132.34 (d, JCP = 9.2 Hz, =CHPh); 135.60 (Cquat,arom); 136.96 (Cquat,arom); 166.21 (d, 
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JCP = 7.5 Hz, C=O). 31P NMR δ (121 MHz, ppm): 21.70. IR ν (cm-1): 1760 (C=O); 
1249 (P=O); 1050, 1024 (P-O). MS m/z (%): 400 (100, [M+H]+). Chromatography: Rf 
= 0.31 (Hex/EtOAc/MeOH 20/78/2). Yield: 92%. Yellow oil. 
 
Dimethyl 1-(4-methoxybenzyl)-4-oxo-2-[(E)-2-phenylethenyl]-2-azetidinyl 
phosphonate (23d)  
1H NMR δ (300 MHz, ppm): 3.06 (1H, dd, CHAHBCO, JAB = 14.6 Hz, 
JHP = 5.8 Hz); 3.45 (1H, dd, CHAHBCO, JAB = 14.6 Hz, JHP = 8.0 Hz); 
3.76 (3H, d, JHP = 10.7 Hz, OCH3); 3.77 (3H, d, JHP = 10.5 Hz, OCH3); 
3.78 (3H, s, OCH3(Ph)); 4.32 (1H, d, JAB = 15.1 Hz, CHAHBPh); 4.69 
(1H, d, JAB = 15.1 Hz, CHAHBPh); 6.16 (1H, dd, J = 16.2 Hz, JHP = 8.8 
Hz, =CH); 6.53 (1H, dd, J = 16.2 Hz, JHP = 3.3 Hz, =CHPh); 6.84-6.90 
(2H, multiplet, CHarom); 7.11-7.38 (7H, multiplet, CHarom). 13C NMR δ 
(75 MHz, ppm): 45.32 (CH2Ph); 47.87 (CH2CO); 53.61 (d, JCP = 8.1 Hz, OCH3); 53.97 
(d, JCP = 8.6 Hz, OCH3); 55.30 (OCH3(Ph)); 59.28 (d, JCP = 167.3 Hz, CqP); 113.99 (2x 
CHarom);  122.88 (d, JCP = 6.9 Hz, =CH); 126.63, 128.44, 128.59 (CHarom); 128.74 
(CH2Cq,arom); 130.39 (CHarom); 134.08 (d, JCP = 9.2 Hz, =CHPh); 135.40 (Cq,arom); 
159.19 (OCq,arom); 166.00 (d, JCP = 8.1 Hz, C=O). 31P NMR δ (121 MHz, ppm): 24.06. 
IR ν (cm-1): 1756 (C=O); 1248 (P=O); 1036 (br., P-O). MS m/z (%): 402 (100, [M+H]+). 
Chromatography: Rf = 0.18 (EtOAc). Yield: 39%. Orange oil. 
 
Dimethyl 1-allyl-4-oxo-2-[(E)-2-phenylethenyl]-2-azetidinyl phosphonate 
(23e)  
1H NMR δ (300 MHz, ppm): 3.07 (1H, dd, JAB = 14.6 Hz, 
JHP = 5.8 Hz, CHAHBC=O); 3.44 (1H, dd, JAB = 14.6 Hz, JHP = 8.0 Hz, 
CHAHBC=O); 3.83 (3H, d, JHP = 10.5 Hz, OCH3); 3.85 (3H, d, 
JHP = 10.5 Hz, OCH3); 3.88-4.12 (2H, multiplet, CH2N); 5.24 (1H, dd, 
Jcis = 10.2 Hz, J = 1.1 Hz, =CHAHB); 5.31 (1H, dd, Jtrans = 17.1 Hz, 
J = 1.4 Hz, =CHAHB); 6.03-5.91 (1H, multiplet, CH=CH2); 6.47 (1H, 
dd, Jtrans = 16.2 Hz, JHP = 8.3 Hz, =CH); 6.79 (1H, dd, 
Jtrans = 16.2 Hz, JHP = 3.6 Hz, =CHPh); 7.27-7.42 (5H, multiplet, CHarom). 13C NMR δ 
(75 MHz, ppm): 44.97 (CH2N); 47.85 (CH2C=O); 53.79 (d, JCP = 7.5 Hz, OCH3); 54.07 
(d, JCP = 6.9 Hz, OCH3); 58.88 (d, JCP = 167.3 Hz, Cq-P); 118.35 (=CH2); 123.02 (d, 
JCP = 6.9 Hz, =CH); 126.81 (2 x CHarom); 128.68 (CHarom); 128.84 (2 x CHarom); 132.57 
(CH=CH2); 134.18 (d, JCP = 9.2 Hz, =CHPh); 135.62 (d, JCP = 1.7 Hz, Cq,arom); 165.97 
(d, JCP = 7.5 Hz, C=O). 31P NMR δ (121 MHz, ppm): 24.23. IR ν (cm-1): 1760 (C=O); 
1253 (P=O); 1053, 1031 (P-O). MS m/z (%): 322 (100, [M+H]+). Chromatography: Rf 
= 0.23 (EtOAc). Yield: 62%. Yellow oil. 
 
Dimethyl 1-isopropyl-4-oxo-2-[(E)-2-phenylethenyl]-2-azetidinyl 
phosphonate (23f)  
1H NMR δ (300 MHz, ppm): 1.43 (3H, d, J = 6.9 Hz, CH3); 1,45 (3H, 
d, J = 6.9 Hz, CH3); 2.96 (1H, dd, JAB = 14.6 Hz, JHP = 5.5 Hz, 
CHAHB); 3.32 (1H, dd, JAB = 14.6 Hz, JHP = 7.7 Hz, CHAHB); 3.59 (1H, 
septet, J = 6.9 Hz, CH); 3.81 (3H, d, JHP = 9.1 Hz, OCH3); 3.85 (3H, 
d, JHP = 9.4 Hz, OCH3); 6.43 (1H, dd, Jtrans = 16.2 Hz, JHP = 10.2 Hz, 
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=CH); 6.84 (1H, dd, Jtrans = 16.1 Hz, JHP = 3.0 Hz, =CHPh); 7.26-7.42 (5H, multiplet, 
CHarom). 13C NMR δ (75 MHz, ppm): 20.87 (CH3); 22.14 (CH3); 47.13 (CH2); 47.49 
(CH); 53.83 (d, JCP = 7.2 Hz, OCH3); 53.92 (d, JCP = 7.2 Hz, OCH3); 58.06 (d, JCP = 
167.9 Hz, Cquat); 123.41 (d, JCP = 8.1 Hz, =CH); 126.79 (2 x CHarom); 128.70 (CHarom); 
128.86 (2 x CHarom); 134.33 (d, JCP = 9.2 Hz, =CHPh); 135.66 (Cq,arom); 165.39 (d, JCP = 
8.1 Hz, C=O). 31P NMR δ (121 MHz, ppm): 24.75. IR ν (cm-1): 1752 (C=O); 1252 
(P=O); 1055, 1031 (P-O). MS m/z (%): 324 (100, [M+H]+). Chromatography: Rf = 
0.22 (EtOAc). Yield: 85%. Yellow oil. 
 
Dimethyl 1-phenyl-2-furan-2-yl-4-oxo-2-azetidinyl phosphonate (23g)  
1H NMR δ (270 MHz, ppm): 3.60 (1H, dd, JAB = 9.2 Hz, 
JHP = 2.6 Hz, CHAHBC=O); 3.65 (1H, dd, JAB = 9.2 Hz, JHP = 4.3Hz, 
CHAHBC=O); 3.74 (3H, d, JHP = 10.6 Hz, OCH3); 3,80 (3H, d, 
JHP = 10.9 Hz, OCH3); 6.39 (1H, dd, J = 1.7 Hz, J = 2.0 Hz, =CH) ; 
6.88 (1H, d, J = 3.3Hz, =CH); 7.03-7.08 (1H, CHarom); 7.23-7.34 (2H, 
multiplet, CHarom); 7.42 (1H, d, J = 1.0 Hz,  =CHO); 7.64 (1H, 
multiplet, CHarom); 7.66 (1H, multiplet, CHarom). 13C NMR δ (68 MHz, 
ppm): 47.56 (d, JCP = 2.4 Hz, CH2C=O); 53.66 (d, JCP = 7.3 Hz, OCH3); 54.52 (d, 
JCP = 7.3 Hz, OCH3); 55.91 (d, JCP = 172.1 Hz, NCqP); 110.91 (=CH); 112.54 (=CH); 
117.79 (2x); 124.49; 128.91 (2x) (CHarom) ; 137.36 (Cq,arom) ; 143.66 (=CHO) ; 146.44 
(d, JCP = 20.8 Hz, =CqO) ; 163.77 (d, JCP = 7.4 Hz, C=O). 31P NMR δ (109 MHz, ppm): 
21.80. IR ν (cm-1): 1762 (C=O) ; 1260 (P=O). MSEI m/z (%): 322(3); 205(20); 204(66); 
203(40); 174(100); 173(61); 171(95); 120(11); 110(30); 96(37); 95(43); 94(35); 77(62). 
Chromatography: Rf = 0.26 (Hex/EtOAc 20/80). Yield: 89%. Yellow oil. 
 
Dimethyl 1-benzyl-2-furan-2-yl-4-oxo-2-azetidinyl phosphonate (23h)  
1H NMR δ (270 MHz, ppm): 3.48 (1H, dd, JAB = 14,5 Hz, JHP = 
7.9 Hz, CHAHBC=O); 3.56 (1H, dd, JAB = 14.5 Hz, JHP = 5.9 Hz, 
CHAHBC=O); 3.68 (6H, d, JHP = 10.9 Hz, OCH3); 4.42 (2H, s, CH2Ph); 
6,28 (1H, t, J = 1,7 Hz, =CH); 6.59 (1H, dd, J = 1,7 Hz, J = 1,0 Hz, 
=CH); 7.15-7.21 (5H, multiplet, CHarom); 7.30 (1H, s, =CHO). 13C 
NMR δ (68 MHz, ppm): 45.89 (CH2Ph); 46.07 (CH2); 53.54 (d, JCP = 8.6 Hz, OCH3); 
53.84 (d, JCP = 7.3 Hz, OCH3); 54.75 (d, JCP = 173.4 Hz, NCqP); 110.83 (=CH); 111.93 
(=CH); 127.24, 128.19 (2x), 128.44 (2x) (CHarom); 135.83 (Cq,arom); 143.34 (=CHO); 
146.79 (d, JCP = 19.5 Hz, =CqO); 166.21 (d, JCP = 8.6 Hz, C=O). 31P NMR δ (109 MHz, 
ppm): 21.36. IR ν (cm-1): 1754 (C=O); 1261 (P=O). MSEI m/z (%): 337(6); 231(21); 
228(17); 227(100); 203(14); 173(12); 94(10); 93(10); 91(59); 65(9). Chromatography: 
Rf = 0.29 (Hex/EtOAc 20/80). Yield: 99%. Yellow oil. 
 
Dimethyl 1-allyl-2-furan-2-yl-4-oxo-2-azetidinyl phosphonate (23i)  
1H NMR δ (300 MHz, ppm): 3.46 (1H, dd, JAB = 14.7 Hz, 
JHP = 7.8 Hz, CHAHBC=O); 3.53 (1H, dd, JAB = 14.7 Hz, JHP = 6.1 Hz, 
CHAHBC=O); 3.79 (3H, d, JHP = 10.7 Hz, OCH3); 3.79-3.86 (1H, 
multiplet, CHAHBN); 3.86 (3H, d, JHP = 10.7 Hz, OCH3); 3.95 (1H, dd, 
JAB = 16.0 Hz, J = 5.8 Hz, CHAHBN); 5.06 (1H, dd, Jcis = 10.2 Hz, 
J = 1.4 Hz, =CHAHB); 5.12 (1H, dd, Jtrans = 17.1 Hz, J = 1.4 Hz, =CHAHB); 5.76-5.63 
(1H, multiplet, CH=CH2); 6.40-6.42 (1H, multiplet, =CH); 6.69-6.70 (1H, multiplet, 
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=CHCq); 7.46-7.47 (1H, multiplet, =CHO). 13C NMR δ (75 MHz, ppm): 44.33 (CH2N); 
46.14 (d, JCP = 2.3 Hz, CH2); 53.71 (d, JCP = 6.9 Hz, OCH3); 54.12 (d, JCP = 5.8 Hz, 
OCH3); 54.64 (d, JCP = 174.2 Hz, CqP); 111.03 (CH=CH); 111.76 (d, JCP = 2.3 Hz, 
CH=Cq); 117.78 (=CH2); 131.66 (CH=CH2); 143.35 (=CHO); 147.28 (d, JCP = 18.5 Hz, 
O-C=CH); 166.03 (d, JCP = 8.1 Hz, C=O). 31P NMR δ (121 MHz, ppm): 22.06. IR ν 
(cm-1): 1764 (C=O); 1645 (C=C); 1260 (P=O); 1055, 1036 (P-O). MS m/z (%): 203 
(100); 286 (24, [M+H]+). Chromatography: Rf = 0.20 (Hex/EtOAc 20/80). Yield: 
55%. Orange oil. 
 
Dimethyl 1-benzyl-4-oxo-2-phenyl-2-azetidinyl phosphonate (23j)  
1H NMR δ (270 MHz, ppm): 3.24 (1H, dd, JAB = 14.8 Hz, JHP = 
6.3 Hz, CHAHBC=O); 3.60 (3H, d, JHP = 9.6 Hz, OCH3); 3.63 (1H, dd, 
JAB = 14.8 Hz, JHP = 6.3 Hz, CHAHBC=O) ; 3.64 (3H, d, JHP = 9.6 Hz, 
OCH3) ; 4.60 (1H, d, JAB = 15.5 Hz, NCHAHB); 4.74 (1H, d, 
JAB = 15.5 Hz, NCHAHB); 7.17-7.41 (10H, multiplet, CHarom). 13C 
NMR δ (68 MHz, ppm): 47.04 (NCH2); 48.52 (CH2C=O); 53.53 (d, 
JCP = 7.3 Hz, OCH3); 53.95 (d, JCP = 6.1 Hz, OCH3); 61.28 (d, JCP = 163.5 Hz, Cq); 
127.17, 127.24, 127.42, 128.35, 128.43 (2x), 128.50 (2x) (CHarom); 135.50 (d, 
JCP = 8.6 Hz, Cq,arom); 136.55 (Cq,arom); 167.19 (C=O, JCP = 7.3 Hz). 31P NMR δ (109 
MHz, ppm): 23.84. IR ν (cm-1): 1759 (C=O) ; 1251 (P=O). MSEI m/z (%): 346(5); 
240(27); 236(100); 103(15); 92(16); 91(76); 77(12); 65(12). Chromatography: Rf = 
0.23 (Hex/EtOAc 70/30). Yield: 92%. Yellow oil. 
 
4.3.2 Hydrogenation of diethyl 1-benzyl-4-oxo-2-(2-phenylethyl)-2-azetidinyl 
phosphonate (273) 
A heterogeneous mixture of 1.5 mmol lactam 23c and Pd/C (10 mol% Pd) in 
ethanol was stirred for 14 h under a 4 bar H2 atmosphere. The catalyst was 
then removed by filtration over celite® and the solvent was evaporated under 
reduced pressure.  
 
1H NMR δ (300 MHz, ppm): 1.33 (6H, t, J = 7.2 Hz, CH3); 1.92-2.18 
(2H, multiplet, CH2Ph); 2.26 (1H, ~td, J ≈ 12 Hz, J = 5.2 Hz, 
CHAHBCq); 2.51 (1H, ~td, J ≈ 12 Hz, J = 5.2 Hz, CHAHBCq); 2.98 (1H, 
dd, JAB = 14.9 Hz, J = 6.2 Hz, CHAHBCO); 3.18 (1H, dd, 
JAB = 14.9 Hz, J = 8.5 Hz, CHAHBCO); 4.04-4.21 (4H, multiplet, 
OCH2); 4.25 (1H, d, JAB = 15.1 Hz, CHAHBPh); 4,73 (1H, d, 
JAB = 15.1 Hz, CHAHBPh); 6.70-6.82 (2H, multiplet, CHarom); 7.05-
7.49 (8H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 16.54 (d, JCP = 5.8 Hz, CH3); 
16.62 (d, JCP = 5.8 Hz, CH3); 29.12 (d, JCP = 9.2 Hz, CH2Ph); 32.83 (d, JCP = 9.2 Hz, 
CH2Cq); 43.12 (CH2CO);  45.41 (CH2Ph); 58.42 (d, JCP = 163.8 Hz, CquatP); 62.64 (d, 
JCP = 8.1 Hz, OCH2); 63.01 (d, JCP = 6.9 Hz, OCH2); 126.07, 127.78, 128.18, 128.34, 
128.73, 129.03 (CHarom); 136.59 (Cq,Bn); 140.50 (Cq,Ph); 166.13 (d, JCP = 6.9 Hz, C=O). 
31P NMR δ (121 MHz, ppm): 24.46. IR ν (cm-1): 1757 (C=O); 1245 (P=O); 1043, 1021 
(P-O). MS m/z (%): 402 (83, [M+H]+); 264 (100, [M+H-P(O)(OEt)2]+). Yield: 91%. 
Yellow oil. 
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4.3.3 Preparation of dimethyl 1-allyl-6-oxo-2-((E)-phenylethenyl)piperidin-2-yl 
phosphonate (24) 
A solution of N-chlorobutyryl aminoalkenyl phosphonate 25b (1.51 g, 3.92 
mmol) in dry THF (15 ml) was cooled  to -78°C and 5.75 ml LiHMDS (1.0 M 
solution in hexane) was added dropwise using a syringe. The mixture was 
stirred for 5 minutes at -78°C and was then allowed to warm up to room 
temperature. Stirring was continued for 1 h. Then, the mixture was poured 
into 20 ml of 0.5 M HCl(aq) and 15 ml of diethyl ether. After vigorously 
mixing both phases, the organic phase was collected. The aqueous phase was 
washed twice with 10 ml of diethyl ether. The combined organic phases are 
dried using MgSO4. A brown oil was obtained after filtration of the solids and 
evaporation of the solvent under reduced pressure. δ-lactam 24 could be 
obtained in pure form after column chromatography. 
 
 
1H NMR δ (300 MHz, ppm): 1.72-1.98 (2H, multiplet, CH2); 2.06-
2.21 (1H, multiplet, CHAHB); 2.34-2.53 (3H, multiplet, CH2CO, 
CHAHB); 3.81 (3H, d, JHP = 10.5 Hz, OCH3); 3.83 (3H, d, 
JHP = 10.5 Hz, OCH3); 4.23-4.29 (2H, multiplet, NCH2); 5.10-5.18 (2H, 
multiplet, =CH2); 5.90-6.03 (1H, multiplet, HC=CH2); 6.33 (1H, dd, 
J = 16.2 Hz, JHP = 10.2 Hz, =CH); 6.63 (1H, dd, J = 16.2 Hz, 
JHP = 3.5 Hz, =CHPh); 7.24-7.39 (5H, multiplet, =CHarom). 13C NMR δ 
(75 MHz, ppm): 16.86 (d, JCP = 5.8 Hz); 32.22 (CH2); 32.47 (CH2); 48.78 (NCH2); 
53.10 (d, JCP = 6.9 Hz, OCH3); 54.24 (d, JCP = 6.9 Hz, OCH3); 65.81 (d, 
JCP =156.9 Hz, CqP); 115.91 (=CH2); 126.63 (2 x CHarom); 126.75 (=CH); 
128.29, 128.75 (3x CHarom); 132.62 (d, JCP = 10.4 Hz, =CHPh); 134.98 
(HC=CH2); 135.93 (Cq,arom); 171.34 (d, JCP = 3.5 Hz, C=O). 31P NMR δ (121 MHz, 
ppm): 25.93. IR ν (cm-1): 1646 (C=O); 1245 (P=O); 1046, 1028 (P-O). MS m/z (%): 
350 (100, [M+H]+); 240 (51, [M+H-PO(OMe)2]+. Chromatography: Rf = 0.14 (EtOAc). 
Yield: 15%. Yellow oil. 
 
 
4.4 Origin of the regioselectivity towards four-membered phosphono 
lactams 
4.4.1 Preparation of benzylbut-2-enylideneamine (19o) 
An equimolar mixture of crotonaldehyde (0.10 mol) and benzylamine was 
stirred at 0°C and 3.02 g of solid KOH (0.036 mol) was added. The mixture 
was stirred for 10 minutes at 0°C and 20 minutes at room temperature and 
was then filtered over MgSO4. The resulting oil was distilled immediately (bp. 
50°C, 0.02 mbar) and the distillate was collected in a flask at -5°C (ice/salt 
bath). The product was highly unstable at ambient temperatures and should 
be used immediately or should be kept at -32°C for short periods. 
N
O
P(OMe)2
O
  179 
 
1H NMR δ (300 MHz, ppm): 1.88 (3H, d, J = 5.2 Hz, CH3); 4.61 
(2H, s, NCH2); 6.12-6.34 (2H, multiplet, HC=CH); 7.20-7.35 (5H, 
multiplet, CHarom); 7.94 (1H, d, J = 8.2 Hz, N=CH). 13C NMR δ (75 
MHz, ppm): 18.48 (CH3); 65.04 (NCH2); 127.00, 128.08, 128.57 (CHarom); 132.29 
(=CH); 139.63 (Cq,arom); 140.77 (=CH); 163.45 (C=N). IR ν (cm-1): 1655 (C=N); 1626 
(C=C). Yield: 32%. 
 
4.4.2 Preparation of dimethyl (2E)-1-(benzylchloroacetylamino)but-2-enyl 
phosphonate (21q) 
A solution of imine 19o (10 mmol) in dry THF (15 ml) was stirred at -40°C 
under a nitrogen atmosphere. Chloroacetyl chloride (10 mmol in 3 ml of dry 
THF) was added dropwise using a syringe and the mixture was stirred for 10 
minutes at -40°C. Then triethyl phosphite (10 mmol in 3 ml of dry THF) was 
added and the mixture was refluxed for 2 h.  Finally the solvent was 
evaporated under reduced pressure. The final mixture mainly consisted of 
vinyl phosphate 259b and enamide 278. Using column chromatography, the 
desired (chloroacetyl-benzyl-amino)-but-2-enyl phosphonate 21q could be 
obtained in only 9% yield next to the corresponding 1,4-adduct 277 in 5% 
yield. 
 
Dimethyl (2E)-1-(benzylchloroacetylamino)but-2-enyl phosphonate (21q) 
1H NMR δ (300 MHz, ppm): 1.63-1.67 (3H, multiplet, CH3); 3.75 
(1 H, d, JHP = 11.3 Hz, OCH3); 3.79 (1 H, d, JHP = 11.3 Hz, OCH3); 
3.86 (1 H, d, J = 11.7 Hz, CHAHBCl); 3.96 (1 H, d, J = 11.7 Hz, 
CHAHBCl); 4.78 (1H, d, J = 17.9 Hz, CHAHBPh); 4.92 (1H, d, 
J = 17.9 Hz, CHAHBPh); 5.44-5.59 (1 H, multiplet, =CH); 5.90-6.01 
(1 H, multiplet, =CH-CH3); 7.13-7.43 (5 H, multiplet, CHarom). 13C NMR δ (75 MHz, 
ppm): 18.09 (CH3); 41.61 (CH2Cl); 49.51 (CH2Ph); 53.07 (d, JCP = 6.9 Hz, OCH3); 
53.86 (d, JCP = 6.9 Hz, OCH3); 54.24 (d, JCP = 156.9 Hz, CHP); 120.99 (=CH); 126.03 
(2 x CHarom); 127.68 (CHarom); 128.95 (2 x CHarom); 135.28 (d, JCP = 12.7 Hz, =CH-
CH3); 136.92 (Cq,arom); 167.42 (C=O). 31P NMR δ (121 MHz, ppm): 24.49. IR ν (cm-1): 
1661 (C=O); 1606 (C=C); 1250 (P=O); 1032 (P-O). MS m/z (%): 346 (74 [M+H]+); 236 
(100, [M+H-P(O)(OMe)2]+. Chromatography: Rf = 0.25 (EtOAc).  Yield: 9%. Yellow oil. 
 
Dimethyl 3-(benzylchloroacetylamino]-1-methylprop-2-enyl phosphonate 
(277) 
1H NMR δ (300 MHz, ppm): 1.26 (3H +3H, dd, JHP = 18.2 Hz, 
J = 7.2 Hz, CH3, m+M); 2.55-2.78 (1H + 1H, multiplet, CHP, 
m+M); 3.58-3.67 (6H + 6H, multiplet, OCH3, m+M); 4.09 (2H, s, 
CH2Cl, m); 4.30 (2H, s, CH2Cl, M); 4.81-4.95 (2H + 2H, multiplet, 
CH2Ph, m+M); 5.02-5.10 (1H, multiplet, =CH, m); 5.14 (1H, ddd, 
J = 14.0 Hz, J = 8.8 Hz, JHP  ≈ 7.0 Hz, =CH, M); 6.66 (1H, dd, J = 14.0 Hz, 
JHP = 5.0 Hz, =CHN, M); 7.15-7.46 (5H + 5H + 1H, multiplet, CHarom, m+M, =CHN, m). 
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13C NMR δ (75 MHz, ppm): 14.31 (CH3, JCP = 5.8 Hz); 33.03 (d, JCP = 141.9 Hz, CHP, 
M); 33.15 (d, JCP = 141.9 Hz, CHP, m); 41.36 (CH2Cl, M); 41.82 (CH2Cl, m); 47.19 
(CH2Ph, M); 41.82 (CH2Ph, m); 52.77, 52.90, 53.00 (OCH3, m+M); 109.88 (d, 
JCP = 9,2 Hz, =CH, m); 112.29 (d, JCP = 10.4 Hz, =CH, M); 125.58, 127.03, 127.26, 
127.73, 127.92, 128.11, 128.57 (CHarom, m+M, =CHN, m); 128.71 (=CHN, M); 128.86, 
129.03 (CHarom, m+M); 135.21 (Cq,arom, m); 136.05 (Cq,arom, M); 165.46 (C=O). 31P NMR 
δ (121 MHz, ppm): 32.07 (M); 32.59 (m). IR ν (cm-1): 1678, 1652 (C=C, C=O); 1242 
(P=O); 1056, 1031 (P-O). MS m/z (%): 346 (100, [M+H]+); 236 (17, 
[M+H+P(O)(OMe)2]+). Chromatography: Rf = 0.16 (EtOAc).  Yield: 5%. Yellow oil. 
 
4.4.3 Preparation of diethyl [benzylchloroacetylamino][(1R,5S)-6,6-
dimethylbicyclo[3.1.1]hept-2-en-2-yl]methyl phosphonate (21p) 
To a mixture of aminoalkenyl phosphonate 22u (5 mmol), 
triethyl amine (5.5 mmol) and dry THF (10 ml), chloroacetyl 
chloride (7.5 mmol in 2 ml of dry THF) was added. The 
mixture was stirred for 30 minutes at room temperature, 
protected from moisture using a CaCl2 tube. Then, the 
mixture was poured into 15 ml of a saturated NaHCO3(aq) solution and was 
extracted with 15 ml of diethyl ether. The remaining aqueous phase was 
extracted two times more with 5 ml of diethyl ether. The combined organic 
phase were dried using MgSO4. After filtration of the solids and evaporation 
of the solvent under reduced pressure, the N-chloroacetyl aminoalkenyl 
phosphonate 21p was obtained as a mixture of two diastereomers (crude 
yield: 89%; ratio 44:56). Both isomers could be separated using column 
chromatography. 
 
Major isomer: 
1H NMR δ (300 MHz, ppm): 0.86 (3H, s, CH3); 1.10 (1H, d, J = 8.5 Hz, CHAHB); 1.17 
(3H, t, J = 7.0 Hz, CH2CH3); 1.25 (3H, s, CH3); 1.29 (3H, t, J = 7.0 Hz, CH2CH3); 2.05-
2,10 (1H, multiplet, CHCH2); 2,25 (1H, ~t, J = 5,0 Hz, CHCquat=); 2,32-2,58 (3H, 
multiplet, CHAHB & CH2); 3.88 (2H, s, CH2Cl); 3.92-4,01 (2H, multiplet, OCH2); 4.08-
4.22 (2H, multiplet, OCH2); 4.59 (1H, d, JAB = 17.9 Hz, CHAHBN); 4.86 (1H, d, 
JAB = 17.9 Hz, CHAHBN); 5.40-5.50 (1H, multiplet, CHP); 5.97 (1H, s (br.), CH=); 7.24-
7,37 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 16.15 (d, JCP = 5.8 Hz, 
CH2CH3); 16.36 (d, JCP = 5.8 Hz, CH2CH3); 21.33 (CH3); 26.03 (CH3); 31.64, 31.70 
(CH2 & CH2CH=); 37.97 (Cq); 40.08 (CHCH2); 41.51 (CH2Cl); 45.21 (CHCq=, 
JCP = 9.2 Hz); 50.02 (CH2N); 56,15 (CHP, JCP = 154.6 Hz); 61,73 (OCH2, JCP = 6.9 Hz); 
63.06 (d, JCP = 5.8 Hz, OCH2); 126.01 (2 x CHarom + CH=); 127.43 (CHarom); 128.79 (2 
x CHarom); 136.94 (Cq,arom); 139.69 (=Cq); 168.41 (CO). 31P NMR δ (121 MHz, ppm): 
20.77. IR ν (cm-1): 1663 (C=O); 1606 (C=C); 1249 (P=O); 1050, 1029 (P-O). MS m/z 
(%): 454 (100, M+H]+). Chromatography: Rf = 0.22 (Hex/EtOAc 40/60).  Yield: 18%. 
Pale yellow oil. 
Minor isomer: 
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1H NMR δ (300 MHz, ppm): 0.63 (1H, d, J = 8.8 Hz, CHAHB); 0.88 (3H, s, CH3); 1.23-
1.32 (9H, multiplet, 2 x CH2CH3, CH3); 1.93-2.04 (1H, multiplet, CHCH2); 2.10 (1H, 
~t, J = 5.5 Hz, CHCq=); 2,.15-2.27 (3H, multiplet, CHAHB & CH2); 3.88 (2H, s, CH2Cl); 
4.03-4.18 (4H, multiplet, OCH2); 4.78 (2H, s, CH2N); 5.46 (1H, d (br.), JHP = 21.2 Hz, 
CHP); 6.19 (1H, s (br.), CH=); 7.14-7.35 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, 
ppm): 16.27, 16.31, 16.35 (CH2CH3); 20.92 (CH3); 26.11 (CH3); 31.48 (CH2); 31.83 
(CH2CH=); 38.20 (Cq); 40.00 (CHCH2); 41.90 (CH2Cl); 45.75 (d, JCP = 12,7 Hz, CHCq=); 
48.69 (CH2N); 55.48 (d, JCP = 156.9 Hz, CHP); 62.19 (d, JCP = 6.9 Hz, OCH2); 62.68 
(d, JCP = 6.9 Hz, OCH2); 125.78 (2 x CHarom); 127.04 (d, JCP = 5.8 Hz, =CH); 127.34 
(CHarom); 128.83 (2 x CHarom); 137.08 (Cq,arom); 139.15 (=Cq); 168.52 (d, JCP = 3.5 Hz, 
CO). 31P NMR δ (121 MHz, ppm): 20.46. IR ν (cm-1): 1663 (C=O); 1606 (C=C); 1251 
(P=O); 1046, 1029 (P-O). MS m/z (%): 454 (100, [M+H]+). Chromatography: Rf = 0.29 
(Hex/EtOAc 40/60).  Yield: 14%. Pale yellow oil. 
 
 
4.4.4 Preparation of diethyl [1-benzyl-2-(6,6-dimethyl-bicyclo[3.1.1]hept-2-en-
2-yl)-4-oxo-azetidin-2-yl] phosphonate (23l) 
0.08 g (2.0 mmol) of a NaH emulsion in mineral oil was washed three times 
with petroleum ether. Then, 5 ml of dry THF was added and the suspension 
was stirred at room temperature under a nitrogen atmosphere. A solution of 
0.74 g (1.6 mmol) of N-chloroacetyl aminoalkenyl phosphonate 21p as a 
single diastereomer in 5 ml of dry THF was added dropwise using a syringe. 
The mixture was refluxed for 3 h. After cooling, the mixture was poured in 25 
ml of water and extracted with 20 ml of diethyl ether. The remaining water 
phase was then washed two times with 10 ml of diethyl ether. The combined 
organic phases were dried with MgSO4, and after filtration the solvent was 
removed under reduced pressure. The 4-phosphono β-lactam 23l could be 
obtained in pure form as a mixture of diastereomers (ratio: 41/59) using 
column chromatography. 
 
1H NMR δ (300 MHz, ppm): 0.71 (3H, s, CH3, m); 0.77-0.81 (1H, 
multiplet, CHCHAHBCH, m); 0.79 (3H, s, CH3, M); 1.02 (1H, d, 
J = 8.8 Hz, CHCHAHBCH, M); 1.14 (3H, s, CH3, m); 1.23 (3H, s, CH3, 
M); 1.25-1.34 (2x 6H, multiplet, CH2CH3, m+M); 1.87-2.03 (2x 1H, 
multiplet, CH, m+M); 2.12-2.41 (2x 4H, multiplet, CHCq=, CH2, 
CHCHAHBCH, m+M); 2.83 (1H, dd, JAB = 14.7 Hz, J = 5.5 Hz, CHACHBCO, m); 2.90 
(1H, dd, JAB = 14.7 Hz, J = 6.3 Hz, CHAHBCO, M); 3.253 (1H, dd, JAB = 14.7 Hz, 
J = 8.5 Hz, CHAHBCO, M); 3.257 (1H, dd, JAB = 14.9 Hz, J = 7.2 Hz, CHAHBCO, m); 
3.89-4.22 (2x 4H, multiplet, OCH2, m+M); 4.34 (1H, d, JAB = 15.5 Hz, NCHAHB, m); 
4.45 (1H, d, JAB = 15.8 Hz, NCHAHB, M); 4.52 (1H, d, JAB = 15.5 Hz, NCHAHB, m); 4.58 
(1H, d, JAB = 15.8 Hz, NCHAHB, M); 5.61-5.67 (1H, multiplet, =CH, M); 5.90-5.95 (1H, 
multiplet, =CH, m); 7.20-7.37 (2x 5H, multiplet, CHarom).  13C NMR δ (75 MHz, ppm): 
16.46 (d, JCP = 5.8 Hz, CH2CH3); 16.60 (d, JCP = 5.8 Hz, CH2CH3); 20.79 (CH3, m); 
21.25 (CH3, M); 25.92 (CH3, m); 26.09 (CH3, M); 31.25, 31.60, 31.64, 31.75 (CH2, 
CHCH2CH, m+M); 37.60 (Cq, M); 37.68 (Cq, m); 40.03 (CH, M); 40.23 (CH, m); 41.87 
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(d, JCP = 5.8 Hz, CHCq=, m); 43.29 (d, JCP = 3.5 Hz, CHCq=, M); 44.81 (CH2CO, M); 
44.91 (CH2CO, m); 46.42 (NCH2, m); 46.82 (NCH2, M); 60.33 (d, JCP = 166.1 Hz, CqP, 
m); 60.95 (d, JCP = 165.0 Hz, CqP, M); 62.46, 62.55, 62.67, 62.82, 62.94, 63.04 
(OCH2, m+M); 123.45 (d, JCP = 9.2 Hz, =CH, M); 124.99 (d, JCP = 5.8 Hz, =CH, m);  
127.27, 127.42, 128.29, 128.37, 128.84, 129.71, 130.54 (CHarom, m+M); 136.67 
(Cq,arom, m); 136.98 (Cq,arom, M); 141.29 (d, JCP = 8.1 Hz, =Cq, m); 142.16 (d, 
JCP = 6.9 Hz, =Cq, M); 167.41 (d, JCP = 6.9 Hz, C=O, M). 31P NMR δ (121 MHz, ppm): 
21.86 (M); 22.00 (m). IR ν (cm-1): 1760 (C=O); 1673 (C=C); 1247 (P=O); 1046, 1024 
(P-O). MS m/z (%): 418 (100, M+H]+). Chromatography: Rf = 0.37 (EtOAc). Yield: 
25%. Yellow oil. 
 
Also a side product, originating from the unreacted allyl anion, could be 
recovered during column chromatography: 
 
Diethyl [benzyl(2-chloroacetyl)amino](6,6-dimethyl-bicyclo[3.1.1]hept-2-
ylidene)methyl phosphonate (281) 
1H NMR δ (300 MHz, ppm): 0.33 (3H, s, CH3); 0.84 (3H, s, CH3); 
1.23-1.30 (1H, multiplet, CHCHAHBCH); 1.327 (3H, t, J = 7.2 Hz, 
CH2CH3); 1.331 (3H, t, J = 7.2 Hz, CH2CH3); 1.81-2.04 (3H, 
multiplet, CHCH2); 2.23-2.35 (1H, multiplet, CHCHAHBCH); 2.67 
(1H, t, J = 4.4 Hz, CHCq=); 2.72-2.98 (2H, multiplet, CH2Cq=); 
3.98 (1H, d, JAB = 14.0 Hz, CHAHBCl); 4.00-4.15 (4H, multiplet, OCH2); 4.17 (1H, d, 
JAB = 14.0 Hz, CHAHBCl); 4.19 (1H, d, JAB = 14.6 Hz, NCHAHB); 5.10 (1H, d, 
JAB = 14.6 Hz, NCHAHB); 7.19-7.45 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, 
ppm): 16.54 (d, JCP = 6.9 Hz, CH2CH3); 21.60 (CH3); 21.94 (d, JCP = 3.5 Hz, CH2Cq=); 
23.38 (CH2); 25.16 (CH3); 26.71 (CHCH2CH); 40.00 (CH); 40.29 (Cq); 42.56 (CH2Cl); 
47.03 (d, JCP = 12.7 Hz, CHCq=); 53.10 (NCH2); 62.15 (d, JCP = 6.9 Hz, OCH2); 62.23 
(d, JCP = 5.8 Hz, OCH2); 122.51 (d, JCP = 215.8 Hz, =CqP); 127.68, 128.49 (CHarom); 
128.92 (=Cq); 129.77 (CHarom); 136.75 (Cq,arom); 167.79 (d, JCP = 11.5 Hz, C=O). 31P 
NMR δ (121 MHz, ppm): 12.95. IR ν (cm-1): 1674 (C=O); 1236 (P=O); 1049, 1023 (P-
O). MS m/z (%): 454 (100, [M+H]+); 456 (36 [M+H+2]+). Chromatography: Rf = 0.40 
(EtOAc). Yield: 10%. Yellow oil. 
 
4.4.5 Dimethyl (2E)-[acetylisopropylamino]-3-phenylprop-2-enyl phosphonate 
(255b) 
To a solution of aminoalkenyl phosphonate 22h (6.64 mmol) in dry THF 
(15 ml), 1.05 g (13.28 mmol) of pyridine and 0.16 g (1.33 mmol) of DMAP was 
added. The mixture was stirred at room temperature under a nitrogen 
atmosphere. Then, 0.78 g (9.96 mmol) of acetyl chloride in 5 ml of THF was 
added using a syringe. The mixture was stirred for 1 h at room temperature 
and one more hour at reflux temperature. Finally the reaction mixture was 
washed with a saturated solution of NaHCO3(aq) and a 0.5 M solution of HCl(aq) 
consecutively. The resulting organic phase was dried using MgSO4 and 
evaporated to obtain 255b in 66% yield as yellow crystals. 
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1H NMR δ (300 MHz, ppm): 1.21 (3H, d, J = 6.6 Hz, CH3); 
1.35 (3H, d, J = 6.6 Hz, CH3); 2.19 (3H, s, CH3CO); 3.69 (3H, 
d, JHP = 10.6 Hz, OCH3); 3.89 (3H, d, JHP = 10.6 Hz, OCH3); 
3.96-4.34 (2H, multiplet, CHP, NCH); 6.49-6.62 (2H, multiplet, 
HC=CH); 7.21-7.40 (5H, multiplet, CHarom). 13C NMR δ (75 
MHz, ppm): 20.95 (CH3); 21.74 (CH3); 21.92 (CH3CO); 50.55 (NCH); 51.97 (d, 
JCP = 6.9 Hz, OCH3); 53.00 (d, JCP = 161.5 Hz, CHP); 54.80 (d, JCP = 5.8 Hz, OCH3); 
122.94 (d, JCP = 2.3 Hz, =CH); 126.66 (2 x CHarom); 127.96 (CHarom); 128.54 (2 x 
CHarom); 133.56 (d, JCP = 12.7 Hz, =CHPh); 136.39 (Cq,arom); 169.77 (CO). 31P NMR δ 
(121 MHz, ppm): 26.55. IR ν (cm-1): 1639 (br., C=O, C=C); 1230 (br., P=O); 1049, 
1030 (P-O). MS m/z (%): 326 [M+H]+. Mp.: 51-52°C. Yield: 66%. Yellow crystals. 
 
4.4.6 Anion trapping experiment with H+ 
0.10 g (2.5 mmol) of a sodium hydride suspension in mineral oil was washed 
three times with petroleum ether to remove the mineral oil. Then 2 ml of dry 
THF was added to the sodium hydride and the mixture was cooled to -78°C 
under a nitrogen atmosphere. Then, 0.68 g of 255b (2.1 mmol in 6 ml of 
THF) was added dropwise using a syringe. The mixture was kept at -78°C for 
10 minutes and was then allowed to warm up to room temperature over a 2 h 
period. After adding water and 1N HCl(aq) for neutralization, the reaction 
mixture was extracted with ether. After drying with MgSO4 and evaporation 
of the solvent, 0.61 g of a mixture was obtained consisting of starting 
material 255b (13%) and isomer 287 (87%), which could be obtained in pure 
form after flash chromatography. From the 3JCP and the 3JHP coupling 
constants, an E geometry of the double bond can be concluded. 
 
Dimethyl (acetylisopropylamino)-3-phenylprop-1-enyl phosphonate (287) 
1H NMR δ (300 MHz, ppm): 1.26 (3H, d, J = 6.7 Hz, CH3); 
1.37 (3H, d, J = 6.7 Hz, CH3); 1.98 (3H, s, CH3CO); 3.55 (2H, 
ddd, JAB = 16.2 Hz, J = 7.4 Hz, JHP = 3.3 Hz, CH2); 3.80 (6H, d, 
JHP = 10.7 Hz, OCH3); 4.26 (1H, septet, J = 6.7 Hz, NCH); 6.98 
(1H, dt, JHP = 13.2 Hz, J = 7.4 Hz, =CH); 7.16-7.43 (5H, 
multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 19.51 (CH3); 20.41 (CH3); 23.12 
(CH3CO); 34.48 (d, JCP = 13.8 Hz, CH2); 50.63 (NCH); 52.95 (d, JCP = 6.9 Hz, OCH3); 
53.03 (d, JCP = 5.8 Hz, OCH3); 126.97 (CHarom); 128.33 (CHarom); 128.95 (CHarom); 
131.49 (d, JCP = 214.6 Hz, CqP); 136.66 (Cq,arom); 148.07 (d, JCP = 27.7 Hz, =CH); 
170.41 (CO). 31P NMR δ (121 MHz, ppm): 15.69. IR ν (cm-1): 1659 (br., C=O, C=C); 
1251 (P=O); 1050, 1029 (P-O). MS m/z (%): 326 (100, [M+H]+). Chromatography: Rf 
= 0.17 (EtOAc/MeOH 98/2). Yield: 42%. Yellow oil. 
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5 Synthesis of 2-phosphono pyrroles 
5.1 Preparation of α-alkyl crotonaldehydes 
5.1.1 Preparation of but-2-enylidene-cyclohexylamine (19p) 
A solution of crotonaldehyde (0.143 mol) in benzene (14.3 ml) was added 
dropwise to a mixture of cyclohexyl amine (0.30 mol) and potassium 
carbonate (43 mmol) at -15°C. After the addition was complete, the mixture  
was stirred for 1 h at 0°C and 2.5 h at room temperature. Distillation of the 
mixture at 10 mbar gave a major fraction (bp. 55-57°C) which on 
redistillation at 42 mbar gave the pure imine (bp. 95-100°C). 
 
1H NMR δ (300 MHz, ppm): 0.97-1.95 (10H, multiplet, 5x CH2); 1.87 
(3H, d, J = 5.2 Hz, CH3); 2.90-2.99 (1H, multiplet, NCH); 6.06-6.27 
(2H, multiplet, HC=CH); 7.86 (1H, d, J = 7.7 Hz, N=CH).  13C NMR δ 
(75 MHz, ppm): 18.38 (CH3); 24.91 (2x CH2); 25.64 (CH2); 34.50 (2x 
CH2); 69.49 (CHN); 132.49 (=CH); 139.82 (=CHCH3); 160.42 (N=CH).  
IR ν (cm-1): 1656 (C=N); 1625 (C=C). Yield: 42%. 
5.1.2 Alkylation of but-2-enylidene-cyclohexylamine (19p) 
A mixture of diisopropyl amine (20 mmol) and HMPA (20 mmol) in 40 ml of 
dry THF was stirred at 0°C under a nitrogen atmosphere. Butyl lithium 
(8.4 ml of a 2.5 M solution in hexane) was added dropwise using a syringe. 
After stirring for 15 minutes, imine 19p (20 mmol in 10 ml of dry THF) was 
added dropwise using a syringe. Stirring was continued for 15 minutes and 
then, the mixture was cooled to -78°C. After stirring for 30 minutes at -78°C, 
the alkyl bromide (21.4 mmol in 5 ml of THF) wass added dropwise using a 
syringe. Stirring was continued for 4 h before the reaction was quenched 
using 20 ml of a saturated NH4Cl(aq) solution at -78°C. The intermediate imine 
was then extracted with 40 ml of diethyl ether. The remaining water phase 
was extracted two times more with 10 ml of diethyl ether. Then 20 ml of a 
NaOAc/HOAC buffer mixture (12.5 ml HOAc, 12.5 ml H2O, 5.4 g NaOAc) was 
added to the combined organic phases. The resulting biphasic system was 
stirred vigorously for 1 h at room temperature. Then, the organic phase was 
collected, washed with 10 ml of a 0.5 M HCl(aq) solution and three times with 
10 ml of a saturated NaHCO3(aq) solution and dried using MgSO4. The 
corresponding aldehyde was then obtained in reasonable purity after 
filtration of the solids and evaporation of the solvent under reduced pressure. 
No further purification was performed at this stage and the crude mixture 
was used immediately for conversion to the corresponding aminoalkenyl 
phosphonate 22p,q. 
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5.2 Benzylation of α-aminoalkenyl phosphonates 
To a roundbottom flask, 3.1 mmol of α-aminoalkenyl phosphonate 22 was 
added together with 3 g of K2CO3, 0.23 g (1.5 mmol) of NaI and 4 ml of 
acetone. Then 0.79 g (4.65 mmol) of benzyl bromide was added and the 
mixture was refluxed during 5 to 10 h. The course of the reaction was 
conveniently monitored using 31P NMR spectra directly from the reaction 
mixture. After complete conversion of the starting material, the solids were 
removed by filtration and the solvent by evaporation under reduced pressure. 
The corresponding N-benzyl α-aminoalkenyl phosphonate 32 can be obtained 
in pure form as a pale yellow oil using column chromatography over silica gel 
using a hexane, ethyl acetate mixture as a mobile phase. 
 
Dimethyl (2E)-1-(allylbenzylamino)-3-phenylprop-2-enyl phosphonate 
(32a) 
 1H NMR δ (300 MHz, ppm): 3.10 (1H, dd, JAB = 14.0 Hz, 
J = 7.7 Hz, CHAHB); 3.51 (1H, d, JAB = 13.8 Hz, CHAHBPh); 
3.63-3.68 (1H, multiplet, CHAHB); 3.68 (3H, d, JHP = 10.5 Hz, 
OCH3); 3.85 (3H, d, JHP = 10.7 Hz, OCH3); 3.85 (1H, dd, 
JHP = 24.2 Hz, J = 9.1 Hz, CHP); 4.22 (dd, JAB = 13.8 Hz, 
J = 1.9 Hz, CHAHBPh); 5.19-5.29 (2H, multiplet, =CH2); 5.79-5.93 (1H, multiplet, 
CH=CH2); 6.37 (1H, ddd, J = 16.7 Hz, J = 9.1 Hz, JHP = 6.3 Hz, =CH); 6.60 (1H, 
J = 15.7 Hz, JHP = 3.03 Hz, =CHPh); 7.20-7.45 (10H, multiplet, CHarom). 13C NMR δ 
(75 MHz, ppm): 52.65 (d, JCP = 6.9 Hz, OCH3); 53.68 (d, JCP = 6.9 Hz, OCH3); 54.25 
(d, JCP = 6.9 Hz, CH2); 55.16 (d, JCP = 8.4 Hz, CH2Ph); 59.45 (d, JCP = 160.4 Hz, CHP); 
117.66 (=CH2); 119.75 (=CH); 126.67, 127.05, 128.12, 128.33, 128.51, 128.65, 
128.77, 129.03 (CHarom); 136.28 (Cq,arom); 136.39 (CH=CH2); 136.96 (d, JCP = 6.9 Hz, 
=CHPh); 139.40 (Cq,arom). 31P NMR δ (121 MHz, ppm): 27.11. IR ν (cm-1): 1642, 1601 
(C=C); 1243 (P=O); 1039 (br., P-O). MS m/z (%): 262 (13); 372 (100, [M+H]+). 
Chromatography: Rf = 0.26 (Hex/EtOAc 40/60).  Yield: 61%. Pale yellow oil. 
 
Dimethyl (2E)-1-(allylbenzylamino)-2-methyl-3-phenylprop-2-enyl 
phosphonate (32b) 
 1H NMR δ (300 MHz, ppm): 2.07 (3H, s, CH3); 3.25 (1H, dd, 
JAB = 14.2 Hz, J = 7.4 Hz, NCHAHB); 3.62-3.70 (1H, multiplet, 
NCHAHB); 3.72 (3H, d, JHP = 10.5 Hz, OCH3); 3.72-3.86 (2H, 
multiplet, CHP, CHAHBPh); 3.84 (3H, d, JHP = 10.5 Hz, OCH3); 
4.18 (1H, dd, JAB = 13.8 Hz, JHP = 2.5 Hz, CHAHBPh); 5.15-5.26 (2H, multiplet, =CH2); 
5.79-5.92 (1H, multiplet, =CH); 6.66 (1H, s (br.), =CHPh); 7.20-7.39 (10H, multiplet, 
CHarom).  13C NMR δ (75 MHz, ppm): 18.63 (d, JCP = 6.9 Hz, CH3); 52.86 (d, 
JCP = 8.1 Hz, OCH3); 52.98 (d, JCP = 6.9 Hz, OCH3); 63.92 (d, JCP = 153.5 Hz, CHP); 
117.83 (=CH2); 126.82, 127.02, 128.21, 128.28, 128.88, 129.12 (CHarom); 131.95 (d, 
JCP = 4.6 Hz, =Cq); 132.38 (d, JCP = 11.5 Hz, =CHPh); 136.49 (=CH); 137.40 (=Cq,arom); 
139.80 (CH2Cq,arom).  31P NMR δ (121 MHz, ppm): 27.35. IR ν (cm-1): 1247 (P=O); 
1037 (br., P-O). MS m/z (%): 386 (100, [M+H]+). Chromatography: Rf = 0.26 
(Hex/EtOAc 60/40).  Yield: 50%. 
P(OMe)2
N
Bn
O
P(OMe)2
N
Bn
O
  186 
 
Dimethyl (2E)-1-(allylbenzylamino)-2-benzylbut-2-enyl phosphonate (32c) 
 1H NMR δ (300 MHz, ppm): 1.83 (3H, d, J = 6.6 Hz, CH3); 3.20 
(1H, d, JAB = 14.9 Hz, CqCHAHBCq); 3.34-3.39 (2H, multiplet, 
NCH2CH=); 3.46 (3H, d, JHP = 10.5 Hz, OCH3); 3.53 (1H, d, 
JHP = 20.6 Hz, CHP); 3.66 (3H, d, JHP = 10.5 Hz, OCH3); 3.68-
3.74 (1H, multiplet, CqCHAHBCq); 3.86-3.88 (2H, multiplet, 
NCH2); 5.05-5.16 (2H, multiplet, =CH2); 5.73 (1H, dxdxt, 
J = 17.3 Hz, J = 10.2 Hz, J = 6.5 Hz, =CH); 6.27 (1H, q, J = 6.6 Hz, =CHCH3); 6.92 
(2H, d, J = 6.6 Hz, CHarom); 7.10-7.39 (8H, multiplet, CHarom). 13C NMR δ (75 MHz, 
ppm): 14.44 (CH3); 35.74 (d, JCP = 11.5 Hz, CqCH2Cq); 51.81 (d, JCP = 6.9 Hz, OMe); 
52.65 (d, JCP = 6.9 Hz, OMe); 54.20 (d, JCP = 3.5 Hz, NCH2CH=); 54.91 (s (br.), NCH2); 
58.41 (d, JCP = 140.8 Hz, CHP); 117.63 (=CH2); 126.06, 126.98 (CHarom); 127.72 (d, 
JCP = 5.8 Hz, =CHCH3); 128.29, 128.81, 129.22 (CHarom); 133.22 (d, JCP = 10.4 Hz, 
=Cq); 137.16 (=CH); 139.45 (=CqCH2Cq,arom); 140.29 (Cq,arom). 31P NMR δ (121 MHz, 
ppm): 28.84. IR ν (cm-1): 1236 (P=O); 1053, 1030 (P-O). MS m/z (%): 400 (100, 
[M+H]+). Chromatography: Rf = 0.45 (Hex/EtOAc 50/50).  Yield: 50%. Yellow oil. 
 
Dimethyl (2E)-1-(allylbenzylamino)-2-isopentyl-3-phenylprop-2-enyl 
phosphonate (E-(32d)) 
 1H NMR δ (300 MHz, ppm): 0.83-0.88 (3H, multiplet, CH3); 
1.12-1.35 (6H, multiplet, CH3, CH2, CH); 2.05-2.17 (1H, 
multiplet, CHAHBCq=); 2.40-2.49 (1H, multiplet, CHAHBCq=); 
3.42-3.57 (2H, multiplet, NCH2); 3.75 (3H, d, JHP = 10.5 Hz, 
OCH3); 3.83 (1H, d, JHP = 21.5 Hz, CHP); 3.87 (3H, d, JHP = 
10.5 Hz, OCH3); 3.96 (1H, d, JAB = 13.5 Hz, CHAHBPh); 4.04 
(1H, dd, JAB = 13.8 Hz, J = 3.9 Hz, CHAHBPh); 5.15-5.28 (2H, multiplet, =CH2); 5.77-
5.90 (1H, multiplet, =CH); 7.12 (1H, s (br.), =CHPh); 7.21-7.35 (10H, multiplet, 
CHarom).  13C  NMR δ (75 MHz, ppm): 14.07 (CH3), 22.37 (CH3); 28.02 (CH2); 31.27 
(d, JCP = 10.4 Hz, CH2Cq=); 31.81 (CH); 52.05 (d, JCP = 6.9 Hz, OCH3); 53.11 (d, 
JCP = 6.9 Hz, OCH3); 54.25 (d, JCP = 4.6 Hz, NCH2); 55.08 (d, JCP = 4.6 Hz, NCH2Ph); 
58.72 (d, JCP = 144.2 Hz, CHP); 117.68 (=CH2); 126.65, 126.97, 128.17, 128.20, 
128.74, 129.10 (CHarom); 131.36 (d, JCP = 5.8 Hz, =CHPh); 136.96 (=CH); 137.15 (d, 
JCP = 8.1 Hz, =Cq); 137.68 (Cq,arom); 139.96 (CH2Cq,arom).  31P NMR δ (121 MHz, ppm): 
28.72 IR ν (cm-1): 1247 (P=O); 1058, 1029 (P-O); MS m/z (%): 442 (100, [M+H]+); 
332 (32, [M+H-PO(OMe)2]+). Chromatography: Rf = 0.50 (Hex/EtOAc 50/50). Yield: 
34%. Yellow oil. 
 
Dimethyl (2Z)-1-(allylbenzylamino)-2-isopentyl-3-phenylprop-2-enyl 
phosphonate (Z-(32d)) 
 1H NMR δ (300 MHz, ppm): 0.84-0.96 (3H, multiplet, CH3); 1.32-
1.46 (4H, multiplet, CH3, CH); 1.61-1.72 (2H, multiplet, CH2); 2.40-
2.63 (2H, multiplet, CH2Cq=); 3.05 (1H, dd, JAB = 14.3 Hz, J = 7.4 Hz, 
NCHAHB); 3.47-3.57 (1H, multiplet, NCHACHB); 3.55 (1H, d, 
JAB = 14.0 Hz, CHAHBPh); 3.69 (3H, d, JHP = 10.7 Hz, OCH3); 3.71 
(3H, d, JHP = 10.7 Hz, OCH3); 4.05 (1H, dd, JAB = 14.0 Hz, 
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JHP = 1.9 Hz, CHAHBPh); 4.54 (1H, d, JHP = 24.8 Hz, CHP); 4.71-4.87 (2H, multiplet, 
=CH2); 5.52-5.65 (1H, multiplet, =CH); 6.70 (1H, s (br.), =CHPh); 7.07-7.35 (10H, 
multiplet, CHarom).  13C NMR δ (75 MHz, ppm): 14.22 (CH3); 22.84 (CH3); 28.60 
(CH2); 32.01 (CH); 33.54 (CH2Cq=); 52.55 (d, JCP = 6.9 Hz, OCH3); 53.08 (d, 
JCP = 6.9 Hz, OCH3); 54.74 (d, JCP = 8.1 Hz, NCH2); 55.55 (d, JCP = 8.1 Hz, NCH2Ph); 
56.82 (d, JCP = 156.9 Hz, CHP); 117.28 (=CH2); 126.69, 126.69, 128.06, 128.37, 
128.44, 128.89 (CHarom); 131.05 (d, JCP = 13.9 Hz, =CHPh); 135.83 (=CH); 136.99 
(=Cq); 137.92 (Cq,arom); 139.93 (CH2Cq,arom).  31P NMR δ (121 MHz, ppm): 27.79. IR 
νmax (cm-1): 1249 (P=O); 1059, 1031 (P-O). MS: m/z (%): 442 (100, [M+H]+); 332 (19, 
[M+H-PO(OMe)2]+). Chromatography: Rf = 0.58 (Hex/EtOAc 50/50). Yield: 11%. 
Yellow oil. 
 
Dimethyl (2E)-1-(allylbenzylamino)-2-phenylbut-2-enyl phosphonate 
(32e) 
 1H NMR δ (300 MHz, ppm): 1.69 (3H, d, J = 6.3 Hz, CH3); 2.95 
(1H, dd, JAB = 13.9 Hz, J = 7.6 Hz, NCHAHB); 3.43 (1H, d, JAB = 13.5 
Hz, CHAHBPh); 3.44-3.51 (1H, multiplet, NCHAHB); 3.70 (3H, d, 
JHP = 10.5 Hz, OCH3); 3.82 (3H, d, JHP = 10.7 Hz, OCH3); 4.03 (1H, 
d, JHP = 24.5 Hz, CHP); 4.02-4.08 (1H, multiplet, CHAHBPh); 4.84-
5.01 (2H, multiplet, =CH2); 5.60-5.74 (1H, multiplet, =CH); 6.41 
(1H, qd, J = 6.8 Hz, JHP = 1.7 Hz, =CHCH3); 7.04-7.36 (10H, multiplet, =CH).  13C 
NMR δ (75 MHz, ppm): 15.10 (CH3); 52.63 (d, JCP = 6.9 Hz, OCH3); 53.27 (d, 
JCP = 6.9 Hz, OCH3); 54.35 (d, JCP = 6.9 Hz, NCH2); 55.27 (d, JCP = 6.9 Hz, CH2Ph); 
60.81 (d, JCP = 156.9 Hz, CHP); 117.58 (=CH2); 126.76, 127.95, 128.13, 128.95 
(CHarom); 129.09 (d, JCP = 4.6 Hz, =CHCH3); 134.12(d, JCP = 8.1 Hz, =Cq); 136.47 
(=CH); 139.43 (CH2Cq,arom); 141.51 (d, JCP = 13.9 Hz, Cq,arom).  31P NMR δ (121 MHz, 
ppm): 27.19. IR (cm-1) νmax: 1246 (P=O); 1057, 1036 (P-O). MS: m/z (%): 386 (100, 
[M+H]+); 276 (10, [M+H-PO(OMe)2]+). Chromatography: Rf = 0.30 (Hex/EtOAc 50/50). 
Yield: 25%. Yellow oil. - The minor (2Z)-isomer could not be obtained in pure form. 
 
Dimethyl (2E)-1-(allylbenzylamino)-2-(2-phenylethyl)but-2-enyl 
phosphonate (32f) 
 1H NMR δ (300 MHz, ppm): 1.64 (3H, d, J = 6.8 Hz, CH3); 2.23-
2.33 (1H, multiplet, CHAHBPh); 2.47-2.57 (3H, multiplet, 
CH2CHAHBPh); 3.32 (1H, dd, JAB = 13.8 Hz, J = 6.1 Hz, NCHAHBCH); 
3.44 (1H, ddd, JAB = 13.8 Hz, J = 6.6 Hz, J = 4.3 Hz, NCHAHBCH); 
3.65-3.81 (2H, multiplet, CHP, NCHAHBPh); 3.68 (3H, d, JHP = 10.6 
Hz, OCH3); 3.83 (3H, d, JHP = 10.7 Hz, OCH3); 3.92 (1H, dd, JAB = 
13.8 Hz, J = 1.1 Hz, NCHAHBPh); 5.11-5.25 (2H, multiplet, =CH2); 
5.79 (1H, ddt, J = 16.6 Hz, J = 10.5 Hz, J = 6.5 Hz, NCH2CH); 6.05 (1H, q, J = 6.8 Hz, 
CH3CH); 7.10-7.38 (10H, multiplet, CHarom). 13C  NMR (75 MHz, ppm) δ: 13.69 (CH3); 
32.95 (d, JCP = 10.7 Hz, CH2Ph); 34.58 (CCH2); 52.10 (d, JCP = 8.1 Hz, OCH3); 52.87 
(d, JCP = 7.0 Hz, OCH3); 54.09 (d, JCP = 4.6 Hz, NCH2CH); 54.84 (d, JCP = 3.4 Hz, 
NCH2Ph); 59.23 (d, JCP = 143.1 Hz, CHP); 117.76 (C=CH2); 125.89 (CHarom); 126.98 
(CHarom); 127.38 (d, JCP = 5.8 Hz, CH3CH); 128.29 (2 x CHarom); 128.38 (2 x CHarom); 
128.52 (2 x CHarom); 129.10 (2 x CHarom); 133.48 (d, JCP = 8.0 Hz, HC=CH2); 137.12 
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(Cq,arom); 140.17 (Cq,arom); 141.97 (=Cq). 31P NMR (121 MHz, ppm) δ: 29.01 IR ν 
(cm-1): 1241 (P=O); 1028 (P-O). MS: m/z (%): 414 (100, [M+H]+). Chromatography: 
Rf = 0.41 (Hex/EtOAc 40/60). Yield: 92%. Yellow oil. 
 
Dimethyl (2E)-1-[benzyl(2-methylprop-2-enyl)amino]-3-phenylprop-2-enyl 
phosphonate (32g)  
 1H NMR δ (300 MHz, ppm): 1.79 (3H, s, CH3); 3.02 (1H, d, JAB 
= 12.7 Hz, NCHAHBPh); 3.47 (1H, d, JAB = 13.8 Hz, NCHAHBC); 
3.51 (1H, d, JAB = 12.7 Hz, NCHAHBPh); 3.68 (3H, d, JHP  = 10.5 
Hz, OCH3); 3.82 (3H, d, JHP = 10.7 Hz, OCH3); 3.82 (1H, dd, JHP 
= 23.7 Hz, J = 9.8 Hz, CHP); 4.22 (1H, dd, JAB = 13.8 Hz, J = 
2.2 Hz, NCHAHBC); 4.91 (1H, s, C=CHAHB); 4.98 (1H, s, C=CHAHB); 6.38 (1H, ddd, J = 
15.7 Hz, J = 9.8 Hz, JHP = 6.3 Hz, CHCHP); 6.70 (1H, dd, JHP = 3.0 Hz, J = 15.7 Hz, 
PhCH); 7.22-7.45 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 20.64 (CH3); 
52.85 (d, JCP = 6.9 Hz, OCH3); 53.31 (d, JCP = 6.9 Hz, OCH3); 55.14 (d, JCP = 6.9 Hz, 
NCH2C); 57.84 (d, JCP = 8.1 Hz, NCH2Ph); 59.01 (d, JCP = 160.4 Hz, CHP); 113.63 
(C=CH2); 119.74 (CHCHP); 126.75 (2 x CHarom); 127.10 (CHarom); 128.22 (CHarom); 
128.40 (2 x CHarom); 128.75 (2 x CHarom); 128.84 (2 x CHarom); 136.40 (Cq arom); 137.28 
(d, JCP = 15.0 Hz, PhCH); 139.57 (Cq arom); 143.53 (C=CH2). 31P NMR δ (121 MHz, 
ppm): 27.48 IR ν (cm-1): 1246 (P=O); 1029 (P-O). MS: m/z (%): 386 (100, [M+H]+). 
Chromatography: Rf = 0.47 (Hex/EtOAc 40/60). Mp. (°C): 78.5. Yield: 86%. Yellow 
crystals. 
 
Dimethyl (allylbenzylamino)[(1R,5S)-6,6-dimethylbicyclo-[3.1.1]hept-2-
en-2-yl]methyl phosphonates (32h) 
The product was obtained as a mixture of two diastereomeric pairs (ratio: 31/69). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 0.89 (3H, s, CH3, m); 0.92 (3H, s, 
CH3, M); 1.22 (1H, d, J = 8.5 Hz, CHAHB, m+M); 1.29 (2x3H, s 
(br.), CH3, m+M); 2.06-2.14 (2x 1H, multiplet, CqCHCH2, m+M); 
2.29-2.36 (3+2H, multiplet, CH2CH=, m+M, CHCq=, M); 2.39-
2.48 (2+1H, multiplet, CHAHB, m+M, CHCq=, m); 3.07 (2x 1H, dd, JAB = 14.0 Hz, 
J = 7.2 Hz, NCHAHB, m+M); 3.54-3.66 (2x 2H, multiplet, NCHAHB, CHP m+M); 3,64 
(3H, d, JHP = 10.5 Hz, OCH3, m); 3.67 (3H, d, JHP = 10.5 Hz, OCH3, M); 3.81 (2x3H, d, 
JHP = 10.5 Hz, OCH3, m+M); 5.08-5.26 (2x 2H, multiplet, =CH2, m+M); 5.56 (1H, s 
(br.), =CH, m); 5.71-5.87 (2+1H, multiplet, =CH, M, CH=CH2, m+M); 7.20-7.36 (5H, 
multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 21.32 (CH3, m); 21.59 (CH3, M); 26.42 
(CH3, m); 26.46 (CH3, M); 31.74 (br.), 31.88 (CH2CH=, CHCH2CH, m+M); 37.82 
(Cq(CH3)2, m); 38.00 (Cq(CH3)2, M); 40.26 (CHCH2, m); 40.31 (CHCH2, M); 45.84 (d, 
JCP = 4.6 Hz, CHCq=, m); 46.60 (d, JCP = 9.2 Hz, CHCq=, M); 51.85 (d, JCP = 6.9 Hz, 
OCH3, m); 51.94 (d, JCP = 6.9 Hz, OCH3, M); 53.01 (d, JCP = 6.9 Hz, OCH3, M); 53.24 
(d, JCP = 6.9 Hz, OCH3, m); 54.31 (d, JCP = 6.9 Hz, NCH2, m); 54.40 (d, JCP = 6.9 Hz, 
NCH2, m); 55.24 (d (br.), JCP = 6.9 Hz, NCH2Ph, m+M); 60.40 (d, JCP = 154.6 Hz, CHP, 
M); 60.57 (d, JCP = 156.9 Hz, CHP, m); 117.41 (=CH2, m); 117.46 (=CH2, M); 125.70 
(d, JCP = 9.2 Hz, =CH, M); 126.04 (d, JCP = 13.9 Hz, =CH, m); 126.85 (br.), 128.15, 
128.93 (CHarom, m+M); 136.90 (CH=CH2, m); 137.00 (CH=CH2, M); 139.86 (Cq,arom, m); 
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139.95 (Cq,arom, M); 140.21 (d, JCP = 5.8 Hz, =Cq, m); 140.66 (d, JCP = 5.8 Hz, =Cq, M).  
31P NMR δ (121 MHz, ppm): 27.16 (m); 27.50 (M). IR ν (cm-1): 1247 (P=O); 1060, 
1036 (br., P-O). MS m/z (%): 390 (100, [M+H]+). Chromatography: Rf = 0.37 
(Hex/EtOAc 40/60). Yield: 66%. Yellow oil. 
 
5.3 Ring closure to 2-phosphono 3-pyrrolines 
To an ovendry roundbottom flask, 0.34 mmol of aminoalkenyl phosphonate 
32 was added together with 4 ml of dry dichloromethane. The solution was 
stirred under a nitrogen atmosphere and 14.4 mg (5 mol%) of Grubbs’ second 
generation catalyst 302 was added. The reaction mixture was then stirred for 
3 – 5 hours at room temperature, depending on the derivative used. The 
course of the reaction was conveniently monitored using 31P NMR spectra of 
samples directly from the reaction mixture. Only in case of phosphonate 32e, 
complete conversion to pyrroline 31e needed 3 h at reflux temperature. The 
reaction mixture was then poured into a seperatory funnel containing 5 ml of 
1N HCl(aq). After vigorous shaking and phase separation, the organic layer 
was removed from the funnel. The remaining aqueous layer was washed 
twice with 2 ml of dichloromethane, then neutralized until slightly basic and 
extracted twice with 4 ml of dichloromethane. The combined organic phases 
were dried using MgSO4. The corresponding pyrrolines 31 were obtained as 
clear, colourless oils after filtration and evaporation of the solvent. 
 
Dimethyl 1-benzyl-2,5-dihydro-1H-pyrrol-2-yl phosphonate (31a) 
1H NMR δ (300 MHz, ppm): 3.29-3.43 (1H, multiplet, CHAHB); 3.65 
(1H, d, JAB = 13.5 Hz, CHAHBPh); 3.71-3.80 (1H, multiplet, CHAHB); 
3.80 (3H, d, JHP = 10.2 Hz, OCH3); 3.83 (3H, d, JHP = 10.2 Hz, OCH3); 
4.09-4.16 (1H, multiplet, CHP); 5.74-5.92 (1H, multiplet, =CHCH2); 
5.87-5.92 (1H, multiplet, =CHCH); 7.22-7.38 (5H, multiplet, CHarom). 13C NMR δ (75 
MHz, ppm): 53.08 (d, JCP = 8.1 Hz, OCH3); 53.70 (d, JCP = 6.9 Hz, OCH3); 60.10 (d, 
JCP = 5.8 Hz, CH2); 60.53 (d, JCP = 8.1 Hz, CH2Ph); 68.36 (d, JCP = 176.5 Hz, CHP); 
124.00 (d, JCP = 5.8 Hz, =CHCH2); 127.00 (CHarom); 128.30 (2 x CHarom); 128.57 (2 x 
CHarom); 130.21 (d, JCP = 12.7 Hz, =CHCH); 139.23 (Cq,arom). 31P NMR δ (121 MHz, 
ppm): 24.58. IR ν (cm-1): 1246 (P=O); 1058, 1031 (P-O). MS m/z (%): 268 (100, 
[M+H]+, 158 (18, [M+H-PO(OMe)2]+). Yield: 44%. Colourless oil. 
 
Dimethyl 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrol-2-yl phosphonate 
(31b) 
1H NMR δ (300 MHz, ppm): 1.86 (3H, s (br.), CH3); 3.19-3.47 (1H, 
multiplet, NCHAHB); 3.63 (d, JAB = 13.2, CHAHBPh); 3.63-3.74 (1H, 
multiplet, NCHACHB); 3.82 (6H, d, JHP = 10.7 Hz, OCH3); 3.92 (1H, 
multiplet, CHP); 4.28 (1H, d, JAB = 13.2 Hz, CHAHBPh); 5.49-5.52 (1H, 
multiplet, =CH); 7.21-7.39 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 14.81 
(CH3); 53.19 (d, JCP = 8.1 Hz, OCH3); 53.36 (d, JCP = 6.9 Hz, OCH3); 59.87 (d, 
JCP = 8.1 Hz, CH2N); 60.56 (d, JCP = 5.8 Hz, CH2Ph); 70.84 (d, JCP = 174.2 Hz, CHP); 
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124.78 (d, JCP = 12.7 Hz, =CH); 126.92, 128.25, 128.60 (CHarom); 133.43 (d, 
JCP = 4.6 Hz, =Cq); 139.37 (Cq,arom). 31P NMR δ (121 MHz, ppm): 24.69. IR ν (cm-1): 
1249 (P=O); 1057, 1029 (P-O). MS m/z (%): 282 (100, [M+H]+). Yield: 58%. 
Colourless oil. 
 
Dimethyl 1,3-dibenzyl-2,5-dihydro-1H-pyrrol-2-yl phosphonate (31c) 
1H NMR δ (300 MHz, ppm): 3.20-3.34 (1H, multiplet, NCHAHB); 3.43 
(1H, d (br.), JAB = 16.2 Hz, CHAHBPh); 3.60 (1H, d, JAB = 13.2 Hz, 
NCHAHBPh); 3.63-3.76 (2H, multiplet, NCHACHB, CHAHBPh); 3.80 
(3H, d, JHP = 10.5 Hz, OCH3); 3.82 (3H, d, JHP = 10.5 Hz, OCH3); 3.89-
3.94 (1H, multiplet, CHP); 4.13 (1H, d, JAB = 13.2 Hz, CHAHBPh); 
5.43-5.48 (1H, multiplet, =CH); 7.20-7.34 (10H, multiplet, CHarom). 
13C NMR δ (75 MHz, ppm): 35.33 (CH2Ph); 53.29 (d, JCP = 6.9 Hz, 
OCH3); 53.39 (d, JCP = 8.1 Hz, OCH3); 59.93 (d, JCP = 6.9 Hz, CH2N); 60.65 (d, 
JCP = 6.9 Hz, CH2Ph); 69.04 (d, JCP = 173.1 Hz, CHP); 125.76 (d, JCP = 11.5 Hz, =CH); 
126.37, 127.06, 128.34, 128.49, 128.73, 129,15 (CHarom); 137.67 (d, JCP = 4.6 Hz, 
=Cq); 138.89, 139.24 (Cq,arom). 31P NMR δ (121 MHz, ppm): 24.69. IR ν (cm-1): 1245 
(P=O); 1056, 1029 (P-O). MS m/z (%): 358 (100, [M+H]+) 248 (34, [M+H-PO(OMe)2]+). 
Yield: 62%. Colourless oil. 
 
Dimethyl 1-benzyl-3-isopentyl-2,5-dihydro-1H-pyrrol-2-yl phosphonate 
(31d) 
1H NMR δ (300 MHz, ppm): 0.90 (3H, ~t, J = 6.7 Hz, CH3); 1.25-1.38 
(4H, multiplet, CH3, CH); 1.42-1.55 (2H, multiplet, CH2); 2.06-2.31 
(2H, multiplet, CH2Cq=); 3.20-3.34 (1H, multiplet, NCHAHB); 3.63 (1H, 
d, JAB = 13.2 Hz, NCHAHBPh); 3.65-3.78 (1H, multiplet, NCHACHB); 
3.80 (3H, d, JHP = 10.2 Hz, OCH3); 3.81 (3H, d, JHP = 10.2 Hz, OCH3); 
3.93-3.99 (1H, multiplet, CHP); 4.24 (1H, d, JAB = 13.2 Hz, CHAHBPh); 
5.51 (1H, s (br.), =CH); 7.21-7.38 (5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 
14.15 (CH3); 22.59 (CH3); 27.28 (CH2); 28.76 (CH2Cq=); 31.64 (CH); 53.36 (d, 
JCP = 6.9 Hz, 2xOCH3); 60.02 (d, JCP = 8.1 Hz, CH2N); 60.81 (d, JCP = 6.9 Hz, CH2Ph); 
69.87 (d, JCP = 174.2 Hz, CHP); 123.28 (d, JCP = 11.5 Hz, =CH); 127.01, 128.34, 
128.67 (CHarom); 138.34 (d, JCP = 4.6 Hz, =Cq); 139.45 (Cq,arom). 31P NMR δ (121 MHz, 
ppm): 24.91. IR ν (cm-1): 1249 (P=O); 1058, 1032 (P-O). MS m/z (%): 338 (100, 
[M+H]+); 228 (17, [M+H-PO(OMe)2]+). Yield: 70%. Colourless oil. 
 
Dimethyl 1-benzyl-3-phenyl-2,5-dihydro-1H-pyrrol-2-yl phosphonate 
(31e) 
Could only be isolated together with small amounts of pyrrole 30e 
because of spontaneous oxidation. Spectral data given below are 
determined from the mixture and are indicative. 
1H NMR δ (300 MHz, ppm): 3.51 (3H, d, JHP = 10.5 Hz, OCH3); 3.52-
3.60 (1H, multiplet, NCHAHB); 3.64 (3H, d, JHP = 10.5 Hz, OCH3); 3.82 
(1H, d, JAB = 13.2 Hz, NCHAHBPh); 3.93-4.05 (1H, multiplet, 
NCHACHB); 4.15 (1H, d, JAB = 13.2 Hz, NCHAHBPh); 4.54-4.59 (1H, multiplet, CHP); 
6.17-6.19 (1H, multiplet, =CH); 7.19-7.45 (10H, multiplet, CHarom). 13C NMR δ (75 
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MHz, ppm): 53.20 (d, JCP = 6.9 Hz, OCH3); 60.60 (d, JCP = 4.5 Hz, CH2N); 61.22 (d, 
JCP = 9.2 Hz, CH2Ph); 68.67 (d, JCP = 173.1 Hz, CHP); 126.98 (d, JCP = 11.5 Hz, =CH); 
127.06, 127.24, 127.89, 128.25, 128.43, 128.84 (CHarom); 134.05 (Cq,arom) 137.52 (d, 
JCP = 3.5 Hz, =Cq); 139.12 (Cq,arom). 31P NMR δ (121 MHz, ppm): 24.64. 
 
5.4 Ring closure – oxidation to 2-phosphono pyrroles 
5.4.1 Preparation of N-Benzyl pyrroles 
To an ovendry roundbottom flask, 0.39 mmol of aminoalkenyl phosphonate 32 is 
added together with 4 ml of dry dichloromethane. The solution was stirred under a 
nitrogen atmosphere and 16.4 mg (5 mol%) of Grubbs’ second generation catalyst 
302 was added. The reaction mixture was then stirred for 2 hours at room 
temperature, giving approximately 60% conversion to the pyrroline. Then 94.8 mg 
(0.39 mmol) of TCQ was added and stirring was continued for 3 to 5 hours at room 
temperature.  The course of the reaction was conveniently monitored using 31P NMR 
spectra of samples directly from the reaction mixture. Only in case of phosphonate 
32e, complete conversion to pyrrole 30e needed 5 h at reflux followed by 12 h at 
room temperature. When complete conversion was obtained, the solvent was 
removed under reduced pressure. The pyrroles 30 were obtained in pure form as 
brownish oils using column chromatography on silica gel with a hexane, ethyl 
acetate mixture as a mobile phase. 
 
Dimethyl 1-benzyl-1H-pyrrol-2-yl phosphonate (30a) 
1H NMR δ (300 MHz, ppm): 3.60 (6H, d, JHP = 11.6 Hz, OCH3); 5.36 
(2H, s, NCH2); 6.22-6.26 (1H, multiplet, =CH); 6.86-6.89 (1H, 
multiplet, =CHCq); 6.90-6.94 (1H, multiplet, =CHN); 7.10–7.34 (5H, 
multiplet, CHarom). 13C NMR d (75 MHz, ppm): 52.44 (NCH2); 52.75 
(d, JCP = 4.6 Hz, OCH3); 109.12 (d, JCP = 13.8 Hz, =CH); 117.63 (d, JCP = 227.3 Hz, 
=CqP); 122.47 (d, JCP = 17.3 Hz, =CHCq); 127.19, 127.73, 128.67 (CHarom); 129.04 (d, 
JCP = 11.5 Hz, =CHN); 137.9 (Cq,arom). 31P NMR δ (121 MHz, ppm): 13.63. IR ν (cm-1): 
1250 (P=O); 1029 (br., P-O). MS m/z (%): 266 (100, [M+H]+). Chromatography: Rf = 
0.26 (Hex/EtOAc 40/60). Yield: 75%. Yellow oil. 
 
Dimethyl 1-benzyl-3-methyl-1H-pyrrol-2-yl phosphonate (30b) 
1H NMR δ (300 MHz, ppm): 2.29 (3H, d, J = 1.4 Hz, CH3); 3.53 (6H, 
d, JHP = 11.7 Hz, OCH3); 5.38 (2H, s, NCH2); 6.07-6.09 (1H, multiplet, 
=CH); 6.82 (1H, dd, JHP = 5.0 Hz, J = 2.5 Hz, =CHN); 7.07–7.35 (5H, 
multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 12.93 (CH3); 52.03 (d, 
JCP = 4.6 Hz, OCH3); 52.46 (NCH2); 111.25 (d, JCP = 15.0 Hz, =CH); 
113.49 (d, JCP = 226.1 Hz, =CqP); 126.91, 127.38 (CHarom); 128.54 (d, JCP = 12.7 Hz, 
=CHN); 128.50 (CHarom); 133.47 (d, JCP = 18.5 Hz, =Cq); 138.62 (Cq,arom). 31P NMR δ 
(121 MHz, ppm): 14.82. IR ν (cm-1): 1249 (P=O); 1025 (br., P-O). MS m/z (%): 280 
(100, [M+H]+). Chromatography: Rf = 0.27 (Hex/EtOAc 40/60). Yield: 84%. Yellow 
oil. 
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Dimethyl 1,3-dibenzyl-1H-pyrrol-2-yl phosphonate (30c) 
1H NMR δ (300 MHz, ppm): 3.47 (6H, d, JHP = 11.6 Hz, OCH3); 4.11 
(2H, s, CH2); 5.38 (2H, s, NCH2); 6.02 (1H, dd, JHP = 4.2 Hz, 
J = 2.5 Hz, =CH); 6.84 (1H, dd, JHP = 5.0 Hz, J = 2.5 Hz, =CHN); 
7.07–7.35 (10H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 
33.06 (CH2); 52.07 (d, JCP = 5.8 Hz, OCH3); 52.48 (NCH2); 110.89 (d, 
JCP = 16.2 Hz, =CH); 113.47 (d, JCP = 226.0 Hz, =CqP); 125.70, 
126.92, 127.43, 128.19, 128.51 (CHarom); 128.73 (d, JCP = 11.5 Hz, 
=CHN); 128.80 (CHarom); 137.15 (d, JCP = 18.5 Hz, =Cq); 138.44 (Cq,arom); 141.78 
(Cq,arom). 31P NMR δ (121 MHz, ppm): 14.39. IR ν (cm-1): 1240 (P=O); 1023 (br., P-O). 
MS m/z (%): 356 (100, [M+H]+). Chromatography: Rf = 0.29 (Hex/EtOAc 40/60). 
Yield: 72%. Yellow oil. 
 
Dimethyl 1-benzyl-3-isopentyl-1H-pyrrol-2-yl phosphonate (30d) 
1H NMR δ (300 MHz, ppm): 0.87-0.92 (3H, multiplet, CH3); 1.28-
1.40 (4H, multiplet, CH, CH3); 1.54-1.64 (2H, multiplet, CH2); 2.69 
(2H, t, J = 7.8 Hz, CH2Cq=); 3.52 (6H, d, JHP = 11.6 Hz, OCH3); 5.38 
(2H, s, NCH2); 6.13 (1H, dd, JHP = 4.1 Hz, J = 2.8 Hz, =CH); 6.84 (1H, 
dd, JHP = 5.1 Hz, J = 2.8 Hz, =CHN); 7.06–7.32 (5H, multiplet, 
CHarom). 13C NMR δ (75 MHz, ppm): 14.18 (CH3); 22.67 (CH3); 26.96 
(CH2Cq=); 31.03 (CH2); 31.89 (CH); 52.08 (d, JCP = 5.8 Hz, OCH3); 
52.47 (NCH2); 109.86 (d, JCP = 15.0 Hz, =CH); 112.92 (d, JCP = 226.1 Hz, =CqP); 
126.95, 127.42, 128.55 (CHarom); 128.71 (d, JCP = 12.7 Hz, =CHN); 138.78 (Cq,arom); 
139.38 (d, JCP = 19.6 Hz, =Cq). 31P NMR δ (121 MHz, ppm): 14.87. IR ν (cm-1): 1250 
(P=O); 1025 (br.) (P-O). MS m/z (%): 336 (100, [M+H]+). Chromatography: Rf = 0.46 
(Hex/EtOAc 40/60). Yield: 70%. Yellow oil. 
 
Dimethyl 1-benzyl-3-phenyl-1H-pyrrol-2-yl phosphonate (30e) 
1H NMR δ (300 MHz, ppm): 3.36 (6H, d, JHP = 11.6 Hz, OCH3); 5.57 
(2H, s, NCH2); 6.29 (1H, dd, JHP = 4.0 Hz, J = 2.5 Hz, =CH); 6.94 (1H, 
dd, JHP = 5.0 Hz, J = 2.5 Hz, =CHN); 7.19–7.46 (10H, multiplet, 
CHarom). 13C NMR δ (75 MHz, ppm): 52.09 (d, JCP = 5.8 Hz, OCH3); 
52.95 (NCH2); 110.98 (d, JCP = 13.9 Hz, =CH); 113.79 (d, 
JCP = 226.1 Hz, =CqP); 126.88, 127.32, 127.58, 128.57 (CHarom); 
128.66 (d, JCP = 12.7 Hz, =CHN); 129.46 (CHarom); 135.99 (Cq,arom); 137.46 (d, 
JCP = 18.5 Hz, =Cq); 138.28 (Cq,arom). 31P NMR δ (121 MHz, ppm): 13.77. IR ν (cm-1): 
1249 (P=O); 1053, 1028 (br., P-O). MS m/z (%): 342 (100, [M+H]+). 
Chromatography: Rf = 0.30 (Hex/EtOAc 40/60). Yield: 75%. Brown oil. 
 
Dimethyl 1-benzyl-3-(2-phenylethyl)-1H-pyrrol-2-yl phosphonate (30f) 
1H NMR δ (300 MHz, ppm): 2.87-2.92 (2H, multiplet, CH2Ph); 3.01-
3.06 (2H, multiplet, CH2CH2Ph); 3.47 (6H, d, JHP = 11.6 Hz, 2 x 
OCH3); 5.37 (2H, s, NCH2); 6.13 (1H, dd, J = 4.1 Hz, J = 2.5 Hz, 
NCHCH); 6.84 (1H, dd, J = 5.0 Hz, J = 2.5 Hz, NCH); 7.03-7.35 (10H, 
multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 29.19 (CH2CH2Ph); 
37.89 (CCH2); 52.11 (d, JCP = 5.8 Hz, 2 x OCH3); 52.52 (NCH2); 
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110.12 (d, JCP = 16.2 Hz, NCHCH); 113.32 (d, JCP = 225.0 Hz, CP); 125.81 (CHarom); 
126.87 (2 x CHarom); 127.47 (CHarom); 128.29 (2 x CHarom); 128.58 (2 x CHarom); 128.62 
(d, JCP = 12.7 Hz, NCH); 128.75 (2 x CHarom); 138.24 (d, JCP = 19.6 Hz, NCC); 138.75 
(Cq,arom); 142.32 (Cq,arom). 31P NMR δ (121 MHz, ppm): 14.52. IR ν (cm-1): 1248 (P=O); 
1025 (P-O). MS m/z (%): 370.2 (100, [M+H]+). Chromatography: Rf = 0.27 
(Hex/EtOAc 60/40). Yield: 71%. Brown oil. 
 
5.4.2 Preparation of NH-pyrroles 
To an ovendry roundbottom flask, 0.61 mmol of aminoalkenyl phosphonate 
22e,m was added together with 6 ml of dry dichloromethane and 149 mg 
(0.61 mmol) of TCQ. The solution was stirred under a nitrogen atmosphere 
and 25.7 mg (5 mol%) of Grubbs’ second generation catalyst 302 was added. 
The reaction mixture was then stirred during 23 hours at reflux temperature.  
The course of the reaction was conveniently monitored using 31P NMR 
spectra of samples directly taken from the reaction mixture. When complete 
conversion was obtained, the solvent was removed under reduced pressure. 
The pyrroles 312 were obtained in pure form as brownish oils using column 
chromatography on silica gel with an hexane, ethyl acetate mixture as mobile 
phase. 
 
Dimethyl 1H-pyrrol-2-yl phosphonate (312a) 
1H NMR δ (300 MHz, ppm): 3.73 (6H, d, JH-P = 11.6 Hz, OCH3); 
6.29-6.33 (1H, multiplet, =CH); 6.73-6.76 (1H, multiplet, =CHCq); 
7.07-7.10 (1H, multiplet, =CHN). 13C NMR δ (75 MHz, ppm): 53.00 
(d, JCP = 5.8 Hz, OCH3); 109.93 (d, JCP = 15.0 Hz, =CH); 115.16 (d, JCP = 230.8 Hz, 
=CqP); 118.65 (d, JCP = 17.3 Hz, =CHCq); 124.59 (d, JCP = 12.7 Hz, =CHN). 31P NMR δ 
(121 MHz, ppm): 15.01. IR ν (cm-1): 3199 (NH); 1244 (P=O); 1029 (br.) (P-O). MSEI 
m/z (%): 175 (100, M+); 130 (30); 80 (87); 67 (47). Chromatography: Rf = 0.20 
(EtOAc).  Yield: 39%. Brown oil. 
 
Dimethyl 3-isopentyl-1H-pyrrol-2-ylphosphonate (312b) 
1H NMR δ (300 MHz, ppm): 0.86-0.92 (3H, multiplet, CH3); 1.25-
1.41 (4H, multiplet, CH, CH3); 1.52-1.63 (2H, multiplet, CH2); 2.58 
(2H, t, J = 7.8 Hz, CH2Cq=); 3.71 (6H, d, JHP = 11.6 Hz, OCH3); 6.18-
6.21 (1H, multiplet, =CH); 6.93-6.97 (1H, multiplet, =CHN). 13C NMR 
δ (75 MHz, ppm): 14.04 (CH3); 22.54 (CH3); 26.28 (CH2Cq=); 30.64 
(CH2); 31.70 (CH); 52.44 (d, JCP = 5.8 Hz, OCH3); 110.82 (d, 
JCP = 15.0 Hz, =CH); 111.74 (d, JCP = 229.6 Hz, =CqP); 123.35 (d, JCP = 11.5 Hz, 
=CHN); 135.21 (d, JCP = 18.5 Hz, =Cq). 31P NMR δ (121 MHz, ppm): 16.21. IR ν 
(cm-1): 3215 (NH); 1245 (P=O); 1053, 1030 (P-O). MS m/z (%): 246 (100, [M+H]+). 
Chromatography: Rf = 0.23 (Hex/EtOAc 2/3).  Yield: 27%. Brown oil. 
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5.5 Evaluation of the preparation of bicyclic phosphono β-lactams via 
RCM 
5.5.1 Evaluation of the ring closure of β-lactam 23e 
A solution of 0.32 g (1 mmol) of N-allyl lactam 23e in 2 ml of dry 
dichlormethane was added to a solution of 42.5 mg (5 mol%) of Grubbs’ 
second generation catalyst 302 in 1 ml of dry dichloromethane under a 
nitrogen atmosphere. The resulting mixture was heated under reflux for one 
hour, before the solvent was evaporated under reduced pressure. The dimeric 
azetidinone 314 could be obtained as a mixture of E and Z isomers using 
column chromatography. Signals of the major and minor isomers are 
indicated as ‘m’ and ‘M’ whenever possible. Major/Minor : 67/33. 
 
Tetramethyl 4-oxo-1-[(2E)-4-(4-oxo-2-phosphono-2-(2-phenylethenyl)-
azetidin-1-yl)but-2-enyl]-2-(2-phenylethenyl)azetidin-2-yl phosphonate 
(314) 
1H NMR δ (300 MHz, ppm): 2.89-3.07 (2x 1H, 
multiplet, CHAHB, m+M); 3.33-3.54 (2x 1H, multiplet, 
CHAHB, m+M); 3.79-3.94 (2x 7H, multiplet, 2x OCH3, 
CHAHBN, m+M); 4.04-4.18 (2x 1H, multiplet, CHAHBN); 
5.82-5.92 (2x 1H, multiplet, =CHCH2, m+M); 6.36-6.51 
(2x 1H, multiplet, =CHCq, m+M); 6.66-6.83 (2x 1H, 
multiplet, =CHPh, m+M); 7.26-7.42 (2x 5H, multiplet, 
=CHarom). 13C NMR δ (75 MHz, ppm): 43.52 (NCH2, m); 
43.63 (NCH2, M); 47.57 (CH2, m); 47.89 (CH2, M); 53.82 
(d, JCP = 8.1 Hz, OCH3); 54.13 (d, JCP = 6.9 Hz, OCH3); 
58.72 (d, JCP = 167.3 Hz, CHP, m); 58.75 (d, 
JCP = 167.3 Hz, CHP, M); 122.70 (d, JCP = 6.9 Hz, =CHCq, m); 122.84 (d, JCP = 6.9 Hz, 
=CHCq, m); 126.87 (CHarom, m+M); 128.15 (=CHCH2, m); 128.22 (=CHCH2, M); 
128.70, 128.83 (CHarom, m+M); 134.26 (d, JCP = 9.2 Hz, =CHPh, M); 134.31 (d, 
JCP = 9.2 Hz, =CHPh, m); 135.50 (br., Cq,arom); 165.87 (d, JCP = 8.1 Hz, CO, m+M).  31P 
NMR δ (121 MHz, ppm): 24.21 (m); 24.27 (M). IR ν (cm-1): 1757 (C=O); 1251 (P=O); 
1032 (br., P-O). MS m/z (%): 615 (100, [M+H]+). Chromatography: Rf = 0.18 
(CH3CN/CH2Cl2/MeOH 77/20/3).  Yield: 43%. Yellow oil. 
 
5.5.2 Preparation of N-acetyl 2-phosphono pyrrolines 
A 0.05 M solution of 1-(acetylallylamino)alkenyl phosphonate 21e or 255a in 
dry dichloromethane was stirred at room temperature under a nitrogen 
atmosphere. Then, 5 mol% of Grubbs’ second generation catalyst 302 was 
added and the reaction mixture was refluxed for 2 h, giving complete 
conversion to the corresponding pyryolines. The solvent was evaporated 
under reduced pressure and the catalyst was removed over a short silica gel 
column. 
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Dimethyl 1-chloroacetyl-2,5-dihydro-1H-pyrrol-2-yl phosphonate (34) 
Obtained as a mixture of two rotamers (ratio 33/67 at 22°C) 
1H NMR δ (300 MHz, ppm): 3.80 (3H, d, JHP = 10.7 Hz, OCH3, 
M); 3.82 (3H, d, JHP = 10.5 Hz, OCH3, M); 3.77-3.84 (7+1H, 
multiplet, OCH3, m, NCHAHB, m+M); 4.10 (2H, s, CH2Cl, M); 
4.24 (1H, d, JAB = 12.9 Hz, CHAHBCl, m); 4.41-4.48 (2x1H, 
multiplet, NCHAHB, m+M); 4.61 (1H, d, JAB = 12.9 Hz, CHAHBCl, m); 5.08-5.14 (1H, 
multiplet, CHP, m); 5.17-5.23 (1H, multiplet, CHP, M); 5.84-6.12 (2x2H, multiplet, 
HC=CH, m+M). 13C NMR δ (75 MHz, ppm): 41.66 (CH2Cl, m); 41.75 (CH2Cl, M); 
53.12 (d, JCP = 5.8 Hz, OCH3, M); 53.71 (d, JCP = 6.9 Hz, OCH3, m); 53.89 (d, JCP = 
6.9 Hz, OCH3, M); 54.09 (NCH2, M); 54.13 (d, JCP = 6.9 Hz, OCH3, m); 54.62 (NCH2, 
m); 61.32 (d, JCP = 158.1 Hz, CHP, M); 61.49 (d, JCP = 160.4 Hz, CHP, m); 123.41 (d, 
JCP = 8.1 Hz, =CH, m); 124.76 (d, JCP = 6.9 Hz, =CH, M); 127.80 (d, JCP = 10.4 Hz, 
=CH, M); 129.25 (d, JCP = 10.4 Hz, =CH, m); 165.09 (CO, M); 166.17 (CO, m). 31P 
NMR δ (121 MHz, ppm): 21.66 (m); 22.91 (M). IR ν (cm-1): 1666 (C=O); 1623 
(C=C); 1247 (P=O); 1036 (br., P-O). MS m/z (%): 254 (100, [M+H]+); 256 (28, 
[M+H+2]+). Chromatography: Rf = 0.10 (EtOAc).  Yield: 63%. Brown oil. 
 
Dimethyl 1-acetyl-2,5-dihydro-1H-pyrrol-2-yl phosphonates (315) 
Obtained as a mixture of two rotamers (ratio 28/72 at 22°C) 
1H NMR δ (300 MHz, ppm): 2.13 (3H, s, CH3, M); 2.27 (3H, s, CH3, 
m); 3.81 (3H, d, JHP = 10.2 Hz, OCH3, M); 3.81 (3H, d, JHP = 10.5 Hz, 
OCH3, m); 4.00-4.11 (1H, multiplet, NCHAHB, m); 4.31-4.39 (2H, 
multiplet, NCH2, M); 4.63 (1H, dd, J = 16.9 Hz, J = 16.9 Hz, NCHAHB, 
m); 4.90 (1H, s (br.), CHP, m); 5.15-5.21 (1H, multiplet, CHP, M); 5.83-6.12 (2x2H, 
multiplet, HC=CH, m+M). 13C NMR δ (75 MHz, ppm): 21.98 (CH2Cl, m); 22.28 
(CH2Cl, M); 52.78, 52.84, 53.67 (br., OCH3, m+M, NCH2, m); 54.81 (NCH2, M); 60.47 
(d, JCP = 158.1 Hz, CHP, M); 62.42 (d, JCP = 160.4 Hz, CHP, m); 123.63 (d, JCP = 
8.1 Hz, =CH, m); 124.91 (br., =CH, M); 128.11 (d, JCP = 10.4 Hz, =CH, M); 129.64 (d, 
JCP = 9.2 Hz, =CH, m); 169.12 (CO, M); 170.29 (CO, m). 31P NMR δ (121 MHz, ppm): 
23.86 (m); 22.18 (M). IR ν (cm-1): 1651 (C=O); 1620 (C=C); 1245 (P=O); 1033 
(br., P-O). MS m/z (%): 220 (100, [M+H]+). Chromatography: Rf = 0.13 
(EtOAc).  Yield: 68%. Brown oil. 
 
 
6 Synthesis of tricyclic phosphono pyrrolidines 
6.1 Preparation of dimethyl (acryloylbenzylamino)furan-2-ylmethyl 
phosphonate (321) 
A solution of 5 mmol of 1-benzylamino-2-furan-2-ylmethyl phosphonate (22y) and 
10 mmol of pyridine in 12 ml of dry THF was stirred at room temperature under a 
nitrogen atmosphere.  A solution of 7.5 mmol of acryloyl chloride in 3 ml of dry THF 
was added dropwise to the reaction mixture using a syringe and stirring was 
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continued for 3 h at room temperature. Then the mixture was poured into 15 ml of a 
saturated NaHCO3(aq) solution and 15 ml of diethyl ether. The organic phase was 
collected and the remaining water phase was washed twice with 10 ml of diethyl 
ether. The combined organic phases were then washed with 10 ml of 1 M HCl(aq) and 
dried with MgSO4. The product was obtained in high purity after filtration of the 
solids and evaporation of the solvent under reduced pressure. 
 
1H NMR δ (300 MHz, ppm): 3.71 (3H, d, JHP = 10.7 Hz, OCH3); 
3.80 (3H, d, JHP = 11.0 Hz, OCH3); 4.81 (1H, d, JAB = 18.2 Hz, 
NCHAHB); 5.10 (1H, d, JAB = 18.2 Hz, NCHAHB); 5.63 (1H, dd, 
J = 10.1 Hz, JAB = 2.1 Hz, =CHAHB); 6.19 (1H, multiplet, CH=CHO); 
6.32 (1H, dd, J = 16.5 Hz, J = 9.9 Hz, HC=CH2); 6.46 (1H, dd,  
J = 16.5 Hz, JAB = 2.2 Hz, =CHAHB); 6.62 (1H, d, J = 2.7 Hz, CH=CqO); 6.70 (1H, d, 
JHP = 23.2 Hz, CHP); 6.88 (2H, multiplet, CHarom); 7.09-7.20 (3H, multiplet, CHarom); 
7,25 (1H, d (br.), J = 1.1 Hz, CHO). 13C NMR δ (75 MHz, ppm): 47.19 (d, 
JCP = 162.7 Hz, CHP); 48.95 (CH2N); 53.44 (d, JCP = 6.9 Hz, OCH3); 53.84 (d, 
JCP = 6.9 Hz, OCH3); 110.75 (CH=CHO); 112.79 (CH=Cq); 125.38 (2x CHarom); 126.76 
(CHarom); 127.35 (HC=CH2); 128.31 (2x CHarom); 129.90 (=CH2); 137.54 (Cq,arom); 
143.28 (CHO); 146.31 (d, JCP = 10.4 Hz, CqO); 166.91 (d, JCP= 3.5 Hz, C=O). 31P NMR 
δ (121 MHz, ppm): 21.48. IR ν (cm-1): 1029 (P-O); 1053 (P-O); 1229-1252 (P=O); 
1647 (C=O). MS m/z (%): 350 (100 [M+H]+). Yield: 99%. 
 
6.2 Preparation of dimethyl (3-t-butyl-4-oxo-6-phenyl-10-oxa-3-aza-
tricyclo[5.2.1.01,5]dec-8-en-2-yl) phosphonate (323b) 
A solution of 5 mmol of t-butylaminofuran-2-ylmethyl phosphonate (22ab) and 10 
mmol of pyridine in 12 ml of dry THF was stirred at room temperature under a 
nitrogen atmosphere. A solution of 7.5 mmol of cinnamoyl chloride in 3 ml of dry 
THF was added dropwise to the reaction mixture using a syringe. The mixture was 
then refluxed for 7 h. Afterwards, the mixture was poured into 15 ml of a saturated 
NaHCO3(aq) solution and 15 ml of diethyl ether. The organic phase was collected and 
the remaining water phase was washed twice with 10 ml of diethyl ether. The 
combined organic phases were then washed with 10 ml of 1 M HCl(aq) and dried with 
MgSO4. After filtration of the solids and evaporation of the solvent under reduced 
pressure, a brown oil was found from which the ring closed product could be 
obtained in pure form using column chromatography. 
 
Dimethyl (3-t-butyl-4-oxo-6-phenyl-10-oxa-3-aza-tricyclo[5.2.1.01,5]dec-8-
en-2-yl)-phosphonate (323b) 
1H NMR δ (300 MHz, ppm): 1.56 (9H, s, 3x CH3); 2.84 (1H, d, 
J = 4.4 Hz, CHCqO); 3.75 (1H, dd, J = 4.4 Hz, J = 4.4 Hz, 
CHPh); 3.87 (3H, d, JHP = 5.8 Hz, OCH3); 3.90 (3H, d, 
JHP = 5.8 Hz, OCH3); 4.41 (1H, d, JHP = 5.0 Hz, CHP); 5.12 (1H, 
d, J = 4.4 Hz, CHO); 6.28 (1H, dd, J = 6.0 Hz, J = 1.7 Hz, 
=CHCHO); 6.75 (1H, d, J = 6.0 Hz, =CHCq); 7.13-7.29 (5H, multiplet, CHarom). 13C 
NMR δ (75 MHz, ppm): 27.89 (3x CH3); 49.13 (CHPh); 53.18 (d, JCP = 6.9 Hz, OCH3); 
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53.93 (d, JCP = 6.9 Hz, OCH3); 55.76 (CHCqO); 56.37 (NCq); 57.19 (d, CHP, 
JCP = 162.7 Hz); 81.67 (CHO); 91.14 (d, JCP = 8.1 Hz, CqO); 126.76 (CHarom); 128.04 
(2x CHarom); 128.34 (2x CHarom); 134.21 (=CHCq); 135.50 (=CHCHO); 139.20 (Cq,arom); 
175.52 (C=O). 31P NMR δ (121 MHz, ppm): 22.78. IR ν (cm-1):  1687 (C=O); 1251 
(P=O); 1032, 1046 (P-O). MS m/z (%): 392 (100, [M+H]+). Chromatography: Rf = 
0.27 (Hex/EtOAc 50/50). Yield: 19%. Yellow oil. 
 
 
6.3 Intramolecular Diels-Alder with furane (IMDAF) 
A solution of 1.25 g of a suitable allylamino-1-furan-2-yl-methyl phosphonate 
in 13 ml of toluene was refluxed until complete disappearance of the starting 
material was obtained (monitoring by 31P NMR). Then the solvent was 
removed under reduced pressure and the corresponding adducts were 
obtained in good purity. Further purification could be performed using 
column chromatography. 
 
Dimethyl 3-(2-chloroacetyl)-10-oxa-3-aza-tricyclo[5.2.1.01,5]dec-8-en-2-yl 
phosphonates (35a) 
The product was obtained as a mixture of two diastereoisomers (ratio: 27/73). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 1.64 (1H, dd, JAB = 11.6 Hz, 
J = 7.7 Hz, CHAHB, M); 1.86 (1H, ddd, JAB = 11.6 Hz, J = 4.4 Hz, 
J = 2.8 Hz, CHAHB, M); 2.33-2.42 (1H, multiplet, CH, m); 2.56-2.65 
(1H, multiplet, CH, M); 3.29 (1H, ~t, J ≈ 8.5 Hz, CHAHBN, M); 3.43 
(1H, dd, J = 12.1 Hz, J = 7.7 Hz, NCH2, m); 3.82 (3H, d, JHP = 10.7 Hz, OCH3, M); 
3.86 (3H, d, JHP = 11.0 Hz, OCH3, m); 3.88 (3H, d, JHP = 11.0 Hz, OCH3, M); 3.90 (3H, 
d, JHP = 10.7 Hz, OCH3, m); 4.03-4.15 (3+1H, multiplet, CH2Cl, M, CHAHBN, m+M); 
4.22 (1H, d, JAB = 12.9 Hz, CHAHBCl, m); 4.47 (1H, d, JAB = 12.9 Hz, CHAHBCl, m); 
4.68 (1H, d, JHP = 7.2 Hz, CHP, m); 4.97 (1H, d, JHP = 10.7 Hz, CHP, M); 5.04-5.09 
(2x1H, multiplet, OCH, m+M); 6.46 (2x 1H, dd, J = 5.9 Hz, J = 1.8 Hz, =CHCHO, 
m+M); 6.57 (1H, d, J = 5.8 Hz, =CH, m); 6.68 (1H, d, J = 5.8 Hz, =CH, M). 13C NMR δ 
(75 MHz, ppm): 34.38 (CH2); 36.51 (CH, m); 41.87, 42.04 (CH2Cl, m+M, CH, M); 
52.53 (NCH2, m+M); 53.45, 53.52, 53.60, 54.03, 54.12 (OCH3, m+M); 54.91 (d, JCP = 
159.2 Hz, CHP, M); 56.40 (d, JCP = 162.7 Hz, CHP, M); 79.22 (CHO, M); 79.31 (CHO, 
m); 94.01 (d, JCP = 9.2 Hz, OCq, M); 95.47 (d, JCP = 8.1 Hz, OCq, m); 132.75 (=CHCq, 
m); 133.06 (=CHCq, M); 137.6 (=CH, M); 137.79 (=CH, m); 165.76 (C=O, M); 166.45 
(C=O, m). 31P NMR δ (121 MHz, ppm): 21.31 (M); 21.48 (m). IR ν (cm-1): 1663 (C=O); 
1261 (P=O); 1050 (br., P-O). MS m/z (%): 322 (100, [M+H]+); 324 (32, [M+H+2]+). 
Chromatography: Rf = 0.33 (EtOAc/MeOH 97/3). Yield: 75%. Yellow oil. 
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Dimethyl 3-(4-chlorobutyryl)-10-oxa-3-aza-tricyclo[5.2.1.01,5]dec-8-en-2-
yl phosphonates (35b) 
The product was obtained as a mixture of two diastereoisomers (ratio: 20/80). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 1.59-1.67 (1H, multiplet, CHAHB, 
m); 1.63 (2x 1H, dd, JAB = 11.7 Hz, J = 7.7 Hz, CHAHB, m+M); 
1.85 (1H, ddd, JAB = 11.7 Hz, J = 4.4 Hz, J = 2.8 Hz, CHAHB, 
M); 2.06-2.24 (2x 2H, multiplet, CH2, m+M); 2.36-2.62 (1+3H, 
multiplet, CH2CO, M, CH, m+M); 2.76-2.86 (2H, multiplet, 
CH2CO, m); 3.25 (1H, ~t, J ≈ 9 Hz, NCHAHB, M); 3.44 (1H, dd, J = 11.8 Hz, 
J = 7.7 Hz, NCHAHB, m); 3.65 (2x2H, t, J = 6.1 Hz, CH2Cl); 3.79 (3H, d, JHP = 10.7 Hz, 
OCH3, M); 3.87 (3H, d, JHP = 10.7 Hz, OCH3, M); 3.77-3.88 (7H, multiplet, OCH3, 
NCHAHB, m); 3.99 (1H, ~t, J ≈ 9 Hz, NCHAHB, M); 4.52 (1H, d, JHP = 8.0 Hz, CHP, m); 
4.99 (1H, d, JHP = 10.2 Hz, CHP, M); 5.03-5.07 (2x1H, multiplet, OCH, m+M); 6.45 
(2x 1H, dd, J = 5.8 Hz, J = 1.7 Hz, =CHCHO, m+M); 6.60 (1H, d, J = 5.8 Hz, =CH, m); 
6.69 (1H, d, J = 5.8 Hz, =CH, M). 13C NMR δ (75 MHz, ppm): 27.51 (CH2, M); 27.85 
(CH2, m); 31.04 (CH2CO, M); 31.16 (CH2CO, m); 34.31 (CH2CHO, M); 34.51 (CH2CHO, 
m); 39.71 (CH, m); 41.79 (CH, M); 44.61 (CH2Cl, M); 44.78 (CH2Cl, m); 51.74 (NCH2, 
m); 52.71(NCH2, M); 53.19, 53.22, 53.30, 53.97 (OCH3, m+M); 54.13 (d, JCP = 
159.2 Hz, CHP, M); 56.61 (d, JCP = 162.7 Hz, CHP, M); 79.04 (CHO, m); 79.13 (CHO, 
M); 94.11 (d, JCP = 9.2 Hz, OCq, M); 95.29 (d, JCP = 9.2 Hz, OCq, m); 132.97 (=CHCq, 
m); 133.31 (=CHCq, M); 137.32 (=CH, M); 137.49 (=CH, m); 171.14 (C=O, M); 171.89 
(C=O, m). 31P NMR δ (121 MHz, ppm): 21.61 (m); 22.16 (M). IR ν (cm-1): 1656 (C=O); 
1250 (P=O); 1040 (br., P-O). MS m/z (%): 350 (100, [M+H]+); 352 (33, [M+H+2]+). 
Chromatography: Rf = 0.13 (EtOAc). Mp.: 91.3°C. Yield: 47%. Yellow crystals. 
 
Dimethyl 3-(isobutyryl)-10-oxa-3-aza-tricyclo[5.2.1.01,5]dec-8-en-2-yl 
phosphonates (35c) 
The product was obtained as a mixture of two diastereoisomers (ratio: 15/85). Only 
the signals of the major isomer are reported. 
1H NMR δ (300 MHz, ppm): 1.11 (3H, d, J = 6.9 Hz, CH3); 1.17 
(3H, d, J = 6.9 Hz, CH3); 1.62 (1H, dd, JAB = 11.6 Hz, J = 7.7 Hz, 
CHAHB); 1.83 (1H, ddd, JAB = 11.6 Hz, J = 4.4 Hz, J = 3.0 Hz, 
CHAHB); 2.53-2.65 (1H, multiplet, CH); 2.64 (1H, septet, J = 6.9 Hz, 
CH(CH3)2); 3.28 (1H, dd, JAB = 9.5 Hz, J = 9.5 Hz, CHAHBN); 3.78 
(3H, d, JHP = 10.7 Hz, OCH3); 3.86 (3H, d, JHP = 10.7 Hz, OCH3); 4.01 (1H, ddd, 
JAB = 9.5 Hz, J = 9.5 Hz, J2 = 0.9 Hz, CHAHBN); 5.03-5.06 (2H, multiplet, CHO, CHP); 
6.44 (1H, dd,  J = 6.0 Hz, J = 1.9 Hz, =CHCq); 6.70 (1H, d, J = 6.0 Hz, =CHCHO). 13C 
NMR δ (75 MHz, ppm): 18.37 (CH3); 19.68 (CH3); 32.20 (CH(CH3)2); 34.43 (CH2); 
41.87 (CHCq); 52.49 (CH2N); 53.20 (d, JCP = 5.8 Hz, OCH3); 53.28 (d, JCP = 5.8 Hz, 
OCH3); 54.03 (d, JCP = 159.2 Hz, CHP); 79.10 (CHO); 93.98 (d, JCP = 10.4 Hz, CqO); 
133.52 (=CHCq); 137.49 (=CH); 176.47 (C=O). 31P NMR δ (121 MHz, ppm): 21.63 
(m); 22.44 (major). IR ν (cm-1): 1639 (C=O); 1249 (P=O); 1040 (br., P-O). MS m/z (%): 
316 (100, [M+H]+). Mp.: 110-111°C. Yield: 53%. Yellow crystals. 
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Dimethyl 3-(2,2-dichloroacetyl)-10-oxa-3-aza-tricyclo[5.2.1.01,5]dec-8-en-
2-yl phosphonates (35d) 
The product was obtained as a mixture of two diastereoisomers (ratio: 31/69). 
Signals of the major and minor isomers are indicated as ‘m’ and ‘M’ whenever 
possible. 
1H NMR δ (300 MHz, ppm): 1.66 (1H, dd, JAB = 11.6 Hz, 
J = 7.7 Hz, CHAHB, M); 1.87 (1H, ddd, JAB = 11.6 Hz, J = 4.4 Hz, 
J = 2.9 Hz, CHAHB, M); 2.34-3.44 (1H, multiplet, CH, m) 2.59-2.69 
(1H, multiplet, CH, M); 3.46 (1H, dd, JAB = 9.5 Hz, J = 9.5 Hz, 
NCHAHB); 3.82 (3H, d, JHP = 10.7 Hz, OCH3); 3.89 (3H, d, 
JHP = 10.7 Hz, OCH3); 3.72-3.94 (8H, multiplet, OCH3, NCH2, m) 4.17 (1H, ddd, 
JAB = 9.5 Hz, J = 9.5 Hz, J = 0.9 Hz, NCHAHB, M); 4.60 (1H, d, JHP = 6.6 Hz, CHP, m); 
4.98 (1H, d, JHP = 11.0 Hz, CHP, M); 5.07 (2x 1H, multiplet, CHO, m+M); 6.14 (1H, s, 
CHCl2, M); 6.43-6.50 (2x 1H, multiplet,  =CHCHO, m+M); 6.56 (1H, d, J = 6.1 Hz, 
=CHCq, m); 6.70 (1H, d, J = 5.8 Hz, =CHCq, M). 13C NMR δ (75 MHz, ppm): 34.29 
(CH2, m); 34.40 (CH2, M); 39.32 (CH, m); 42.14 (CH, M); 52.42 (NCH2, M); 53.30, 
53.51, 54.31, 54.35 (NCH2, m, OCH3, m+M); 55.61 (d, JCP = 158.1 Hz, CHP, M); 
56.46 (d, JCP = 161.5 Hz, CHP, m); 65.19 (CHCl2, M); 65.32 (CHCl2, m); 79.20 (CHO, 
M); 79.38 (CHO, m); 93.72 (d, JCP = 8.1 Hz, OCq, M); 95.49 (d, JCP = 6.9 Hz, OCq, m); 
132.48 (=CHCq, m); 132.91 (=CHCq, M); 137.60 (=CH, M); 137.93 (=CH, m); 162.50 
(C=O, M); 163.28 (C=O, m). 31P NMR δ (121 MHz, ppm): 20.80 (M); 20.91 (m). IR ν 
(cm-1): 1677 (C=O); 1253 (P=O); 1021-1054 (P-O). MS m/z (%): 356 (100, [M+H]+); 
358.3 (63 [M+H+2]+); 360.0 (9 [M+H+4]+). Chromatography: Rf = 0.33 (EtOAc). 
Mp.: 120-121°C. Yield: 94%. Yellow crystals. 
 
Dimethyl 3-(2,2,2-trichloroacetyl)-10-oxa-3-aza-tricyclo[5.2.1.01,5]dec-8-
en-2-yl phosphonates (35e) 
The product was obtained in quantitative yield as a mixture of two diastereoisomers 
(ratio: 21/79). The major isomer could be obtained in pure form by washing the 
crystals several times with acetone. The remaining filtrate was enriched with the 
minor isomer, which could be obtained in pure form by subsequent column 
chromatography. 
 
Major isomer: 
1H NMR δ (300 MHz, ppm): 1.42 (1H, dd, JAB = 11.8 Hz, 
J = 7.4 Hz, CHAHB); 1.81 (1H, ddd, JAB = 11.8 Hz, J = 3.6 Hz, 
J = 3.6 Hz); 2.08 (1H, multiplet, CH); 3.40 (1H, dd, JAB = 11.3 Hz, 
J = 11.3 Hz, CHAHBN); 3.79 (3H, d, JHP = 11.0 Hz, OCH3); 3.83 (3H, 
d, JHP = 11.0 Hz, OCH3); 4.73 (1H, dd, JAB = 11.3 Hz, J = 6.9 Hz, 
CHAHBN); 5.07 (1H, d, JHP = 14.0 Hz, CHP); 5.25 (1H, d, J = 4.4 Hz, OCH); 6.46 (2H, 
multiplet, HC=CH). 13C NMR δ (75 MHz, ppm): 28.70 (CH2); 44.77 (d, JCP = 2.3 Hz, 
CH); 53.36 (d, JCP = 6.9 Hz, OCH3); 53.61 (d, JCP = 5.8 Hz, OCH3); 55.70 (NCH2); 
56.03 (d, JCP = 160.4 Hz, CHP); 81.36 (CHO); 92.97 (CCl3); 94.42 (d, JCP = 4.6 Hz, 
OCq); 134.39 (=CHCq); 136.86 (=CH); 159.69 (C=O). 31P NMR δ (121 MHz, ppm): 
20.70. IR ν (cm-1): 1675 (C=O); 1261 (P=O); 1058, 1039 (P-O). MS m/z (%): 390 (86, 
[M+H]+); 392 (100, [M+H+2]+); 394 (24, [M+H+4]+). Mp.: 176-177°C. 
Chromatography: Rf = 0.25 (EtOAc). White crystals. 
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Minor isomer: 
1H NMR δ (300 MHz, ppm): 1.67 (1H, dd, JAB = 11.6 Hz, 
J = 7.7 Hz, CHAHB); 1.87 (1H, ddd, JAB = 11.6 Hz, J = 4.1 Hz, 
J = 3.3 Hz); 2.59-2.68 (1H, multiplet, CH); 3.80-3.89 (1H, multiplet, 
CHAHBN); 3.83 (3H, d, JHP = 11.0 Hz, OCH3); 3.89 (3H, d, 
JHP = 10.7 Hz, OCH3); 4.39 (1H, dd, J = 10.5 Hz, J = 9.6 Hz, 
CHAHBN); 5.04-5.10 (2H, multiplet, CHP, OCH); 6.47 (1H, dd, J = 5.9 Hz, J = 1.7 Hz, 
=CHCHO); 6.69 (1H, d, J = 5.9 Hz, =CH). 13C NMR δ (75 MHz, ppm): 34.54 (CH2); 
42.96 (CH); 53.54 (d, JCP = 6.9 Hz, OCH3); 53.63 (d, JCP = 6.9 Hz, OCH3); 54.64 
(NCH2); 57.94 (d, JCP = 158.1 Hz, CHP); 79.10 (CHO); 93.08 (CCl3); 93.18 (d, JCP = 
3.5 Hz, OCq); 132.83 (=CHCq); 137.57 (=CHCHO); 159.52 (C=O). 31P NMR δ (121 
MHz, ppm): 20.89. IR ν (cm-1): 1672 (C=O); 1259 (P=O); 1054, 1037 (P-O). MS m/z 
(%): 390 (90, [M+H]+); 392 (100, [M+H+2]+); 394 (28, [M+H+4]+). Mp.: 121-122°C. 
Chromatography: Rf = 0.39 (EtOAc). White crystals. 
 
Dimethyl 3-allyl-10-oxa-3-aza-tricyclo[5.2.1.01,5]dec-8-en-2-yl 
phosphonate (320) 
1H NMR δ (300 MHz, ppm): 1.36 (1H, dd, JAB = 11.4 Hz, 
J = 7.3 Hz, CHAHB); 1.72 (1H, ddd, JAB = 11.4 Hz, J = 4.5 Hz, 
J = 2.5 Hz, CHAHB); 2.07-2.22 (2H, multiplet, CH, NCHAHB); 3.16 
(dd, 1H, JAB = 13.6 Hz, J = 8.2 Hz, NCHAHBCH=); 3.29 (1H, d, 
JHP = 6.6 Hz, CHP); 3.37 (1H, ddd, J = 6.4 Hz, J = 6.4 Hz, 
J = 1.7 Hz, NCHAHB); 3.77 (1H, ddt, JAB = 13.7 Hz, J = 4.8 Hz, J = 1.7 Hz, 
NCHAHBCH=); 3.86 (3H, d, JHP = 10.7 Hz, OCH3); 3.88 (3H, d, JHP = 10.7 Hz, OCH3); 
4.99 (1H, dt, J = 4.4 Hz, J = 1.4 Hz, CHO); 5.13 (1H, d, J = 10.1 Hz, =CHAHB); 5,21 
(1H, dd, J = 17.2 Hz, J2 = 1.1 Hz, =CHAHB); 5.91 (1H, dddd, J = 17.2 Hz, J = 10.1 Hz, 
J = 8.2 Hz, J = 4.8 Hz, =CH); 6.33 (1H, ddd, J = 6.1 Hz, J = 1.7 Hz, J = 0.6 Hz, 
=CHCHO); 6.62 (1H, d, J = 6.1 Hz, =CHCqO). 13C NMR δ (75 MHz, ppm): 30.32 
(CH2); 42.57 (CH); 53.26 (d, JCP = 7.0 Hz, OCH3); 53.63 (d, JCP = 8.1 Hz, OCH3); 
58.45, 58.60 (NCH2, NCH2CH=); 61.02 (d, JCP = 178.8 Hz, CHP); 79.47 (CHO); 96.67 
(d, JCP = 5.8 Hz, CqO); 117.38 (=CH2); 134.83 (=CHCqO); 134.91 (=CH); 135.63 
(=CHCHO). 31P NMR δ (121 MHz, ppm): 24.64. IR ν (cm-1):  1644 (C=C); 1235-1256 
(P=O); 1035, 1061 (P-O). MS m/z (%): 286 (100, [M+H]+). Chromatography: Rf = 
0.25 (EtOAc).  Yield: 23%. Yellow oil. 
 
Dimethyl 3-benzyl-4-oxo-10-oxa-3-aza-tricyclo[5.2.1.01,5]dec-8-en-2-yl 
phosphonate (323a) 
1H NMR δ (300 MHz, ppm): 1.65 (1H, dd, JAB = 12.4 Hz, 
J = 8.8 Hz, CHAHB); 2.25 (1H, ddd, JAB = 11.8 Hz, J = 4.6 Hz, 
J = 3.6 Hz, CHAHB); 2.67 (1H, dd, J = 8.8 Hz, J = 3.6 Hz, CHCq); 
3.82 (3H, d, JHP = 10.6 Hz, OCH3); 3.83 (3H, d, JHP = 10.7 Hz, 
OCH3); 3.93 (1H, d, JHP = 5.5 Hz, CHP); 4.26 (1H, d, JAB = 15.1 Hz, 
NCHAHB); 5.03 (1H, d, J = 4.6 Hz, CHO); 5.33 (1H, d, JAB = 15.1 Hz, CHAHBN); 6.38 
(1H, dd, J = 6.1 Hz, J = 1.7 Hz, =CHCHO); 6.58 (1H, d, J = 6.1 Hz, =CHCq) 7.20-7.36 
(5H, multiplet, CHarom). 13C NMR δ (75 MHz, ppm): 28.87 (CH2); 45.30 (NCH2); 46.60 
(CHCq); 53.13 (d, JCP = 6.9 Hz, OCH3); 53.47 (d, JCP = 6.9 Hz, OCH3); 54.84 (d, 
JCP = 162.7 Hz, CHP); 78.31 (CHO); 89.61 (d, JCP = 6.9 Hz, CqO); 127.60 (CHarom); 
N
O
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P(OMe)2
O
O
N
P(OMe)2
O
O
O
N
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O
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128.01 (2x CHarom); 128.66 (2x CHarom); 132.71 (=CHCq); 135.18 (Cq,arom); 136.91 
(=CHCHO); 174.84 (C=O). 31P NMR δ (121 MHz, ppm): 21.95. IR ν (cm-1):  1648 
(C=O); 1252 (P=O); 1029, 1052 (P-O). MS m/z (%): 350 (100, [M+H]+). Yield: 96%. 
Colourless oil. 
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  CHAPTER 5   
 
General  Discussion, Conclusions 
 and  Perspectives 
 
 
 
 
 
 
 
 
During the last five decades, the biological potential of the aminoalkyl 
phosphonates has been widely acknowledged with their use as amino acid 
bioisosteres, calcium complexing agents, tetrahedral transition state analogues, 
etc… This success has also brought azaheterocyclic phosphonates under the 
attention of many researchers, for example as conformationally restricted 
derivatives. However, this class of compounds is far less known and additional 
synthetic methods are required to obtain a wider variety of compounds belonging to 
this class. Mainly two strategies can be applied covering this challenge: (a) 
phosphonylation of a preformed azaheterocyclic ring, or (b) cyclization of a 
phosphonylated precursor. The latter can be considered to be the most versatile 
pathway and was evaluated for different substrates and ring closure reaction types 
in this research.  
 
Mainly α-aminoalkyl phosphonates have been used in this research as starting 
materials for further functionalization and ring closure. Next to the widely applied 
Kabachnik-Fields type three component condensation, α-aminoalkyl phosphonates 
can also be obtained via phosphonylation of a suitable imine. To overcome the poor 
nucleophilicity of dialkyl phosphites (i), they can be silylated first using TMSCl and 
a base. However, nucleophilic addition of (iii) to imines proceeded slowly, 
generating side products because of prolonged reaction times.  
 
O
P
H
OEt
OEt
P
HO
OEt
OEt
i ii
TMSCl P
TMSO
OEt
OEt
iii
Et3N, CH2Cl2
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Furthermore, when α,β-unsaturated imines (iv) were used, an unprecedented 1,4-
1,2-tandem addition was observed using dialkyl trimethylsilyl phosphites (iii). The 
reaction course was complicated by the occurrence of a kinetically favoured, 
reversible 1,2-addition. However, the more slowly proceeding 1,4-addition yields 
enamine (viii) which readily tautomerizes to the corresponding imine (ix) under 
acidic conditions. A fast second phosphite addition then yields the 
thermodynamically favoured 3-phosphonyl 1-aminoalkyl phosphonates (PAP) (xii). 
Imines carrying a less steric phenyl group on the nitrogen atom failed to react in the 
1,4-addition because the 1,2-addition is too much favoured causing the initial 
equilibrium to shift completely away from the imine (iv). From the atom balance of 
the reaction, it was clear that protons were consumed during the reaction. 
Therefore, the reaction was greatly enhanced by adding sulphuric acid to the 
medium. The intermediate enamine (viii) and imine (x) could only be detected by 
depleting the reaction mixture of protons causing the reaction to stop at the 
enamine stage. The second role of the acid appeared to be the activation of the 
imine by protonation. The reaction with tris(trimethylsilyl) phosphite proceeds via 
similar reaction kinetics, however yielding the corresponding free phosphonic acids 
after a final methanolysis. 
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Trialkyl phosphites (TAP) were found to perform the same 1,4-1,2-tandem addition. 
Modified reaction conditions were required to ensure dealkylation of the 
intermediate phosphonium salts. Nevertheless, a similar effect of protons to the 
reaction was observed. In the case of trialkyl phosphites, 1,2-addition is kinetically 
disfavoured. Therefore, no initial equilibrium with the 1,2-adduct was found. The 
1,4-adduct (xv) is the main reaction intermediate and the final 1,2-addition is the 
rate limiting step.  
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For this reason, only the 1,4-adducts could be obtained when the highly steric tBu 
group was used on nitrogen and optimal conversion to PAP was obtained with a 
phenyl substituent. This reactivity order is opposite to that of the DAPTMS addition, 
making both methods perfectly complementary. The difference in affinity towards 
1,2- or 1,4-addition between TAP and DAPTMS can not be explained based on steric 
or hard/soft dissimilarities. Coordination of the electrophilic silicon atom with the 
imine nitrogen atom brings the nucleophile and electrophile into close vicinity to 
each other, favouring nucleophilic attack in the 1,2-position. TAP on the other hand 
lacks any coordination and prefers 1,4-attack, probably because of steric reasons. 
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An excellent method to prepare the desired α-aminoalkyl phosphonates (xxiii) was 
developed then by refluxing aldimines in the presence of two equivalents of dialkyl 
phosphite (DAP) in methanol. No other additives were required. The excess of 
phosphite was easily removed via an acid/base extraction and the α-aminoalkyl 
phosphonates were obtained in high yield and purity. Furthermore, complete 
regioselectivity was observed when α,β-unsaturated imines are used. This 
observation supported the reaction mechanism proceeding through a four-
membered ring transition state (xxii).  
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The resulting α-aminoalkyl phosphonates (xxiii) could then be acylated using 
chloroacetyl chloride and triethyl amine, pyridine or pyridine/DMAP, depending on 
the R1 substituent. Furyl derivatives were converted most easily, while poor results 
were obtained with phenyl or alkyl derivatives. The same N-chloroacetyl aminoalkyl 
phosphonates (xxvi) could be obtained from the corresponding imines (xviii) via a 
one-pot acylation/phosphonylation in THF. Using these conditions, a very reactive 
acyliminium intermediate (xxiv) was formed, that could easily hydrolyse or 
eliminate hydrochloric acid. Therefore, this method was only useful when aromatic 
imines are used. Addition of a trialkyl phosphite then yielded phosphonium salt 
(xxv) which was subsequently dealkylated by the chloride anions present in the 
reaction medium. Also in this case, bad results were obtained with imines derived 
from benzaldehyde. When α,β-unsaturated imines were used, 1,4-addition of the 
phosphite was observed as a side reaction (up to 25%). 
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Treatment of the obtained N-chloroacetyl aminoalkyl phosphonates (xxvi) with a 
strong base, such as sodium hydride or LiHMDS, resulted in a phosphorus 
stabilized carbanion which is subsequently alkylated intramolecularly. The 
corresponding 4-phosphono β-lactams (xxviii) were obtained in high yield and 
purity, opposite to similar substrates reported before, carrying a carboxylate group 
instead of a phosphonate. This clearly illustrates the remarkable efficiency of a 
phosphonate group in stabilizing a carbanion. Nitrogen or phosphonate 
deprotection of the 4-phosphono β-lactams failed using several generally applied 
methods. 
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When N-chloroacetyl aminoalkenyl phosphonates (xxix) were used, an ambident 
anion was formed that could ring close to a four- or a six-membered ring. 
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Surprisingly, only the highly strained four-membered ring (xxxii) was formed. 
Replacing the phenyl group in (xxix) with a methyl resulted in problematic 
preparation of the corresponding N-chloroacetyl aminoalkenyl phosphonate and a 
complex mixture during the ring closure. When phosphonate (xxxiv) containing a 
bicyclic cyclohexenyl substituent was evaluated, no trace of the six-membered ring 
was found. 
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Intermolecular reactions with the anion generated from N-acetyl aminoalkenyl 
phosphonate (xxxv) which is not prone to intramolecular reactions, demonstrated 
its ambident nature. Reaction with hard (H+, D+) or soft electrophiles mainly 
proceeded at the γ-position. Therefore, HSAB considerations were not satisfactory to 
explain the particular regioselectivity of the intramolecular alkylation, which 
proceeded exclusively at the α-position. This was also confirmed by theoretical 
calculations displaying only small differences in hardness of both anionic positions. 
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Finally, the key factor determining the regioselectivity was found to be a hindered 
rotation around the N-Cα bond, causing the amide group to be pointing away from 
the γ-anionic position. This was confirmed by optimized conformation calculations 
of the anions and the transition states for four- en six-membered ring formation. 
Solvent and counterion effects needed to be taken properly into account in order to 
be able to correctly predict the actual conformations. 
 
From these results, it was clear that the alkenyl substituent and the nitrogen alkyl 
substituent are very proximate in this type of molecules. This property appeared to 
be advantageous for the synthesis of pyrrolines and pyrroles using RCM. For this 
reason, substituted acroleines (l) were converted to the corresponding α-
aminoalkenyl phosphonates (lii). Benzylation using benzyl bromide in the presence 
of K2CO3 then yielded phosphonates (liii) that were treated with 2nd generation 
Grubbs’ ruthenium catalyst to yield the corresponding 2-phosphono 3-pyrrolines 
(liv). Although ring-closing metathesis (RCM) has been developed to a powerful 
technique for the preparation of medium-sized rings, it has not been evaluated for 
the synthesis of azaheterocyclic phosphonates, until now. Furthermore, the RCM 
reaction proceeded smoothly in the presence of a nucleophilic nitrogen atom 
without the need to convert it to the hydrochloric acid salt. Also very high 
substitution patterns were well tolerated by the RCM catalyst on condition that 
initiation could occur on one of both olefins. 
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Furthermore, a one-pot protocol using Grubbs’ 2nd generation catalyst together with 
tetrachloroquinone (TCQ) was developed at the SynBioC research group to obtain 
the corresponding pyrroles. Applying this methodology to substrates (liii) then 
yields the corresponding 2-phosphono pyrroles (lv). A synergism was observed 
between the RCM catalyst and TCQ enhancing the oxidation rate and allowing 
substrates to the reaction that otherwise fail to react because of catalyst inhibition. 
Although phosphono pyrroles may possess interesting biological properties, they 
have been studied only very scarcely in the past. 
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In an attempt to synthesize carbapenem type structure (lxiii), β-lactam (lx) was 
submitted to the RCM catalyst. However, only dimerization occurred, probably 
because the lactam (lx) is missing the favourable conformation observed with N-acyl 
aminoalkenyl phosphonates (lix). When the five membered ring was constructed 
first using an RCM reaction, the subsequent ring closure to lactams (lxiii) failed. 
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Finally, the observed conformational properties of N-acyl aminoalkyl phosphonates 
have also been exploited to obtain complex azaheterocyclic phosphonates using an 
IMDAF reaction. For this purpose, (acylamino)-furan-2-yl-methyl phosphonates lxvi 
have been prepared using the reaction conditions described above. The 
cycloaddition was performed under thermal conditions in toluene giving the tricyclic 
phosphonates lxviii in high yield. The reaction rate was strongly dependent on the 
steric bulk of the amide side chain. Furthermore, a high degree of stereocontrol was 
observed during the cycloaddition reaction. The most stable stereoisomers were 
formed under thermodynamic control. 
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From the results in this research, some perspectives to future work have to be 
formulated regarding the preparation of azaheterocyclic phosphonates. Firstly, the 
structural characterization of the diphosphonylation products of α,β-unsaturated 
imines (PAP’s) should help other researchers to more easily detect these products in 
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their reaction mixtures when trying to make aminoalkyl phosphonates. In the past, 
many research groups have overlooked these products as minor constituents of 
their reaction mixtures because of their low visibility in NMR and their high 
retention on polar stationary phases during chromatographic purifications.  
 
Furthermore, the mechanistical considerations of the double addition reactions 
have led to a better understanding of the use of dialkyl, trialkyl and silylated 
phosphites as nucleophiles in phosphonylation reactions of imines. This should 
enable researchers to select the right nucleophile and reaction conditions 
depending on the type of aminoalkyl phosphonates desired. 
 
Secondly, using α-aminoalkyl phosphonates as substrates, a variety of 
azaheterocyclic phosphonates have been synthesized. A thorough screening of these 
derivatives is required in order to establish their biological potential, which may 
also be enhanced by further modification, e.g. dealkylation or hydrolysis of the 
phosphonate esters, nitrogen deprotection, ring opening of the oxa-bridge in the 
IMDAF products,… Also the PAP’s, being derivatives of glutamic acid, deserve a 
profound investigation of their biological activity. 
 
Finally, the structural insights that have been gained by studying the four-
membered ring formation starting from N-chloroacetyl aminoalkenyl phosphonates 
can be elaborated to a more diverse strategy to obtained azaheterocyclic 
phosphonates.  
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 
 
Summary 
 
 
 
 
 
 
 
 
 
In this thesis, new synthetic pathways to azaheterocyclic phosphonates were 
studied. Starting from imines, different types of aminoalkyl phosphonates can be 
obtained depending on the nucleophile and the reaction conditions used. With 
dialkyl phosphites, the desired α-aminoalkyl phosphonates are obtained in high 
yield and purity after a simple acid, base extraction. When dialkyl trimethylsilyl 
phosphites are reacted with α,β-unsaturated imines, 3-phosphono 1-aminoalkyl 
phosphonates (PAP’s) are obtained when the reaction is performed in a sufficiently 
strong acidic medium. The mechanism involves an initial 1,4-addition of the 
phosphite, followed by tautomerization of the intermediate enamine and a second 
phosphite addition. Similar products are obtained when trialkyl phosphites are 
used together with formic acid. However, the different impact of steric bulk of the 
substrate to the reaction end-product reveals mechanistic differences between both 
nucleophilic reagents. 
 
The obtained α-aminoalkyl phosphonates can be smoothly acylated to obtain N-
chloroacetyl aminoalkyl phosphonates. The same products can also be obtained 
starting from the imines in a one-pot acylation, phosphonylation through an 
intermediate acyliminium ion. However, several side reactions can be observed 
when using the second method. When treated with a strong base, a phosphorus 
stabilized carbanion is generated in the N-chloroacetyl aminoalkyl phosphonate, 
which then smoothly undergoes intramolecular alkylation yielding 4-phosphono β-
lactams. 
 
Also in the case of N-chloroacetyl aminoalkenyl phosphonates, that are giving rise 
to an ambident allyl anion, four-membered rings are formed exclusively. This 
unexpected phenomenon was studied in more detail on experimental and 
theoretical grounds. The transition state for the more stable six-membered ring is 
disfavoured with about 25 kJ/mol because of a restricted rotation about the N-C(P) 
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σ-bond. For this reason, the N-alkyl chain is proximate to the P-alkenyl chain. This 
conformational property of the N-acyl aminoalkyl phosphonates can also be 
exploited in other ring clsoure reactions. 
 
The aminoalkyl phosphonates under investigation therefore are excellent substrates 
for an RCM reaction between an N-allyl and the P-alkenyl chain. In this way, 2-
phosphono 3-pyrrolines can be formed. Also substrates containing basic nitrogen 
atoms are converted smoothly by the RCM catalyst. Basic 2-phosphono 3-pyrrolines 
can be oxidized to the corresponding 2-phosphono pyrroles using 
tetrachloroquinone. Both reactions, RCM and oxidation, can be performed in the 
same pot at the same time. Even more, a synergism between both reactions can be 
observed when secondary amines are used in the reaction. 
 
Finally, N-allyl furan-2-ylmethyl phosphonates are excellent substrates in IMDAF 
reactions because of their aforementioned conformational properties. In this way, 
tricyclic phosphono pyrrolidines can be formed with controlled stereochemistry. The 
reaction rate of the IMDAF reaction is enhanced due to the presence of a bulky 
phosphonate group. The stereochemistry of the products can be examined through 
careful investigation of the NMR spectral data. 
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 
 
Samenvatting 
 
 
 
 
 
 
 
 
 
In dit onderzoek werden nieuwe synthesewegen naar azaheterocyclische fosfonaten 
onderzocht. Verschillende types aminoalkylfosfonaten kunnen bekomen worden 
uitgaande van iminen, afhankelijk van het nucleofiel en de reactiecondities die 
worden gebruikt. Met dialkylfosfieten kunnen de gewenste α-aminoalkyl fosfonaten 
met hoog rendement en zuiverheid bekomen worden na een eenvoudige zuur, base 
extractie. Wanneer dialkyl trimethylsilylfosfieten gereageerd worden met α,β-
onverzadigde iminen, worden 3-fosfono-1-aminoalkylfosfonaten bekomen als de 
reactie uitgevoerd wordt onder voldoende zure condities. Het mechanisme van deze 
reactie omvat een 1,4-additie gevolgd door een tautomerisatie van het intermediaire 
enamine en een tweede fosfietadditie. Wanneer trialkylfosfieten gebruikt worden in 
combinatie met mierenzuur, worden dezelfde producten bekomen. De verschillende 
impact van de stericiteit van het substraat op het uiteindelijke eindproduct onthult 
mechanistische verschillen tussen beide fosforreagentia. 
 
De bekomen α-aminoalkylfosfonaten kunnen gemakkelijk geacyleerd worden tot N-
chlooracetyl aminoalkylfosfonaten. Dezelfde producten kunnen ook bekomen 
worden uitgaande van de iminen via acylering en fosfonylering van het 
intermediaire acylfosfonaat in één pot. Bij deze tweede methode kunnen echter 
verschillende zijreacties optreden. Wanneer de N-chlooracetyl aminoalkylfosfonaten 
behandeld worden met een sterke base, ontstaat een anion dat door de 
fosfonaatgroep gestabilseerd wordt en vervolgens verder reageert met de vorming 
van een 4-fosfono-β-lactam via intramoleculaire alkylatie. 
 
Ook wanneer N-chlooracetyl aminoalkenylfosfonaten gebruikt worden, die 
aanleiding geven tot een ambident allylanion, worden enkel de vierringen gevormd. 
Deze onverwachte regioselectiviteit werd in meer detail bestudeerd op experimentele 
en theoretische basis. De transitietoestand voor de meer stabiele zesring ligt 
25 kJ/mol hoger dan deze voor de vierring, omwille van een gehinderde rotatie rond 
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de N-C(P) σ–binding. Hierdoor is de N-alkyl keten dichtbij de P-alkenyl keten 
gepositioneerd. Deze bijzondere conformatie van N-chlooracetyl aminoalkyl-
fosfonaten kan ook uitgespeeld worden voor andere types ringsluitingen. 
 
Zo zijn de aminoalkylfosfonaten uit dit onderzoek uitermate geschikt voor een RCM 
reactie tussen een N-allyl en de P-alkenyl groep. Op deze manier worden 2-fosfono-
3-pyrrolines gevormd. Ook deze substraten met een basisch stikstofatoom worden 
gemakkelijk omgezet door de RCM katalysator. Basische 2-fosfono-3-pyrrolines 
kunnen geoxideerd worden tot de overeenkomstige 2-fosfonopyrrolen met 
tetrachloorquinon. Beide reacties, RCM en oxidatie, kunnen tegelijkertijd in 
hetzelfde medium uitgevoerd worden. Bovendien kan een synergie worden 
waargenomen tussen beide reacties wanneer secundaire amines als substraat 
worden gebruikt. 
 
Tenslotte zijn ook N-allyl furan-2-ylmethyl fosfonaten ideale substraten in IMDAF-
reacties omwille van hun bijzondere conformatie zoals die hierboven werd 
beschreven. Op deze manier kunnen tricyclische fosfonopyrrolidines bereid worden 
met een vaste stereochemie. De reactiesnelheid van de IMDAF-reactie wordt 
verhoogd door de aanwezigheid van de omvangrijke fosfonaatgroep. De 
stereochemie van de producten kan bestudeerd worden aan de hand van de NMR 
spectrale gegeven. 
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Appendix A:  
Phosphorus reagents and intermediates: properties 
 
 
 Abbreviation δ(31P) Solvent Properties 
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DEP 7.9 CDCl3 Colourless liquid; bp. 50°C/2 mmHg 
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OH
 
 5.5 D2O White, sticky solid 
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TMP 142.0 CDCl3 
Colourless liquid; bp. 111°C, very bad 
smell 
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OEt
OEt
OEt
 
TEP 139.6 CDCl3 
Colourless liquid; bp. 156°C, very bad 
smell 
P
OTMS
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DMPTMS 126.2 CDCl3 Colourless liquid; bp. 38°C/10 mmHg 
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OEt
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DEPTMS 128.0 CDCl3 Colourless liquid; bp. 66°C/15 mmHg 
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 113.2 CDCl3 
Colourless liquid; bp. 129-
130°C/25 mmHg 
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P
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OTMS
 
 -13.8 CDCl3 Colourless liquid; bp. 92-93°C/20 mmHg 
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Appendix C:  
Selected NMR data of α-amino phosphonates 22 
 
 
 
  CHP  
 
δ(31P) δ(1H) 2J (Hz) δ(13C) 1J (Hz) 
 
22.95 4.48 25.9 54.06 154.6 
P(OEt)2
HN
Ph
O
 
26.70 ~3.70 # 57.41 156.9 
P(OMe)2
HN
Bn
O  
24.42  3.67 19.3 57.72 154.6 
P(OEt)2
HN
Bn
O
 
26.79  ~3.69 # 57.30 155.8 
P(OMe)2
HN
PMB
O  
26.77 ~3.78 # 57.72 156.9 
P(OMe)2
HN
O  
26.90 3.71 19.5 57.45 156.9 
P(OMe)2
HN
O  
24.44 3.70 19.1 59.11 155.8 
P(OEt)2
HN
O
NH
 
27.04 3.82 20.0 56.26 156.9 
P(OMe)2
HN
O  
24.85 3.77 21.2 56.71 155.8 
P(OEt)2
HN
O  
27.02 3.90 24.2 53.89 158.1 
P(OMe)2
HN
O  
26.42 3.86 24.8 54.16 155.8 
P(OEt)2
HN
O  
26.98 3.70 21.5 62.97 153.5 
P(OMe)2
HN
O  
26.94 
27.64 
3.66 
4.25 
20.6 
22.6 
59.74 
54.78 
152.3 
156.9 P(OMe)2
NH
O
 
23.84 3.93 24.2 62.69 162.7 
P(OMe)2
HN
OCl  
26.87 3.80 22.6 60.82 156.9 
P(OMe)2
NH
O
 
27.40 4.29 26.4 54.52 160.4 
P(OMe)2
HN
O
 
27.40 3.41 21.7 58.90 154.6 
P(OMe)2
NH
O
 
27.56 3.50 21.5 60.17 154.6 
P(OMe)2
NH
O
Ph  
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  CHP  
 
δ(31P) δ(1H) 2J (Hz) δ(13C) 1J (Hz) 
 
18.28 3.95 # 54.09 154.6 
P(OMe)2
ClH2N
O
Bn
NO2  
25.70 4.12 18.1 56.50 155.8 
P(OMe)2
HN
O
NO2  
26.87 
26.60 
3.49 
3.46 
20.9 
21.2 
60.00 
59.56 
156.9 
156.9 
P(OMe)2
HN
Bn
O  
24.37 
24.57 
3.45 
3.43 
20.9 
21.2 
50.29 
59.90 
156.9 
156.9 
HN
P(OEt)2
Bn
O  
27.04 
26.76 
3.50 
3.54 
21.2 
20.9 
59.55 
59.96 
156.9 
156.9 
P(OMe)2
HN
O  
26.96 
26.82 
3.55 
3.58 
23.1 
23.1 
58.07 
58.39 
159.2 
156.9 
P(OMe)2
HN
O  
27.02 
26.49 
3.57 
3.47 
25.3 
24.7 
55.22 
55.68 
161.5 
161.5 
P(OMe)2
HN
O  
24.01 4.12 22.3 52.71 161.5 
P(OMe)2
HN
Bn
O
O
 
24.16 4.06 22.3 52.80 162.7 
P(OMe)2
HN
O
O
 21.82 ~3.98 # 53.29 161.5 
HN
P(OEt)2
O
O  
24.27 4.26 25.6 49.27 167.3 
P(OMe)2
HN
tBu
O
O
 26.44 4.05 20.1 59.29 154.6 
P(OMe)2
HN
Bn
O  
27.00 4.17 22.3 57.98 154.6 
P(OMe)2
HN
O
 
24.74 ~4.14 # 58.30 153.5 
P(OEt)2
HN
O
 
31.77 2.78 16.8 57.59 144.2 
P(OMe)2
HN
O  
31.75 2.78 14.5 59.25 142.0 
P(OMe)2
HN
Bn
O  
31.84 2.81 16.5 57.39 144.2 
P(OMe)2
HN
O  
     
 
# Coupling constant could not be measured due to overlapping signals. 
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Appendix D:  
Selected 31P and 13C NMR data‡ of 4-phosphono β-lactams  
 
 
 
 
N
O R1
R2
P(OR3)2
2
3 4
 
 
 
    31P 13C (2) 13C (3) 13C (4) 
Nr R1 R2 R3 δ (ppm) δ (ppm) 3J (Hz) δ (ppm) 2J (Hz) δ (ppm) 1J (Hz) 
23a Ph PhCH=CH Me 24.19 163.41 8.1 49.42 0 59.82 168.5 
23b Bn PhCH=CH Me 24.01 166.06 6.9 47.87 0 59.34 167.3 
23c Bn PhCH=CH Et 21.70 166.21 7.5 47.81 0 59.47 166.7 
273 Bn PhCH2CH2 Et 24.46 166.13 6.9 43.12 0 58.42 163.8 
23d PMB PhCH=CH Me 24.06 166.00 8.1 47.87 0 59.28 167.3 
23e Allyl PhCH=CH Me 24.23 165.97 7.5 47.85 0 58.88 167.3 
23f iPr PhCH=CH Me 24.75 165.39 8.1 47.13 0 58.06 167.9 
23g Ph Furyl Me 21.80 163.77 7.4 47.56 2.4 55.91 172.1 
23h Bn Furyl Me 21.36 166.21 8.6 46.07 0 54.75 173.4 
23i Allyl Furyl Me 22.06 166.03 8.1 46.14 2.3 54.64 174.2 
23j Bn Ph Me 23.84 167.19 7.3 48.52 0 61.28 163.5 
23l# 21.86 167.41 6.9 44.81 0 60.95 165.0 
23l¤ 
Bn 
 
Et 
22.00 Not observed 44.91 0 60.33 166.1 
 
‡ All data were collected at 22°C with deuterated chloroform as a solvent 
# Major isomer 
¤ Minor isomer 
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Appendix E:  
Selected 31P and 13C NMR data‡ of pyrrolines 31 and 
pyrroles 30, 312 
 
 
 
N
R1
P(OMe)2
R2
O
1
2
3
4
 
 
   31P 13C (1) 13C (2) 13C (3) 13C (4) 
Nr R1 R2 δ (ppm) δ (ppm) 1J (Hz) δ (ppm) 2J (Hz) δ (ppm) 3J (Hz) δ (ppm) 3J (Hz) 
31a Bn H 24.58 68.36 176.5 130.21 12.7 124.00 5.8 60.10 5.8 
31b Bn Me 24.69 70.84 174.2 133.43 4.6 124.78 12.7 59.87 8.1 
31c Bn Bn 24.69 69.04 173.1 137.67 4.6 125.76 11.5 59.93 6.9 
31d Bn isoamyl 24.91 69.87 174.2 138.24 4.6 123.28 11.5 60.02 8.2 
31e Bn Ph 24.64 68.67 173.1 137.52 3.5 126.98 11.5 60.60 4.5 
 
 
 
 
 
N
R
1
P(OMe)2
R
2
O
1
3
4
2
 
 
   31P 13C (1) 13C (2) 13C (3) 13C (4) 
Nr R1 R2 δ (ppm) δ (ppm) 1J (Hz) δ (ppm) 2J (Hz) δ (ppm) 3J (Hz) δ (ppm) 3J (Hz) 
312a H H 15.01 115.16 230.8 118.65 17.3 109.93 15.0 124.59 12.7 
312b H isoamyl 16.21 111.74 229.6 135.21 18.5 110.82 15.0 123.35 11.5 
30a Bn H 13.63 117.63 227.3 122.47 17.3 109.12 13.8 129.04 11.5 
30b Bn Me 14.82 113.49 226.1 133.47 18.5 111.25 15.0 128.54 12.7 
30c Bn Bn 14.39 113.47 226.0 137.15 18.5 110.89 16.2 128.73 11.5 
30d Bn isoamyl 14.87 112.92 226.1 139.38 19.6 109.86 15.0 128.71 12.7 
30e Bn Ph 13.77 113.79 226.1 137.46 18.5 110.98 13.9 128.66 12.7 
30f Bn Phenethyl 14.52 113.32 225.0 138.24 19.6 110.12 16.2 128.62 12.7 
 
‡ All data were collected at 22°C with deuterated chloroform as a solvent; the resolution of the 13C 
experiment used, was 1.2 Hz. 
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Appendix F:  
Selected NMR data‡ of 3-(acyl)-10-oxa-3-aza-
tricyclo[5.2.1.01,5]dec-8-en-2-yl phosphonates 35 
 
 
 
 
N
O
R
O
P(OMe)2
O
H
1
4
56
8 9
2
7
3
N
O
R
O
P(OMe)2
O
H
Hα
Hα
H
Hβ
Hβ
 
 
13C and 31P NMR data 
 
  35a 35b 35c 35d 35e 
 R : CH2Cl
 (CH2)3Cl
 CH(CH3)2 CHCl2
 CCl3 
  M m M m M m M m M m 
C1 δ 94.01 95.47 94.11 95.29 93.98 # 93.72 95.49 94.42 93.18 
C1 JCP 9.2 8.1 9.2 9.2 10.4 # 8.1 6.9 4.6 3.5 
C2 δ 54.91 56.40 54.13 56.61 54.03 # 55.61 56.46 56.03 57.94 
C2 JCP 159.2 162.7 159.2 162.7 159.2 # 158.1 161.5 160.4 158.1 
C4 δ 52.53 52.53 52.71 51.74 52.49 # 52.42 # 55.70 54.64 
C5 δ 41.87 36.51 41.79 39.71 41.87 # 42.14 39.32 44.77 42.96 
C5 JCP 0 0 0 0 0 # 0 0 2.3 0 
C6 δ 34.38 # 34.31 34.51 34.43 # 34.40 34.29 28.70 34.54 
C7 δ 79.22 79.31 79.13 79.04 79.10 # 79.20 79.38 81.36 79.10 
C8 δ 137.6 137.79 137.32 137.49 137.49 # 137.60 137.93 136.86 137.57 
C9 δ 133.06 132.75 133.31 132.97 133.52 # 132.91 132.48 134.39 132.83 
C=O δ 165.76 166.45 171.14 171.89 176.47 # 162.50 163.28 159.69 159.52 
31P δ 21.31 21.48 22.16 21.61 22.44 21.63 20.80 20.91 20.70 20.89 
 
 
1H NMR coupling constants: 
 
  35a 35b 35c 35d 35e 
 R : CH2Cl
 (CH2)3Cl
 CH(CH3)2 CHCl2
 CCl3 
  M m M m M m M m M m 
H6α-H5 7.7 # 7.7 # 7.7 # 7.7 # 7.4 7.7 
H5-H6β 2.8 # 2.8 # 3.0 # 2.9 # 3.6 3.3 
H6α-H6β 11.6 # 11.7 # 11.6 # 11.6 # 11.8 11.6 
H7-H6β 4.4 # 4.4 # 4.4 # 4.4 # 4.4 4.1 
 
‡ All data were collected at 22°C with deuterated chloroform as a solvent 
# Could not be measured adequately 
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